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1  SUMMARY 
Eukaryotic genomes are packed in chromatin that comprises an ever repeating succession of 
nucleosomes with DNA wrapped around octamers of histone proteins. Dynamic regulation of 
chromatin structure enables controllable access to the underlying DNA and hence is crucial to all 
nuclear processes, including DNA transcription, replication and repair. Many interconnected 
mechanisms are in place to regulate chromatin structure. These include chemical modifications of 
histone proteins, such as lysine acetylation and methylation, which directly alter the properties of 
nucleosomes  to  form  repressive  structures  or  install  signaling  marks  for  dedicated  effector 
proteins. 
The original research described in this cumulative thesis is contained in two published articles and one 
submitted manuscript centering on histone lysine acetylation in Drosophila melanogaster. In the first 
two articles, we characterise the functions of two multi-protein complexes containing the lysine 
acetyltransferase MOF (males absent on the first). If incorporated in the male-specific lethal dosage 
compensation complex (MSL-DCC) MOF acetylates lysine 16 on histone H4 (H4.K16ac) on gene 
bodies on the male X chromosome, which is critical for the two-fold transcriptional stimulation of its 
target genes. The underlying process, dosage compensation, serves to adjust gene expression levels 
between the single male and the two female X chromosomes. Combining genome-wide mapping and 
transcriptome studies with the analysis of defined reporter loci in transgenic flies and cell lines, we 
provided evidence that MOF-mediated H4.K16ac has an inherent strong transcriptional activation 
potential, which is, however, constrained to the physiological two-fold range in the context of fly 
dosage compensation. In contrast, MOF as a component of the non-specific lethal (NSL) complex 
binds promoters of active housekeeping genes located on all chromosomes in male and female flies. 
However, transcriptional activation through the NSL complex is found only at a subset of these 
binding sites. These NSL-regulated genes are enriched for a specific core promoter sequence and 
depleted for the insulator proteins CP190 and BEAF as well as the heterochromatin protein HP1c. In 
summary, these studies describe the context-specific localization and transcriptional activation modes 
of the acetyltransferase MOF through its incorporation into two distinct multi-protein complexes. 
Histones have acquired impressive patterns of acetylation sites, where the individual abundance and 
the context of co-occurrence with other marks potentially confers very different functions. However, 
the current methodologies are too limited to systematically evaluate changes in rare and combinatorial 
modification motifs. Moreover, how different enzymes contribute to complex motifs is only poorly 
understood. In the third study, we generated a catalogue of histone acetylation and methylation motifs 
that describe the changes in response to ablation of every known or suspected lysine acetyltransferase 
and deacetylase. To achieve this goal, we first optimised liquid chromatography mass spectrometry 
workflows that enabled highly accurate and precise quantification of combinatorial histone 
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modification motifs. The comprehensiveness of the dataset not only allowed us to recognise class-
specific properties to these enzyme families but also to describe the histone modification system as an 
interconnected, flexible network that compensates the loss of an individual component. We describe 
the specific responses of the histone acetylome upon ablation of each acetyltransferase. To our surprise 
we also observed that depletion of almost every acetyltransferase triggered a systemic response that 
effectively maintained global histone acetylation levels. Finally, we documented that dosage 
compensation is not restricted to the change of the single H4.K16ac mark, but accompanied by a 
specific re-distribution of acetylation and methylation motifs. In summary, this study provides further 
evidence that chromatin pathways are highly interconnected and highlights the necessity to study the 
function of each individual component in the context of the system.  
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ZUSAMMENFASSUNG 
Eukaryotische Genome sind in einer Chromatinstruktur eingebettet. Chromatin besteht in seiner 
einfachsten Organisationsform aus einer Aneinanderreihung von Nukleosomen, in denen DNA 
spulenförmig um Oktamere aus Histonproteinen gewunden ist. Die Chromatinstruktur wird sehr 
dynamisch reguliert. Dies ist wichtig für Prozesse wie die Transkription, Replikation und DNA 
Reparatur, bei denen Faktoren kontrollierten Zugriff zur DNA benötigen. Im Zellkern existieren viele 
ineinandergreifende Mechanismen, um die Chromatinstruktur für die jeweiligen Prozesse zu 
regulieren. Dazu gehören chemische Modifikationen an den Histonproteinen, wie zum Beispiel Lysin-
Acetylierung und Lysin-Methylierung. Diese Modifikationen haben einerseits das Potenzial, direkt das 
Gleichgewicht zwischen kompakten und zugänglichen Chromatinorganisationsformen zu beinflussen. 
Zum anderen wirken Histonmodifikationen als Signale für Effektorproteine, welche wiederum 
Änderungen in der Chromatinstruktur herbeiführen oder direkt biologische Prozesse wie die 
Transkription in Gang setzen können. 
Diese kumulative Dissertation enthält zwei publizierte und einen eingereichten Originalartikel, die 
sich mit dem Thema der Histon-Acetylierung in der Fruchtfliege Drosophila melanogaster 
auseinandersetzen. In den ersten beiden Artikeln charakterisieren und vergleichen wir die Funktionen 
von zwei Multiproteinkomplexen, welche die Acetyltransferase MOF beinhalten. MOF innerhalb des 
„Dosis-Kompensations-Komplexes“ acetyliert Lysin 16 auf Histone H4 (H4.K16ac) entlang der Gene 
auf dem männlichen X-Chromosom. Diese Acetylierung ist wichtig für den Prozess der 
Dosiskompensation, bei dem durch die zweifache Stimulation der Transkription von Genen auf dem 
einzelnen männlichen X-Chromosom die „Gen-Dosis“ gegenüber den Genen auf den zwei weiblichen 
X-Chromosomen angepasst wird. In unserer Studie haben wir genomweite Lokalisations- und 
Transkriptionskartierungsmethoden mit der Analyse von definierten Reportergenen in transgenen 
Fliegen und Zellsystemen verbunden. Dies erlaubte uns festzustellen, dass zwar die MOF-vermittelte 
H4.K16-Acetylierung ein starkes Potenzial hat, die Transkription zu stimulieren, dieses Potenzial 
jedoch im Kontext der Dosiskompensation auf  eine feinjustierte zweifache Erhöhung gedrosselt ist. 
Im Gegensatz dazu fungiert MOF innerhalb des NSL-Komplexes (non-specific lethal) als Promoter-
typischer Ko-Aktivator. Der NSL-Komplex bindet Promotoren von „Haushaltsgenen“ entlang aller 
Chromosomen in männlichen sowie in weiblichen Zellen. Unsere detaillierte genombiologische-
bioinformatische Analyse zeigte allerdings, dass nur ein Teil der gebundenen Gene auch vom NSL-
Komplex reguliert werden. Diese NSL-regulierten Gene enthalten eine spezifische Promotersequenz-
Signatur und werden im Gegensatz zu den anderen gebundenen aber nicht-regulierten Genen 
tendenziell nicht von den Insulatorproteinen CP190 und BEAF sowie vom Heterochromatinprotein 
HP1c gebunden. Zusammenfassend zeigen diese beiden Studien, dass die Lokalisationen und 
Funktionen von MOF stark von den assoziierten Multiproteinkomplexen geprägt werden.  
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Histone zeigen eine hohe und beeindruckende Anzahl von Modifikationsmustern. Die individuelle 
Häufigkeit sowie das gemeinsame Auftreten mit anderen Modifikationen vermitteln 
höchstwahrscheinlich sehr verschiedene biologische Funktionen. Die technischen Möglichkeiten, um 
niedrig-abundante sowie spezielle Kombinationen von Modifikationsmustern zu detektieren und deren 
Änderungen zu quantifizieren, sind zurzeit noch sehr begrenzt. Des Weiteren ist es noch unzureichend 
verstanden, wie verschiedene Enzyme zu komplexen Modifikationsmotiven beitragen. In der dritten 
Studie haben wir umfassend katalogisiert, wie sich einfache und komplexe Acetylierungs- und 
Methylierungsmotive auf Histon-Proteinen ändern, nachdem wir systematisch jede bekannte oder 
vermutete Acetyltransferase und Deacetylase aus Drosophila-Zellen entfernt haben. Um dies zu 
erreichen, war es zuerst nötig, spezielle Protokolle der Flüssigchromatographie-Massenspektrometrie 
(LC-MS) zu optimieren, welche uns erlaubten, Änderungen in kombinatorischen Modifikations-
mustern akkurat und präzise zu quantifizieren. Der große Umfang dieses Kataloges in zwei 
Dimensionen – alle bekannten und vermuteten Enzyme gegenüber vielen Modifikationsmustern – 
erlaubte uns nicht nur, enzymklassenspezifische Eigenschaften zu erkennen und zu beschreiben, 
sondern auch das Histon-Modifikations-System als ein höchstverwobenes und flexibles Netzwerk zu 
dokumentieren, in dem der Verlust von einzelnen Komponenten systemisch kompensiert wird. Der 
überraschendste Befund war die Feststellung, dass nach dem einzelnen Entfernen fast jeder 
Acetyltransferase die Gesamtbilanz aus acetylierten und nicht-acetylierten Histonen konstant war. 
Schließlich untersuchten wir genauer, welche systemischen Auswirkungen der Prozess der 
Dosiskompensation auf die Histonmodifikationslandschaft mit sich bringt. Hier stellten wir fest, dass 
Dosiskompensation nicht nur auf dem bekannten Acetylierungssignal H4.K16ac beruht, sondern dass 
sich systemweit auch andere Acetylierungs- und Methylierungsmotive umverteilten. Die Ergebnisse 
dieser Studie erbringen weitere Hinweise, dass Chromatinregulationsmechanismen komplexe, 
miteinander verbundene Signalwege darstellen, bei denen die Funktion einzelner Komponenten im 
Kontext des Systems studiert werden sollte. 
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2 INTRODUCTION 
The evolution of the eukaryotic cell is accompanied by impressive innovations that enable the 
development of highly complex multi-cellular organisms and ensure adequate responses to internal 
and external stimuli. One fascinating invention was the organisation of eukaryotic genomes into 
chromatin. Chromatin is a dynamic structure that consists of an ever repeating succession of a single 
fundamental ‘building block’, the nucleosome. In the nucleosome, DNA is wrapped around an 
octamer of four histone proteins, namely H2A, H2B, H3 and H4. Chromatin exists in a continuum of 
states that allow (euchromatin) or permit (heterochromatin) access to the underlying DNA. Many 
interconnected mechanisms determine the structure and function of chromatin and thereby regulate 
most biological processes that utilise DNA. These mechanisms include i) post-translational, chemical 
modifications at histones, ii) ATP-dependent chromatin remodelling, iii) the replacement of canonical 
histones by histone variants, iv) association of linker histones and constitutive non-histone proteins, v) 
DNA methylation, vi) non-coding RNAs and vii) the organisation of chromatin fibres within the three-
dimensional nuclear architecture. The concerted action of these mechanisms allows the 
implementation of specific genetic programs. 
In this introduction, I will primarily focus on describing post-translational histone modifications 
(PTMs) and their significance in regulating chromatin structure and transcription. After introducing 
the nucleosome and higher-order chromatin structure, I will describe post-translational modifications 
through lysine acetylation on histones, which is the main topic of my PhD studies. In addition, I will 
briefly discuss lysine methylation at histones because there is well-documented cross-talk between the 
two types of modifications. Finally, I will introduce the phenomenon of Drosophila dosage 
compensation that provides an illustrative example of how a single histone acetylation site contributes 
to the transcriptional upregulation of an entire chromosome.  
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2.1 The nucleosome is the basic repeat unit of chromatin 
The term chromatin was coined by Walther Flemming in the 1890s describing nuclear structures that 
stain strongly with basophilic dyes (Flemming 1882). Around the same time, analysing the chemical 
composition of the cell nucleus, Friedrich Miescher identified nucleic acid and Albrecht Kossel 
characterised a protein component that he termed Histon (Miescher 1871, Kossel 1884). However, it 
was not before the 1970s when experiments on  endonuclease-mediated chromatin digestion, histone 
cross-linking and electron microscopy of chromatin particles revealed the nucleosome as the 
fundamental repeat unit of chromatin (Hewish and Burgoyne, 1973; Kornberg, 1974; Kornberg and 
Thomas, 1974; Olins and Olins, 1974; Oudet et al., 1975).  
Another 20 years later, Richmond and colleagues solved the crystal structure of a nucleosome at 2.8 Å 
resolution (Figure 1, (Luger et al., 1997)). It reveals that 147 base pairs (bp) of DNA are wrapped in 
1.65 left-handed (negative) superhelical turns around an octamer of the canonical histones H2A, H2B, 
H3 and H4. Positive charges of the histone proteins contact the negatively charged phosphate 
backbone of DNA every ~10.4 bp, establishing 14 relatively weak histone-DNA contacts. The histone 
octamer is a modular assembly formed by association of two H3-H4 dimers to form an (H3-H4)2 
tetramer followed by binding of two H2A-H2B dimers on either side of the tetramer. Each histone 
consists of a globular core domain and N- and C-terminal domains (‘tails’) that protrude from the core 
particle. The globular core constitutes the characteristic histone fold domain, which is comprised of 
three α-helices separated by two loops. Interactions between the histone folds of H3 stabilise the H3-
H4 pairs whereas the H2A-H2B pairs interact with the tetramer through a homologous 4-helix bundle 
between the H2B and H4 folds. Further contacts between the H2A docking domain towards H3-H4 
and among the H2A loop 1 regions of the H2A-H2B dimers stabilise the nucleosome. Of particular 
importance is the interaction between an acidic patch at the H2A-H2B dimer with the basic patch at 
the H4 tail because it is a critical target for the regulation of nucleosome stability and chromatin 
structure through the action of chromatin remodelling enzymes and histone acetylation (discussed in 
detail in 2.3.1). 
The nucleosome is not a static particle but rather shows transient DNA breathing and ‘open 
nucleosome states’. Recent studies applying fluorescence resonance energy transfer (FRET), high-
speed atomic force microscopy (HS-AFM) and small-angle X-ray scattering (SAXS) provided 
evidence for a dynamic nucleosome where DNA reversibly dissociates, H2A-H2B dimers partially 
disrupt from the (H3-H4)2 tetramer while still associated to DNA and nucleosomes undergo 
spontaneous sliding and even complete dissociation in the absence of ATP-dependent remodelling 
(Mangenot et al., 2002; Li et al., 2005; Zlatanova et al., 2009; Andrews and Luger, 2011; Bohm et al., 
2011; Miyagi et al., 2011; Luger et al., 2012). These findings have strong implications for concepts 
how transcription factors access DNA within the context of chromatin.  
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2.2 Higher-order chromatin structures 
Nucleosomes are arranged on DNA like ‘beads on a string’ forming the primary structure of 
chromatin, called the ’10 nm fibre’. The nucleosomes are separated by linker DNA, which show 
variable length distributions typically between 10 bp and 50 bp in a context- and species-specific 
manner (Clapier and Cairns, 2009). Linker histones such as H1 and H5 bind to DNA at the entry and 
exit sites of nucleosomes and protect 20 bp of linker DNA against micrococcal nuclease. Although 
linker histones are not part of the nucleosome core particle they contribute to the secondary structure 
of chromatin, such as the 30 nm fibre described in vitro.   
Linear arrays of nucleosomes (primary structure) are proposed to fold into three-dimensional 
assemblies of higher-order structures (e.g. 30 nm fibre). Two competing models of the 30 nm fibre 
have been put forward based on in vitro experiments on reconstituted chromatin fibres and the crystal 
structure of a tetranucleosome particle (Figure 2). In the ‘one-start’ solenoid model, neighbouring 
nucleosomes interact with each other and follow a helical trajectory with six to eight nucleosomes per 
turn (Finch and Klug, 1976; Widom and Klug, 1985; Robinson et al., 2006; Routh et al., 2008; 
Kruithof et al., 2009). The two-start zigzag model proposes that two rows of nucleosomes form a two-
start helix with interactions between alternating nucleosomes (Dorigo et al., 2004; Schalch et al., 2005; 
Song et al., 2014). It should be stressed that parameters such as linker length, the size of the 
nucleosomal array and whether H1, H5 or no linker histone was used strongly favour the one or the 
other model (Routh et al., 2008; Grigoryev et al., 2009).  
In contrast to the above mentioned in vitro studies, whether higher order chromatin structures exist in 
vivo is controversially discussed (Horowitz et al., 1990; Tremethick, 2007; Maeshima et al., 2010; 
Nishino et al., 2012). Evidence supporting the existence of 30 nm fibres are currently limited to highly 
specialised cell types, including transcriptionally silent chicken erythrocytes and starfish 
spermatozides (Woodcock, 1994; Horowitz et al., 1997). In contrast, there is yet no evidence for 
higher order chromatin structures in interphase and metaphase chromosomes examining different 
species and cell types, including mitotic HeLa cells (Tremethick, 2007; Maeshima et al., 2010; 
Nishino et al., 2012). According to the recently proposed ‘polymer melt’ model, the high 
concentration of nucleosomes in the nucleus preferentially drives inter-fibre interactions so that 
individual fibres strongly interdigitate. However, the polymer melt model also predicts that 30 nm 
fibres form transiently during transitions between different chromatin condensation states such as the 
ones that may occur upon transcriptional activation (Maeshima et al., 2010). Together, these studies 
suggest that there is no uniform secondary structure of chromatin in the cell. Instead, highly dynamic 
global and local transitions in chromatin structure provide an excellent window of opportunity for 
regulatory mechanisms (Tremethick, 2007; Maeshima et al., 2010; Fussner et al., 2011) 
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Depending on the precise modification and residue, three principal modes of action are discussed. 
First, a modification may have a direct structural impact by modulating DNA-histone or nucleosome-
nucleosome interactions. Second, specific modifications or combinations thereof may constitute marks 
that are bound by proteins with structural or enzymatic activities. Third, a modification may prevent or 
promote the placement of another mark.  
2.3.1 Lysine acetylation 
Early studies linking histone acetylation to gene activity 
In the early 1960s, seminal work by Vincent Allfrey and others demonstrated that the basic, arginine-
rich histone proteins inhibit the transcription of DNA (Allfrey and Mirsky, 1962; Huang and Bonner, 
1962; Allfrey et al., 1963). In 1963, lysine acetylation was the first chemical modification described 
on histones (Phillips, 1963). One year later, after presenting evidence that lysine acetylation and 
methylation occurs after translation, Allfrey surmised: ‘Such modifications of histone structure, 
acetylation in particular, may affect the capacity of the histones to inhibit ribonucleic acid synthesis in 
vivo’ (Allfrey et al., 1964). In the 1970s, acetylated histones were found at actively transcribed 
chromatin (Sealy and Chalkley, 1978; Vidali et al., 1978). In the late 1980s, two landmark studies 
contributed by the labs of Roger Kornberg and Michael Grunstein demonstrated that nucleosomes 
repress transcription in vitro but can relieve repression when ablated in vivo (Lorch et al., 1987; Han 
and Grunstein, 1988). Acetylation was mapped to lysines on the histone termini, thereby providing the 
rationale that charge neutralization of histones decreases its affinity towards DNA and destabilises 
nucleosome-nucleosome interactions (Nelson, 1982; Hong et al., 1993). Abrogating acetylation by 
mutating individual lysine residues on H4 in yeast cells diminished the capacity to induce transcription 
(Durrin et al., 1991) while the presence of acetylation promoted the binding of transcription activators 
(Lee et al., 1993; Vettese-Dadey et al., 1996) .  
Comparing individual and combined lysine site mutations, Grunstein and co-workers derived two 
conclusions that were strongly influential to the field of chromatin biology and still dominates today’s 
reasoning of how histone acetylation regulates transcription. In these experiments performed in S. 
cerevisiae, they substituted lysine (K) residues to arginines (R), which mimics the positive charges but 
cannot be acetylated (Durrin et al., 1991). First, they discovered that the yeast GAL1 promoter is not 
sufficiently induced in mutants harbouring triple-R or tetra-R mutations whereas single KR 
substitutions of the four N-terminal lysine residues (K5, K8, K12, K16) do not diminish GAL1 
induction. Based on these observations, they concluded that individual lysine acetylation sites function 
redundantly by neutralizing the charge state on the histone H4 tail. Following this reasoning, one 
would predict that mutating all four lysines to glutamines (Q), which resembles lysine structurally and 
mimics the charge neutralization conferred by acetylation, results in increased promoter activation. 
However, Grunstein and co-workers observed a tenfold reduction in the GAL1 activity for tetra-Q 
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mutants, similar to the effects observed in triple-R mutants, suggesting that permanent charge 
neutralization alone cannot sufficiently explain the observed effects of histone acetylation in 
transcriptional activation. Second, when they compared how the mutants affect different promoters, 
they observed that the histone H4 tail is required to activate inducible gene promoters (GAL1, PHO5), 
but is less critical for rapid response genes (CUP1) and shows no effect on the expression of 
housekeeping genes (GAL4, PRC1). They concluded that the function of histone acetylation is to 
induce but not maintain transcription. Further, they speculated that specific gene promoters, such as 
CUP1, may be depleted of nucleosomes and hence require chromatin-independent induction systems 
(Durrin et al., 1991).   
Regulating transcription by histone acetylation  
Different mechanisms are discussed how histone acetylation regulates transcription. As described in 
the next section, lysine acetylation can directly influence the folding of chromatin at different levels. 
This includes compromising the stability of individual nucleosomes or interfering with the formation 
of nucleosomal fibres. Ultimately, the resulting chromatin structure is more permissive, which allows 
access of transcription factors to the underlying DNA.  
In addition to dampening the repressive effect of chromatin directly, histone acetylation can promote 
transcription by recruiting effector proteins that recognise acetylated lysines via bromodomains 
(Dhalluin et al., 1999; Filippakopoulos and Knapp, 2012; Sanchez et al., 2014). These domains are 
frequently found in many co-activators, chromatin remodelers and acetyltransferases and their 
integrity correlates with the ability to stimulate transcription. In contrast to other histone PTM binding 
motifs, such as the ones that recognise methylated lysines (chromodomain, PHD finger, tandem tudor 
domain), bromodomains often display only low affinity towards individually acetylated lysines 
(Ruthenburg et al., 2007). However, there is emerging evidence that the affinity and specificity of 
bromodomains is modulated by adjacent modifications (Filippakopoulos et al., 2012). Moreover, 
multiple acetylation sites may increase the affinity. In a thought-provoking study it was reported that 
the bromodomain 1 (BD1) of Brdt shows a high affinity towards the di-acetylated mark H4.K5acK8ac 
(KD of 22 µM), while it displayed 10 times lower affinities towards other di-acetyl combinations on 
the same H4 peptide (Moriniere et al., 2009). This tantalizing result may suggest that certain 
bromodomains read combinatorial patterns of acetylation motifs rather than individual acetylation 
marks. This reminds on a structural study that proposes a ‘helical wheel’ organization of the H4 tail 
(Baneres et al., 1994). According to this model, 100° phasing between individual amino acids of the 
H4 tail results in a positioning of the four lysines K5, K8, K12 and K16 directly next to each other. 
Such configuration may provide an excellent configuration to present modifications for combinatorial 
read-out by bromodomains. 
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Many examples are documented where histone acetylation synergistically functions with other 
chromatin modifying principles. For example, while histone acetylation recruits chromatin remodelers 
that in turn create permissive chromatin structures, additional co-activators bind to newly accessible 
acetylated lysines and further promote and maintain active transcription (Gregory et al., 1998; Reinke 
et al., 2001; Kasten et al., 2004; Devaiah and Singer, 2013). Moreover, some individual genes may 
require a rapid turnover of acetylation instead of a permanently fixed acetylation state for their 
activation (Hazzalin and Mahadevan, 2005). Lastly, histone acetylation has been shown to mark 
individual genes for rapid re-activation after mitosis (‘gene bookmarking’, (Zhao et al., 2011)).  
Regulating higher order chromatin structure by histone acetylation 
Acetylation of histone H4 provides the best-understood case for how post-translational histone 
modifications directly regulate higher-order chromatin structure. Central to this function is the 
interaction between an acidic patch at the H2A-H2B dimer with the basic patch at the H4 tail (amino 
acids 16-20) (Luger et al., 1997; Zhou et al., 2007). A special role for the H4 tail compared to the 
other histone tails was already observed early on and was contributed to bridging of adjacent 
nucleosomes, binding of linker DNA and association with H2B within the same nucleosome (Fletcher 
and Hansen, 1995; Tse and Hansen, 1997; Hansen et al., 1998; Chodaparambil et al., 2007; Kan et al., 
2009; Allahverdi et al., 2011). In a landmark study, Peterson and colleagues used a native chemical 
ligation strategy to generate nucleosomal arrays with homogenously labelled acetylated lysine 16 on 
histone H4 (H4.K16ac). These arrays inhibited the formation of inter-fibre contacts (the proposed 30 
nm fibre) and reduced nucleosome oligomerization through cross-fibre interactions (Shogren-Knaak et 
al., 2006). The concept that acetylation of H4.K16 reduces the propensity to form higher-order 
chromatin structures was reinforced by studies from the Rhodes and Nordenskiöld labs. Using very 
long nucleosomal arrays (containing 61 copies of the ‘601’ nucleosome positioning sequence instead 
of 12 copies used by Peterson and colleagues), stoichiometric concentrations of linker histone H5 and 
only 30% of acetylated H4.K16, the study by Rhodes and co-workers emphasised the dominant role of 
H4.K16ac over individual or combined H3 and H4 tail deletions (Robinson et al., 2008). Nordenskiöld 
and colleagues extended these observations by documenting that shorter nucleosomal arrays (12 
copies of 601 sequence) with mono-acetylated H4.K16ac have a stronger unfolding effect than either 
mutating or acetylating the adjacent lysines on H4 (K5, K8, K12) (Allahverdi et al., 2011).  
In comparison to acetylation on the H4 tail, our knowledge of how other histone PTMs affect higher-
order chromatin structures is rudimentary. Muir and colleagues reported that nucleosomal arrays 
modified with ubiquitylated lysine 120 on H2B also decrease chromatin compaction in a distinct but 
synergistic manner to H4.K16ac (Fierz et al., 2011). An inverse effect was reported for nucleosomal 
arrays decorated with tri-methylated H4.K20, which increased folding and required less divalent 
magnesium ions to form condensed chromatin (Lu et al., 2008). More subtle effects were observed for 
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nucleosomes with di-methylated H3.K79, which displayed altered nucleosomal surfaces and 
consequently may affect binding of effector proteins (Lu et al., 2008). Despite the importance of 
comparing the effect of different histone PTMs on chromatin folding, it should be stressed that 
additional parameters including the type and concentrations of salts and highly charged molecules 
such as polyamines greatly influence the extent of the observed effects and the susceptibility towards 
individual chemical modifications (Lu et al., 2008; Allahverdi et al., 2011; Liu et al., 2011; Korolev et 
al., 2012).   
In addition to directly affecting the folding of chromatin fibres, histone acetylation modulates the 
targeting and enzymatic activity of chromatin remodelling complexes. For example, it was proposed 
that binding of the remodeler subunit BPTF to H4.K16ac and H3.K4me3 through its bromodomain 
and PHD finger contributes to its localization at specific chromatin regions (Ruthenburg et al., 2011). 
Acetylation of H3.K56 promotes a switch in the enzymatic activity of the remodeler complex SWR-C 
to not only incorporate but also remove the histone variant H2A.Z (Watanabe et al., 2013).  
An illustrative and complicated case is the relationship between ISWI-containing complexes and 
acetylation at H4.K16. This histone mark is necessary and sufficient for the strong decondensation 
phenotype of the male X chromosome in Drosophila mutants devoid of ISWI ((Deuring et al., 2000; 
Corona et al., 2002), see also 2.4 for a detailed discussion on dosage compensation, the underlying 
process that regulates this male X-chromosome specific phenomenon). However, a series of studies 
aiming to address the underlying mechanism of this clear phenotypic observation show partly 
controversial results. While early studies demonstrated that H4.K16ac-containing peptides and mono-
nucleosomes moderately inhibited the enzymatic activity of ISWI and the ISWI-containing ACF 
complex (Clapier et al., 2001; Corona et al., 2002; Shogren-Knaak et al., 2006), this effect was not 
observed in a recent study using more physiological nucleosomal arrays containing H4.K16ac 
((Klinker et al., 2014), and see also (Nightingale et al., 2007)). The situation might be even more 
complex because ISWI is also required for the incorporation of the linker histone H1 (Lusser et al., 
2005; Maier et al., 2008), which in turn counteracts H4.K16ac mediated decondensation (Corona et 
al., 2007). Moreover, the N-terminus of ISWI resembles the basic patch of H4 and confers 
autoinhibitory functions, which is relieved by binding to the unmodified H4 tail (Clapier and Cairns, 
2012). In summary, these studies illustrate the complications of the in vitro approach in dissecting how 
individual histone modifications influence enzymatic activities on chromatin. In vivo, these 
modifications do not occur in isolation but rather co-occur with other marks along the same histone 
molecule.  
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Lysine acetyltransferases  
Lysine acetyltransferases transfer an acetyl moiety from acetyl-CoA to the ε-amino group of a target 
lysine. Since their first isolation in the mid 1990s (Kleff et al., 1995; Brownell et al., 1996), dozens of 
lysine acetyltransferases have been identified and many characterised (Sterner and Berger, 2000; Yang 
and Seto, 2007; Aka et al., 2011). Because their activities had initially been attributed to histones only, 
they had been named histone acetyltransferases (HATs). However, with the identification of an 
increasing number of non-histone substrates, their nomenclature has been updated to lysine 
acetyltransferases (KATs) (Allis et al., 2007). It is a general notion that KATs are rather promiscuous 
enzymes that target multiple lysines on histone and non-histone substrates. Many KATs function 
within the context of multi-subunit protein complexes where accessory subunits confer genomic 
targeting and influence the substrate specificity (Lee and Workman, 2007). 
Based on their sequence homology, KATs are grouped into two main families (GNAT and MYST). In 
addition, a third class contains proteins with acetyltransferase activity that do not share sequence 
similarities with the two main families. Prominent members of this third class are the closely related 
and metazoan-specific co-activators CBP and p300 and the fungal-specific Rtt109.  
Despite their sequence divergence, all KATs contain a structurally conserved core region of a three-
stranded β-sheet and a long parallel α-helix (Yuan and Marmorstein, 2013). Latter contains four 
conserved motifs (A-D) that are important for acetyl-CoA binding. The conserved core region is 
flanked by family-specific arrangement of α-helices and β-sheets. Interestingly, although CPB/p300 
and Rtt109 do not show conservation at the sequence level, their structures show a high overall 
similarity (Wang et al., 2008a). Together, the conserved core region and the flanking segments form a 
cleft to accommodate the histone target. Both GNAT- and MYST-type KATs contain a conserved 
glutamate deep within the active centre that acts as a general base for catalysing the nucleophilic 
attack of the primary target lysine on the thioester bond of acetyl-CoA. In GNAT-type KATs, acetyl-
CoA and the histone target first form a ternary complex with the enzyme before catalysis can occur 
(bi-bi mechanism). MYST-type KATs form first an acetylated intermediate on a conserved cysteine 
before a glutamate residue facilitates the transfer of the acetyl group from the cysteine to the histone 
lysine target (ping-pong catalytic mechanism) (Yuan and Marmorstein, 2013). In contrast, p300 does 
not employ a general base but rather uses a conserved tyrosine as a general acid for catalysis. 
According to the proposed hit-and-run mechanism, the histone peptide interacts only weakly with the 
surface of p300, allowing the target lysine to enter into the pocket of the active centre. Together with 
its less apolar catalytic groove, this may explain the low degree of substrate selectivity for CBP/p300 
(Liu et al., 2008).   
The Gcn5-related N-acetyltransferase (GNAT) family is the largest group of KATs and includes the 
well-characterised enzymes HAT1 (KAT1), GCN5 (KAT2A), PCAF (KAT2B) as well as ELP3, 
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ATAC2, CDY, ECO1 (ESCO1/2) and MEC17. HAT1 acetylates lysines 5 and 12 on histone H4, 
which is considered to promote the incorporation of the histone (H3-H4)2 dimer into chaperone 
complexes and their subsequent nuclear import. For a detailed discussion on HAT1 functions and 
substrate specificity, please see 3.4.4. Yeast GCN5 has long been known as a potent transcriptional 
co-activator. GCN5 is the catalytic subunit of at least four yeast complexes (SAGA, SLIK, ADA and 
HAT-A2), two Drosophila complexes (SAGA and ATAC) and its two human paralogues GCN5L and 
PCAF incorporate into at least four mutually exclusive complexes (PCAF, STAGA, TFTC and 
ATAC) (Nagy and Tora, 2007; Spedale et al., 2012). While recombinant yGCN5 acetylates lysines 8 
and 16 on H4 and lysine 14 on H3, incorporation into multi-subunit complexes changes its substrate 
specificities (ADA: H3 lysines K18 and K23; SAGA: H3 lysines 9, 14 and 18) (Grant et al., 1999). 
The analysis of yeast gcn5 mutants confirmed the H3 target sites, albeit the reductions varied strongly 
among the individual sites and showed also decreased H3.K27ac levels (Durant and Pugh, 2006). In 
contrast, Drosophila mutants lacking GCN5 display reduced acetylation levels on lysines 9 and 14 on 
H3 and 5 and 12 on H4. However, a recent study reported that disruption of the Drosophila SAGA 
complex only reduced H3.K9ac while leaving the other acetylation sites unchanged (Mohan et al., 
2014). Interestingly, deleting murine PCAF and GCN5L causes only reduced H3.K9ac levels (Jin et 
al., 2011), which is in contrast to other studies that reported a number of other putative substrate sites 
in mammalian cells including H3.K14ac, H3.K18ac and H4 sites (Yang et al., 1996; Herrera et al., 
1997; Ogryzko et al., 1998; Zheng et al., 2013b). 
The MYST group comprises its founding members human MORF, yeast YBF2 (SAS3), yeast SAS2 
and mammalian TIP60 (Esa1 in yeast) as well as MOF, HBO1 and MOZ. MOF (males-absent on the 
first) is an exceptionally specific KAT that presumably targets only a single lysine residue, H4.K16. 
MOF’s role in transcriptional regulation is best understood in Drosophila where it is a key subunit of 
the MSL-DCC complex and essential for X chromosome dosage compensation in male flies. 
Drosophila dosage compensation provides a paradigm for transcriptional regulation by a specific 
histone acetylation site and will be discussed in detail in section 2.4. During my PhD studies, I 
contributed to the understanding of MOF’s function in a second multi-protein complex, the non-
specific lethal (NSL) complex (discussed in sections 3.1-3.4). In addition to regulating transcription, 
studies conducted in mammals pointed to MOF’s role in DNA damage repair, maintenance of 
pluripotency, autophagy, and apoptosis (Li et al., 2012; Fullgrabe et al., 2013; Yang et al., 2014). 
Whether these additional functions are exerted in the context of the human MSL, NSL or novel 
complexes and whether they require the enzymatic activity of MOF is not well understood.  
TIP60 and its yeast homolog Esa1 are the catalytic subunit of the NuA4 complex and have been 
shown to acetylate histone H4 (K5, K8, K12 and K16), H3 (K14) and H2A (K5) as well as numerous 
non-histone proteins including p53, c-myc, ATM and AR (Sterner and Berger, 2000; Sapountzi and 
Cote, 2011). TIP60 functions as a co-activator for a wide range of transcription factors, including 
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NFkB, p53 and nuclear receptors. In addition to regulating transcription, TIP60 has a central role 
during DNA damage repair. First, acetylation of the DNA damage response protein ATM stimulates 
the autophosphorylation and activation of this central kinase, leading to phosphorylation of H2A.X, 
which is a prominent DNA damage signal (Sun et al., 2005). Second, acetylation of H4 renders 
chromatin accessible and thereby promotes the association of the DNA repair machinery (Tamburini 
and Tyler, 2005; Murr et al., 2006). Third, during the late steps of repair, TIP60 acetylates 
phosphorylated H2A.X, which promotes its exchange with the non-phosphorylated H2A.X (Kusch et 
al., 2004).  
The closely related acetyltransferases MOZ and MORF have central roles during normal 
development and fusion proteins with CBP are frequently found in human leukemias. In the mouse, 
MOZ has been shown to acetylate H3.K9ac and is required for the self-renewal capacity of 
hematopoietic stem cells and the proper development of the thymus and the cardiovascular system 
(Voss et al., 2012). MORF is required for the self-renewal capacity of adult neural stem cells in the 
mouse (Merson et al., 2006; Sheikh et al., 2012) and was shown to acetylate H4 at lysines 5, 8, 12 and 
16 (Champagne et al., 1999).  
Studies on the acetyltransferase HBO1 in different experimental setups such as human cell lines and 
hbo1 null mouse mutants reported conflicting results with regard to its role during DNA replication, 
cell cycle regulation and histone substrate selection (see discussion in 3.4.4). In summary, the MYST 
family is a functionally diverse class of acetyltransferases that are implicated in the regulation of 
transcription and DNA damage repair and required for proper development.  
The two closely related acetyltransferases CBP and p300 (one member in Drosophila: dCBP/nejire) 
are ubiquitously expressed potent transcriptional co-activators that have been shown to acetylate a 
wide range of histone sites (H2A: K5; H2B: K12, K15; H3: K14, K18, K23, K27, K56; H4: K5, K8, 
K12, K16) (Bannister and Kouzarides, 1996; Ogiwara et al., 2011; Wang et al., 2013b). In addition, 
they form a platform to recruit other factors involved in transcriptional regulation, including other 
acetyltransferases (GCN5, PCAF), sequence-specific DNA-binding transcription factors (among them 
p53, c-myb, FOXO3a), general transcription factors (TFIIB) and nuclear hormone receptors (ER, AR) 
– many of these proteins are also potent acetylation substrates for CBP/p300 (Wang et al., 2013b). The 
potential of CBP/p300 to stimulate transcription seems to be context-dependent. For example, while 
genes regulated by the nuclear hormone receptor PPAR strictly depend on the HAT activity of 
CBP/p300, other CBP/p300 bound genes rely on the ‘platform’ function to recruit other activators but 
do not require the enzymatic activity of these KATs (Jin et al., 2011; Bedford and Brindle, 2012). Not 
surprisingly, cbp or p300 null mice show early embryonic lethality and their deficiencies or 
deregulation in humans contributes to cancer, neurodegenerative disorders and heart disease (Bedford 
and Brindle, 2012; Valor et al., 2013).  
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Lysine deacetylases 
Lysine acetylation is reversed by lysine deacetylases (KDACs). These enzymes are grouped based on 
sequence homology, phylogenetic analysis and co-factor dependency in four classes. The zinc-
dependent ‘classical’ deacetylases, biochemically isolated first in 1996 (Taunton et al., 1996) and 
named according their initially described substrates as histone deacetylases (HDACs) are sorted in 
class I (HDACs 1-3 and 8), class II (HDACs 4-7, 9 and 10) and class IV (HDAC 11). The NAD+-
dependent deacetylases of class II are named according their founding member silent-information 
regulator-2 (Sir2, (Imai et al., 2000; Landry et al., 2000; Smith et al., 2000)) as Sirtuins and contain 
seven members in humans (SIRT1-7). In comparison to lysine acetyltransferases, deacetylases display 
an even more relaxed substrate specificity directed against many acetyl-lysines in histones and non-
histone proteins (Feldman et al., 2012; Rauh et al., 2013). 
The class I HDACs function as classical transcription repressors that promote repressive chromatin 
structures by deacetylating all four core histones (Yang and Seto, 2008). The four mammalian class I 
HDACs (two in Drosophila: HDAC1 and 3) are homologs of the yeast transcription repressor RPD3. 
HDAC1 and HDAC2 are highly similar proteins, interact with each other and form the catalytic core 
of three well-defined multi-protein complexes (SIN3, NURD and CoREST). NURD and CoREST 
contain SANT-domain containing proteins, which bind histones and stimulate the histone deacetylase 
activity (Cunliffe, 2008). In addition, other chromatin-modifying activities and histone PTM-
recognizing proteins are integral components in these deacetylase complexes, providing the basis for 
coupling histone deacetylation with histone lysine demethylation (LSD1 within CoREST), 
nucleosome remodelling (Mi-2 within NURD) and recognition of methylated DNA (MBD2 within 
NURD) and histones (mammalian ING2 and yeast EAF3 within SIN3). HDAC3 also shows high 
sequence similarity to HDAC1/2 but contains only a single instead of two 14-3-3 phosphorylation site 
binding motifs. HDAC3 is the catalytic subunit of the N-CoR/SMRT co-repressor complexes that in 
addition also contain the lysine demethylase JMJD2A/KDM4A. In contrast to the other class I HDAC 
members, HDAC8 has not yet been found in a stable protein complex and it functions are less well 
characterised. Recent studies indicated that HDAC8 interacts with multiple components of the 
cohesion complex (Joshi et al., 2013) and it shows deacetylase activity against one cohesion subunit 
(SMC3, (Deardorff et al., 2012)).  
Mammalian class II HDACs are related to yeast Hda1 and are grouped into class IIa (HDACs 4, 5, 7 
and 9) and class IIb (HDACs 6 and 10). Class IIa HDACs contain multiple conserved phosphorylation 
motifs at their N-termini and a central deacetylase domain. These phosphorylation motifs are critical 
for the nucleocytoplasmic shuttling of these enzymes and their function as essential signal transducers 
downstream of many cytosolic signalling cascades. Vertebrate class IIa HDACs show a very low 
intrinsic deacetylase activity that is caused by a substitution of tyrosine to histidine within the catalytic 
domain (Lahm et al., 2007). In line, the catalytic activity purified from cellular HDAC4 and HDAC7 
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likely results from its association with HDAC3 (Fischle et al., 2001; Fischle et al., 2002). 
Interestingly, the single class IIa HDAC in D. melanogaster, HDAC4, does not contain this 
substitution, suggesting that the enzyme has a robust deacetylase activity in the fly. HDAC6 contains a 
tandem deacetylase domain and a C-terminal zinc finger, predominantly localises to the cytosol, where 
it deacetylates numerous proteins including α-tubulin, cortactin and HSP90. In comparison to the other 
zinc-dependent deacetylases, the functions of the vertebrate-specific class IIb HDAC10 and the highly 
conserved class IV HDAC11 are less well understood. 
Members of the sirtuin family of class III deacetylases couple lysine deacetylation with NAD+ 
hydrolysis to yield nicotinamide and O-acetyl-ADP-ribose in addition to the non-acetylated product. 
The requirement for NAD+ directly links the enzymatic activity of sirtuins to the energy status of the 
cell. In line, sirtuins have received much attention as critical regulators for metabolic processes 
including glycolysis, gluconeogenesis and fat oxidation and higher levels of SIRT1 were initially 
reported to mediate the effects of caloric restriction that increases life span in yeast, C. elegans and D. 
melanogaster. More recent studies, however, questioned the capacity of lifespan extension of SIRT1 
in flies (sir2) and worms (sir-2.1) (reviewed in (Feldman et al., 2012; Sauve and Youn, 2012)). Of 
note, while SIRT1 knockout mice show normal lifespan, SIRT6 deficient mouse mutants display 
phenotypes of accelerated aging. Sirtuins show distinct localization patterns in mammalian cells, 
where SIRT1, SIRT6 and SIRT7 are pre-dominantly found in the nucleus, SIRT2 in the cytosol, and 
SIRT3-5 in the mitochrondria (Verdin et al., 2010). In addition to their deacetylase activity, individual 
members have been suggested to remove other acyl groups including malonyl and succinyl (Du et al., 
2011). Moreover, SIRT4 and SIRT6 display ADP-ribosyltransferase activity. Indeed, until recently, no 
deacetylation reaction had been reported for SIRT4, yet a recent acetylome microarray study 
suggested multiple deacetylation targets for this enzyme (Rauh et al., 2013).  
A reoccurring theme is that KATs and KDACs regulate the enzymatic activity of each other and of 
other chromatin-modifying activities. For example, SIRT1 mediated deacetylation of SUV39H1 
increases the catalytic activity of this methyltransferase and is necessary for proper heterochromatin 
formation (Vaquero et al., 2007). Likewise, autoacetylated hMOF is deacetylated by SIRT1, which 
increases the affinity of MOF towards nucleosomes in vitro and is necessary for target gene binding in 
vivo (Lu et al., 2011). In turn, hMOF acetylates the SIRT1 inhibitor protein DBC1 to generate more 
active SIRT1 molecules. In a negative-feedback loop, SIRT1 deacetylates its own inhibitor and 
thereby restricts its activity (Zheng et al., 2013a).  
 
 
INTRODUCTION  
 
30
2.3.2 Lysine methylation 
Lysine methylation is catalysed by lysine methyltransferases (KMTs, formerly: histone 
methyltransferases (HMTs)) and reversed by lysine demethylases (KDMs, formerly: histone 
demethylases (HDMs)). These enzymes add or remove up to three methyl-groups and show a high 
specificity towards the specific lysine residue and degree of methylation. All lysine methyltransferases 
require S-adenosyl methionine (SAM) as a methyl-donor and most KMTs share a specific catalytic 
domain (SET domain: Su(var)3-9, Enhancer of Zeste, Trithorax). Histone demethylases are classified 
according their catalytic mechanism in flavin adenine dinucleotide (FAD)-dependent amine oxidase, 
and Fe(II) and α-ketoglutarate-dependent dioxygenase (Smith and Denu, 2009). Genome-wide 
localization studies using chromatin-immunoprecipitation combined with microarray or deep-
sequencing (ChIP-chip, ChIP-Seq) revealed that lysine methyl marks can be grouped into active 
(H3.K4me3, H3.K36me3, H3.K79me2) and repressive (H3.K9me3, H3.K27me3, H4.K20me3) 
signatures. Because methylation does not change the positive charge state of lysines, its primary 
function is likely to recruit or oppose specific effector proteins. Those effector proteins recognise 
methylated lysines through highly dedicated protein folds, including chromodomains, PHD fingers 
and MBT domains and thereby connect lysine marks to a whole range of downstream processes 
(Taverna et al., 2007).  
Tri-methylation of lysine 4 on H3 (H3.K4me3) is a hallmark of gene promoters.  This mark may 
stimulate transcription via the recruitment and/or stabilization of the transcription factor TFIID, the 
chromatin remodeler BPTF/NURF and the H3.K9me2-demethylase PHF8 (Taverna et al., 2007; Herz 
et al., 2013). H3.K4me3 is catalysed by a single enzyme in yeast (SET1) but three enzymes in 
Drosophila (SET1, TRX, TRR) and at least six enzymes in mammalian cells (MLL1-4, SETD1A, 
SETD1B). The expansion of this family in higher eukaryotes indicates a high level of specification 
and potentially redundancy. In line with this, MLL1 pre-dominantly localises to the hox gene cluster 
and mll1 knockout mice display characteristic homeotic phenotypes (Yu et al., 1995). Compared with 
the highly specific lysine methyltransferases, the catalytic activity of many lysine demethylases is 
strongly influenced by their interacting proteins. Consequently, individual demethylases do not only 
revert specific methylation states on H3.K4 but also act on other lysine residues (for example 
KDM2B: H3.K4me3 and H3.K36me1/2, LSD1: H3.K4me2/3 and H3.K9me1/2) (Hojfeldt et al., 
2013).  
In contrast to H3.K4me3, the mono-methylated form (H3.K4me1) is not restricted to promoters but it 
is broadly distributed across the genome and enriched on the bodies of active genes and enhancers 
(Herz et al., 2013). In a recent study, Shilatifard and co-workers could demonstrate that Drosophila 
mutants lacking the responsible enzyme for H3.K4me1 (TRR) also lose the enhancer-mediated gene 
activation of the cut locus. Moreover, they observed a global decrease of the enhancer mark 
H3.K27ac. Together with previous studies that showed an interaction between the H3.K27me3-
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demethylase UTX (KDM6A) with TRR (MLL3/MLL4), these results support the model that an 
acetylation-methylation switch at H3.K27 regulates the transition from an inactive but poised to an 
active enhancer (Herz et al., 2012). 
Methylation of H3.K36 and H3.K79 is found on actively transcribed gene bodies. Similar to the 
enzymes that catalyse H3.K4 methylation, there is only a single yeast enzyme (SET2) that sets all 
three methylation states of H3.K36 whereas three Drosophila (SET2, MES-4 and ASH1) and at least 
six mammalian (SET2, ASH1L, SETMAR, NSD1-3) enzymes preferentially generate either the mono- 
and di-methylated states or the tri-methylated state, respectively. Early studies suggested that 
H3.K36me3 is recognised by the chromodomain of EAF3 to recruit the RPD3S complex, which in 
turn deacetylates histones at gene bodies and thereby supresses cryptic transcription (Carrozza et al., 
2005; Keogh et al., 2005). However, a recent report demonstrated that RPD3S still localises to genes 
in the absence of H3.K36me3 – yet it is inactive – suggesting that this mark promotes the activity 
rather than the recruitment of a deacetylase complex (Drouin et al., 2010).  
Methylation to H3.K79 is unique in many instances. First, it is catalysed by a non-processive 
methyltransferase (DOT1L) that does not contain a SET domain but structurally is related to arginine 
methyltransferases (Min et al., 2003). Second, although there is evidence for dynamic changes of 
H3.K79me2 during the cell cycle, no demethylase is known that actively removes this mark (Nguyen 
and Zhang, 2011). Third, despite being present at all active gene bodies, only a few genes seem to 
require this mark for their activity. Instead, accumulating evidences point towards a role in DNA 
repair (via BP53 recruitment) and activation of the G1/S checkpoint (Huyen et al., 2004; Wysocki et 
al., 2005; Nguyen and Zhang, 2011).  
Di- and tri-methylated H3.K9 is a classical marker for constitutive heterochromatin found at genomic 
regions that contain repetitive DNA elements. In a self-reinforcing spreading mechanism, SUV39H1/2 
catalyse H3.K9me2/3 that is subsequently bound by HP1-α, which in turn binds and stabilises 
SUV39H1/2 at these regions. In addition, HP1 also recruits SUV420H1, which catalyses H4.K20me3 
to confer further condensation. Cells lacking the SUV39 and SUV420 enzymes display derepressed 
satellite transcription, chromosome translocation and mitotic defects (Peng and Karpen, 2009; Black et 
al., 2012; Jorgensen et al., 2013). In addition to repeat DNA silencing and genomic integrity, 
H3.K9me2 also represses genes that are covered by large megabase-scale domains found in 
differentiated but not pluripotent cells (Wen et al., 2009). Similar to the HP1-α-SUVAR39H1/2 
feedback loop at pericentric heterochromatin, these domains may be established and stabilised by a 
self-reinforcing process that involves di-methylation of H3.K9 by G9a followed by stabilization of the 
enzyme via binding of G9a to H3.K9me2 (Shinkai and Tachibana, 2011). Interestingly, in contrast to 
most other chromatin enzymes, H3.K9 methylating enzymes do not form stable multi-subunit 
assemblies but rather engage in transient interactions. For example, while the methyl-CpG binding 
protein MBD1 recruits the H3.K9 methyltransferase SETDB1 into a S-phase specific complex with 
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CAF-1 (Sarraf and Stancheva, 2004), the co-repressor KAP-1 directs SETDB1 to silence individual 
genes (Schultz et al., 2002).  
Methylation to H3.K27 is generally associated with gene repression. H3.K27me1 is found at 
constitutive heterochromatin together with H3.K9me3 yet its function is not well understood. In 
addition, low levels of H3.K27me1 are detected at active genes that presumably arise from the 
demethylation of H3.K27me2/3 by UTX or JMJD3 (Swigut and Wysocka, 2007). H3.K27me2/3 are 
prominent marks of facultative heterochromatin that are set by the polycomb repressive complex 
PRC2. ChIP-chip/Seq experiments documented several binding modes of these histone modifications 
and their respective enzymes (EZH1/2). Similar to H3.K9me2/3, these marks span extended domains 
of several 100 kb in differentiated but not pluripotent cells. In addition, individual genes (in particular 
developmental genes), intergenic regions (potentially coding for ncRNAs), subtelomeric regions and 
LTR retrotransposons are targeted by these modifications (Hawkins et al., 2010). Mechanistically, 
H3.K27me3 represses transcription by antagonizing the acetylation mark on the same residue and by 
providing a platform for the PC subunit of the PRC1 complex. Transcription repression by the PRC1 
complex is achieved by compacting nucleosomal arrays (via PSC in Drosophila and CBX in 
vertebrates) and ubiquitylation of H2A.K119 by the PRC1 subunit RING1. However, how 
H2A.K119ubi impedes transcription is not yet known . In addition, there is accumulating evidence that 
PRC1/2 interferes with the transcriptional machinery. However, whether this occurs on the level of 
RNA polymerase II recruitment, promoter-proximal release or by inhibiting mediator targeting is 
controversially discussed (Chopra et al., 2011; Margueron and Reinberg, 2011; Lehmann et al., 2012; 
Simon and Kingston, 2013). 
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2.4 Dosage compensation in the fruit fly Drosophila melanogaster 
Dosage compensation describes the process of adjusting transcription levels between the unequal 
numbers of sex chromosomes in heterogametic species. Although different species have evolved 
different strategies to balance gene expression between the sexes, they all utilise chromatin-based 
mechanisms. In mammalian females, one of the two X chromosomes is inactivated by a concerted 
step-wise process including recruitment of the polycomb silencing machinery via the long non-coding 
RNA Xist (X-inactive specific transcript) followed by the incorporation of the histone variant 
macroH2A, deacetylation of histones and DNA hyper-methylation (Wutz, 2011; Jeon et al., 2012; 
Dupont and Gribnau, 2013). In the nematode worm Caenorhabditis elegans, the dosage compensation 
complex contains components of the meiotic/mitotic condensin complex, which halves the 
transcription output of the two hermaphrodite X chromosomes (Meyer, 2005). Drosophila also employ 
a subtle but vital transcriptional adjustment, but there, dosage compensation occurs in males to double 
the transcription from the single X chromosome (Straub and Becker, 2007). Male flies have evolved a 
unique ribonucleoprotein complex that contains the activities from an acetyltransferase, an E3 ligase 
and a helicase (see below). Recent studies suggest that dosage compensation in mammals and 
nematodes involves a second mechanism, that, similar to male flies, upregulates the expression from 
the X chromosome(s) in order to balance the expression towards the autosomes (Deng et al., 2014). 
The molecular mechanisms of this newly identified principle are largely elusive and are just beginning 
to be unveiled (Deng et al., 2013).   
Research on dosage compensation in Drosophila has a long history. The geneticist Hermann Joseph 
Muller introduced the term ‘dosage compensation’ based on observations made in the 1920s and 
1930s, where the single gene copy of an eye colour marker encoded on the male’s X chromosome 
produces almost the same eye colour as the genes from the two female X chromosomes (Bridges 1922, 
Muller 1931, Muller 1950). In 1964, the cytologist Rudkin showed that the single X chromosome in 
males has a comparable ‘thickness’ to the paired female X chromosome, suggesting enhanced 
transcriptional activity in males (Rudkin 1964). One year later, Mukherjee and Beerman confirmed 
this prediction. Incubating salivary glands with tritiated uridine allowed them to observe a similar 
incorporation between the single male and the two female X chromosomes (Mukherjee and Beermann, 
1965). Detecting similar levels of activity from the X-linked gene glucose-6-phosphate dehydrogenase 
between male and male flies lend further support (Komma, 1966). Together, these experiments 
establish that a transcription-based process calibrates the gene expression output between the single 
male and the two female X chromosomes.  
Elegant genetic experiments identified the components of the molecular machinery that mediates 
dosage compensation. A series of genetic screens identified four autosomal loci that, when mutated, 
killed male but not female flies and reduced the rate of X chromosome transcription (Fukunaga et al., 
1975; Belote and Lucchesi, 1980b, a). The genes were named according to their male-specific lethal 
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phenotype, msl1, msl2, msl3 and mle (maleless). Immunological stainings of polytene chromosomes 
with sera raised against the MSL proteins demonstrated highly overlapping and almost exclusive 
localization of those factors to the X chromosome, corroborating their function to act directly on this 
chromosome. The observation that an acetylated histone isoform, H4.K16ac, also predominantly 
localised to the male X chromosome not only directly suggested a potential mechanism for how 
dosage compensation works but also provided an intuitive correlation and beautiful visualization of 
increased acetylation and transcriptional hyper-activation (Turner et al., 1992). Soon thereafter, the 
enzyme that catalysis this histone mark was identified in a genetic screen for male-lethality causing 
mutations on the X chromosome: males absent on the first (mof) encodes a gene product with a 
recognizable MYST-type acetyltransferase domain (Hilfiker et al., 1997; Gu et al., 1998) and 
specificity towards acetylating H4.K16 (Akhtar and Becker, 2000). Around the same time, two non-
coding RNAs (RNA on the X, roX1 and rox2) were found to be exclusively expressed in male cells, 
where they are only detectable at the male X chromosome (Amrein and Axel, 1997; Meller et al., 
1997). The ribonucleoprotein complex MSL-DCC, containing the five MSL proteins and two roX 
RNAs, forms only in male flies, because msl2 expression is inhibited in female cells by the action of 
the master sex regulator sex-lethal (Kelley et al., 1995; Bashaw and Baker, 1997; Kelley et al., 1997).  
The MSL-DCC binds X chromosomal active genes in a multi-step process. According to the prevalent 
model, a core complex containing MSL1 and MSL2 binds around 250 ‘high-affinity’ sites (HAS) 
located in coding regions evenly distributed across the 22 mega base pairs  of the X chromosome 
(Gelbart and Kuroda, 2009; Conrad and Akhtar, 2011; Straub and Becker, 2011). MSL1 acts as a 
scaffold to allow binding of MOF and MSL3. This results in a full MSL-DCC complex that is capable 
to spread in cis from the high affinity sites to active genes. Several factors may stimulate the spreading 
process. First, MOF mediated acetylation of H4.K16 is required for efficient spreading (Gu et al., 
1998). Second, efficient loading of the roX RNAs by the helicase activity of MLE facilitates the 
transfer of the complex from HAS to active genes (Morra et al., 2011). Third, mutating the enzyme 
that places H3.K36me3 on gene bodies lead to reduced binding of the MSL-DCC to active genes 
while its localization on HAS was not disturbed (Larschan et al., 2007; Bell et al., 2008). However, 
while an initial study suggested that MSL3 binds H3.K36me3 using its own chromodomain (Sural et 
al., 2008), subsequent structural and biochemical studies could not confirm a direct interaction 
between them. Rather, they suggested that the chromodomain of MSL3 binds H4.K20me1 (Kim et al., 
2010; Moore et al., 2010). How the MSL-DCC recognises and utilises H3.K36me3 for spreading 
remains elusive. Fourth, the precise levels of the MSL proteins are important. Excess of subunits lead 
to ectopic binding events at lower affinity sites present on the autosomes, whereas decreased MSL 
protein levels (or absence of the spreading factors MSL3 and MOF) reduced binding to active genes 
(Kelley et al., 1999; Dahlsveen et al., 2006; Straub et al., 2008). Remarkably, the MSL-DCC auto-
regulates the correct amounts of its subunits. MSL2 was recently shown to possess an E3 ligase 
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activity that marks excess subunits with polyubiquitylation and thereby promotes subsequent 
degradation by the proteasome (Villa et al., 2012). Moreover, absence of MSL2 (or MSL1) increases 
the spatial distance between HAS measured by 3D fluorescence in situ hybridization (3D-FISH) 
experiments (Grimaud and Becker, 2009). Together, these observations lead to the current model for 
selective X chromosome targeting and spreading of the MSL-DCC: Transcription from the two roX 
loci provides a seed for the self-assembly of a dosage compensated domain within the X chromosome. 
Active, dosage compensated genes are located in the interior of this domain, whereas inactive genes 
that are not bound by the MSL-DCC reside at the periphery. A gradient of MSL-DCC complexes 
originates in the core of this domain and diffuses along a gradient of high and low affinity sites 
towards the periphery. Adjusting precise complex levels restricts its targeting exclusively to the X 
chromosome (Grimaud and Becker, 2010).  
Although increased transcription from the male X chromosome was the founding observation that 
defined ‘dosage compensation’, the precise molecular mechanism that mediates ‘two-fold up’ has 
remained largely mysterious until today. High-resolution ChIP mapping of the MSL proteins and the 
H4.K16ac mark showed localised binding to the gene bodies of active genes, with a tendency to enrich 
towards the gene’s 3’ end (Smith et al., 2001; Alekseyenko et al., 2006; Gilfillan et al., 2006). Based 
on this observation, Lucchesi and colleagues suggested the model that dosage compensation occurs at 
the level of transcriptional elongation. Conceivable, local decondensation of chromatin caused by 
H4.K16ac marked nucleosomes may facilitate the transition of RNA polymerase II through an 
otherwise repressive chromatin template (Smith et al., 2001). Two recent studies largely supported this 
model by documenting increased occupancy of RNA polymerase (or nascent transcripts arising from 
it) over the gene bodies but not at the promoters (Larschan et al., 2011; Ferrari et al., 2013). Still, how 
increased acetylation of H4.K16ac brings about a fine-tuned transcriptional stimulation in the two-fold 
range has remained elusive. Interestingly, Akhtar and Becker observed early on that tethering MOF to 
a yeast promoter boosts transcription far beyond the two-fold range (Akhtar and Becker, 2000), 
indicating that additional mechanisms are in place that coordinate a fine-tuned response to arrive at the 
final ‘two-fold up’.   
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3.1.1 Summary, significance and own contribution 
 
Summary and significance  
Although it is established that acetylation of H4.K16 by MOF is required for dosage compensation, it 
is unknown how the precise two-fold stimulation is achieved. At the time when we started this project, 
the Akhtar group had recently identified a novel MOF-containing complex in male cells, the non-
specific lethal (NSL) complex, which contains two components of the nuclear pores and a number of 
poorly characterised proteins, including NSL1 and MBD-R2 (Mendjan et al., 2006). In their 
subsequent work, they demonstrated that MOF binds genome-wide to many promoters in male and 
female cells, suggesting novel roles for MOF independent of dosage compensation (Kind et al., 2008). 
The objective of this study was to compare the molecular context and effect on transcription of MOF 
in male and female flies.  
Combining affinity-purification mass spectrometry, genome-wide mapping and transcriptome studies 
and the analysis of reporter loci in transgenic flies and cell systems, we arrived at four main 
conclusions. First, in female cells, MOF resides in a similar complex as described before by the 
Akhtar group, containing NSL1, NSL2, NSL3, MBD-R2 and MCRS2, but lacking the nuclear pore 
proteins. Second, in male and female cells, the NSL complex (using MBD-R2 as a marker) binds at 
promoters of many active genes along all chromosomes. Ablation of MBD-R2 reduced transcription of 
target genes genome-wide and at a defined reporter locus, indicating that the NSL complex is a global 
transcription activator. Third, in male cells, MOF distributes dynamically between the MSL-DCC and 
NSL complex. Introducing low levels of MSL2 in female cells causes a global redistribution of MOF 
away from promoters of genes on all chromosomes towards gene bodies on the male X chromosome. 
Fourth, the strong activation potential of MOF-mediated H4.K16ac is constrained in the context of 
dosage compensation. Reconstituting the different targeting principles of MOF at defined reporter loci 
in transgenic flies revealed that MOF within the NSL complex activates transcription strongly in a 
distance-dependent manner, typical for promoter-type transcriptional activators. In contrast, MOF 
recruitment in the context of the MSL-DCC promoted a distance-independent stimulation of 
transcription in the two-fold range, reminiscent for dosage compensation. Importantly, the reporter 
locus was decorated with similar levels of H4.K16ac in both conditions, suggesting that additional 
factors constrain the strong activation potential of this histone mark. In line with these observations, 
we observed a positive correlation between the levels of H4.K16ac and the gene expression strength 
for genes in both sexes and on all chromosomes, except for the male X chromosome. Remarkably, 
depriving MSL2 in male tissue-culture cells increased the expression of the MOF-regulated reporter 
gene. These observations led us to propose the model that the MSL-DCC harnesses a strong activator 
(MOF through H4.K16ac) and dampens its activity to achieve a precise two-fold stimulation 
characteristic for dosage compensation.  
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The molecular entity that constrains the activation potential of MOF/H4.K16ac is unknown but several 
repressive chromatin components, which have previously been genetically linked to dosage 
compensation (Deuring et al., 2000; Spierer et al., 2005; Spierer et al., 2008), provide attractive 
candidates for such activities. In addition, advancing our understanding of the recently identified ‘over 
compensating males’ (ocm) gene (Lim and Kelley, 2013) and characterizing the molecular targets of 
the E3 ligase MSL2 may provide further insights (see discussion in section 4). In summary, this report 
defines an entry point to study the contribution of repressive activities to the process of dosage 
compensation, which promises to refine our understanding of the general principles that regulate 
genome balancing at the level of chromosome-wide transcription control.  
 
Own contribution 
For this study led by Dr. Matthias Prestel, I designed and performed all genomic experiments and 
contributed to the characterization of the reporter loci by ChIP-qPCR in adult male and female flies. I 
prepared the main figures 2F, 3, 4, 5 and 7, the supplementary figures S3 to S6 and contributed to the 
writing of the manuscript.  
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3.1.2 Published manuscript 
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The H4K16 acetyltransferase MOF plays a crucial
role in dosage compensation in Drosophila but has
additional, global functions. We compared the
molecular context and effect of MOF in male and
female flies, combining chromosome-wide mapping
and transcriptome studies with analyses of defined
reporter loci in transgenic flies. MOF distributes
dynamically between two complexes, the dosage
compensation complex and a complex containing
MBD-R2, a global facilitator of transcription. These
different targeting principles define the distribution
of MOF between the X chromosome and autosomes
and at transcription units with 50 or 30 enrichment. The
male X chromosome differs from all other chromo-
somes in that H4K16 acetylation levels do not corre-
late with transcription output. The reconstitution of
this phenomenon at a model locus revealed that
the activation potential of MOF is constrained in
male cells in the context of the DCC to arrive at the
2-fold activation of transcription characteristic of
dosage compensation.
INTRODUCTION
The organization of chromatin affects all aspects of gene tran-
scription. The most prominent chromatin features that can be
correlated with particular functional states are various histone
modifications. Many of these modifications affect chromatin
structure indirectly by providing binding sites for modulators of
local chromatin organization (Fischle, 2008). By contrast, the
acetylation of histone H4 at lysine 16 (H4K16ac) is known to
affect chromatin structure directly by preventing the compaction
of the nucleosomal chain into 30 nm fibers (Robinson et al., 2008;
Shogren-Knaak et al., 2006). Accordingly, targeting H4K16 acet-
ylation to a promoter in vitro or in yeast can lead to profound
derepression of transcription (Akhtar and Becker, 2000).
H4K16ac is the major modification involved in the process of
dosage compensation in Drosophila. Dosage compensation
mechanisms counteract the adverse effects of sex chromosome
aneuploidy in a variety of organisms (Lucchesi et al., 2005). In
Drosophila, like in mammals, females are characterized by two
X chromosomes, whereas males only have one X and a gene-M
poor, degenerate Y chromosome. The halved dose of X-linked
genes in males is counteracted by elevating their transcription
levels by roughly 2-fold (Hamada et al., 2005; Straub et al.,
2005a). This subtle yet vital adjustment of gene expression
depends on the acetyltransferase MOF, which preferentially
acetylates H4K16 on the X chromosome in males (Akhtar and
Becker, 2000; Hilfiker et al., 1997; Smith et al., 2000). MOF is
part of a dosage compensation complex (DCC, also known as
male-specific-lethal [MSL] complex), a ribonucleoprotein
assembly that specifically associates with the X chromosome.
The DCC also contains the MSL proteins MSL1, MSL2, and
MSL3; the RNA helicase maleless; and two noncoding RNAs.
The DCC only forms in males due to the male-specific expres-
sion of MSL2. Targeting to the X chromosome is a multistep
process involving the recognition of a relatively low number of
high-affinity sites (HAS) or chromosomal entry sites (CES) by
MSL1–MSL2 followed by transfer to transcribed gene
sequences (reviewed in Gelbart and Kuroda, 2009; Lucchesi
et al., 2005; Straub and Becker, 2007). The phenomenon of
dosage compensation presents a unique opportunity to study
mechanisms of coregulation of genes on a chromosome-wide
scale.
Current models for dosage compensation assume that enrich-
ment of H4K16ac on the male X chromosome leads to decom-
paction of the chromatin fiber, which may facilitate transcription
elongation. However, several observations indicate that the role
of MOF in dosage compensation is more complex. First, ectopic
expression of MOF in yeast leads to a much stronger activation
of a reporter gene than the 2-fold effects that characterize
dosage compensation (Akhtar and Becker, 2000). The principles
that harness the activation potential of MOF on the male X chro-
mosome in Drosophila are unknown. Further, MOF is expressed
in male and female cells (Hilfiker et al., 1997). Low levels of MOF
can be detected at gene-rich interbands of all polytene chromo-
somes in female larvae and on male autosomes (Bhadra et al.,
2000; Kind et al., 2008). MOF was originally isolated due to the
male-specific lethality of its loss-of-function phenotype (Hilfiker
et al., 1997). However, MOF mutant females are developmentally
delayed and have a decreased fertility (Gelbart et al., 2009). Akh-
tar and colleagues recently suggested roles for MOF in gene
expression beyond dosage compensation (Kind et al., 2008).
To which extent MOF can catalyze H4K16 acetylation outside
of the context of the DCC is controversial (Gelbart et al., 2009;
Kind et al., 2008; Morales et al., 2004).
The issue is further complicated by the observation that MOF
can be part of an alternative, ‘‘NSL’’ complex that was isolated
from male tissue culture (SL2) cells or mixed-sex embryosolecular Cell 38, 815–826, June 25, 2010 ª2010 Elsevier Inc. 815
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Figure 1. A Model System to Study the
Sex-Specific Regulation by MOF
(A) MOF expression construct. Genomic DNA
containing the mof locus and flanking sequences
were modified by inserting a GAL4 DNA-binding
domain and a FLAG tag. GAL4-DBD, GAL4 DNA-
binding domain; CD, chromodomain; ZN, zinc
finger domain; HAT, histone acetyltransferase
domain.
(B) Reporter constructs (RC). The RC5 reporter has
five binding sites for the Gal4 activator (53UAS)
located 50 to the lacZ gene, which is controlled
by the minimal hsp70 promoter. The transforma-
tion marker mini-white is transcribed from its own
promoter. Arrows indicate the direction of tran-
scription. In the RC3 construct the lacZ gene was
inverted, such that the UAS sites reside 30 of the
lacZ gene.
(C and D) MOF activates transcription of the lacZ
(C) and mini-white (D) genes. Total RNA was iso-
lated from male (black bars) or female (open
bars) adult flies. lacZ or mini-white transcripts
were determined by RT-PCR and plotted as
enrichments over an internal gapdh1 control value.
The enrichments indicated above the bars refer to
the RNA values in the presence of MOF-Gal4 rela-
tive to the values in its absence (panels to the left).
Error bars represent mean ± SEM. See also
Figure S1.
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Balancing Transcription for Dosage Compensation(Mendjan et al., 2006). In this context, MOF associates with
several poorly characterized factors with interesting domain
organization, such as the ‘‘nonspecific-lethals’’ (NSL1, NSL2,
and NSL3), dMCRS1, and MBD-R2 (Mendjan et al., 2006).
To gain more insight into the diverse molecular context of MOF
function, we affinity purified a MOF complex from female cells
that shares many subunits with the ‘‘NSL complex’’ described
by the Akhtar group, including MBD-R2. Genome-wide tran-
scriptome studies show that MBD-R2 is a general facilitator of
transcription. Combining chromatin immunoprecipitation with
probing DNA microarrays (ChIP-chip), we mapped the chromo-
some-wide interactions of MOF, MSL1 (a marker for the DCC),
and MBD-R2 (a marker for the alternative complex) in adult flies
sorted according to sex. MOF colocalizes with MBD-R2 at the 50
end of most active genes in females. In males, most of MOF is
found in the context of the DCC on the coding regions of active
X chromosomal genes. Ectopic reconstitution of the DCC in
female cells relocalizes MOF to the X chromosome, which
suggests that MOF distributes in a dynamic equilibrium between
the two complexes.
Targeting MOF via a heterologous DNA-binding domain to an
autosomal reporter locus in flies allowed contrasting the activa-
tion potential of MOF in either sex. In the context of MBD-R2 in
females, MOF was a potent activator of transcription from
nearby promoters. In the context of the DCC, this activation
was limited to 2-fold, reminiscent of dosage compensation.
Ablation of MBD-R2 and of MSL2 in tissue culture cells allowed816 Molecular Cell 38, 815–826, June 25, 2010 ª2010 Elsevier Inc.adjusting the relative levels of the two complexes. Interestingly,
reduction of MSL2 led to increased transcription. Taken
together, our data suggest that dosage compensation involves
a hitherto unappreciated principle that constrains the activation
potential of this acetylation mark.
RESULTS
Construction of Model Loci to Study the Sex-Specific
Regulatory Potential of MOF
To dissect the function of MOF in the context of the intact
organism, we employed fly lines bearing reporter gene loci to
which regulatory proteins can be recruited (Figure 1). One
reporter locus contains binding sites for the yeast transcription
factor Gal4 (‘‘upstream activating sequences’’; UASGal)
upstream of lacZ and mini-white genes (RC5, Figure 1B [Zink
and Paro, 1995]). Basal transcription of the lacZ gene from
a minimal promoter can be boosted by activator binding to the
UAS element. The mini-white gene, which is transcribed from
its own promoter, has been shown to be responsive to dosage
compensation in an appropriate X chromosomal context (Qian
and Pirrotta, 1995). However, chromosome-wide DCC interac-
tion studies (Straub et al., 2008) showed that the white gene
does not contain a high-affinity binding site for the DCC (HAS),
and the reporter cassette in the autosomal context only shows
background binding of MOF in both sexes (see below). A second
set of transgenic flies was generated that express MOF fused to
Molecular Cell
Balancing Transcription for Dosage Compensationa GAL4 DNA-binding domain (MOF-Gal4; Figure 1A). Crossing
reporter and activator lines leads to recruitment of MOF to the
reporter locus in the offspring.
We reasoned that the tethering site might substitute for a HAS,
which are frequently found outside of coding regions. According
to the prevalent model, these sites serve to distribute DCC to
close-by transcribed genes (Alekseyenko et al., 2008; Straub
et al., 2008). The well-defined reporter gene locus allows
studying the effects of MOF recruitment in male flies, where
MOF is part of the dosage compensation system, and in females,
where the function of MOF has not been studied yet.
We expressed MOF-Gal4 from the endogenous mof promoter
to avoid distortions due to overexpression (see Figure S1A
available online). The MOF-Gal4 transgene was functional, since
it rescued the male-specific lethality of the mof1 allele (Hilfiker
et al., 1997). The fusion protein incorporated into the DCC, as
Gal4 staining colocalized with the DCC on the male X chromo-
some as well as on a few autosomal sites (Figure S1D). Expres-
sion of MOF-Gal4 did not affect the survival or fertility of females.
The RC5 element integrated at 93B (Zink and Paro, 1995) was
stained with the Gal4 antibody in polytene chromosomes of
female and male larvae (Figures S1C, S1D, and S2A–S2D).
Binding of MOF-Gal4 to the UAS recruited the other DCC
members in males, but not in females (Figures S2A–S2D).
Taken together, these results establish the functionality of
MOF-Gal4 in our experimental setup, which enabled us to study
its impact on reporter gene transcription in the different molec-
ular contexts of male and female flies.
Different Modes of Activation by MOF in Male
and Female Flies
We tested the ability of tethered MOF to activate transcription of
the lacZ and mini-white genes in the context of the RC5
construct by quantitative RT-PCR analysis of RNA from sorted
male and female adult flies. Expression of MOF-Gal4 activated
both genes in both sexes. In males, the activation of the lacZ
gene was in the 2-fold range relative to the level in the absence
of MOF. Unexpectedly, the gene was expressed considerably
stronger in females than in males (Figure 1C). We were con-
cerned that assembly of a DCC at the UAS of RC5 in males might
sterically hinder preinitiation complex formation at the minimal
hsp70 promoter of the lacZ gene, resulting in lower expression.
Therefore, we generated the RC3 fly line in which the UAS is
placed 30 of the lacZ gene (Figure 1B). Recruitment of MOF-Gal4
to the 30 UAS led to activation of lacZ in the 2-fold range in males,
but stronger stimulation in females (Figure 1C). The mini-white
gene, whose start site is about 4.5 kb away from the tethering
site in either construct, was also induced by MOF-Gal4, with
stronger effects in females (Figure 1D). Plotting the degree of
activation of the reporter genes as a function of distance from
the UAS to the promoters shows that recruitment of MOF leads
to an approximately 2-fold activation of transcription within the
tested zone of 5 kb in males. In contrast, activation in females
was strongly distance dependent and stronger if MOF was close
to the transcription start (Figure S1B). Taken together, these
results document the activation potential of MOF in both sexes
and suggest different modes of activation. The 2-fold,
distance-independent activation in males is reminiscent ofM
a dosage compensation regime. However, in females the
distance-sensitive activation that exceeds 2-fold is more akin
to promoter-proximal activation.
As activation by MOF is thought to be based on its acetylating
function, we wondered whether different levels or distribution
patterns of the H4K16ac mark could explain the sex-specific
activation differences. We adapted a chromatin immunoprecip-
itation (ChIP) protocol for adult flies (Negre et al., 2006), which
allowed testing for the presence of regulators and the
H4K16ac mark in hand-sorted male and female flies along the
reporter using four PCR amplicons (Figures 2A–2E). Normalizing
the ChIP values to background levels of MOF binding at a region
50 of the GAPDH1 gene enabled a comparison of different chro-
matin preparations. The X chromosomal, dosage-compensated
armadillo (arm) locus served as internal control for physiological,
male-specific interaction of the DCC and H4K16 acetylation.
ChIP directed against MOF confirmed the recruitment of
similar levels of MOF-Gal4 to the tethering site in both reporter
loci and sexes (Figures 2A and 2B). Crosslinking of MOF was
reduced with increasing distance from the tethering site, but still
significant at the 30 end of the mini-white gene, 8.5 kb away from
the UAS (compare to levels at the arm locus), consistent with the
observed spreading of DCC from engineered autosomal HAS
(Alekseyenko et al., 2008). MOF recruitment was similar in both
reporter lines, although in RC5 the distance-dependent decline
was more pronounced in females. The H4K16ac levels corre-
sponded well to those of MOF-Gal4, with strong enrichments
at the site of tethering and a distance-dependent reduction. In
males, H4K16ac levels tended to spread further from the teth-
ering site (Figures 2C and 2D). In the absence of MOF-Gal4
only background levels of endogenous MOF were observable.
MSL2 was recruited to the RC3 locus by MOF-Gal4 only in
males, as expected since MSL2 is the male-specific determinant
of the DCC (Figure 2E). Binding across the locus closely paral-
leled that of MOF. The recruitment of MSL2 confirmed that
MOF functions in the context of a DCC in males, as suggested
by the polytene chromosome staining. Strikingly, in the absence
of the DCC in females, MOF catalyzed comparable levels of
H4K16ac at the reporter locus. Unexpectedly, H4K16ac levels
at the reporter genes do not correlate linearly with the corre-
sponding transcription levels, as H4K16ac is moderately higher
in males than in females (Figures 2C and 2D), yet the transcrip-
tion is significantly stronger in females (Figures 1C and 1D). By
contrast, transcription output correlated well with the number
of RNA polymerase molecules at the 50 of the lacZ gene, deter-
mined by ChIP of the integral Rpb3 subunit (Muse et al., 2007)
(Figure 2G). The levels of two other factors related to dosage
compensated chromatin, the nucleosome-remodeling ATPase
ISWI (Deuring et al., 2000) and the supercoiling factor SCF
(Furuhashi et al., 2006) were unchanged upon recruitment of
MOF (data not shown).
H4K16 acetylation appears not to be an absolute requirement
for transcription since recruitment of an intact yeast GAL4
activator (without MOF) to the RC5 reporter led to profound
activation to similar levels in both sexes without enrichment of
H4K16ac (Figures S2E and S2F).
We conclude that the contributions of H4K16ac to transcrip-
tion are highly context dependent. To further substantiate thisolecular Cell 38, 815–826, June 25, 2010 ª2010 Elsevier Inc. 817
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Figure 2. Chromatin Interactions upon MOF Recruitment
Chromatin constituents were monitored by ChIP in sorted male and female adult flies. The presence of sequences in the immunoprecipitate corresponding to four
amplicons along the reporter loci (arrows, see schematics on top) was determined by qPCR. The RC3 locus was probed in (A), (C), and (E) and the RC5 locus in (B)
and (D). Chromatin was from females or males of the reporter lines in the absence of MOF-Gal4 (light and dark gray bars, respectively) or in the presence of
MOF-Gal4 (white and black bars). Error bars represent mean ± SEM. (A) and (B) display MOF interactions at the RC3 and RC5 reporters, respectively. (C)
and (D) show the corresponding H4K16 acetylation levels. (E) MSL2 interactions were revealed at the RC3 reporter. (F) Genome-wide correlation of gene expres-
sion and H4K16ac levels in SL2 cells, using the values of Kind et al. (2008). (G) Binding of the polymerase II subunit Rpb3 50 to the lacZ gene. All ChIP experiments
were internally controlled by monitoring interactions at the X chromosomal and dosage compensated armadillo gene. Error bars represent mean ± SEM. See also
Figure S2.
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Balancing Transcription for Dosage Compensationconclusion, we performed an analysis of the global relationship
between H4K16ac levels (Kind et al., 2008) and gene transcrip-
tion in Drosophila SL2 cells. We found that H4K16ac correlates
positively with transcription on all female chromosomes as well
as on the male autosomes, but this correlation was not observed
on the male X chromosome (Figure 2F). Taken together with our
earlier finding that MOF can strongly activate transcription in
yeast (Akhtar and Becker, 2000), the data suggest that H4K16
acetylation has a potential for strong transcriptional activation,
which is diminished in the context of the DCC in males where
a higher than 2-fold activation would lead to nonphysiological
overcompensation.
Identification of MOF Interactors in Female Cells
So far the data suggest that MOF can activate transcription in
two distinct settings. In male flies, MOF mainly resides in the
DCC. The molecular context in females is not known. Akhtar
and colleagues recently reported the purification of an alternative
MOF complex (the NSL complex) from mixed-sex Drosophila
embryos and the Schneider-derived Sf4 cell line, which has
male features (Mendjan et al., 2006). In order to explore the
existence of an alternative complex in female cells, we estab-
lished a Kc cell population stably expressing FLAG-tagged
MOF-Gal4. Control cells expressed only the hygromycin resis-
tance, but no tagged protein. Extracts from both cell
populations were subjected to FLAG-affinity purification, and
MOF interactors were identified by mass spectrometry. Compar-
ison of the identified peptides revealed robust scores for MOF,
MBD-R2, NSL1, NSL2, NSL3, WDS, and MCRS2 exclusively in
the MOF purification (Table S1A). These proteins had previously
been identified as MOF interactors by Mendjan et al. (2006). The
proteins Z4, Chriz/chromator, and exosome subunits that had
also been suggested to interact with MOF were retrieved in our
control purification and hence do not qualify as MOF associated
(Table S1). In further contrast to the complex described by Mend-
jan et al., we did not find nuclear pore complex components in
either purification. To rule out the possibility that substoichiomet-
ric amounts of nucleoporins escaped mass spectrometry detec-
tion, we probed for MTOR and Nup153 by western blotting but
failed to detect them in our purifications (data not shown). Our
data highlight MBD-R2, NSL1, NSL2, NSL3, WDS, and MCRS2
as subunits of one or more MOF complexes in female cells, which
may provide the molecular context for MOF function.
MBD-R2 Is a Marker of Active Genes
The alternative MOF complex was purified from female cells, but
the data of Mendjan et al. (2006) suggest that a related complex
also exists in male cells. Since MBD-R2 was the MOF interactor
with the highest score in both purifications, we provisionally term
the alternative complex the ‘‘MOF-MBD-R2’’ complex. As we
wished to follow MBD-R2 as a marker for this complex, we raised
polyclonal antibodies against MBD-R2 and confirmed their
specificity (Figures S3F–S3H). Staining of polytene chromo-
somes revealed localization of MBD-R2 at the majority of
gene-rich interbands of all larval polytene chromosomes of
both sexes (data not shown).
For high-resolution mapping, we combined ChIP with probing
tiled microarrays (ChIP-chip) (Straub et al., 2008). To distinguishM
between the sexes, we established chromosome-wide binding
profiles in sex-sorted adult flies (Figures S3B–S3E and S6). We
found genome-wide binding of MBD-R2 in female (Figure S3E)
and male flies (Figure 3A) with a preference for genes over inter-
genic sequences (Figure S3A). In order to correlate the MBD-R2
chromosome interaction profile with gene expression, we gener-
ated the ChIP-chip profile of MBD-R2 in SL2 cells. In brief, the
majority of binding events observed in adult flies also occur in
SL2 cells (Figure S6B). We determined the transcriptional status
of those cells by Affymetrix gene expression profiling of two
biological replicates. We found that most MBD-R2-bound genes
are transcriptionally active, whereas unbound genes are rarely
transcribed (Figure 3B). MBD-R2, therefore, appears to be a
marker of active chromatin. Interestingly, the amount of
MBD-R2 loading is not directly proportional to the expression
level. Above a certain (low) expression threshold, MBD-R2
binding does not systematically increase with transcription
(Figure 3B). MBD-R2 binds the same loci in both sexes without
significant preference for any of the chromosomes (Figures 3C
and 3D). The male and female X chromosomes are bound to
roughly similar extents (compare Figure 3A and Figure S3E,
Figures 3C, 3D, 7B).
Colocalization of MOF with DCC and MBD-R2
To correlate MOF binding with either MBD-R2 or MSL1 (a marker
for the DCC), we generated binding profiles for MOF in flies of
sorted sex and for MSL1 in males. In agreement with previously
published SL2 cell profiles (Gilfillan et al., 2006), MSL1 associ-
ates almost exclusively with X chromosomal genes in male flies
(Figure S3D). Here, MOF predominantly colocalizes with MSL1.
MOF binds the autosomes in males with much lower but still
significant levels (Figure S3B), in agreement with mapping data
in SL2 cells and polytene chromosome staining (Bhadra et al.,
1999; Kind et al., 2008). By contrast, the MOF levels in female
flies were similar on all chromosomes and clearly elevated rela-
tive to male autosomes (Figure S3C, Figure 7A).
MOF binding generally correlates with both MSL1 and
MBD-R2 with interesting difference upon closer look. In the
absence of the DCC, on male autosomes and all female chromo-
somes, MOF colocalizes extensively with MBD-R2 (correlation
coefficient above 0.9, Figures 4A and 4B). Unexpectedly, most
of the MOF-bound genes on the male X chromosome recruit
both, MSL1 and MBD-R2 (Figure 4C). However, MOF correlates
highly with MSL1, whereas the association of MBD-R2 varies
(Figure 4A). An assessment of the binding profiles along the
gene bodies shows that the distributions differ (Figure 4D).
Next, we calculated the average binding signal along a window
of 4 kb around the transcriptional start site (TSS) or the transcrip-
tional termination (TT) site (Figure 4E). Avoiding complications
arising from close-by, nested, and overlapping genes in the
compact Drosophila genome, we selected nonoverlapping,
active genes with a minimal length of 2 kb. To avoid bias by
outliers, the genes were grouped according to their expression
levels. The study revealed an enrichment of MSL1 (Figure S4)
and MOF toward the 30 end of genes on the male X chromosome
(Figure 4E), consistent with previous observations in SL2 cells
(Gilfillan et al., 2006; Kind et al., 2008). In striking contrast to
MOF and MSL1, MBD-R2 is enriched toward the 50 end of genesolecular Cell 38, 815–826, June 25, 2010 ª2010 Elsevier Inc. 819
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Figure 3. MBD-R2 Binds Active Genes Globally
(A) Chromosome-wide binding of MBD-R2 in male flies. Oligonucleotide probe signals are plotted along the major chromosomes as indicated (note that the
entire X chromosome is represented, but only parts of each autosome). Significant bound probes (tileHMM, see the Supplemental Experimental Procedures)
are marked in red. Numbers along the x axis denote the physical position along the chromosomes in megabase pairs (Mb).
(B) MBD-R2 binds active genes independent of expression level. Genes were grouped in equal-sized bins according to their expression levels (GST RNAi
expression set, see Figure 5). The ordinate depicts the signal distribution of average gene binding values in the respective groups, assessed by MBD-R2
ChIP-chip in SL2 cells.
(C) MBD-R2 binding coincides in male and female flies. Correlation of the ChIP-chip binding signal (averaged gene binding score, see the Supplemental
Experimental Procedures) of X chromosomal genes (upper panel) or autosomes (lower panel) from at least three biological replicates from both sexes. Spearman
correlation coefficient rho = 0.94 (p < 2.2e-16).
(D) ChIP-chip profiles of MBD-R2 in male and female flies along a representative X chromosomal region. The profiles are related to a gene representation at the
bottom of the panel, where genes drawn above the line are transcribed from left to right and genes below the line are transcribed from right to left. Active genes are
marked in red, inactive genes in black (Chintapalli et al., 2007). The x and y axis are denoted as in (A).
See also Figure S3.
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Balancing Transcription for Dosage Compensationand peaks around the TSS (Figure 4E). In the absence of the
DCC, on all female genes and on male autosomal genes, MOF
enriches with MBD-R2 at the 50 ends.
In summary, we generated a high-resolution chromosome-
wide binding profile of MOF, MSL1, and MBD-R2 in primary fly
tissue (summarized in Figure S6B). The DCC-binding pattern is
very similar in male flies and in SL2 cells. Colocalization suggests
that MOF resides in the DCC on the male X chromosome and
with the MOF-MBD-R2 complex on all other chromosomes.
Most active genes are bound by the MOF-MBD-R2 complex,
which enriches at the 50 end of genes in the absence of DCC.
MBD-R2 Acts as a Genome-wide Transcriptional
Activator
MBD-R2 preferentially associates with the 50 ends of active
genes. Does it contribute to transcriptional activation? Unfortu-820 Molecular Cell 38, 815–826, June 25, 2010 ª2010 Elsevier Inc.nately, flies bearing mutant alleles of MBD-R2 die early during
development precluding a loss-of-function analysis. We thus
ablated MBD-R2 in SL2 cells by RNA interference (RNAi)
(Figure S3G) and investigated the transcriptome changes. Tran-
scription profiles were obtained from two biological replicates of
cells subjected to RNAi targeting the central and the 30 part of the
MBD-R2 transcript and controlled for nonspecific effects with
RNAi directed at glutathion-S-transferase (GST) sequences.
The transcriptomes of the two MBD-R2 RNAi samples and of
the biological replicates were highly similar, precluding off-target
effects (Figure S5). Next, we sorted all active genes in equal-
sized bins according to the MBD-R2 ChIP-chip signal. Plotting
those bins against the expression change after RNAi revealed
that the more a given gene was bound by MBD-R2, the more
its expression was reduced after ablation of the factor (Figure 5).
There was no significant difference between X and autosomes in
Molecular Cell
Balancing Transcription for Dosage Compensationthis respect (data not shown). We conclude that MBD-R2 is
a transcription activator.
The DCC Integrates Activating and Restrictive
Principles
The enrichment of MBD-R2 toward the 50 ends of genes and its
global stimulation of transcription suggests a contribution of
MBD-R2 to the activation of the reporter loci. In support of this
hypothesis, we found by ChIP roughly twice as much MBD-R2
at the 50 end of the lacZ gene upon MOF recruitment in female
flies compared to males (Figure 6D). Figure 6A graphically illus-
trates the relative occupancy of MBD-R2, MSL2, and tethered
MOF (H4K16 acetylation) at the 50 lacZ site in RC5 males and
females (data from Figures 2 and 6D and not shown). MOF
recruitment and H4K16ac levels are similar in both sexes. In
females lacking MSL2, MBD-R2 accumulates to higher levels
than in males. Conceivably, here all MOF is associated with
MBD-R2. The situation is more complicated in male cells, where
MSL2 (the DCC) localizes to the tethering site in addition to
MBD-R2. Given the limited number of UAS elements, it is
possible that MBD-R2 and the MSL proteins compete for inter-
action with tethered MOF. In order to test this hypothesis, we
expressed MSL2 in females bearing the RC5 reporter, which
leads to ectopic formation of the DCC and transforms the flies
into pseudomales (Kelley et al., 1995). MSL2 was recruited to
the tethering site by ChIP, suggesting the assembly of the
DCC (Figure 6B). Strikingly, at the same time the levels of
MBD-R2 at this site were reduced to about 50%, in support
of a competition between MSL2 and MBD-R2 for MOF binding
(Figure 6D). Remarkably, measuring b-galactosidase activity
under those conditions revealed a reduction of reporter gene
expression, down to roughly 2-fold above basal levels (Fig-
ure 6E). Of note, MOF and H4K16ac levels did not change
upon MSL2 expression (data not shown). This result documents
the lower transcription activation potential of the DCC relative to
the MBD-R2 complex at the reporter locus. We tested whether
elevation of another DCC subunit, MSL1, also constrained
MOF-dependent activation. Overexpression of MSL1 in the
context of MOF-Gal4 recruitment in females does not lead to
formation of the DCC (males show reduced viability) (Chang
and Kuroda, 1998). Recruitment of MSL1 by MOF (Figure 6C)
only led to a slight reduction of MBD-R2 levels (Figure 6D), con-
comitant with a minor reduction of lacZ expression (Figure 6F).
The reduced expression of the reporter locus upon DCC
assembly in females led us to hypothesize that the DCC may
not only contain an activator (MOF) but also a ‘‘constraining prin-
ciple’’ that limits the overall activation to a 2-fold range. In order
to test this hypothesis, we resorted to SL2 cells, which contain
both the DCC and MBD-R2 complex. We cotransfected these
cells with an expression plasmid for MOF-Gal4 and plasmids
bearing UASGal-responsive luciferase reporter genes whose
transcription we monitored. The UASGal tethering site was
placed either 50 or 30 of the reporter gene in an effort to create
a situation resembling that of RC5 and RC3, respectively. In
order to selectively monitor the function of either complex alone,
we knocked down either MSL2 or MBD-R2 using two nonover-
lapping RNAi constructs. Remarkably, the luciferase expression
from both constructs increased relative to the control RNAi uponM
ablation of MSL2, in support of the hypothesis that the DCC
restricts the activation potential of MOF activation (Figure 6G).
The increased activation may well be due to increased associa-
tion of MBD-R2 with tethered MOF, since RNAi against MBD-R2
led to a reduction of reporter gene expression (Figure 6G).
Dynamic Distribution of MOF between the DCC
and the MBD-R2 Complex
These data suggest a dynamic distribution of MOF between
DCC and MBD-R2 complexes, which depends on the relative
levels of either component. In order to test whether such a
scenario would also apply on a genome-wide scale, we gener-
ated ‘‘pseudomale’’ flies as before by ectopic expression of
MSL2 in females and generated chromosome-wide binding
profiles for MBD-R2 and MOF. Given the differential distribution
of MOF in male and female cells (Figures S3B and S3C), we ex-
pected to see a relocalization of MOF from the autosomes to the
X chromosome. Strikingly, we found this to be the case. Even
modest expression of MSL2 (and concomitant DCC assembly)
led to a significant relocalization of MOF from autosomes to
the X chromosome (Figures 7A and 7C), while the localization
of MBD-R2 did not change (Figure 7B). This result suggests
that the relative levels of the two targeting principles, MBD-R2
and DCC, determine the distribution of MOF between the X
and the autosomes.
DISCUSSION
Acetylation of H4K16ac is unique among the histone acetylation
events in that it reduces the interaction between H4 and H2A/
H2B in close-by nucleosomes and hence counteracts the
compaction of nucleosomal arrays into fibers (Robinson et al.,
2008; Shogren-Knaak et al., 2006). The large potential of
H4K16ac and of MOF, the enzyme responsible for its placement,
for regulated chromatin opening and activation of transcription
has been revealed in model systems (Akhtar and Becker,
2000). MOF was originally discovered in Drosophila due to its vital
role in dosage compensation, which so far is mainly attributed to
its H4K16 acetylation function (Akhtar and Becker, 2000; Hilfiker
et al., 1997; Smith et al., 2000). Dosage compensation involves
a subtle, 2-fold activation of transcription of most X chromosomal
genes in males. The principles that allow such precise adjust-
ment of transcription are unknown and the contribution of
H4K16 acetylation to this fine-tuning is equally mysterious.
Despite the male-specific lethality associated with MOF muta-
tions, MOF also has less prominent functions in female cells,
where it is expressed at considerable levels (Bhadra et al.,
2000; Kind et al., 2008). We have now identified an additional
molecular context for MOF function in female Kc cells by identi-
fying MOF interactors. Previously, Akhtar and colleagues had
shown the existence of a highly related complex in male cells
and mixed sex embryos (Mendjan et al., 2006). A hallmark of
this complex is the subunit MBD-R2, an uncharacterized protein
featuring similarity to methyl-CpG-binding domains and several
types of zinc fingers (Bienz, 2006). Because of the differences
between the interactors we purified and the NSL complex
described by Mendjan et al. (2006), we provisionally refer to
the MOF complex in Kc cells as the MOF-MBD-R2 complex.olecular Cell 38, 815–826, June 25, 2010 ª2010 Elsevier Inc. 821
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Figure 5. MBD-R2 Is a Genome-wide Transcriptional Activator
Active genes (Muse et al., 2007) were grouped according to their averaged
MBD-R2 binding score and plotted against their expression change after
MBD-R2 RNAi (log2 [MBD-R2 RNAi/control RNAi]). Genes were categorized
in groups with increasing binding score as represented in the box plots. Genes
were considered ‘‘active’’ if elongating polymerase was bound significantly in
the ChIP-chip profile of Muse et al. (2007). Similar results were obtained if
genes with an expression value of at least 4 in the control samples (Affymetrix
scale) were classified as ‘‘active.’’
See also Figure S5.
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assemblies they form is not known yet.
Male cells contain MBD-R2 (or NSL) complexes in addition to
the DCC, and Mendjan et al. (2006) suggested that the NSL
complex and the DCC might compete for MOF recruitment.
Biochemical studies are needed to firmly establish such a
scenario. However, our chromosome-wide profiles are indeed
consistent with a dynamic distribution of MOF between these
two complexes. The global chromosomal interaction pattern of
MOF correlates well with the association profile of MBD-R2;
conceivably, the MBD-R2 context is the only targeting determi-
nant for MOF in female cells. This targeting scenario is chal-
lenged by forced expression of MSL2 in females that leads to
ectopic DCC assembly in potential competition for MOF.
Remarkably, we observed a massive relocalization of MOF
from the autosomes to the X chromosome. This creates a situa-
tion reminiscent of male cells, where we find that MOF preferen-
tially colocalizes with MBD-R2 on autosomes, but with the DCC
on the X chromosome. We suppose that the balancing of the
genome—dosage compensation—involves a dynamic distribu-
tion of MOF between the two complexes.
Our data suggest that the two MOF complexes have different
roles in transcription. The DCC mainly localizes to gene bodies
with a 30 enrichment, which has led to the speculation that
dosage compensation regulates elongation efficiency (Alek-
seyenko et al., 2006; Gilfillan et al., 2006). MBD-R2 also activates
transcription but, in contrast to the DCC, binds active genes
globally with a 50 bias. The defined setting of our reporter gene
system revealed that, depending on context, tethering MOF
installed two different activation modes. In females, in the
context of MBD-R2, activation was variable, distance depen-
dent, and correlated with H4K16 acetylation levels as well as
enhanced polymerase loading. This scenario is akin to short-
range stimulation of transcription initiation by ‘‘promoter-
specific’’ regulators.
By contrast, transcription stimulation in males was dominated
by the DCC. Activation was in the 2-fold range and distance
independent, a scenario compatible with dosage compensation,
despite of the high H4K16 acetylation levels that correlate with
higher transcription rates in female cells. We thus hypothesized
that the activating effect of H4K16 acetylation is constrained
by an opposing principle associated with the formation of the
DCC. This hypothesis has been strengthened by several of our
results. First, a global analysis reveals that H4K16ac levelsFigure 4. MBD-R2 and MOF Colocalize on Active Genes under All Circ
(A and B) Correlation between chromosomal binding of MOF and MSL1 or MOF a
binding score per gene (see the Supplemental Experimental Procedures) of M
correlation coefficients (rho) are p < 2.2e-16.
(C) The majority of active genes on the male X are bound by MBD-R2, MOF, and
(D) Binding of MSL1, MOF, and MBD-R2 along a representative region of the X chr
to the gene representation at the bottom of the panel. All genes are active. Genes
left to right or right to left, respectively.
(E) Differential distribution of MOF and MBD-R2 across the gene bodies. Cumula
were aligned at the transcriptional start site (TSS) and transcriptional termination s
TSS and TT in a sliding window (10 bp step size, 300 bp window). For this analysis,
minimally 2 kb long, do not overlap with other genes, and are expressed. The gene
into ‘‘low’’ (black), ‘‘intermediate’’ (orange), ‘‘high’’ (blue), and ‘‘very high’’ (purple
See also Figure S4.
M
roughly correlate with transcription on all female chromosomes
and on male autosomes, but not on the male X chromosome.
Second, reduction of MSL2 levels in SL2 cells led to activation
of a reporter gene, while ablation of MBD-R2 resulted in reduced
transcription. Finally, ectopic expression of MSL2 in females
resulted in reduced levels of MBD-R2 at the reporter locus and
limited the stimulation of transcription to a 2-fold range.
The finding that a HAT may be programmed by association
with distinct sets of subunits is not without precedent. For
example, the catalytic activity of GCN5 is modulated dependingumstances, Except for the Male X Chromosome
nd MBD-R2 on male (A) or female (B) chromosomes. Scatter plots of averaged
BD-R2, MOF, and MSL1 on male chromosomes as indicated. All spearman
MSL1. Venn diagram of significantly bound active genes.
omosome in males (left panel) and females (right panel). The profiles are related
depicted above or below the line of physical coordinates are transcribed from
tive plots of MOF (left) and MBD-R2 (right). ChIP-binding signals along genes
ite (TT). The average binding score is plotted 2 kb bp up- and downstream of the
637 X chromosomal genes and 740 autosomal genes were selected, which are
s were grouped according to their gene expression level (Chintapalli et al., 2007)
) categories. The x axis denotes the distance to the TSS and TT in base pairs.
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Figure 6. Sex-Specific Cofactor Recruitment upon MOF Binding
(A) Schematic illustration of the relative occupancy of chromatin constituents at the 50 lacZ site in male and females. The graph summarizes data presented in
Figures 2B, 2D, and 6B and data not shown for MSL2. Displayed are the ratios of ChIP enrichment of the indicated antibodies in females (white bar) and males
(black bar). MOF or H4K16ac levels are similar in both sexes. MSL2 is only enriched in males (background levels in females). Females lacking MSL2 accumulate
more MBD-R2 than males.
(B and C) Ectopic expression of MSL2 (B) and MSL1 (C) in females leads to enrichment of the corresponding protein at the RC5 locus upon MOF recruitment
(control represents the RC5 locus in the absence of MOF-Gal4). Error bars represent mean ± SEM. Overexpressing MSL1 males could not be analyzed due
to lethality. White bars, female flies; black bar, male flies.
(D) ChIP with MBD-R2 in females expressing either MSL2 as in (B) or MSL1 (C). Tethering MOF to the lacZ reporter leads to a 2-fold enrichment of MBD-R2 in
females versus males. Expression of MSL2 (pseudomales) reduces the MBD-R2 levels. Expression of MSL1 has only a minor impact. Presentation as in (B).
(E and F) Change of lacZ induction (b-galactosidase activity) by MOF upon ectopic expression of MSL2 (E) or MSL1 (F). Presentation as in (B).
(G) Reporter gene activity in SL2 cells after ablation of MSL2 and MBD-R2. SL2 cells were treated with dsRNA against GST (control), MSL2, or MBD-R2
sequences. Three days after RNAi treatment, cells were transfected with an expression vector for Gal4-MOF and a firefly luciferase reporter furnished with UASGal
elements either 50 of the minimal thymidine kinase promoter or 30 of the firefly luciferase gene. Transfection efficiency was normalized by coexpression of a Renilla
luciferase expression plasmid.T test, two-sided and unpaired, error bars represent mean ± SEM.
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Balancing Transcription for Dosage Compensationon the SAGA or ATAC context (Carre et al., 2008). While this
manuscript was revised, Conaway and colleagues reported
on a change in substrate specificity for human MOF, depending
on its residence within the MSL or NSL context (Cai et al., 2010).
It will be interesting to see whether the different complex environ-
ments also reprogram the catalytic activity of MOF in Drosophila.
In summary, our data suggest that the precise 2-fold activation
in Drosophila dosage compensation is achieved by constraining
the activation potential of H4K16 acetylation. Deciphering the
underlying mechanism will help to reveal the principles that824 Molecular Cell 38, 815–826, June 25, 2010 ª2010 Elsevier Inc.govern genome balancing at the level of chromosome organiza-
tion and remains as a challenge for future work.
EXPERIMENTAL PROCEDURES
Further detailed experimental procedures are described in the Supplemental
Information.
Fly Stocks
All P element constructs were injected into y1,w1118 and raised on standard fly
food.
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Figure 7. MOF Redistributes to the X Chromosome in Female Flies
Overexpressing MSL2
(A and B) Box plots present ChIP-chip signals of autosomal or X chromosomal
probes, which represent the binding of MOF (A) and MBD-R2 (B) in wild-type
(WT) females, MSL2 expressing females (pseudomales) and wild-type males.
The ordinates depict the log2-normalized values of probes. The 99% confi-
dence interval (CI) of the true difference in means between X chromosomal
and autosomal MOF binding is shown. The red line depicts the median from
all probes.
(C) Chromosome-wide difference plots of MOF binding between pseudomales
and females. The difference of oligonucleotide probe signals between pseudo-
males and females is plotted along the major chromosomes as indicated
(note that only part of the autosomes are represented). Significant (adjusted
p values < 0.05) gains are marked in red, significant losses are marked in
blue. Numbers along the x axis denote the physical position along the chromo-
somes in megabase pairs (Mb).
See also Figure S6.
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M
The RC5 reporter fly line is a gift from R. Paro and was originally published as
U/I5 in Zink and Paro (1995). Fly strains expressing Hsp70Gal4, Hsp83MSL1,
and Hsp70MSL2 are published (Chang and Kuroda, 1998; Rank et al., 2002;
Straub et al., 2005b).Antibodies
The MOF antibody was raised in rabbit using the complete protein as antigen
(Akhtar and Becker, 2000; Morales et al., 2004). An MBD-R2 fragment
corresponding to amino acids 1–355 was expressed in E. coli BL21 cells fused
to an N-terminal GST tag, purified on glutathione beads, and used to raise
polyclonal antibodies in rabbits. Antibodies against H4K16ac were obtained
from ACTIVE MOTIF (#39167) and the GAL4 antibody from SantaCruz Biotech-
nology (sc-577). MSL1 and MSL2 antibodies were previously published
(Gilfillan et al., 2006, 2007).RNA Quantification
Total RNA was isolated from six adult females or seven males. Flies were
frozen in liquid nitrogen, grained to powder, and suspended and purified
with Trizol (Invitrogen). cDNA was synthesized with SuperScript II Reverse
Transcriptase (Invitrogen). Quantification was performed with the real-time
PCR ABI 7000 (primer see qPCR primers). Values were normalized to
gapdh1.ChIP-qPCR
ChIP material was quantified by real-time PCR (ABI 7000, Applied Biosys-
tems). Approximately 1 ng of the purified input DNA was used per reaction.
Depending on the antibody, 2%–5% of the ChIP material was required
per reaction. Enrichment was calculated over input. Since various chromatin
preparations of different genotypes and sexes were compared, we standard-
ized to the autosomal gapdh1 locus after input normalization. ChIP experi-
ments were performed in technical and biological replicates. Primers
used are indicated in Table S1. Each experiment was performed at least in
triplicate.ACCESSION NUMBERS
The microarray data are located at the Gene Expression Omnibus under the
accession numbers GSE20695 (ChIP data) and GSE20744 (Affymetrix data).SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, four tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at doi:10.1016/j.molcel.2010.05.022.ACKNOWLEDGMENTS
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(A-D) Polytene stainings upon MOF recruitment in the RC5 line, zoomed 
in at the 93B integration site 
(E,F) The yeast GAL4 activator regulates gene expression independent 
on H4K16 acetylation 
 
3 
Figure S3: 
supplement 
to Figure 3 
(A-E) Genome-wide binding of MBD-R2 and MOF in females and males, 
and MSL1 in males 
(F-H)  MBD-R2 antibody specificity control 
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Table S1: Mass spectrometry data for the MOF-MBD-R2 complex purification 
 
 
protein scores MOF IP scores control IP 
MOF 2415 0 
MBD-R2 700 0 
NSL1 572 0 
NSL2 142 0 
NSL3 438 0 
Wds 232 0 
dMCRS2 212 0 
Rrp4 35 116 
Rrp6 118 463 
Rrp42 63 142 
Dis3 405 723 
Z4 61 56 
chromator 37 29 
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Table S2: Cloning primer 
 
 
 
Table S3: ChIP-qPCR primer 
 
 
cloning 
primer 
Forward reverse template clone # 
MBD-R2 CCATGGGGCCAT
ATGGATACCGCG
GAGATCGAAGC 
AACAGTTCTAGACTAG
TGCTCGCCCACAATGA
GGAAACC 
SD10773 
Mof-
FLAG-3’ 
TGCATGCTCGACT
ACAAAGACGACG
ACGACAAATAGCA
TACGGAACCTGG 
TAGGGCCCCCCGGGTT
TTTCGTTTGGAGGGGT 
genomic mof 
RsrII-GAL 
4 
ATCGGTCCGAAG
CTACTGTCTTCTA
TC 
TACGGACCGGCCGGC
GATACAGTCAA 
pAS MOF 
(Akhtar and Becker, 2000) 
KpnI-
5xUAS 
GAATGGTACCTAT
ACTCCGGCGCTC 
GAATGGTACCCTCGGA
TCCAAGCTT 
RC5 construct 
(in this paper) 
Locus Forward Reverse 
armadillo 
5’ 
CACGAACTCCATGTTATTGACTGT
C 
ATTCTGGGCTGGCATGTAACT 
lacZ 5’ GCAACTACTGAAATCTGCCAAG GTTTTCCCAGTCACGACGTT 
lacZ 3’ GCTACATGACATCAACCATATCAG 
C 
GATCCTCTAGAGTCGAGGCC 
TL lacZ 
3’ 
TGTTGAAGTGGCGAGCGATAC GGTCGGGATAGTTTTCTTGCG 
white 5’ GATCATATCATGATCAAGACATCT
AAAGGC 
GTGCATCTAGGATCAGCTTAA
AATAT 
white 3’ TGTGCGTTAGGTCCTGTTCATTG CCTGTTCGGAGTGATTAGCGT
TAC 
gapdh1 GTGACCTACGCAGAAAGCTAG GCTATTACGACTGCCGCTTTTT
C 
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Table S4: RNAi primer 
 
Construct Forward Reverse 
MBD-
R2_1 
TTAATACGACTCACTATAGG
GAGATGGAGCCACCAAGTG
TG 
 
TTAATACGACTCACTATAGGGATGT
CGGTCTGGTCATTAGATG 
MBD-
R2_2 
TTAATACGACTCACTATAGG
GATC GACGTCGCGT 
CTGTTG 
TTAATACGACTCACTATAGGGA 
GACAGGATTTGCGCAACTAT 
GST TTAATACGACTCACTATAGG 
GAGAATGTCCCCTATACTAG 
GTTA 
TTAATACGACTCACTATAGGGAGAA
CGCAT CCAGGCACAT TG 
msl2_1 TTAATACGACTCACTATAGG 
GAGAATGGCCCAGACGGCA
T AC   
TTAATACGACTCACTATAGGGAGAC
AGCGATGTGGGCATG TC 
msl2_2 TAATACGACTCACTATAGGG 
TTCCCCTGCTGCCCACAG 
TAATACGACTCACTATAGGGCTCTG
ACGGGATTGAGGTC   
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Supplemental experimental procedures 
 
Cloning procedures 
An 8 kb ApaI-XhoI fragment containing the intron-free genomic mof locus was 
isolated from clone RP98-11C13 and subcloned into the pBS-SKII. The 147 amino 
acid GAL4 binding domain (GAL4-DBD) was furnished with RsrII restriction sites via 
PCR and inserted into the unique RsrII site 111 bp downstream of the mof translation 
start site. A FLAG tag was added at the 3‟ end of the mof gene. mof was expressed 
from flanking sequences within KpnI-XhoI fragment and the 3‟ flanking gene CG3033 
was removed via PCR (see primers in supplement) (Fig. 1A). The MOF over-
expression construct was created by amplifying the hsp83 promoter and the 94 
amino acid (aa) GAL4-DBD from the hsp83/GAL4/Dorsal construct (Flores-Saaib et 
al., 2001). A mof cDNA, containing a 3‟ FLAG tag, was isolated via PCR and fused to 
the above described hsp83-GAL4-DBD amplicon in a pBluescript yielding hsp83-
GAL(94)MOF-FLAG. For P-element-mediated transformation the MOF expressing 
constructs were cloned into the SmaI site of the P-element transformation vector 
pYES (Patton et al., 1992). The RC3 reporter construct was cloned by inserting a 
5xUAS of the pUAST-vector (Brand and Perrimon, 1993) into the KpnI-SphI site. 
Subsequent digestion with KpnI allowed inserting a KpnI-BamHI hsp70-lacZ fragment 
from the pHZR vector (Gindhart et al., 1995) after blunting. 
For antibody production cDNA fragments of MBD-R2 (1-355 aa of the smaller isoform 
A) and of NSL1 (aa 562-932) were ordered from the Drosophila Genomics Resource 
Center and cloned into the pGEX 2TKN. All primers are listed in the table S2. 
The firefly reporter construct pGL3-Tkmod (Gilfillan et al., 2007) was modified as 
follows. To minimize steric promoter inhibition we introduced 214 bp of the human 
rDNA locus into the SmaI site. For the 5‟ UAS construct the KpnI-5xUAS fragment 
was amplified via PCR and added into the KpnI site (see primers in supplement). The 
3‟UAS construct was obtained by cloning the same KpnI-5xUAS PCR fragment blunt 
into the HpaI site 3‟ of the firefly luciferase gene. Details are available upon request. 
 
Stable cell lines and protein purification 
Kc cells were cotransfected with phsp83-GAL(94)MOF-FLAG and pCoHygro 
(Dignam et al., 1983; Van der Straten et al., 1989). Stable transformants were 
selected in the presence of 500µg/ml Hygromycin B. A Hygromycin B-resistant clone 
without hsp83-GAL(94)MOF-FLAG expression served as a control. Stable lines were 
expanded in roller bottles to a final density of 3x106 cells/ml.  
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Nuclear extracts were prepared based on the protocols by Dignam and Roeder 
(Dignam et al., 1983) and Heberlein and Tjian (Heberlein and Tjian, 1988). PBS-
washed Kc cells were resuspended in 5 times of the packed cell volume (PCV) 
hypotonic buffer A: (10mM HEPES pH 7.6, 15mM KCl, 2mM MgCl2, 0.1mM EDTA), 
kept on ice for 15 min and then dounced 10-15 times with a tight B pestle. Buffer B 
(50mM HEPES pH 7.6, 1M KCl, 30mM MgCl2, 0.1mM EDTA) was added immediately 
in a 1:10 ratio to obtain buffer AB. Nuclei were obtained by centrifugation and 
subsequently resuspended in one PCV of buffer AB. Nuclei were extracted by adding 
1/10 volumes of 4M (NH4)2SO4 and incubation for 15 minutes with gentle mixing 
followed by ultracentrifugation at 48,000 rpm (TLA-55) for 2 hours. The clear 
supernatant was subsequently precipitated with 0.3g freshly ground (NH4)2SO4 per 
ml supernatant. Precipitate was resuspended in HEMG150 (25mM  HEPES pH7.6, 
150mM NaCl, 12.5mM MgCl2, 0.1mM EDTA, 20% glycerol), dialysed against 
HEMG150 for 4 hours, snap-frozen and stored at -80°C. All buffers contained 1mM 
DTT, 1mM Na2S2O5 and 0.5mM PMSF. Final nuclear extracts contained additional 
protease inhibitors Leupeptin, Pepstatin and Aprotinin. 
For Anti-FLAG immunopurification 30µl of anti-FLAG M2 agarose beads (Sigma, 
A2220) were equilibrated with HEMG150 and mixed with 500µl nuclear extract for 2 
hours. Nonspecifically bound material was washed-off three times for 15 minutes with 
wash buffer (25mM HEPES pH 7.6, 150/250mM NaCl, 12.5mM MgCl2, 0.1mM EDTA, 
0.01% NP-40). Bound proteins were eluted with HEMG150 containing 0.5 mg/mL 
FLAG peptide and the soluble protein fraction collected after centrifugation. 
Mass Spectrometry – Ammoniumbicarbonate (40 mM final concentration) and 
Trypsin (sequencing grade, modified; Promega; 2 µl of 0.2 µg/µl solution) were 
added to the eluate and proteins were digested over-night at 37°C while shaking (600 
rpm).  
For protein identification probes were directly used for nano-ESI-LC-MS/MS. Each 
sample was first separated on a C18 reversed phase column (75 µm i.d. x 15 cm, 
packed with C18 PepMap™, 3 µm, 100 Å; LC Packings) via a linear acetonitrile 
gradient. MS and MS/MS spectra were recorded on an Orbitrap mass spectrometer 
(Thermo Scientific). The resulting spectra where analyzed via the Mascot™ Software 
(Matrix Science) using the NCBInr Protein Database. 
 
ß-Galactosidase assay 
To measure the expression of lacZ a -galactosidase assay was performed as 
previously described (Fitzsimons et al., 1999) with modifications. 3-6 adult flies (3-4 
days old) were collected and frozen in liquid nitrogen. Flies were grained and 
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resolved in 50 mM potassium phosphate buffer (pH 7.5) with 1 mM MgCl2. The 
protein concentration was determined according to Bradford. CPRG (Roche Cat No. 
10884308001) was used as substrate. The kinetic of this colorimetric assay 
(mOD/min) was determined with a multi-well plate absorption reader (time frame: 
minimum 20 min, interval: 20 sec, wavelength: 574 nm; BioTek PowerWave HT) at 
37°C and normalized to the protein concentration. Biological replicates were 
performed. 
 
Luciferase assay 
8x106 SL2 cells were seeded in 25 cm2 flask in 3 ml standard Schneider medium 
without serum and treated with 40 µg dsRNA (GST, msl2 or MBD-R2). After 1h, 6 ml 
Schneider medium with serum was added. Cells were incubated for 3 days and 
subsequently distributed in 6 well plates for transfection (1.5x106 per well). A plasmid 
mix was prepared, containing the activator MOF-Gal4 (MOF promoter), the UAS-
containing firefly luciferase reporter and the Renilla luciferase reporter (both tk 
promoter) for normalisation. Transfection was performed according to the Effectene 
transfection kit (Qiagen, #301427). After 2.5 days cells were harvested, lysed by 
freezing and thawing in 300 mM KCl, 50 mM HEPES pH 7.6, 0.5 mM EDTA, 0.1% 
NP40 and 1 mM DTT in the presence of protease inhibitors. 1/10 of the lysate was 
assayed for luciferase activity in a Lumat LB 9501 (Berthold), according to the 
Promega Dual-Luciferase assay Manual (#E1960). 
 
Chromatin preparation and chromatin immunoprecipitation 
Chromatin was prepared from sex-sorted adult flies. The protocol from Negre et al. 
(Negre et al., 2006) was applied with some modification: 300 mg of 3-4 days old flies 
were crushed in 5 ml A1 (60 mM KCl, 15 mM NaCl, 4 mM MgCl2, 15 mM HEPES 
(pH 7.6), 0.5% Triton X-100, 0.5 mM DTT, 10 mM sodium butyrate, protease inhibitor 
cocktail (Roche, Cat No. 04693132011)) with a final concentration of 2.35% 
formaldehyde at 18°C for 15 min. Fixation was stopped with a final concentration of 
250 mM glycine. After 3 washes with A1 the pellet was equilibrated in lysis buffer 
(140 mM NaCl, 15 mM HEPES (pH 7.6), 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-
100, 0.5% sodium deoxycholate, protease inhibitor cocktail, 0.5mM DTT). The pellet 
was suspended in lysis buffer with 0.1% SDS and 0.5% N-lauroylsarcosine and 
rotated for 10 min at 4°C. Chromatin was sonicated (Branson (microtip), 4 times at 21 
watt) in the presence of glass beads (212-300 µm) in a volume of 2 ml in 15 ml falcon 
tubes. Cell debris was removed by centrifugation and the chromatin containing 
supernatant was stored in aliquots at -80°C.  
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For chromatin immunoprecipitation (ChIP) the DNA concentration of the chromatin 
was determined and 7.5 µg of DNA was used per IP in 500 µl lysis buffer plus 250 µl 
PBS (1xPBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitor 
cocktail. Chromatin was pre-cleared with protein-A and -G beads at 4°C for 30 min. 
After pre-clearing an aliquot was saved for input DNA purification. Immuno-
precipitation was carried out at 4°C overnight. The amount of antibody used per ChIP 
was adjusted individually. For the pull down 30 µl protein A and G beads were used 
per ChIP at 4°C for 3 h. Beads were washed 5 times in PBS, rinsed once in EB buffer 
(10 mM Tris-Cl, pH 8.5). De-crosslinking was performed in 100 µl EB with 0.6% SDS 
and a final concentration of 0.5 µg proteinase K and RNAse A. Digest was carried 
out at 55°C for 3 h and de-crosslinking at 65°C for 6 h. ChIP and input DNA were 
purified with phenol/chloroform using MaXtract High Density tubes (Qiagen, Cat No. 
129056) and subsequent ethanol precipitation. 
Chromatin preparation of SL2 cells was performed as previously described in Straub 
et al. (2008). 
 
ChIP-chip data analysis 
ChIP-chip data analysis was essentially performed as in Straub et al. 2008. Briefly, 
input and IP DNA were amplified using the WGA kit (Sigma) according to an online 
protocol (http://www.epigenome-noe.net/researchtools/protocol.php?protid=30). 
Labeling and hybridization to NimbleGen arrays was carried out at ImaGenes (Berlin, 
Germany). We used a custom array layout (approx. 1 probe/100bases, isothermal 
selection) comprising the euchromatic part of the entire X chromosome, 5 Mb of 2L, 
2R and 3L, respectively, as well as 10 Mb of 3R. Data analysis was performed using 
R/Bioconductor (www.Rproject.org; www.bioconductor.org). Raw signals of 
corresponding biological replicates were normalized and log2 transformed using the 
„vsn‟ package (Huber et al., 2002). Averaged binding scores per gene present the 
enrichments (log2 ratio of IP and input) normalized on the gene length. Enrichment 
statistics (IP versus input signals) were computed using the „sam‟ algorithm within 
Bioconductor (Tusher et al., 2001). Fdr values of the sam statistic were determined 
using „locfdr‟ (Efron, 2007). Region summarization was performed using the HMM 
algorithm of tileHMM (Humburg et al., 2008) with the following parameters: fragment 
size of 700, maximal gap of 400, minimal length of 400 and minimal score of 0.8. 
Genes were considered „bound‟ significantly with more than 5 tileHMM „bound‟ 
probes. Hierarchical cluster analysis of the binding pattern across genes was carried 
out using the „hclust‟ package of R. p values for figure 7B were Benjamini-Hochberg 
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adjusted. All data correspond to Drosophila genome version dm2 and annotation 
version gadfly 4.3. 
 
Transcriptome analysis 
Cultivation of the male Drosophila cell line SL2 and RNA interference (RNAi) of target 
genes were carried out as described previously (Straub et al., 2005). In brief, 1.5x106 
SL2 cells were incubated with 10 µg dsRNA for 1 hour in serum-free medium. 
Sequences of primers used for dsRNA production are listed in the table S4. After 
addition of serum-containing medium cells were incubated for 7 days at 26°C before 
RNA extraction. Preparation of chromatin extracts and western blot confirmation of 
target gene knockdown has been described previously. Depletion efficiency was 
quantified using a Li-Cor Odyssey system with -tubulin as  reference. 
RNA was isolated using Trizol (Invitrogen) followed by a purification using RNeasy kit 
(Quiagen) according to the instructions of the suppliers. RNA labeling and cDNA 
hybdridization to a Drosophila Genome GeneChip 2.0 was performed by ImaGenes 
(Berlin, Germany). Two biological replicate experiments were performed with a total 
of four control RNAi (3x GST RNAi and 1x mock RNAi) and six MBD-R2 RNAi (3x 
with each dsRNA construct). Data analysis was performed using R/Bioconductor 
(www.Rproject.org; www.bioconductor.org). Intensity values were normalized, 
summarized and log2 transformed using the „gcrma‟ package (Wu and Irizarry, 
2005). Other normalization methods (vsn, quantile) were also tested and performed 
similarly. Quality control assessment was performed using the R package 
“arrayQualityMetrics” (Kauffmann et al., 2009). We did not observe significant batch 
effects of the biological replicates. The transcriptome changes are similar upon 
treatment of two distinct dsRNA constructs targeting the MBD-R2 transcripts (Figure 
S3). Thus, the expression values for the control samples and the MBD-R2 RNAi 
samples were averaged, respectively. Significant change of gene expression was 
calculated using locfdr based on a sam statistics (Efron, 2007; Tusher et al., 2001). 
Genes were considered “differentially expressed” with an fdr cutoff of 0.35. 
Alternatively, an eBayes moderated t test or a limma statistic followed my multiple 
testing correction (locfdr) gave similar results. The results are robust to various 
parameters in data analysis, as assessed by choosing varying thresholds. The 
expression data of adult flies were taken from Chintapalli et al. and analyzed using 
the same algorithms of the MBD-R2 data set. All values of the expression set data 
are log2 normalized with a theoretical dynamic range of 2exp16 (Affymetrix.com). 
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3.2.1 Summary and own contribution 
 
In this review written by Dr. Matthias Prestel (50%), Prof. Peter Becker (25%) and myself (25%), we 
discuss the implications of the findings presented in section 3.1 in the context of general strategies to 
balance aneuploid genomes. It has been proposed before that three types of compensatory mechanisms 
are in place to respond to genome aneuploidies. According to this model, dosage compensation in 
male flies is a composite of a more general feedback or buffering principle and an additional feed-
forward mechanism exerted by the MSL-DCC. We expand this model by suggesting that the precise 
two-fold activation during dosage compensation is achieved by a balancing of counteracting activating 
and repressive activities.  
In addition to contributing to the text, I prepared the figures 1, 3 and 4.  
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3.2.2 Published review article 
 
Complex genomes are more than just the sum of their 
genes, but are rather complex regulatory systems in 
which the expression of each individual gene is a function 
of the activity of many other genes, so that the levels of 
their protein products are maintained within a narrow 
range. Such homeostasis favors the maintenance of the 
appropriate stoichiometry of subunits in multiprotein 
complexes or of components in signal transduction path­
ways, and defines the ‘ground state’ of a cell [1]. In diploid 
genomes, both alleles of a gene are usually active and this 
‘double dose’ of each gene is figured into the equation. 
Thus, deviations from diploidy, such as the deletion or 
duplication of genes or of larger chromosomal fragments 
(aneuploidy), unbalance the finely tuned expression of 
the genome. Segmental aneuploidies of this kind can 
arise from failed or faulty repair of chromosomal damage 
due to irradiation, chemical insult or perturbation of 
replication, or from illegitimate recombination during 
meiosis. Loss or duplication of entire chromosomes 
(monosomy or trisomy, respectively) can arise from non­
disjunction during cell division. Depending on the extent 
of the aneuploidy and on the genes affected, the fine 
balance of trans­acting factors and their chromosomal 
binding sites that define the gene­expression system is 
disturbed, and the fitness of the cell or organism 
challenged.
Often, aneuploidies have been associated with a variety 
of developmental defects and malignant aberrations, 
such as Down syndrome or certain breast cancers 
(reviewed in [2,3]). The phenotypes associated with 
changes in gene copy number can not only be the result 
of the deregulation of the affected gene(s), but may also 
reflect trans­acting effects on other chromosomal loci or 
even more global alterations of the entire regulatory 
system. This is particularly true if genes coding for 
regulatory factors, such as transcription factors, are 
affected (reviewed in [4,5]).
Strategies for re-balancing aneuploid genomes
Genome­wide studies in different organisms reveal that 
the expression of a substantial number of genes directly 
correlates with gene dose (the primary dosage effect) [6]. 
In other cases, the measured expression levels do not 
reflect the actual copy number, as compensatory mecha­
nisms aimed at re­establishing homeostasis take effect 
[4,5]. Imbalances due to aneuploidy may be compensated 
for at any step of gene expression from transcription to 
protein stability. Excess subunits of multiprotein 
complexes that are not stabilized by appropriate inter­
actions are susceptible to degradation (see [1] for a 
discussion of compensation at the protein level). Dosage­
compensation mechanisms at the level of transcription 
are versatile, intricate, and in no instance are they fully 
understood.
In principle, three types of compensatory responses to 
aneuploidies are recognized: buffering, feedback, and 
feed­forward, which may act individually or, more likely, 
in combination [7]. Oliver and colleagues [7] define 
buffering as ‘the passive absorption of gene dose pertur­
bations by inherent system properties’. Currently, the 
nature of this general or ‘autosomal’ buffering is un­
known, but its existence can be deduced from comparing 
gene expression to DNA copy number in healthy and 
aneuploid genomes [8­11]. The system properties 
referred to by Oliver and colleagues can be considered as 
the sum of the biochemical equilibria of the system ‘living 
cell’, which are predicted to moderate the effect of the 
reduction of one component. Apparently, the deletion of 
one gene copy (that is, a twofold reduction in gene 
expression) can be partially compensated for by 
increasing the steady­state mRNA levels originating from 
Abstract
Diploid genomes are exquisitely balanced systems of 
gene expression. The dosage-compensation systems 
that evolved along with monosomic sex chromosomes 
exemplify the intricacies of compensating for differences 
in gene copy number by transcriptional regulation.
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the remaining allele by, on average, 1.5­fold [7,11]. 
Interestingly, Stenberg and colleagues [11] observed that 
buffering appears to compensate for deficiencies better 
than for gene duplications, which leaves open the 
existence of a general sensor of monosomy that mediates 
the effect. A general buffering will also ameliorate the 
conse quences of widespread mono­allelic gene expres­
sion due to parental imprinting (cases where a single 
allele is expressed, depending on whether it is inherited 
from the father or mother) [12].
In contrast to the general and nonspecific buffering just 
described, a ‘feedback’ mechanism would be defined as 
gene­specific ­ sensing and readjusting the levels of 
specific molecules by appropriate, specific mechanisms. 
Finally, ‘feed­forward’ anticipates the deviation from the 
norm and hence can only be at work in very special 
circumstances. Prominent examples where feed­forward 
scenarios are applicable are the widely occurring mono­
somies in the sex chromosomes of heterogametic organ­
isms (for example, the XX/XY sex­chromosome system), 
which are present in each and every cell of the species.
In contrast to aneuploidies that arise spontaneously, 
these ‘natural’ monosomies and their associated dosage­
compensation mechanisms are the products of evolution. 
Research on dosage­compensation mechanisms associa­
ted with sex chromosomes continues to uncover un­
expected complexities and intricacies. The somatic cells 
of the two sexes of the main model organisms of current 
research ­ mammals, nematode worms (Caenorhabditis 
elegans) and fruit flies (Drosophila melanogaster) ­ differ 
in that those of females are characterized by two X 
chromosomes, while those of males have one X and one 
Y chromosome (mammals and Drosophila); or one sex 
(XX) is a hermaphrodite and the males have just a single 
X and no Y chromosome (X0) (C. elegans) [13]. 
Remarkably, different dosage­compensation strategies for 
balancing gene expression from the X chromosome 
between the sexes have evolved independently in these 
three cases (Figure 1), as we shall discuss in this article. 
There is increasing evidence that in all three cases, the 
transcription of most genes on the single male X 
chromosome is increased roughly twofold [14­16]. In 
fruit flies, this upregulation of the X chromosome is 
limited to males. In mammals and worms, however, the X 
chromosomes appear to be also upregulated in the XX 
sex, which necessitates additional compensatory measures. 
In female mammals, one of the X chromosomes is 
globally silenced, whereas in hermaphrodite worms, gene 
expression on both X chromosomes is downregulated by 
about 50% (Figure 1). An emerging principle is that the 
net fold­changes of dosage compensation are not 
achieved by a single mechanism (that is, there is no 
simple switch for ‘twofold up’), but by integration of 
activating and repressive cues, as discussed later.
In what follows we summarize recent insight into the 
dosage­compensation mechanisms of the XX/XY sex 
chromosome systems, which nicely illustrate the 
evolution of global, genome­wide regulatory strategies. 
However, compensation systems of this type are not 
absolutely required for the evolution of heterogametic 
sex. Birds, some reptiles, and some other species use the 
ZW/ZZ sex­chromosome system, which does not use the 
mechanism of chromosome­wide transcriptional regula­
tion to compensate for monosomy [17­19].
Dosage compensation of sex chromosomes reveals 
the balancing capacity of chromatin
The sex chromosomes of the XX/XY system are thought 
to have originated from two identical chromosomes in a 
slow process that was initiated by the appearance of a 
male­determining gene. In order to be effective, this gene 
should be propagated only in males, which was achieved 
by evolving a Y chromosome that was specifically propa­
gated through the male germline. The necessary suppres­
sion of recombination between this ‘neo­Y’ chromosome 
Figure 1. Schematic representation of different dosage-
compensation systems. (a) Drosophila melanogaster, (b) Homo 
sapiens, (c) Caenorhabditis elegans. Combinations of chromosomes 
in the diploid somatic cells of males and females are shown. The sex 
chromosomes are symbolized by the letters X and Y, autosomes as 
A. Dosage-compensated chromosomes are colored: red indicates 
activation, blue repression. The sizes of the As indicate the average 
expression level of an autosome in a diploid cell. The sizes of the 
X chromosomes reflect their activity state (see text). The arrows 
represent the activating and repressive factors that determine the 
activity of the corresponding sex chromosome. In Drosophila (a), 
the male X chromosome is transcriptionally activated twofold in the 
male to match the total level of expression from the two female X 
chromosomes. In mammals (b), X chromosomes are hypertranscribed 
in both sexes, and to equalize X-chromosomal gene expression 
between the sexes, one of the two X chromosomes is inactivated 
in females. In C. elegans (c), males do not have a Y chromosome (O 
indicates its absence) and XX individuals are hermaphrodites. Worms 
also overexpress X-linked genes in a sex-independent manner, 
as indicated by the red-colored Xs, but subsequently halve the 
expression levels of the genes from both X chromosomes in the 
hermaphrodite (indicated by the blue Xs) to equalize gene dosage 
between the sexes.
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and the corresponding sister chromosome (which would 
become the future ‘neo­X’) favored the accumulation of 
mutations, deletions and transposon insertions, an 
erosive process that led to loss or severe degeneration of 
Y chromosomes [20­24]. The progressive erosion of the 
evolving Y left many X­chromosomal genes without a 
corresponding copy on the Y chromosome (the hemi­
zygous state). The initial consequences of gene loss on 
the Y chromosome may have been absorbed by the 
intrinsic biochemical buffering properties of the cell 
noted above [11]. However, when the majority of genes 
on the X chromosome lost their homologs on the Y 
chromosome the co­evolution of regulatory processes to 
overcome the reduced gene dose ­ that is, dosage­
compensation systems ­ increased the fitness of the 
organisms. These dosage­compensation systems are likely 
to originate in the male sex (XY or X0 in the examples 
discussed here), as it is in males that factors acting in a 
dose­dependent manner (such as transcription factors, 
chromatin constituents and components of signal­
transduction cascades) would become limiting [25,26].
A logical adaptation to ensure the survival of males 
would be the increased expression of X­chromosomal 
genes [6]. This intuitively obvious mechanism has long 
been known in Drosophila. Observing the specialized 
polytene chromosomes in larvae (which are composed of 
thousands of synapsed chromatids arising from repeated 
DNA replication without chromosome segregation), 
Mukherjee and Beermann [27] were able to directly 
visualize nascent RNA and found that the single X 
chromosome in males gave rise to almost as much RNA 
as two autosomes. Recent genome­wide expression 
analyses confirmed these early observations [28,29] and 
further genome­wide studies suggest that this mechanism 
may also operate in C. elegans and mammals [14­16]. For 
these species neither the mechanism of this chromosome­
wide regulation nor the factors involved are known.
For Drosophila, however, thanks to decades of out­
standing genetics exploring male­specific lethality, we 
know at least a few of the prominent players. Here, the 
twofold stimulation of transcription on the X chromo­
some is mediated by the male­specific assembly of a 
dosage­compensation complex (the Male­Specific­Lethal 
(MSL) complex), a ribonucleoprotein complex that asso­
ciates almost exclusively with the X chromosome 
(reviewed in [30]; Figure 2). Most subunits of the MSL 
complex are found in both sexes of Drosophila, except for 
the key protein MSL2 and the noncoding roX (RNA­on­
the­X) RNAs, which are only expressed in males (Figure 2), 
thus leading to the assembly of the MSL complex 
exclusively in male cells. The MSL complex associates 
with the transcribed regions of target genes in a multi­
step process that has been reviewed elsewhere [31­33]. 
Key to the stimulation of transcription is the 
MSL­complex subunit MOF (Males­absent­on­the­first; 
also known as KAT8, lysine acetyltransferase 8), a histone 
acetyltransferase with specificity for lysine 16 in the 
amino­terminal tail of histone 4 (H4K16ac). Acetylation 
of this residue is known to reduce interactions between 
nearby nucleosomes and leads to unfolding of nucleo­
somal fibers in vitro [34,35].
Whereas the action of the dosage­compensation 
complex in Drosophila is limited to males, in C. elegans 
and mammals the unknown factors that stimulate X­
chromosomal transcription appear to be active in the 
hermaphrodite and the female, as well as in males. If, 
however, X activation re­balances the male genome in 
these species, it follows that in the XX sex, having two 
hyperactive X chromosomes relative to the autosomes 
must be suboptimal [36]. Consequently, further compen­
sation is needed. Mammals have evolved a strategy of 
inactivating one of the female X chromosomes to achieve 
a level of X­chromosome gene expression closely resemb­
ling that from the single X in males (reviewed in [37]; 
Figure 1b). Which X is inactivated is random, and 
inactivation starts with the stable transcription of the 
long, non­coding Xist (Xi­specific transcript) and RepA 
(repeat A) RNAs from a complex genetic region on the 
future inactive X (Xi) called the X­inactivation center. 
Subsequently, Xist RNA ­ possibly in complex with 
undefined protein components ­ spreads to coat the 
entire Xi. Silencing involves the recruitment and action 
of the Polycomb silencing machinery via the Xist and 
RepA RNAs [38,39], followed by reinforcement through 
the incorporation of histone variants, removal of activat­
ing histone modifications and DNA methylation [37]. 
Remarkably, the independent evolution of nematode 
worms arrived at a very different solution to the problem. 
C. elegans equalizes the gene dose by halving the 
expression levels of genes on both X chromosomes in the 
hermaphrodite, using a large dosage­compensation 
complex containing components of the meiotic/mitotic 
condensin. The involvement of condensins may point to 
regu la tion at the level of chromatin fiber compaction 
([40] and references therein). The scenario shown 
schema tically in Figure 1c for C. elegans suggests that 
dosage compensation in this species involves a twofold 
increase in X­linked transcription in both sexes, which is 
opposed by a twofold repression in hermaphrodites. The 
underlying mechanisms are still mysterious.
This short summary of the three very different dosage­
compensation systems reveals two common denomi­
nators. First, they all adapt factors and mechanisms, 
which are already involved in other regulatory processes, 
for the compensation task by harnessing them in a new 
molecular context. Furthermore, these factors are all 
known for their roles in modulating chromatin structure. 
It seems that chromatin can adopt a variety of structures 
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with graded activity states, which can be used either to 
completely switch off large chromosomal domains or to 
fine­tune transcription (either up or down) in the twofold 
range. Dosage compensation therefore integrates with 
other aspects of chromatin organization. In Drosophila, 
the male X chromosome that accumulates the H4K16 
acetylation mark is particularly sensitive to mutations in 
general chromatin organizers. Prominent among these is 
the zinc finger protein Su(var)3­7 (suppressor of varie­
gation 3­7), a heterochromatin constituent known to 
bind HP1 (heterochromatin protein 1). Normal levels of 
Su(var)3­7 are required for proper dosage compensation 
and to ensure the selective binding of the dosage­
compensation complex to the X chromosome [41­43]. 
The male X polytene chromosome bloats when 
Su(var)3­7 levels are reduced and condenses when the 
protein is in excess. These changes in chromatin 
condensation depend on a functional dosage compen­
sation complex, suggesting that the MOF­catalyzed 
acetylation of histone 4, and subsequent unfolding effect 
of H4K16ac, is constrained by as yet unknown counter­
acting factors (Figure 3a), conceivably by ones that 
promote chromatin compaction.
Selective, massive unfolding of the dosage­compen­
sated male X chromosome in Drosophila is also observed 
when the nucleosome remodeling factor (NURF) is 
inactivated [44,45]. Nucleosome remodeling by NURF 
may thus also serve to counteract excessive unfolding due 
to H4K16 acetylation. Tamkun and colleagues [46] 
suggested that NURF might achieve this task by 
maintaining sufficiently high histone H1 levels on the X 
chromosome. Clearly, the degree of chromatin compac­
tion can be adjusted by integration of unfolding and 
compacting factors.
Figure 2. The Drosophila melanogaster male dosage-compensation complex. The complex, called the MSL complex in Drosophila, consists 
of five proteins (MSL1, MSL2, MSL3, MOF, MLE) and two non-coding roX RNAs. The proteins, but not the roX RNAs, are evolutionarily conserved, 
as related proteins can be found in yeast and humans (for details see [30,68,69]). The box lists the conserved protein domains of the individual 
members of the Drosophila MSL complex and their identified functions for dosage compensation. MSL2 is the only male-specific protein subunit; all 
other subunits are present in both sexes. The two roX RNAs (see bottom of table) are also only expressed in males. The curved arrows symbolize the 
known enzymatic activities in the dosage-compensation complex. MLE is an RNA helicase that hydrolyzes ATP to effect conformational changes 
in DNA and RNA [70]. MOF is a lysine acetyltransferase with specificity for lysine 16 of histone H4. Abbreviations of the protein domains are: CXC, 
cysteine-rich domain; ZnF, zinc finger; PEHE, proline-glutamic acid-histidine-glutamic acid; HAT, histone acetyltransferase; MYST, MOZ (monocytic 
leukemia zinc finger protein), YBF2/SAS3 (something about silencing 3), SAS2 and TIP60 (60 kDa Tat-interactive protein); MRG, mortality factor on 
chromosome 4 related gene and DExH, aspartic acid-glutamic acid-x-histidine.
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Harnessing MOF for dosage compensation
Further analysis of the role of Drosophila MOF in dosage 
compensation suggests that it may affect gene expression 
by modulating the productivity of the transcription 
machinery in the chromatin context. Although MOF is 
able to acetylate non­histone substrates [47,48], its main 
substrate in the context of dosage compensation is the 
strategic H4K16. Biochemical studies showed that this 
modification interferes directly with the folding of the 
nucleosomal chain into 30­nm fibers in vitro [35,49]. 
Accordingly, H4K16 acetylation by MOF has the 
potential to counteract chromatin­mediated transcrip­
tional repression [50,51] (Figure 3a). In the simplest 
scenario, the only task of the MSL complex in Drosophila 
would be to enrich MOF on the X chromosome relative 
to the autosomes. However, studies of the effect of MOF 
in yeast or in a cell­free chromatin transcription system 
showed that H4K16 acetylation does not automatically 
increase transcription by twofold, but by many­fold [50]. 
This strong activation potential of MOF can also be 
visualized in Drosophila. We recently established Droso­
phila lines in which MOF is tethered to a β­galactosidase 
reporter gene engineered to reside on an autosome [51]. 
Sorting adult flies according to sex allowed comparison 
of MOF­dependent reporter gene stimulation in male 
flies, where MOF is part of the dosage­compensation 
complex, and in females, where its molecular context was 
initially unknown. In females, MOF recruitment 
stimulated transcription from a proximal promoter by an 
order of magnitude. The effect faded with increasing 
distance between recruitment site and transcription start 
site and therefore appears to be related to local chromatin 
opening by promoter­bound co­activators.
By contrast, the molecular context of the MSL complex 
in males restricted the activation effect of MOF to the 
twofold range reminiscent of dosage compensation, and 
this effect was observable over a distance of 5 kb [51]. 
Notably, similar H4K16 acetylation levels accompanied 
the very different activation modes in the two sexes. So it 
seems that the activation potential of H4K16 acetylation 
revealed in females is constrained in males. Ectopic 
assembly of the MSL complex in females by expression of 
MSL2 constrained the strong activation to a twofold 
range [51]. We concluded from these and further studies 
that the Drosophila dosage­compensation complex 
achieves a twofold activation of transcription by 
integrating activating and repressive principles [51].
MOF serves as an example of the principle that dosage 
compensation employs chromatin modifiers that are also 
functional in other contexts. MOF is expressed at only 
slightly lower levels in females than in males, and it also 
resides in at least one other complex in addition to the 
MSL complex. Mendjan et al. [52] first reported the 
existence of an alternative complex (the NSL complex, 
for ‘Non­Specific­Lethal’) in mixed­sex embryos and 
male cells of Drosophila, which contained a number of 
poorly characterized nuclear proteins and two 
Figure 3. Possible mechanisms for dosage compensation. 
(a) The twofold activation of the single male X chromosome in 
Drosophila could be achieved by a large, MOF-dependent activation 
of transcription through H4K16 acetylation and its counteraction 
by yet unknown factors, mediated by the dosage-compensation 
complex in males [51]. In (a,b), transcriptional level 1 refers to the 
normal regulated level of transcription from a single uncompensated 
X chromosome in females. (b) Furthermore, the twofold activation 
of the male X chromosome could be achieved by a combination 
of mechanisms: a general buffering/feedback component and a 
dedicated feed-forward mechanism (dosage compensation as 
suggested in (a)) [7]. The effects of these two processes could add 
up to the expected twofold compensation required to equalize 
the expression of X-linked genes between the sexes. (c) Precise 
transcription levels could result from negotiation between a number 
of activating and repressive factors (up and down arrows). In this 
instance, transcriptional level 1 refers to a ‘basal’ transcription state. 
This hypothetical model assumes that additional factors beyond 
those mentioned in (a) and (b) contribute to final transcription 
levels, such as male-enriched protein kinases, heterochromatin 
components, chromatin remodelers, and others (for details, see text).
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components of nuclear pores [52]. The closely related 
MOF­MBD­R2 complex, purified by us from female 
Drosophila cells [51], shares several prominent compo­
nents with the NSL complex, including WDS (Will Die 
Slowly, a homolog of mammalian WDR5 (WD repeat­
containing protein 5), dMCRS2 (microspherule protein 1), 
a forkhead­associated domain protein, and MBD­R2 (an 
uncharacterized protein harboring similarity to methyl­
CpG­binding domains) [53]. In contrast to the NSL 
complex, the MOF­MBD­R2 complex does not contain 
nuclear pore components [51].
The evidence so far suggests that the MOF­MBD­R2 
complex provides the molecular context for the strong 
activation elicited by MOF in females. Globally, MOF co­
localizes with MBD­R2 to active genes with enrichment 
towards their 5’ ends on all chromosomes in male and 
females, except for the male X chromosome (Figure 4). In 
male Drosophila cells, MOF is enriched on the X 
chromo some, where it co­localizes with MSL­complex 
components (such as MSL1) with a bias towards the 3’ 
end (Figure 4). In male Drosophila cells, MOF apparently 
distributes dynamically between the two complexes. 
Ectopic expression of MSL2 in female cells, which leads 
to assembly of a dosage­compensation complex, re­
localizes MOF from the autosomes to the X chromosome 
and from the 5’ end to the 3’ end of transcribed genes. 
The 3’ enrichment suggests that dosage compensation in 
Drosophila may act at the level of transcription 
elongation [54,55].
The earlier notion that MOF, a global activator of trans­
cription, was harnessed to balance the X­chromosomal 
monosomy in male Drosophila is supported by the fact 
that the H4K16­specific acetyltransferase activity has 
been conserved during evolution, although its biological 
function has not [56,57]. MOF (KAT8) is the best­studied 
member of the evolutionarily conserved family of MYST 
acetyltransferases (MOZ (monocytic leukemia zinc finger 
protein), YBF2/SAS3 (something about silencing 3), 
SAS2 and TIP60 (60 kDa Tat­interactive protein)). To the 
best of our knowledge, mammalian MOF is not involved 
in dosage compensation, but in regulating gene expres­
sion in more specific ways and in maintaining genome 
stability. Knock­down of human MOF impairs the signal­
ing of DNA damage via the ATM pathway in response to 
double­strand breaks, causing increased cell death and a 
loss of the cell­cycle checkpoint response [58]. Mouse 
MOF is essential for oogenesis and embryogenesis [59]. 
Loss of H4K16ac is a cancer hallmark [60] and MOF is 
deregulated in a number of diseases [61,62].
As in Drosophila, mammalian MOF resides in several 
distinct complexes. These include the MOF­MLL1­NSL 
complex, which is required for the expression of the Hox 
9a gene [63]; a complex containing the homologs of the 
Drosophila MSL3 and MSL1 that contributes to global 
H4K16 acetylation [64,65]; and a complex most closely 
related to the Drosophila NSL complex [52], containing 
human NSL1 (MSL1v1) and PHF20 (PHD finger protein 
20, the homolog of MBD­R2), in addition to other NSL 
protein homologs. This complex has attracted particular 
attention as it is not only responsible for the majority of 
H4K16ac in human cells [66], but also acetylates p53 at 
lysine 120 (K120) [66,67]. p53 in which K120 is mutated 
can no longer trigger the apoptotic pathway, yet its role 
in the cell­cycle checkpoint is not impaired. Evidently, 
the substrate specificity of human MOF and the 
physiological processes in which it is involved are largely 
determined by the molecular context of the acetyl trans­
ferase, defined by the composition of the different 
complexes. In Drosophila, however, one of the complexes 
has been adapted to serve the goal of balancing the 
genome for dosage compensation.
Negotiation for small effects
Although the mechanisms through which aneuploidies 
are compensated for are still mysterious, a number of 
overarching principles have emerged during recent years, 
Figure 4. Schematic representation of the distribution of the 
key regulators of dosage compensation on a target gene in 
Drosophila. The gene is depicted as a gray bar at the top of the 
figure, with the arrow representing the transcription start site. The 
figure is based on genome-wide binding studies of MOF, MBD-R2 
and MSL1. The upper panel shows that MBD-R2 is enriched at 
promoters (5’) on all chromosomes in both sexes, underscoring its 
function as a general transcriptional facilitator. MOF co-localizes with 
the promoter peak of MBD-R2 on all chromosomes except for the 
male X chromosome, where it is more enriched towards the 3’ end 
of the target gene as a result of its association with the dosage-
compensation complex (bottom panel). The MSL1 profile serves as a 
marker for the presence of the dosage-compensation complex [51]. 
For details see text.
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mainly through studies of the X­chromosome mono­
somies. First, there is no simple switch for ‘two­fold up’ 
or ‘two­fold down’. Optimal expression levels are nego­
tiated by opposing principles. The X­chromosomal 
expres sion in hermaphrodite C. elegans results from 
integration of a global, twofold increase in expression in 
both sexes and a different counteracting hermaphrodite­
specific principle, which halves the expression again 
(Figure 1c).
The first genome­wide comparison of copy number and 
transcription in Drosophila revealed that a local or 
chromosomal hemizygosity is compensated for by the 
integration of at least two different mechanisms: an 
approximately 1.5­fold compensation can be attributed to 
general buffering or feedback effects, whereas the 
remain ing compensation is contributed by the evolution 
of a feed­forward mechanism involving a dedicated 
dosage­compensation complex [7] (Figure 3b). Further­
more, the twofold activation in male Drosophila is a 
composite of a much larger stimulation, which is opposed 
by a repressive principle (Figure 3a). We therefore envis­
age that adjustment of the optimal gene expression levels 
may be a consequence of negotiation between a number 
of counteracting activating and repressing principles 
(Figure 3c). The complex and layered organization of 
chromatin appears to us as an advanced equalizer with 
many levers to allow optimal tuning of the transcription 
melody.
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3.3.1 Summary, significance and own contribution 
Summary, significance and discussion with recent literature  
The NSL complex is found at a subset of active genes but what determines whether a gene is bound 
and activated by the complex was unknown. In this study, we generated new and analysed existing 
genomic data sets to unveil the determinants that target the complex and define whether it engages in 
transcriptional activation. We found that the NSL complex primarily targets the promoters of active 
housekeeping genes. There, it co-localises with WDS, the chromatin remodeler subunit NURF301, the 
H3.K4 methyltransferase trithorax and the interband protein chromator. Importantly, only a subset of 
the genes that associate with the NSL complex are regulated by it. Comparing ChIP-chip data of 
chromatin regulators and promoter DNA sequences between regulated and non-regulated genes 
revealed that the set of NSL-activated promoters are enriched for the promoter DNA motif ‘Ohler 5’ 
and depleted for the insulators CP190 and BEAF as well as the heterochromatin protein 1c (HP1c). 
Together, these results show that the capacity of the NSL complex to activate transcription is highly 
context dependent. Moreover, our study suggests that not only tissue-specific genes employ dedicated 
transcription factors, but that housekeeping genes are also regulated by distinct sets of co-activators. 
Our observation that NURF301 and trithorax co-localise with the NSL complex was surprising at the 
time because these proteins were traditionally studied for their roles in regulating very restricted gene 
sets during specific developmental programs (Ringrose and Paro, 2004; Badenhorst et al., 2005). 
However, there is accumulating evidence that, under specific conditions, trithorax and its mammalian 
homologue MLL1 interact with the NSL complex (Petruk et al., 2001; Dou et al., 2005; Zhao et al., 
2013; Tie et al., 2014). In addition, the bromodomain of the mammalian NURF301 homolog, BPTF, 
has been reported to bind H4.K16ac (Ruthenburg et al., 2011).  
Recent studies confirmed our finding of NSL complex binding to housekeeping genes in Drosophila 
cells (Lam et al., 2012) and reported the conservation of this binding mode also in mouse cells 
(Chelmicki et al., 2014; Ravens et al., 2014). Interestingly, a deeper comparison of these articles also 
reveals some noteworthy differences. First, while we reported that only a minor subset of NSL bound 
genes are down-regulated after ablating either NSL1 or MBD-R2, Akhtar and colleagues described 
that a major fraction of NSL occupied genes are regulated by the complex, as assessed by measuring 
polymerase II occupancy on target and non-target gene promoters upon depleting NSL1 or NSL3 
(Lam et al., 2012). Furthermore, Akhtar and co-workers reported that the core promoter motif ‘DRE’ 
correlates best with the capacity of the NSL complex to regulate transcription, but our analysis 
suggests that while the binding ‘strength’ of NSL1 correlates best with this motif (‘DRE’), 
transcriptional regulation by the complex is rather associated with motif ‘Ohler 5’. These 
discrepancies can be, at least in part, attributed to the different approaches to evaluate the effect on 
transcription upon NSL ablation. While we monitored directly the steady-state mRNA levels, Akhtar 
and colleagues used diminished ChIP occupancy of the RNA polymerase II subunit Rpb3 as a proxy 
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for transcriptional regulation. It is conceivable that reduced polymerase II loading at promoters may 
not always translate into a decrease of mRNA production. Likewise, monitoring steady-state mRNA 
levels may be too insensitive in cases where newly generated transcripts are outnumbered by a large 
pool of pre-existing mRNA molecules. An alternative and complementary approach would be to 
analyse the polymerase II isoform that is phosphorylated on serine 5 at its CTD along gene bodies, 
which has been documented to show an overall good correlation with gene activity measured by bulk 
mRNA levels (Kharchenko et al., 2011; Regnard et al., 2011).  
Second, while the Drosophila NSL complex primarily binds promoters (Feller et al., 2012; Lam et al., 
2012), a substantial fraction of mouse NSL binding events was additionally detected at enhancers 
(Chelmicki et al., 2014). Interestingly, while Akhtar and colleagues reported that the mouse NSL 
complex regulates key pluripotency factors in addition to housekeeping genes and that most 
transcription regulatory potential is observed from NSL sites at enhancers (Chelmicki et al., 2014), 
Tora and colleagues only observed minor intergenic binding of mouse NSL1 and no deregulation of 
pluripotency genes (Ravens et al., 2014).  This discrepancy may be in part attributed to monitoring and 
ablating different components of the NSL complex (NSL1 in Ravens et al. vs. NSL3 and MCRS2 in 
Chelmicki et al.).  
An important recent structure-function study provided strong evidence that the interaction between 
WDR5 (human homolog to the fly WDS), which is a component of many multi-protein complexes 
including the MLL1 complex and the ATAC complex (Suganuma et al., 2008; Shilatifard, 2012), is 
also a central constituent of the NSL complex that tethers NSL1 to NSL2 and is essential for 
recruitment of the complex to its target genes (Dias et al., 2014). This study also shows that WDS uses 
the same regions for interacting with NSL1 and NSL2 as it does for its interaction within the MLL1 
complex. This finding provides strong structural support that WDR5 is a shared component of the 
NSL and MLL complex rather than tethering the acetyltransferase and methyltransferase complexes to 
a super-complex, as it has been suggested before (Dou et al., 2005; Li et al., 2009).  
 
Own contribution 
Prof. Peter Becker and I conceived the project and wrote the manuscript. I performed all genomic and 
cell biological experiments, analysed the data and prepared all figures. I initiated the collaboration 
with Dr. Johannes Söding and Holger Hartmann, who performed the core promoter analysis. Dr. 
Matthias Prestel developed and characterised the NSL1 antibody and conducted most of the reporter 
gene experiments. Dr. Tobias Straub supervised the bioinformatic analysis and provided important 
scripts. 
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ABSTRACT
The MOF (males absent on the first)-containing NSL
(non-specific lethal) complex binds to a subset of
active promoters in Drosophila melanogaster and
is thought to contribute to proper gene expression.
The determinants that target NSL to specific pro-
moters and the circumstances in which the complex
engages in regulating transcription are currently
unknown. Here, we show that the NSL complex pri-
marily targets active promoters and in particular
housekeeping genes, at which it colocalizes with
the chromatin remodeler NURF (nucleosome re-
modeling factor) and the histone methyltransferase
Trithorax. However, only a subset of housekeeping
genes associated with NSL are actually activated by
it. Our analyses reveal that these NSL-activated pro-
moters are depleted of certain insulator binding pro-
teins and are enriched for the core promoter motif
‘Ohler 5’. Based on these results, it is possible to
predict whether the NSL complex is likely to regulate
a particular promoter. We conclude that the regula-
tory capacity of the NSL complex is highly context-
dependent. Activation by the NSL complex requires
a particular promoter architecture defined by com-
binations of chromatin regulators and core promoter
motifs.
INTRODUCTION
Eukaryotic organisms consist of a diversified set of highly
specialized cells. Their individual identities are determined
by the appropriate expression of cell-specific genes while a
battery of genes that are expressed in all cells maintain
general (‘housekeeping’) functions. Gene expression at
the transcriptional level is governed by an intricate inter-
play between transcription regulators and local chromatin
organization. In general, the packaging of genomes into
chromatin brings about a default state of repression, as
nucleosome assembly constantly competes with transcrip-
tion factors for promoter binding sites. Overcoming
this repression requires a concerted action of various
chromatin-modifying principles. These include ATP-
dependent nucleosome remodeling factors, which are
targeted to specific loci by DNA-bound proteins and
post-translational histone marks where they reorganize
nucleosomes to facilitate transcription (1). An example
for such an activity in Drosophila melanogaster is NURF
(nucleosome remodeling factor), whose large regulatory
subunit, NURF301, interacts with a diversity of transcrip-
tion factors and methyl marks on lysine 4 of histone H3
(H3K4me3) (2,3) (and references therein). NURF has also
been reported to bind to acetylated lysine 16 of histone H4
(H4K16ac) (2), a nucleosome modification that prevents
nucleosome–nucleosome interactions that promote the
folding of the nucleosomal fiber into more compact struc-
tures. The acetyltransferase MOF (males absent on the
first) is a major enzyme responsible for this modification
in both, Drosophila and mammalian cells (4,5).
MOF is best known for its key role in the Drosophila
dosage compensation process. It is a subunit of the dosage
compensation complex [DCC, also known as male-specific
lethal (MSL) complex], which brings about the 2-fold
transcriptional activation of genes on the single male X
chromosome to equalize expression with the correspond-
ing genes transcribed from the two female X chromosomes
(6). The DCC is constituted only in male flies and the
five protein components, MSL1, MSL2, MSL3, maleless
(MLE) and MOF, as well as the non-coding roX RNAs
are essential for male viability. According to the current
model, the DCC recruits MOF to the transcribed regions
of X-chromosomal genes. Subsequent acetylation of
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H4K16 renders chromatin more accessible and potentially
facilitates transcriptional elongation (7,8).
With the exception of MSL2, all DCC protein sub-
units are also expressed in female flies, and therefore
also serve more general, yet barely understood functions
(9). For example, the acetyltransferase MOF appears to be
involved in more global transcription regulation as it has
recently been found in an alternative complex together
with MCRS2, the WD40-repeat protein WDS (will-die-
slowly), NSL1, NSL2, NSL3 and the plant homeo
domain (PHD) protein MBD-R2 (10–12). With reference
to the dosage compensation ‘MSL complex’, this alterna-
tive MOF-containing assembly was termed ‘NSL
complex’ (for ‘non-specific lethal’), as its subunits are
essential in both sexes (10). The incorporation of MOF
into either the DCC or the NSL complex is determined
by association of MOF with the PEHE domains of the
respective MSL1 or NSL1 subunits (10). Genome-wide
mapping by chromatin immunoprecipitation (ChIP)
coupled to DNA microarrays (ChIP-chip) identified
MOF binding sites at many, but not all active promoters
in male and female cells (13). Subsequent studies revealed
that MBD-R2 colocalizes with MOF at many active pro-
moters in both sexes, suggesting that the NSL complex
recruits MOF to these sites (12). This is compatible with
a recent ChIP-Seq study (ChIP DNA analyzed by massive
parallel sequencing), which found MCRS2 and NSL1
peaks at promoters in mixed-sex 3rd instar larval
salivary glands (11).
In male cells the association of MOF with NSL subunits
is in competition with its incorporation into the DCC,
which redirects it to the transcribed regions of X chromo-
somal genes (12). However, key aspects of MOF’s target-
ing in the context of the NSL complex are unclear. What
determines the binding of the NSL complex to only a
subset of the active promoters? The available data also
are ambiguous when it comes to the role of the NSL
complex; does it activate or repress target genes, or
perhaps both? Ablating the NSL subunit MBD-R2 in
male embryonic cells resulted in a reduced expression of
many MBD-R2 target genes (12). In contrast, a similar
fraction of genes was found up- and downregulated
when MBD-R2 and NSL3 were depleted in 3rd instar
salivary glands (11).
In this study, we created novel data sets and analyzed
existing ones to compare functional interactions of NSL
subunits in different developmental tissues to better define
the targets of the NSL complex. We systematically
explored the common properties of the NSL target
genes, searching for colocalizing chromatin factors and
prevalent sequence motifs in target promoters. We
traced the NSL complex through monitoring the NSL1
subunit and found that it preferentially binds to pro-
moters of housekeeping genes, which are also approached
by the chromatin remodeler NURF and the
methyltransferase Trithorax. There, NSL1 binding correl-
ates best with the core promoter element DNA
replication-related element (DRE). However, only a
defined fraction of NSL1-bound genes are actually
regulated by the complex. Those promoters are depleted
for insulator proteins and are enriched for the
E-box-derived promoter motif ‘Ohler 5’. Our analysis pro-
vides a functional classification of housekeeping genes ac-
cording to their NSL coregulator requirements.
MATERIALS AND METHODS
Generation of the NSL1 antibody
A cDNA fragment corresponding to NSL1 amino acids
1271–1550 was Polymerase Chain Reaction (PCR)
amplified from cDNA clone #LP09056 (Drosophila
Genomics Resource Center; see Table 1) and cloned
into the pGEX2TKN. The N-terminally glutathion-S-
transferase (GST)-tagged NSL1 fragment was expressed
in Escherichia coli BL21, purified on glutathione beads
and used to raise antibodies in rabbit by a commercial
supplier.
RNA interference in S2 cells, immunoblotting and indirect
immunofluorescence
Male Drosophila S2 cell cultivation and RNA interference
(RNAi) were carried out as described before (12). Briefly,
1.5 10 e6 cells were incubated with 10 mg dsRNA
targeted against NSL1 or GST as a control. Primer
sequences used for dsRNA production are listed in
Table 1. Cells were harvested after 6 or 7 days and pro-
cessed for RNA (see below) and protein. For every 10 e6
cells, cells were lysed for 10min in 100 ml of N-buffer
[15mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid) pH 7.5, 60mM KCl, 15mM NaCl, 0.5mM
ethylene glycol tetraacetic acid pH 8, 0.25% Triton-X,
10mM sodium butyrate, 1mM phenylmethanesulfo-
nylfluoride, 0.1mM Dithiothreitol protease inhibitor
cocktail (Roche)] on ice and the chromatin fraction was
pelleted by centrifugation. RNA for Affymetrix expres-
sion profiling was prepared as described (12). RNA
labeling and cDNA hybdridization to a Drosophila
Table 1. Primer table
Construct Forward primer sequence Reverse primer sequence
NSL1 RNAi amplicon 1 TTAATACGACTCACTATAGGGA
GCGTC CGAGCTCAAC CTTC
TTAATACGACTCACTATAGGGA
CACATGGGTGTGTTCATTAGTC
NSL1 RNAi amplicon 2 TTAATACGACTCACTATAGGGA
GATGTCGCATCAAAGTCAGAGG
TTAATACGACTCACTATAGGGA
GACTCGAGAAGAGCTCGCTGAT
GST RNAi amplicon TTAATACGACTCACTATAGGGAG
AATGTCCCCTATACTAG GTTA
TTAATACGACTCACTATAGGGAGA
ACGCAT CCAGGCACATTG
NSL1 antibody cloning CGCTCCATGGCTTTCATT
AAGTTCCCCTGGAGCACC
ATTTCTAGATTAGATGC
GTCTGCTGCGAACACCCTC
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Genome GeneChip 2.0 was performed at the Gene Center
Affymetrix Microarray Platform (Munich, Germany).
Immunoblot analysis and immunofluorescence micros-
copy (IFM) analysis was performed as described previous-
ly (14). The lamin antibody was obtained from H.
Saumweber (Berlin) and the MSL1 antibody was
described previously (15).
Reporter gene ChIP assay and luciferase reporter assay
The reporter gene ChIP assay and luciferase reporter
assay have been described before (12).
Chromatin extraction and immunoprecipitation
Chromatin extraction and immunoprecipitation were pre-
viously described (12). Briefly, chromatin extracts from
sex-sorted adult flies were prepared and the DNA concen-
tration of the extract was determined. DNA (7.5–15 mg)
were used for a single ChIP experiment. Five microliters of
anti-NSL1 serum was used in a single IP reaction. After
the precipitation and extensive washing, DNA was ex-
tracted with phenol/chloroform, ethanol precipitated and
further cleaned using the GenElute PCR clean-up kit
(SIGMA). DNA was amplified using the whole-genome
amplification kit (WGA, SIGMA). Labeling, hybridiza-
tion to customized high-resolution NimbleGen tiling
arrays (comprising the euchromatic part of the entire X
chromosome, 5 Mb of 2L, 2R and 3L, respectively, as
well as 10 Mb of 3R) (12), scanning and feature extraction
was performed by imaGenes (Berlin).
ChIP-chip data processing
ChIP-chip data analysis was performed using
R/Bioconductor (www.r-project.org; www.bioconductor
.org). Raw signals of the NimbleGen NSL1 ChIP-chip
were normalized and log2-transformed using the ‘vsn’
package (16). IP/input ratios of the modENCODE data
were scaled to a mean of zero and a standard deviation of
one. Promoter enrichments were calculated by
summarizing the probe level signals in a window of
600 bp centered at the transcriptional start site (TSS)
(FlyBase release 5.22). Promoter binding was classified
based on the bimodal distribution of binding values,
where genes within the population of lower values were
considered ‘unbound’ and genes within the population of
higher values were considered ‘bound’. Alternatively,
‘bound’ were selected based on the fdr values from the
‘locfdr’ package applied on the promoter binding values
with a fdr cutoff of <0.2. The results are robust to several
normalization methods and promoter window definitions.
Genes were classified ‘active’ when (i) their Affymetrix
expression value exceeded four (see below) and (ii) RNA
polymerase II [modENCODE profile (17)] was classified
as ‘bound’ on their promoters. A similar result was
obtained using genes which are ‘bound’ (modeled on the
bimodal distribution of the averaged binding along the
transcribed region) by the elongating polymerase [serine
2 phosphorylated RNA polymerase II, data from (18)].
Promoters were classified as ‘peaked’, ‘broad’ and ‘weak
peak’ promoters according to Hoskins et al. (19) and Ni
et al. (20). Hierarchical cluster analysis of the promoter
binding pattern was carried out using the R package
‘hclust’ and the ‘complete’ or ‘ward’ clustering approach
as indicated in the figure legends.
All available modENCODE chromatin ChIP-chip data
sets were screened for factors, which are enriched at
promoter locations (by March 2011). After initial data
quality assessment probe level binding was assessed for
promoter probes (broad: ±300 bp centered at TSS;
narrow: ±100 bp centered at TSS; upstream-biased:
300 - TSS- +100 bp), transcriptional termination (TT)
sites (broad: ±300 bp centered at TT; narrow: ±100 bp
centered at TT; downstream-biased: -100 – TT+ 300 bp),
gene probes (probes corresponding to annotated genes
without promoter and termination probes) and intergenic
probes (defined as probes not found in previous groups).
Only ChIP-chip data sets with a clear enrichment for
promoter probes relative to gene, intergenic and termin-
ation probes were selected for this study.
Transcriptome data analysis
Transcriptome data analysis was conducted as described
previously (12). Briefly, raw signals were normalized,
summarized and log2-transformed using the ‘gcrma’
package. Significant change of gene expression was
calculated applying the ‘locfdr’ package on a ‘sam’ statis-
tics using a cutoff of fdr <0.35. Alternatively, genes with
log2 (NSL1 RNAi–GST RNAi)< (1) were considered
‘down-regulated’. The results are robust to various par-
ameters in data analysis, as assessed by choosing varying
thresholds. All expression data set values are
log2-normalized with a theoretical dynamic range of
2exp16 (Affymetrix.com).
Housekeeping gene definition
Affymetrix expression data sets of 40 different Drosophila
tissues [GSE7763, (21)] were processed as described above
for the NSL1 transcriptome data set. For every gene, the
standard deviation was calculated across all 40 samples
(gene variation index). Filtering for active genes, the dis-
tribution of standard deviations resulted in two major
populations with the best discrimination at a standard
deviation of 1.5 (Supplementary Figure S9A and B).
Consequently, genes with a gene variation index <1.5
were considered housekeeping genes and genes with a
gene variation index >1.5 were considered differentially
regulated genes. The results are robust to different applied
thresholds. In an alternative analysis (presented in
Supplementary Figure S2E), we took the more stringent
call for housekeeping gene function according to the clas-
sification of Weber and Hurst (22). Here, active genes
which belong to either the ‘tau’ class or to the ‘breadth’
class were considered housekeeping genes.
ChIP-Seq data analysis
NSL1 ChIP-Seq and corresponding input data sets (11)
were obtained from the ArrayExpress repository
(E-MTAB-214). Sequence reads were mapped to the
Drosophila melanogaster genome (dm3) using bowtie
(23). Uninformative reads and read anomalies were filtered
out using the R package ‘SPP’ (24), resulting in 7840131
Nucleic Acids Research, 2012, Vol. 40, No. 4 1511
unique NSL1 ChIP reads and 6094163 unique input reads.
Peaks were identified using SPP with the following param-
eters: ‘tag-wtd’ method, fdr=0.01, minimal distance
between detected peaks=100 bp. The input data was
used to determine statistical significance of NSL1 peaks,
resulting in the ‘peak score’.
Core promoter motif analysis
We used the 10 promoter motifs described by Ohler and
colleagues (25) to analyze promoter motif occurrences.
For every motif a log-odds weight matrix description
P of the binding sites is given, which was used to calculate
a motif score for a specific sequence. It ranges between
zero and one and measures how similar a binding site is
to the consensus. In a first step, the log-odds score for the
consensus site LC is determined by
LC ¼
Xw
i¼1
maxfPib : b 2 fA,C,G,Tgg,
where w is the motif length. The motif score given a
specific binding site starting at position k in sequence X
is calculated by
motif score ðX,kÞ ¼
1
LC
Xw
i¼1
PiXk+i1
The motif score is the ratio of the log-odds score of the
site at position k to the log-odds score of the consensus
site. The motif score for the entire sequence X is given by
the highest motif score in the sequence:
motif score ðXÞ ¼ maxkfmotif score ðX, kÞg
For the analyses, we used a threshold of motif score
>0.3 to consider a binding site as functional. The
de novo sequence analysis algorithm will be reported else-
where (Hartmann and Soeding, manuscript in
preparation).
RESULTS
NSL1 colocalizes with MBD-R2 at many active promoters
The genomic interaction profile of MOF differs in adult
male and female flies, reflecting its incorporation into the
male-specific DCC and the general NSL complex (11,12).
We previously monitored the MBD-R2 distribution in
adult male and female flies but could not detect any sig-
nificant difference (12). Since MBD-R2 is the only NSL
complex protein which may interact with DCC members
(10) we sought to compare the genome-wide binding
pattern of the NSL complex with the potential core
subunit of the complex, NSL1. In order to compare the
NSL1 interactions in the genomes of adult male and
female flies, an antibody was raised against NSL1 and
its specificity confirmed combining RNAi with subsequent
detection by indirect immunofluorescence microscopy
(IFM) and immunoblotting (Supplementary Figure S1
and see below). The antibody was then used for
ChIP-chip experiments, where NSL1 was precipitated
from chromatin preparations from hand-sorted adult
male and female flies and the associated DNA was
amplified and hybridized to high-resolution DNA tiling
microarrays representing the X chromosome and an
equivalent amount of the autosomes. The binding profile
in male and female flies did not show any significant dif-
ferences (Supplementary Figure S2A). In addition, NSL1
was found at the same loci as MBD-R2 (Supplementary
Figure S2B), in agreement with the results of the biochem-
ical definition of both proteins as ‘NSL’ complex subunits
(10–12). The ChIP-chip profiling suggested that NSL1
globally binds target loci independent of the fly sex, con-
firming previous ChIP-qPCR analyses at selected loci (11).
Re-examination of the previously published NSL1
ChIP-Seq profiles, which had been generated from salivary
glands of mixed-sex third instar larvae (11), revealed a
systematic enrichment of NSL1 peaks at RNA polymerase
II—promoters relative to genes transcribed by RNA poly-
merases I and III (Table 2). Applying a superior peak
calling algorithm (24) to these data identified the majority
of NSL1 binding events within a window of 200 base pairs
(bp) around the annotated TSS (Figure 1A), implicating
the NSL complex in transcriptional initiation.
In order to avoid the heterogeneous salivary gland tis-
sue, which impedes a comparison of NSL binding with the
transcriptional activity and with other known promoter
binding factors, an NSL1 ChIP-chip profile was generated
from Drosophila S2 cells. These cells are commonly used in
the chromatin community because they provide a homo-
geneous biological material, a fact that allows comparing
our data to other published genomic data sets, such as the
comprehensive collection of chromatin factors and histone
modifications generated by the modENCODE consortium
with a similar ChIP-chip strategy (17).
The newly generated NSL1 ChIP-chip profile correlated
well with our previously published MBD-R2 profile (12)
as well as with the MBD-R2 profile generated by the
modENCODE consortium using a different antibody
(Supplementary Figure S2C). Therefore, in the following
we subsume the individual NSL1 and MBD-R2 profiles as
the ‘NSL complex’ binding, unless stated otherwise. We
related the NSL complex binding at promoters with the
transcriptional activity of the corresponding genes, using
the ChIP-chip profile of the elongating polymerase as a
direct readout for active transcription (18). The NSL
complex binds active genes with high preference, but
only a subset of 60–70% (depending on the threshold)
(Figure 1B, left). A similar result was obtained when
Table 2. NSL1 ChIP-Seq peaks mapped to transcript type
Transcript type MiRNA mRNA ncRNA rRNA snoRNA snRNA tRNA
Number annoted transcripts 194 22 765 189 160 249 47 314
Number NSL1 peaks mapped to transcript TSS 0 4302 14 0 1 1 5
Fraction NSL1-bound transcripts rel. to all transcripts 0 18.9 7.4 0 0.4 2.1 1.6
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elongating polymerase II gene signal (18)], respectively. (C) The NSL complex preferentially associates with housekeeping genes (Welch two sample
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binding at genes, which were grouped according their transcriptional start site usage in ‘peaked’ promoters, ‘broad with peaked’ promoters and ‘weak
peak’ promoters using the data of (19). The window is split for NSL1-bound (right) and -unbound (left) promoters.
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displaying gene activity as a function of polymerase pro-
moter binding (Figure 1B, right) or Affymetrix RNA ex-
pression profiling (data not shown), in agreement with
previous studies examining other markers of the NSL
complex (11,12).
The NSL complex specifically binds promoters of most
housekeeping genes
As noted above, the NSL1 profile is very similar in nuclei
of different sex and developmental stage despite significant
expression differences (Supplementary Figure S2A and D).
This indicates that the NSL complex may associate
with’housekeeping’ genes, which are equally expressed in
these diverse tissues. To test this hypothesis, we classified
genes as ‘housekeeping’ or ‘differentially regulated’ ac-
cording to their expression variation index, i.e. the stand-
ard deviation of expression, when compared between
several Drosophila tissues (21). According to this classifi-
cation the NSL complex showed a significant preference
for ‘housekeeping’ over ‘differentially regulated’ genes
(Figure 1C). The same conclusion was reached when
‘housekeeping’ genes were classified according to the
more exclusive definition of Hurst and colleagues (22)
(Supplementary Figure S2E). This conclusion is further
illustrated by a gene ontology (GO) analysis of bound
and unbound genes, which revealed that active NSL-
bound genes are enriched in housekeeping functions such
as ‘cofactor biosynthetic processes’, ‘microtubule-based
processes’, ‘protein complex biogenesis’ (Supplementary
Figure S3), whereas active genes which are not bound by
the NSL complex are enriched in categories such as ‘sen-
sory perception’, ‘cell adhesion’ and ‘tissue developmental
genes’ (Supplementary Figure S4).
Recent improvements in high-throughput RNA
profiling techniques facilitated quantitative mapping of
TSSs at base pair resolution (19,20). Whereas some pro-
moters possess well-defined TSS, where transcription reli-
ably initiates within a few base pairs (‘focused’ or ‘peaked’
promoters), many promoters show a dispersed zone of
transcription initiation of up to a few hundred base
pairs, which may be dominated by a major TSS (‘broad
promoters’) or not (‘weak peak promoter’) (20). Notably,
differentially regulated genes tend to have peaked pro-
moters whereas housekeeping genes are enriched for
broad or weak promoters (19). Concordantly, we found
that the NSL complex is strongly overrepresented at pro-
moters of the latter classes (Figure 1D).
The NSL complex activates only a specific subset of
bound genes
It has remained controversial whether NSL target genes
are activated or repressed after RNAi ablation of NSL
complex components (11–13). Akthar and coworkers
observed that similar fractions of NSL target genes were
up- or downregulated following RNAi against MOF,
NSL3 and MBD-R2 and subsequent microarray-based
transcriptome profiling (11,13). By contrast, we found
that the transcription of genes that had the NSL subunit
MBD-R2 bound was mostly reduced when MBD-R2
levels were lowered (12). However, since MBD-R2 is the
only NSL complex subunit that was suggested to interact
with components of the DCC (10), it was necessary to
exclude indirect effects. We therefore examined the expres-
sion of NSL target genes after depletion of the core
subunit of the NSL complex, NSL1.
RNAi against NSL1 in S2 cells efficiently depleted
the protein as examined by immunoblotting and IFM
(Supplementary Figure S1). Genome-wide transcriptome
profiling of the NSL1-depleted cells led to the down-
regulation of a considerable fraction of genes (Figure 2A),
most of which had been classified as ‘NSL-bound’ before
(Figure 2B). This is consistent with reporter gene assays
where the transcription brought about by tethering MOF
to a model promoter was diminished upon NSL1 deple-
tion (for details, see Supplementary Figure S5).
Importantly, the expression of the majority of NSL1
target genes was unchanged (Figure 2A), such that only
20–30% of them (depending on the threshold) required
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Figure 2. The NSL complex activates only a subset of its target promoters. (A) The histogram depicts transcriptome changes upon NSL1 depletion
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for active genes based on the transcriptome of control cells. (B) Proportional Venn diagram depicts genes 2-fold up- or down-regulated after RNAi
against NSL1, respectively, and NSL1-bound genes (NSL1 ChIP-chip in S2 cells). Numbers in parentheses indicate the size of the respective genes
sets. Only active genes (total polymerase promoter occupancy determined by the modENCODE consortium) represented on our custom-tailored
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NSL1 for proper expression. The same trend had been
observed earlier in the context with MBD-R2 (12) (and
data not shown). The MBD-R2 ChIP-chip profile and the
MBD-R2 RNAi transcriptome data are indeed very
similar to the NSL1 data (Supplementary Figures S2C
and S5C), arguing that they form a functional complex
bound to chromatin.
We next asked whether the genes that were activated by
the NSL complex coded for related housekeeping func-
tions. The GO classification revealed that the genes
whose expression was diminished upon NSL1 depletion
were enriched in genes involved in nucleic acid metabol-
ism, such as genes involved in transcription, RNA pro-
cessing, translation, DNA replication and DNA repair
(Supplementary Figure S6). Evidently, the NSL complex
only activates a specific subset of the many housekeeping
genes. In order to explore whether the promoters of
NSL-responsive genes could be recognized by a combin-
ation of cis-elements and trans-factors, we set out to iden-
tify chromatin proteins with genome binding profiles
related to the NSL complex and to investigate whether
the promoters regulated by NSL shared particular core
promoter motifs.
The NSL complex co-occupies target promoters
together with the chromatin remodeler NURF
and the histone methyltransferase Trithorax
The NSL1 ChIP-chip profile in S2 cells allowed a direct
comparison with the chromatin profiles recorded by the
modENCODE consortium (17), which used the same cell
line and the same profiling technique. We mined the
modENCODE data for profiles of general chromatin fac-
tors (excluding sequence-specific transcription factors)
and histone modifications, which are preferentially en-
riched at promoters (see ‘Materials and Methods’ section
for a detailed discussion on selection algorithm). We
created a pairwise correlation matrix for 23 selected pro-
tein and histone modification profiles and performed an
unsupervised hierarchical clustering to reveal the extent of
correlation with the NSL complex. We found the profiles
of the interband protein Chromator, the WD40-repeat
protein WDS, the NURF complex subunit NURF301
and the methyltransferase Trithorax highly correlated
with the NSL complex profile (Figure 3A and B;
Supplementary Figure S7). Chromator had been found
in an early NSL complex purification (10) but could not
been recovered in more recent experiments (11,12),
possibly due to more transient or indirect interaction.
Notably, 5–15% of promoters which contain NSL1,
MBD-R2, WDS, NURF301 and Trithorax lack
Chromator. The WD40-repeat protein WDS consistently
copurifies with NSL complex members (10–12) and other
chromatin complexes including the Drosophila ATAC
acetyltransferase complex (26) and mammalian MLL
methyltransferase complexes (27,28). NURF301 is the
diagnostic marker subunit of the Imitation Switch
(ISWI)-containing nucleosome remodeling factor
NURF, which stimulates transcription by remodeling
promoter nucleosomes (29,30). Trithorax was originally
described to counteract the repression of homeotic genes
by the polycomb group proteins (31–33). More recently,
genome-wide ChIP-chip studies have indicated a wide-
spread binding of Trithorax to many promoters (34,35).
The pairwise relationships between the tested factors
are further illustrated by the scatter plots depicted in
Figure 3C, which emphasize that the NSL complex,
WDS, Chromator, NURF301 and Trithorax co-occupy
target promoters at linearly proportional levels
(Figure 3C). Promoters which are strongly bound by the
NSL complex are also highly enriched for NURF301,
Chromator and Trithorax. The same strong correlation
can be seen in an unbiased analysis using all microarray
probe signals, confirming the promoter-focused analysis
described above (Supplementary Figure S7B).
Searching for factors enriched at promoters we found
the heterochromatin protein 1c (HP1c) and, consistent
with previous results (36), the insulator proteins BEAF32
and CP190 (37) enriched at housekeeping promoters
(Supplementary Figure S8). These factors localize to
minor subsets of the NSL/Chromator/NURF301/
Trithorax target promoters (Figures 3 and 5;
Supplementary Figures S7B and 11). Importantly, the
presence of BEAF32, CP190 and HP1c determines
whether the bound NSL complex functions as an activa-
tor or not (see below).
Quantitative NSL1 binding correlates best with the
DNA replication-related element
Conceivably, the association of the NSL complex and its
colocalized chromatin modifiers may be determined by a
particular core promoter architecture. Different pro-
moters are characterized by the presence and combination
of a range of sequence motifs that provide contact surfaces
for general transcription factors and, therefore, modulate
the formation of the transcription pre-initiation complex
(38–40). The core promoter sequence motifs can be clas-
sified as canonical core promoter motifs which have fixed
positions with regard to the TSS, such as the TATA box,
the MTE (motif ten element), the DPE (downstream core
promoter element) and the INR (initiator), or as motifs
with weaker positional information (Ohler 1, Ohler 5,
Ohler 6, Ohler 7, Ohler 8 and DRE) (25,41). Canonical
core promoter motifs are enriched in peaked promoters,
whereas weakly positioned motifs are characteristic of
dispersed promoters. The mechanisms of action of most
dispersed elements are unknown [with the exception of the
DRE (39)].
Since NSL1 peaks within the core promoters of genes
with dispersed transcriptional start sites (Figure 1A and
D) we investigated whether the NSL complex is associated
with a specific set of core promoter motifs. We first
characterized the core promoter motifs with regard to
their distribution at active housekeeping and differentially
regulated genes (Supplementary Figure S9). As the motifs
deviate from their defined consensus sequences in many
cases, a similarity score (motif score) was calculated for
each promoter reflecting the similarity of the sequence to
any of the ten promoter consensus motifs described by
Ohler and colleagues (25) (see ‘Materials and Methods’
section). We found that over 70% of all active promoters
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Figure 3. The NSL complex cooccupies target promoters together with the chromatin remodeler NURF and the histone methyltransferase
Trithorax. (A) Heat map visualized correlation matrix of promoter-enriched chromatin factors and histone modifications at active genes. Pairwise
Spearman correlations were calculated using only active autosomal genes. The dendrogram shows the hierarchical clustering after which the matrix
was sorted. (B) ChIP-chip profile of the indicated proteins along a representative region of the chromosome arm 2L. The gene structure is indicated
below (active genes are red). (C) Pairwise scatter plot of promoter binding for each indicated factor using only active autosomal genes. Spearman
non-parametric correlation coefficients are provided for each pair.
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can be described by these ten motifs, indicating that our
analysis is representative (Supplementary Figure S9). In
agreement with previous analyses (41–43), the promoter
motifs INR, MTE and DPE were clearly overrepresented
in differentially regulated genes, which fits their enrich-
ment at peaked promoters (Supplementary Figures S8
and S9). Accordingly, housekeeping genes are enriched
for the motifs DRE, Ohler1, Ohler 5, Ohler 6 and Ohler 7.
Being able to characterize the core promoter motifs
allowed us to examine whether there is a differential asso-
ciation of NSL with any of them. Active genes were
categorized either as NSL targets or as non-targets based
on their NSL complex promoter occupancy. As expected,
the NSL1 target genes are enriched for the housekeeping
promoter motifs DRE, Ohler 1, Ohler 5, Ohler 6 and
Ohler 7 and depleted for TATA, INR, MTE and DPE.
Consistently, when we performed de novo motif analysis
of the sequences covered by the NSL1 ChIP-Seq peaks
(11), we again obtained the same motifs (Supplementary
Figure S10). This confirms that the NSL1 peaks at core
promoter motifs are diagnostic for housekeeping genes.
Is there any correlation between the ‘strength’ of NSL1
binding and how well an underlying motif matches its
consensus sequence? In order to address this question we
used the NSL1 ChIP-Seq data set (11), which due to its
good dynamic range allowed to categorize the ChIP-Seq
peak score as a surrogate for binding ‘strength’. We
binned the ChIP-Seq peaks in equally sized groups accord-
ing to their peak score [determined by SPP, (24)] and
displayed the fraction of promoters bound by a specific
group at a given motif score (Figure 4A, left). Among the
ten tested core promoter motifs the DRE motif, and to a
lesser extent motif Ohler 7, are the only motifs with scores
that correlate with the NSL1 ChIP-Seq peak score. This
suggests that DRE-containing promoters (and those con-
taining the less abundant Ohler 7 motif) primarily contain
NSL complex targeting clues (Figure 4B).
The combination of chromatin factors and core promoter
motifs enhance the prediction of NSL-regulated promoters
Whether or not a promoter-bound transcription factor
engages in active regulation often depends on the context
of close-by cis elements and interacting factors (44). This
appears to be the case for the NSL complex, as we showed
that the complex only activates a subset of the promoters
it associates with. NSL binds with high preference to a set
of housekeeping promoter motifs and its binding
‘strength’ correlates best with the presence of the DRE
motif. Can the subset of these NSL targets whose tran-
scription is diminished after depletion of NSL (i.e. those
promoters at which the complex is functional as an acti-
vator) be distinguished at the sequence level? We grouped
active genes according to their core promoter motif class
(see ‘Materials and Methods’ section) and monitored the
transcriptome changes after NSL depletion for each
group. Strikingly, only promoters containing the core
promoter motif ‘Ohler 5’ were strongly enriched for
NSL complex functional sites (Figure 5A). We note that
‘Ohler 5’-containing promoters do not show the strongest
correlation to NSL binding strength (Figure 4B)
suggesting that quantitative differences in factor binding
are not directly translated into a functional output.
We had observed that most promoters bound by HP1c,
BEAF32 and CP190 are among those also occupied by the
NSL complex (Figure 3 and Supplementary Figure S11).
Most of the HP1c, BEAF32 and CP190 binding occur
at distinct subsets as the three factors only colocalize
at a minority of sites (Supplementary Figure S11).
Intriguingly, promoters bound by any of the three factors
HP1c, BEAF32 or CP190 are obviously underrepresented
among the genes, whose transcription is activated by the
NSL complex (Figure 5B and Supplementary Figure S11).
In summary, the data suggest that the functionality of a
promoter-associated NSL complex is modulated by posi-
tive effectors (e.g. unidentified interactors of the ‘Ohler 5’
element) and negative regulators (HP1c and the insulator
proteins BEAF32 and CP190).
DISCUSSION
In this study, we show that the NSL complex is a potential
coactivator, which binds to many active genes, but regu-
lates only a specific subset of them. In our efforts to
describe the circumstances that define complex association
and function, we considered the contributions of two
major parameters: the diverse DNA sequences around
the core promoters, which are characterized by combin-
ations of recurring sequence motifs, and the association of
chromatin regulators that have recently been mapped by
the modENCODE consortium. Combining these diverse
data sets, we were able to improve the prediction toward
whether the transcription of an NSL-bound gene is
modulated by the NSL complex. To our knowledge, this
is the first systematic study demonstrating the usefulness
of this type of data integration.
The NSL complex is a transcription cofactor dedicated to
housekeeping genes
Following our observation that the NSL complex binds to
only a subset of all active promoters, we discovered that
the target genes were mostly housekeeping genes. This was
surprising as to our knowledge so far no transcription
coregulator dedicated to housekeeping genes is known.
This may simply reflect the fact that historically the mech-
anisms underlying differential transcription regulation
received more attention. Several lines of evidence support
the conclusion that the NSL complex preferentially local-
izes to the majority of housekeeping promoters. (i) We do
not detect significant differences in the global chromatin
binding profile of NSL complex members in cells of dif-
ferent sex or developmental stage. (ii) Genes that have
NSL bound at their promoters show little expression vari-
ation among different tissues as compared to active genes
that lack the NSL complex. (iii) NSL-bound promoters
are depleted of sequence motifs known to be enriched in
genes differentially regulated during development and in
tissue homeostasis (38). (iv) GO analysis of the active
NSL-bound genes revealed an overrepresentation of
categories for housekeeping functions, whereas the
converse data set of active genes not bound by NSL
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present diverse categories including ‘developmental pro-
grams’ and ‘acute signaling’. Other chromatin constitu-
ents, like HP1c and the insulator proteins BEAF32 and
CP190 also interact preferentially with housekeeping gene
promoters, as previously shown by Ohler and colleagues
(36), but these factors bind to a much more limited
number of genes in this class. Our analysis supports the
concept of global coregulation of functionally related gene
classes by common cofactors.
The developmental regulators NURF and Trithorax
colocalize with NSL at housekeeping promoters
The extensive colocalization of the NSL complex with the
methyltransferase Trithorax and the chromatin remodeler
NURF is puzzling since those factors are best known as
regulators of transcription of very restricted sets of genes
(developmental and highly inducible genes) (30,32), and
only recently has their extensive genome-wide localization
at many active gene promoters been noticed (34,35,45,46).
Conceivably, these three complexes cooperate to regulate
the transcription of housekeeping genes at the level of
chromatin organization and/or transcription initiation.
This hypothesis is supported by previous reports of bio-
chemical or genetic interactions between components
of the three factors. A genetic interaction between the
Xenopus BPTF (the NURF301 homolog) and Xenopus
WDR5 (a homolog of the NSL subunit WDS) has been
reported (47). Furthermore, Dou et al. (27) described a
‘supercomplex’ containing the human NSL as well as the
MLL1 complexes [MLL1 is homologous to Drosophila
Trithorax].
At present it is not clear whether NURF and Trithorax-
containing complexes contribute to the targeting of the
NSL complex (or vice versa), or whether all three regula-
tors are attracted by an additional common denominator
of target promoters. None of the three complexes contains
any specific DNA-binding subunit. NURF can be re-
cruited to inducible genes via direct interactions between
the large NURF301 subunit and transcription factors,
such as the GAGA factor (29) or the ecdysone receptor
(48). However, these interactions certainly do not explain
the widespread targeting of NURF to housekeeping genes
in vivo reported here. We noted a good quantitative cor-
relation between the NSL1 binding levels and the DRE
core promoter motif score, which opens the possibility that
a DRE—recognizing factor may stimulate NSL recruit-
ment. One candidate for such a factor is DREF, which
has been isolated as a DRE binding factor (49). DREF
may also contribute to the recruitment of NURF, since an
association of DREF with NURF has been observed in a
much larger complex based on the immunoaffinity purifi-
cation of the TATA box binding protein (TBP)-related
factor TRF2 (39).
In addition to direct recruitment by DNA-binding
proteins, transcription cofactors may be tethered by spe-
cific local histone modifications through recognition
domains (50). It is likely that this principle will also con-
tribute to the observed colocalization of NSL, NURF and
Trithorax complexes. Trithorax (the Drosophila MLL1
homolog) is an enzyme that methylates histone H3 at
lysine 4 (H3K4me3), a mark that characterizes active pro-
moters (46). Interestingly, WDS, which copurifies with
NSL complexes from Drosophila and mammalian cells
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the presented analysis only active NSL-bound genes were considered (using the modENCODE MBD-R2 data set (17), which allows the comparison
to a larger transcriptome data set). The same conclusion was reached if all active genes (without filtering for NSL complex binding) or different ‘NSL
complex binding’ criteria (such as NSL1 binding) were employed (data not shown). (B) Venn diagram representation of gene sets bound by the NSL
complex (modENCODE MBD-R2 ChIP-chip profile), down-regulated after ablation of the NSL complex and bound by at least one of the three
investigated proteins BEAF32, CP190 and HP1c (17). Numbers in brackets represent the number of genes in the respective group. The
modENCODE MBD-R2 data set served as a surrogate for the NSL complex to minimize technical variation in the comparison with the
BEAF32/CP190/HP1c data sets. Similar results were obtained using the NSL1 data set and the MBD-R2 (12) data set, respectively.
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(27) has been shown to preferentially interact with
methylated H3K4 (28). The mammalian homolog of
NURF301 (BPTF) also recognizes mononucleosomes
marked with methylated H3K4 and acetylated H4K16ac
through its PHD finger and bromodomain, respectively
(51). Acetylation of H4K16 by MOF in the NSL
complex may, therefore, contribute to the local enrich-
ment of NURF at target promoters. Our study gives rise
to numerous testable hypotheses as to the nature of the
interaction network that leads to the observed selective
targeting of the NSL complex.
The NSL complex only regulates a subset of target
promoters
The detailed analysis of the transcriptional effects of the
NSL complex revealed that the NSL complex regulates
only a subset of bound genes. Such a situation is not
without precedent as it has been shown for a number
of transcription factors that many binding events appear
to be non-functional (44). In fact, it is a major challenge to
predict the functional sites from the interaction profiles of
single factors as functionality is frequently determined by
the local clustering of binding sites, synergism between
colocalized proteins, and recently, chromatin accessibility
(52,53). Accordingly, we favor the idea that a combination
of chromatin factors and core promoter elements deter-
mines the activity of the NSL complex at any target
promoter. An even more immediate influence of
promoter DNA on interacting proteins may be imagined
as a direct effect of a DNA sequence on the conformation
and, therefore, the activity of a bound transcription factor
has been described (54).
Alternatively, it is possible that the default state of every
chromatin-bound NSL complex is functional, but that the
realization of this potential is restricted by negative
factors. We found that the presence of either one of the
three proteins HP1c, BEAF32 or CP190 correlated with
lack of NSL1 regulation. Insulator binding proteins like
BEAF32 and CP190 are known to decrease enhancer-
promoter interactions, which may lead to decreased tran-
scriptional output. Interestingly, antagonistic roles for
BEAF32 and DREF have been suggested for some over-
lapping in vivo binding sites (55). Resolving the mechan-
istic intricacies of complex promoter regulation remains a
challenging task for future endeavors.
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Term PValue
GO:0051188~cofactor biosynthetic process 2,33E-12
GO:0031023~microtubule organizing center organization 7,03E-11
GO:0051186~cofactor metabolic process 1,40E-03
GO:0007017~microtubule-based process 1,70E-03
GO:0051297~centrosome organization 1,70E-03
GO:0009108~coenzyme biosynthetic process 3,00E-03
GO:0007098~centrosome cycle 4,50E-03
GO:0000226~microtubule cytoskeleton organization 4,90E-03
GO:0070271~protein complex biogenesis 5,80E-03
GO:0006461~protein complex assembly 5,80E-03
GO:0006732~coenzyme metabolic process 9,70E-03
GO:0016071~mRNA metabolic process 9,80E-03
GO:0043069~negative regulation of programmed cell death 9,90E-03
GO:0060548~negative regulation of cell death 9,90E-03
GO:0006397~mRNA processing 1,03E-02
GO:0022402~cell cycle process 1,17E-02
GO:0000278~mitotic cell cycle 1,17E-02
GO:0051656~establishment of organelle localization 1,50E-02
GO:0033043~regulation of organelle organization 1,55E-02
GO:0007010~cytoskeleton organization 1,82E-02
GO:0006352~transcription initiation 2,25E-02
GO:0043066~negative regulation of apoptosis 2,26E-02
GO:0022403~cell cycle phase 2,40E-02
GO:0007049~cell cycle 2,46E-02
GO:0051298~centrosome duplication 2,63E-02
GO:0007173~epidermal growth factor receptor signaling pathway 2,69E-02
GO:0000279~M phase 2,76E-02
GO:0051130~positive regulation of cellular component organization 2,99E-02
GO:0009314~response to radiation 3,30E-02
GO:0017038~protein import 3,41E-02
GO:0033365~protein localization in organelle 3,44E-02
GO:0006367~transcription initiation from RNA polymerase II promoter 4,07E-02
GO:0006605~protein targeting 4,08E-02
GO:0051640~organelle localization 4,21E-02
GO:0006733~oxidoreduction coenzyme metabolic process 4,92E-02
GO:0048477~oogenesis 5,56E-02
GO:0016044~membrane organization 5,59E-02
GO:0006366~transcription from RNA polymerase II promoter 5,62E-02
GO:0007447~imaginal disc pattern formation 5,73E-02
GO:0007052~mitotic spindle organization 5,77E-02
GO:0006468~protein amino acid phosphorylation 5,88E-02
GO:0031124~mRNA 3'-end processing 6,00E-02
GO:0007276~gamete generation 6,06E-02
GO:0019953~sexual reproduction 6,74E-02
GO:0007051~spindle organization 6,99E-02
GO:0051276~chromosome organization 7,19E-02
GO:0008156~negative regulation of DNA replication 7,27E-02
GO:0007292~female gamete generation 8,03E-02
GO:0016310~phosphorylation 8,32E-02
GO:0007349~cellularization 8,38E-02
GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening 8,59E-02
GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay8,59E-02
GO:0035222~wing disc pattern formation 8,77E-02
GO:0051493~regulation of cytoskeleton organization 8,77E-02
GO:0009628~response to abiotic stimulus 9,11E-02
GO:0032504~multicellular organism reproduction 9,29E-02
GO:0048609~reproductive process in a multicellular organism 9,29E-02
GO:0051301~cell division 9,52E-02
GO:0006281~DNA repair 9,65E-02
GO:0065003~macromolecular complex assembly 9,66E-02
GO:0006259~DNA metabolic process 9,70E-02
GO:0016072~rRNA metabolic process 9,70E-02
GO:0006612~protein targeting to membrane 9,70E-02
GO:0006364~rRNA processing 9,70E-02
 Supplementary Figure 3: Gene Ontology (GO) enriched biological processes of NSL complex bound genes
Gene Ontology (GO) enrichment analysis was performed for biological processes using DAVID GO SLIM  (57).
P values were derived from a Fisher Exact test using the DAVID web-implementation.
All NSL1 bound genes were compared to all active genes in S2 cells.
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Supplementary Figure 4: Gene Ontology analysis of active NSL1 unbound genes
Term PValue
GO:0007606~sensory perception of chemical stimulus 1,57E-07
GO:0055114~oxidation reduction 4,48E-07
GO:0007600~sensory perception 3,79E-06
GO:0050890~cognition 6,59E-06
GO:0007155~cell adhesion 1,49E-05
GO:0022610~biological adhesion 1,49E-05
GO:0035218~leg disc development 1,79E-05
GO:0006952~defense response 2,93E-05
GO:0048569~post-embryonic organ development 5,89E-05
GO:0035286~leg segmentation 1,03E-04
GO:0035285~appendage segmentation 1,03E-04
GO:0046942~carboxylic acid transport 1,03E-04
GO:0015849~organic acid transport 1,03E-04
GO:0006865~amino acid transport 1,35E-04
GO:0015837~amine transport 1,35E-04
GO:0007166~cell surface receptor linked signal transduction 1,41E-04
GO:0007552~metamorphosis 1,44E-04
GO:0035111~leg joint morphogenesis 1,92E-04
GO:0007444~imaginal disc development 2,05E-04
GO:0045087~innate immune response 3,64E-04
GO:0007186~G-protein coupled receptor protein signaling pathway 3,97E-04
GO:0048707~instar larval or pupal morphogenesis 3,99E-04
GO:0048563~post-embryonic organ morphogenesis 4,28E-04
GO:0007560~imaginal disc morphogenesis 4,28E-04
GO:0042742~defense response to bacterium 5,24E-04
GO:0048737~imaginal disc-derived appendage development 5,54E-04
GO:0048732~gland development 5,60E-04
GO:0009886~post-embryonic morphogenesis 6,30E-04
GO:0048736~appendage development 6,39E-04
GO:0006955~immune response 6,55E-04
GO:0035214~eye-antennal disc development 7,53E-04
GO:0035114~imaginal disc-derived appendage morphogenesis 8,79E-04
GO:0007447~imaginal disc pattern formation 9,21E-04
GO:0048565~gut development 9,88E-04
GO:0035107~appendage morphogenesis 0,00101
GO:0016052~carbohydrate catabolic process 0,00139
GO:0009617~response to bacterium 0,00175
GO:0009791~post-embryonic development 0,00192
GO:0050830~defense response to Gram-positive bacterium 0,00215
GO:0007354~zygotic determination of anterior/posterior axis, embryo 0,00215
GO:0035108~limb morphogenesis 0,00221
GO:0060173~limb development 0,00221
GO:0035110~leg morphogenesis 0,00221
GO:0007157~heterophilic cell adhesion 0,00238
GO:0007449~proximal/distal pattern formation, imaginal disc 0,00238
GO:0035220~wing disc development 0,00258
GO:0007431~salivary gland development 0,00261
GO:0035272~exocrine system development 0,00261
GO:0035120~post-embryonic appendage morphogenesis 0,00276
GO:0042067~establishment of ommatidial polarity 0,00283
GO:0010623~developmental programmed cell death 0,00378
GO:0007450~dorsal/ventral pattern formation, imaginal disc 0,00433
GO:0007610~behavior 0,00438
GO:0035215~genital disc development 0,00444
GO:0007219~Notch signaling pathway 0,00492
GO:0007366~periodic partitioning by pair rule gene 0,00509
GO:0001708~cell fate specification 0,00608
GO:0019731~antibacterial humoral response 0,00617
GO:0050877~neurological system process 0,00683
GO:0048190~wing disc dorsal/ventral pattern formation 0,00808
GO:0007362~terminal region determination 0,00834
GO:0050909~sensory perception of taste 0,00834
GO:0009954~proximal/distal pattern formation 0,00834
GO:0006006~glucose metabolic process 0,00866
GO:0006928~cell motion 0,00924
GO:0016337~cell-cell adhesion 0,00933
GO:0002165~instar larval or pupal development 0,00964
GO:0009065~glutamine family amino acid catabolic process 0,01053
GO:0006584~catecholamine metabolic process 0,01053
GO:0009636~response to toxin 0,01053
GO:0040034~regulation of development, heterochronic 0,01053
GO:0018958~phenol metabolic process 0,01053
GO:0034311~diol metabolic process 0,01053
GO:0009712~catechol metabolic process 0,01053
Term PValue
GO:0007451~dorsal/ventral lineage restriction, imaginal disc 0,01073
GO:0048598~embryonic morphogenesis 0,01169
GO:0044275~cellular carbohydrate catabolic process 0,01187
GO:0046164~alcohol catabolic process 0,01187
GO:0006508~proteolysis 0,01269
GO:0007476~imaginal disc-derived wing morphogenesis 0,01297
GO:0007494~midgut development 0,01349
GO:0009996~negative regulation of cell fate specification 0,01349
GO:0042659~regulation of cell fate specification 0,01349
GO:0010453~regulation of cell fate commitment 0,01349
GO:0010454~negative regulation of cell fate commitment 0,01349
GO:0007626~locomotory behavior 0,01432
GO:0007472~wing disc morphogenesis 0,01436
GO:0043473~pigmentation 0,01489
GO:0007164~establishment of tissue polarity 0,0158
GO:0001736~establishment of planar polarity 0,0158
GO:0007435~salivary gland morphogenesis 0,01581
GO:0022612~gland morphogenesis 0,01581
GO:0001654~eye development 0,01737
GO:0019318~hexose metabolic process 0,01837
GO:0009072~aromatic amino acid family metabolic process 0,01867
GO:0035167~larval lymph gland hemopoiesis 0,01867
GO:0006935~chemotaxis 0,01867
GO:0007469~antennal development 0,01867
GO:0007440~foregut morphogenesis 0,01867
GO:0035166~post-embryonic hemopoiesis 0,01867
GO:0007608~sensory perception of smell 0,01867
GO:0001738~morphogenesis of a polarized epithelium 0,02213
GO:0006959~humoral immune response 0,02258
GO:0008219~cell death 0,02319
GO:0016265~death 0,02319
GO:0007411~axon guidance 0,02345
GO:0035289~posterior head segmentation 0,02396
GO:0042688~crystal cell differentiation 0,02396
GO:0008587~imaginal disc-derived wing margin morphogenesis 0,02585
GO:0043067~regulation of programmed cell death 0,02652
GO:0010941~regulation of cell death 0,02652
GO:0007478~leg disc morphogenesis 0,02674
GO:0019730~antimicrobial humoral response 0,02721
GO:0042060~wound healing 0,02983
GO:0012501~programmed cell death 0,03034
GO:0009310~amine catabolic process 0,03038
GO:0006007~glucose catabolic process 0,03224
GO:0019320~hexose catabolic process 0,03224
GO:0048066~pigmentation during development 0,03293
GO:0016054~organic acid catabolic process 0,03293
GO:0046395~carboxylic acid catabolic process 0,03293
GO:0006576~biogenic amine metabolic process 0,03535
GO:0050829~defense response to Gram-negative bacterium 0,03535
GO:0006334~nucleosome assembly 0,03535
GO:0035222~wing disc pattern formation 0,03789
GO:0030030~cell projection organization 0,03796
GO:0000902~cell morphogenesis 0,03819
GO:0005976~polysaccharide metabolic process 0,03902
GO:0046365~monosaccharide catabolic process 0,03963
GO:0042386~hemocyte differentiation 0,04036
GO:0035162~embryonic hemopoiesis 0,04036
GO:0000272~polysaccharide catabolic process 0,04036
GO:0048568~embryonic organ development 0,04036
GO:0048749~compound eye development 0,04235
GO:0046667~compound eye retinal cell programmed cell death 0,04283
GO:0035161~imaginal disc lineage restriction 0,04283
GO:0009253~peptidoglycan catabolic process 0,04283
GO:0006027~glycosaminoglycan catabolic process 0,04283
GO:0000270~peptidoglycan metabolic process 0,04283
GO:0006206~pyrimidine base metabolic process 0,04283
GO:0035287~head segmentation 0,04283
GO:0035223~leg disc pattern formation 0,04283
GO:0007479~leg disc proximal/distal pattern formation 0,04283
GO:0014070~response to organic cyclic substance 0,04416
GO:0007419~ventral cord development 0,04416
GO:0043279~response to alkaloid 0,04416
GO:0006096~glycolysis 0,04557
GO:0045596~negative regulation of cell differentiation 0,0459
GO:0042981~regulation of apoptosis 0,04595
GO:0043068~positive regulation of programmed cell death 0,04734
GO:0030031~cell projection assembly 0,04734
GO:0010942~positive regulation of cell death 0,04734
Gene Ontology (GO) enrichment analysis was performed using active but NSL1 unbound genes against the
background of all active genes. DAVID GO SLIM (57) terms were used for biological processes. P values were
derived from a Fisher Exact test using the DAVID web-implementation.
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Supplementary Figure 6:  Gene Ontology enrichment analysis of NSL1 RNAi downregulated genes
Term Pvalue
GO:0006259~DNA metabolic process 1,30E-05
GO:0006281~DNA repair 2,70E-04
GO:0034660~ncRNA metabolic process 9,00E-04
GO:0006412~translation 7,23E-02
GO:0033554~cellular response to stress 0,001
GO:0006399~tRNA metabolic process 0,001
GO:0006974~response to DNA damage stimulus 0,001
GO:0008033~tRNA processing 0,002
GO:0034470~ncRNA processing 0,005
GO:0006284~base-excision repair 0,006
GO:0006366~transcription from RNA polymerase II promoter 0,011
GO:0006367~transcription initiation from RNA polymerase II promoter 0,012
GO:0006351~transcription, DNA-dependent 0,014
GO:0006352~transcription initiation 0,015
GO:0032774~RNA biosynthetic process 0,016
GO:0006396~RNA processing 0,017
GO:0009451~RNA modification 0,023
GO:0006260~DNA replication 0,032
Downregulated genes (fold change < -2) were compared to all active genes (Aymetrix log2-scale > 4). 
Gene Ontology enrichment analysis was performed using DAVID (57), testing for biological processes using the 
GO SLIM terms. P values were derived from a Fisher Exact test using the DAVID web-implementation. 
A similar result was obtained using the R/Bioconductor package GOstats (data not shown).
Supplementary Figure 6
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Supplementary Figure 8: Summary of factor and sequence occupancies across different conditions. 
Supplementary Figure 8
Factor and sequence occupancy is given relative to all genes in the D. melanogaster 
genome (FlyBase dmel5.32 annotation) (column 2), all active genes (column 3, gene activity 
measured by modENCODE polymerase II dataset), all inactive genes (column 4), all active house-
keeping genes (column 5) and all active “differentially regulated” genes (DRG, column 6). Column 7 
indicates the ratio of active genes over inactive genes, and column 8 indicates the ratio of 
active housekeeping genes over active “differentially regulated” genes. The list was sorted
according to the enrichment towards active housekeeping genes (column 8) and overrepresented
and underrepresented factors are labeled in red and green, respectively. Only modENCODE ChIP-
chip profiles were used.
% Binding to all % Binding to all Enrichment Enrichment
Active Inactive active active Active/ Housekeeping/
Genes Genes Genes Housekeeping DRG Inactive /DRG
BEAF32 17,9 33,5 1,1 39,9 17 31,7 2,3
Ohler 1 7,6 12,7 2,1 15 6,7 5,9 2,2
HP2 2 3,2 0,7 3,8 1,7 4,8 2,2
DRE 14,4 21,2 7,2 24,6 12,3 2,9 2
Ohler 5 8,6 12,1 4,7 14 7,2 2,6 2
Chromator 44,7 80,7 6 92,7 49,4 13,4 1,9
Ohler 7 10,4 15,3 5,1 17,6 9,5 3 1,9
MBD-R2 38,9 71,7 3,7 82,1 44,7 19,4 1,8
WDS 39,6 73,5 3,1 83,9 46,7 23,5 1,8
Trithorax 40,6 74,4 4,4 84,7 47,5 16,7 1,8
CP190 29 47,5 9,2 54 30,5 5,2 1,8
NURF301 42,2 77,5 4,2 87,8 51,1 18,4 1,7
Ohler 6 6 7,6 4,2 8,5 5,1 1,8 1,7
HP1c 15,5 29,1 1 32,6 20 29,1 1,6
H3K4me3 47,5 87,1 5,1 94,9 67 17,2 1,4
Su(var)3-7 1,8 2,6 1,1 2,8 2 2,4 1,4
H3K9ac 46,9 84,5 6,6 92 65,3 12,8 1,4
Nelf-E 28,8 54,9 0,9 59,3 43,3 59,6 1,4
H4K16ac 50,0 80,0 17,5 78,9 58,6 9,7 1,3
Nelf-B 30,7 58,6 0,9 62,7 47,7 62,3 1,3
CTCF 4 4,4 3,5 4,5 4,2 1,2 1,1
Ohler 8 5,8 6,8 4,7 6,9 6,6 1,4 1
TATA 9,7 8,2 11,4 7,9 8,9 0,7 0,9
E(z) 1,3 0,8 1,9 0,7 1,1 0,4 0,6
INR 18,4 15,6 21,5 12,7 23,2 0,7 0,5
H3.3 20,8 32,3 8,4 26,2 48,3 3,8 0,5
MTE 2 1,9 2,2 1,5 3 0,9 0,5
Psc 1,6 1,1 2 0,8 1,9 0,6 0,4
RING 2,9 3,3 2,4 2,4 5,8 1,4 0,4
DPE 3,6 3,4 3,8 2,5 6 0,9 0,4
Mi-2 2,6 4,7 0,3 2,9 9,2 15,8 0,3
GAF 8,3 14,8 1,4 8,6 30,7 10,6 0,3
H3K27me3 35,8 4,1 69,8 1,9 9,8 0,1 0,2
Pc 2 0,5 3,6 0,2 1,2 0,1 0,1
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Supplementary Figure 9
Supplementary Figure 9: Characterization of core promoter motifs at active genes.
(A) Histogram depicting the distribution of standard deviations of active genes across 40 Drosophila tissues (21). Normal distribution
is overlayed with a blue dashed line. (B) Same as (A) but log2 transformed standard deviations. (C) Comparison of gene expression values in housekeeping
genes (left box) and differentially regulated genes (right box). Gene expression values were taking from the log2 transformed Affymetrix control RNAi 
transcriptome dataset. (D) Core promoter motif distribution of active housekeeping genes. Heatmap presentation of motif score (columns) along active 
housekeeping genes (rows). The dendrogram to the right was generated by hierarchical clustering of gene promoters according to their motif score using 
the ‘complete’ method implemented in the R package ‘hclust’. The dendrogram above the heatmap was generated by hierarchical clustering (’ward method’) 
of the Spearman correlated motif scores. Note that 1269 of the 4523 active housekeeping genes do not show any significant signature of at least one of 
the investigated core promoter motifs. See Material and Methods for detailed information on the definition of the ‘motif score’. (E) Same as (D) but for
active differentially regulated genes. Note that 480 of the 1367 active differentially regulated genes do not show any significant signature of at least one of 
the investigated core promoter motifs. 
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Supplementary Figure 10: NSL1 peaks are centered over core promoter motifs 
characteristic for housekeeping genes
motif total number sequences sequence fraction
enriched for motif enriched for motif
DRE 1106 19.9
Ohler 1 703 12.7
Ohler 5 556 10.0
Ohler 7 510 9.2
Ohler 6 251 4.5
Ohler 8 109 2.0
INR 84 1.5
TATA 38 0.7
MTE 33 0.6
DPE 12 0.2
De-novo sequence search (Hartmann and Soeding, in preparation) of the sequence 
surrounding +/- 50 base pairs centered on the NSL1 ChIP-Seq (11) peak summit. 
Column 2 indicates the number of identified sequences containing the respective motif.
Column 3 displays the fractions of each identified motif relative to all identified motifs.
Supplementary Figure 10
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Supplementary Figure 11: HP1c and insulator binding proteins co-localize with the NSL complex at non-functional sites.
(A) Venn diagram representation of gene sets bound by the NSL complex (using the MBD-R2 ChIP-chip profile generated by the
modENCODE consortium) and heterochromatin protein 1c (HP1c), CP190 and BEAF32. (B) Venn diagram representation of 
gene sets downregulated after NSL1 RNAi and bound by the heterochromatin protein 1c (HP1c), CP190 and BEAF32.
Numbers in brackets represent the number of genes in the respective group (for clearity numbers with little information content 
are not shown). We used the modENCODE MBD-R2 data set as a proxy for the NSL complex to minimize technical variation
in the comparison with the BEAF32/CP190/HP1c datasets. Similar results were obtained using the NSL1 dataset and the 
MBD-R2 dataset (12), respectively.
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3.4.1 Summary, significance and own contribution 
 
Summary and significance 
Post-translational protein modifications (PTMs) are at the core of most regulatory systems. Histone 
proteins acquire impressive patterns of PTMs that govern all nuclear processes and often indicate or 
even cause malfunction that manifests in complexes diseases including cancer and neurodegenerative 
diseases.  
Although research in epigenetics and chromatin over the past two decades documented many, mostly 
qualitative, relationships between individual histone PTMs and the enzymes that write and erase these 
marks, a quantitative and comprehensive description of all enzyme-substrate relationships for an entire 
class of PTMs is missing but urgently needed. Such a global description of PTMs and their modifiers 
as a system will greatly facilitate our ability to develop quantitative models on chromatin pathways 
that are not only beneficial to refine our understanding of nuclear processes and their malfunction but 
also to develop new epigenetic therapies. 
In this study, we generated a quantitative and comprehensive catalogue of histone acetylation and 
methylation motifs that describe the changes in response to ablation of each single known or suspected 
lysine acetyltransferase (KAT) and deacetylase (KDAC) in Drosophila melanogaster.  
The comprehensiveness of the dataset not only allows us to define class-specific features that are 
shared among members of enzyme families but also to describe the histone modification system as a 
highly interconnected, responsive network that compensates for the loss of single components.  
Generating this catalogue first required optimization of liquid chromatography mass spectrometry 
(LC-MS) workflows. Our improved LC-MS protocol not only allowed precise and accurate 
quantification of combinatorial histone acetylation and methylation motifs, but also delivered a 
general applicable tool to identify and quantify combinatorial PTM motifs on other proteins.  We 
describe an inherent bias common to most previous histone PTM studies applying LC-MS and provide 
a resource to correct for this bias.  
Our classification of acetylation motifs according to their absolute abundances has direct implications 
on the design and interpretation of genomic experiments.  
The most surprising finding was that ablation of almost every KAT triggered a systemic response to 
effectively maintain global acetylation levels. Its widespread occurrence and observation in different 
species, including human cells, suggests this to be a fundamental, conserved principle. Considering the 
global but distinct changes to the epigenome when inhibiting individual KAT activities may be 
utilised to improve current and develop more effective epigenetic therapies.  
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Applying the methodology to another, already well-documented ‘compensatory system’ revealed that 
chromosome-wide transcriptional fine-tuning during Drosophila dosage compensation is not restricted 
to the change of a single histone PTM (H4.K16ac), but accompanied by an global yet specific re-
distribution of acetylation and methylation marks. This finding provides further evidence that a full 
understanding of the function of a single histone PTM requires to analyse it in the context of the entire 
system.  
In summary, our data not only provides a general resource for enzyme-substrate relationships to KATs 
and KDACs but it also defines a starting point to explore systematically the interconnected network 
properties of chromatin modification pathways.  
 
Own contribution 
Prof. Peter Becker and I conceived the project and wrote the manuscript. I co-developed the LC-MS 
workflow with Dr. Ignasi Forne. I performed all experiments, analysed the data and prepared all 
figures. Most peptide samples were processed by Dr. Ignasi Forne, who also performed the MS 
measurements. Prof. Axel Imhof supervised the LC-MS experiments and contributed important 
reagents. 
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3.4.2 Submitted manuscript 
 
 
Global and specific responses of the histone acetylome 
to systematic perturbation 
 
 
SUMMARY 
Regulation of histone acetylation is fundamental to the utilization of eukaryotic genomes in chromatin. 
Aberrant acetylation contributes to disease and can be clinically combated by inhibiting the 
responsible enzymes.  
Our knowledge of complex histone acetylation patterns is patchy because current methodologies do 
not permit a systematic assessment of rare and combinatorial signatures. We devised a generally 
applicable, sensitive mass spectrometry-based strategy to efficiently and quantitatively monitor 
combinatorial modifications. This was applied to generate a comprehensive inventory of acetylation 
motifs on histones H3 and H4 in Drosophila cells.  
Systematic depletion of every known or suspected acetyltransferase and deacetylase revealed specific 
alterations of histone acetylation signatures, established enzyme-substrate relationships and unveiled 
an extensive crosstalk between neighboring modifications. Unexpectedly, overall histone acetylation 
levels remained remarkably constant upon depletion of individual acetyltransferases. Conceivably, the 
acetylation level is adjusted to maintain the global charge neutralisation of chromatin and the stability 
of nuclei. 
 
 
Highlights 
 System’s view of histone modification motifs and its response to enzyme depletion  
 Extensive crosstalk between lysine acetylation and methylation 
 Global acetylation levels are maintained in response to acetyltransferase ablation  
 Global chromatin features associated with fly dosage compensation  
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INTRODUCTION 
The problem of packaging and organising complex genomes in the nuclei of cells was elegantly solved 
by the evolution of chromatin. The wrapping of DNA around octamers of histone proteins to form an 
ever-repeating succession of nucleosomes is universal among all eukaryotes. The increasing 
complexity of organisms due to the differentiation of cell types, necessitates a structural and functional 
diversification of chromatin. This is mainly achieved by post-translational, chemical modifications of 
histones.  
Currently, we know of more than 10 different types of chemical modifications (such as methylation, 
acetylation, phosphorylation) that alter the properties of amino acids in histones. Collectively, these 
modifications locally define chromatin structure and are fundamental to establishing the gene 
expression programmes that characterise healthy and diseased cells. The enzymes that reversibly 
modify histones are increasingly recognised as targets for therapeutic intervention in cancer tissue and 
neurodegenerative diseases (Dawson and Kouzarides, 2012; Graff and Tsai, 2013). 
Acetylations of histones H3 and H4 are frequent and among the best characterised post-translational 
modifications (Sterner and Berger, 2000; Kouzarides, 2007; Lee and Workman, 2007). The N-terminal 
domains of these two histones (the amino-terminal ‘tail’ domains) alone bear a dozen lysine residues 
subject to acetylation. Additional acetylation has also been reported at internal residues (Tan et al., 
2011).  
The acetylation of lysine has structural consequences: charge neutralization weakens DNA-histone and 
nucleosome-nucleosome interactions and is often correlated to unfolding of nucleosome fibres and 
gene activation (Kouzarides, 2007). Acetylated lysines may contribute to marking individual histones 
as they are recognised by bromodomains of effector proteins. Acetylation of lysines prevents their 
methylation or ubiquitylation and may therefore have secondary effects. Histone acetylation patterns 
in chromatin result from the interplay between an impressive number of dedicated lysine 
acetyltransferases (KATs) and antagonizing deacetylases (KDACs). 
In evaluating the potential of an individual acetylation mark, it is useful to know its abundance. For 
example, a highly abundant acetylation is likely to have a broad, structural function. By contrast, a rare 
acetylation might rather serve as a signal. Currently, our knowledge on the cellular copy number for 
most histone modifications is sparse.  
Different post-translational modifications (PTMs) may reside on the same histone molecule. Many 
cases have been reported where PTM combinations (PTM motifs) rather than individual marks bear 
functional meaning (Fischle et al., 2003). Top-down mass spectrometry suggests the existence of over 
200 different PTM motifs on histones – many of which involve site-specific acetylation – yet their 
exact cellular abundance remains elusive (Pesavento et al., 2008; Young et al., 2009; Jung et al., 
2013). 
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Acetylated lysines may be bound by dedicated bromodomains in effector proteins. Although the 
affinity towards a single acetyl-lysine is low, multiple adjacent acetyl-lysines not only boost the 
affinity but may also tune the targeting selectivity (Ruthenburg et al., 2007; Filippakopoulos et al., 
2012). It is currently not known whether combinatorial acetylation motifs are generated by a single 
KAT or whether they require the action of multiple enzymes, with the exception of the cytoplasmic di-
acetylation of H4 at K5 and 12, which is catalysed by HAT1 (Parthun, 2012). 
Moreover, PTMs neighbouring acetylated lysines can strongly alter the affinity of bromodomains – 
and likewise the enzymatic activity of KATs and KDACs may be modulated by close-by PTMs 
(Fischle et al., 2003; Filippakopoulos et al., 2012). 
Our ability to detect low abundant histone acetylation, or acetylation as part of a PTM motif are 
currently rather limited. Traditionally, histone PTMs are detected with antibodies raised against 
appropriately modified peptides. However, recent studies alarm that antibodies raised against 
individually acetylated lysines (e.g. H4.K12ac) primarily recognise multiply-acetylated peptides (e.g. 
tetra-acetylated H4) and may display substantial off-target reactivity (Suka et al., 2001; Fuchs et al., 
2011; Rothbart et al., 2012). Moreover, antibody detection systems have a limited linear dynamic 
range, precluding a quantitative analysis. Finally, most antibodies are unable to differentially display 
acetylation in combinatorial motifs. 
Peptide modifications are commonly detected by mass spectrometry (MS), however, most current MS 
protocols are hampered by low sensitivity and dynamic range and high-level requirements for 
operating personnel and instrumentation. We optimised existing procedures and developed new 
protocols to establish a robust and generally applicable workflow for accurate and precise 
quantification of modification motifs. We applied this methodology to generate a comprehensive 
inventory of motifs involving acetylation of H3 and H4 in Drosophila cells. This database will become 
a useful tool for further studies. 
In order to learn how acetylation motives are generated we systematically assessed the effects of 
individual acute depletion of all putative KAT and KDAC enzymes in Drosophila. This effort 
identified new activities and specificities and re-defined enzyme-substrate relationships that had been 
controversial or simply unknown. To our surprise, we also uncovered a global response of the histone 
acetylome to interference with certain acetylation pathways, which suggests that the total 
concentration of histone acetylation in nuclei is subject to homeostatic control. 
Our classification of histone acetylation motifs according to their abundance, enzyme-dependence and 
their contribution to the systemic response to acute perturbation of specific acetylation reactions leads 
to testable hypotheses about their contributions to global chromosome architecture and local signalling 
events. 
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RESULTS 
Optimizing liquid chromatography mass spectrometry workflows for accurate and precise 
quantification of single and combinatorial PTMs 
Identifying and quantifying rare, combinatorial modification motifs currently poses a major analytical 
challenge. We optimised liquid chromatography mass spectrometry (LC-MS) workflows for sensitive, 
precise and accurate quantification of PTM motifs containing lysine acetylation and methylation.  
We rapidly isolated histones from cells by acid extraction and chemically acetylated all unmodified 
and mono-methylated lysines with deuterated acetic anhydride (D3AA method (Smith et al., 2003). 
The deuterated (d3) mass tag adds three Daltons to distinguish endogenous from chemical acetylation. 
This also ensures that digestion by trypsin only occurs after arginine, yielding peptides of an 
intermediate size necessary for bottom-up analysis of PTM motifs (Figure 1A). Unlike the more 
common propionylation (Garcia et al., 2007; Schotta et al., 2008; Zheng et al., 2013), chemical 
acetylation yields peptides with similar physicochemical properties to those bearing endogenous 
acetylation. This ensures comparability during the entire LC-MS workflow, including the MS 
quantification.  
We developed a generally applicable targeted MS workflow to increase the dynamic range of MSn 
measurements (see Suppl. Note 1). This was necessary because many combinatorial motifs can only 
be resolved by consecutive MS1 and MS2 scans, and four H4 di-acetyl motifs require MS1-MS2-MS3 
(see below). The targeted approach increased the precision and accuracy to quantify minor differences 
in rare and combinatorial histone PTMs (Figures 1B, C, S1, S2, S3 and Suppl. Note 1).  
Motifs containing methylated lysines in addition to acetylation displayed characteristic shifts in 
retention time (Figures 1A, S1). A systematic analysis of positional isomers (peptides with identical 
mass but PTMs at different positions) revealed some rules. A di- or tri-methyl group close to the N-
terminus of a peptide results in a lower hydrophobicity and thus earlier retention time as compared to 
when the methylation is in the middle. For example, an H3 peptide containing tri-methylated lysine 27 
(K27me3) elutes a few minutes before the same peptide bearing K36me3 (Figure S1B). Furthermore, 
tri-methylated peptides elute shortly before di-methylated ones, followed by unmethylated and, lastly, 
mono-methylated forms. This was true for all histone peptides analysed and allows a precise 
quantification of peptides carrying methylation-only or mixed acetylation-methylation motifs solely 
based on their MS1 values (Figures 1A, S1). 
Positional isomers carrying one or multiple acetylations are not separated chromatographically using 
the D3AA method. Their individual intensities can be quantified using signals generated by a high 
occurrence of targeted MS2 scans (Figures 1A, S2; Tables S1, S2). Because four of the di-acetylated 
histone H4 combinations, including H4.K5acK12ac, cannot be identified and quantified with MS1 and 
MS2 only, we optimised procedures to quantitatively read out prognostic MS3 ions and thereby 
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measured those isoforms by successive MS1-MS2-MS3 scans (Figures S2A, S2B, Suppl. Note 1.2). 
To our knowledge, this is the first direct MS-based quantification of all six histone H4 di-acetylated 
isoforms. 
To validate and benchmark the LC-MS workflow, we used synthetic peptides carrying different 
acetylation motifs at different ratios (Figure S2B, Table S3), which demonstrated a very high 
accuracy. To assess the level of precision, we performed three whole-workflow replicates starting with 
2 million KC cells each. The quantification of 45 histone motifs resulted in a median coefficient of 
variation (CV) of 5.2% (Figure 1B, Table S4). Next, we measured the level of variation for five 
independent biological replicates involving control RNAi treatments of between 2 and 8 million cells. 
Through optimising MS2 and MS3 recordings, the CVs for motifs, which require successive MSn 
measurements were similar (median CV of 10.4) to those for motifs requiring MS1 only (median CV 
of 8.9). However, the CVs of the individual histone PTMs varied between 0.8% and 35.7% (Figure 
1B, Table S4). Similar results were obtained using 75,000 to 300,000 mammalian cells (data not 
shown). The differences in CV for histone PTMs reflect their in vivo abundances, which differ in 
several orders of magnitude (Figures 1D, E) and the technical imprecision specific to any MS 
identifier (Table S4). For example, quantitation of the highly abundant H3.K27me2 motif requires 
only MS1-based quantification with highly precise MS1 quantifier (CV = 5.3%), whereas the low-
abundant H4.K8acK12ac motif requires integration from MS1, MS2 and MS3 peak areas (CV = 
35.7%). Overall, our current LC-MS workflow is able to analyse low amounts of sample and the 
sensitivity, precision and accuracy are improved over state-of-art workflows for quantifying PTM 
motifs.   
 
Correction of LC-MS signal bias  
Modifications change the physiochemical properties of peptides, which may influence several steps 
during the LC-MS workflow and thereby impair accurate quantification (Marx et al., 2013). To assess 
this phenomenon, we determined the LC-MS response factor by measuring a library of synthetic 
peptides containing acetylation and methylation motifs to H3 and normalising the proteotypic signals 
relative to the Q tag abundance (Figure 1C, Suppl. Note 2). Equimolar solutions of peptides with 
different methylation signatures display very drastic differences in the LC-MS response factor, 
corroborating a recent study by Garcia and colleagues (Lin et al., 2014). The effect is most dramatic 
for peptides containing H3.K9me3, whose Q tag normalised LC-MS response factor is 34 times lower 
than that of the K9me1 peptide. Therefore, the interpretation of the cellular abundance of K9me3 is 
underestimated by an order of magnitude if not corrected for.  
On the other hand, H3 peptides bearing K9ac or K14ac have almost identical LC-MS response factors, 
confirming that the D3AA method achieves accurate quantification of acetylation motifs.  
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In summary, experimentally determined LC-MS response factors allowed introducing a correction 
factor specific to histone motifs. Table S3 summarises these factors for a selected set of peptides. Our 
catalogue of correction factors will facilitate the interpretation of published and future PTM datasets 
for relative and absolute abundances of peptides and their PTMs. 
 
The histone acetylation motifs fall into three abundance classes 
We measured the acetylation and methylation levels of all lysines on histone H3 and H4 in Drosophila 
melanogaster KC cells and quantified 45 of over 55 motifs detected (Figure 1D, Table S4, Suppl. Note 
1.3). This included acetylation of K5, K8, K12 and K16 as well as methylation of K20 on histone H4 
and seven acetylation (K9, K14, K18, K23, K27, K36, K37) as well as five methylation sites (K4, K9, 
K27, K36, K79) on H3. We did not detect acetylation or methylation on the remaining six lysines of 
histone H4 and four lysines on histone H3. Although other lysine acetylation sites had been reported 
before (H4.K91ac, H3.K4ac, H3.K56ac, H3.K122ac), their abundance in Drosophila cells must be 
below our detection limit of approximately 0.003% or 182 histone molecules per cell, at least on 
average in an asynchronous population (see below and Suppl. Note 1.3). 
Knowledge of the cellular abundances of histone motifs facilitates the interpretation of chromatin 
maps and may contribute to developing quantitative models for the function of histone modifications. 
For example, H3.K9me3 constitutes a hallmark of repressive chromatin that covers significant regions 
of the fly and mammalian genomes (Kharchenko et al., 2011; Consortium et al., 2012). In support of 
this widespread notion, we measured K9me3 on 39% of H3 molecules, but only if we corrected for the 
differential LC-MS response (without correction: 4.2% H3.K9me3, Table S4).  
The abundances among individual acetylation motifs differ by four orders of magnitude (Figure 1D). 
Plotting the abundance distribution of the 29 histone acetylation motifs revealed three abundance 
classes. H3.K23ac is by far the most abundant acetylation (47% of H3, corresponding to 2.8 million 
molecules/cell). It is present, on average, on every second nucleosome or even on all nucleosomes if 
the arrangement was heterotypic. Eleven motifs were of intermediate abundance (1–12% of histones, 
class median: 3.7%). Most combinatorial acetylation motifs, however, are present on less than 1% of 
histones (17 motifs, class median: 0.3%). For example, the H4.K5acK8acK16ac motif is present in 
only about 7600 estimated copies per cell (for reference, a KC cell has about 6000 active gene 
promoters). It is tempting to speculate that highly abundant histone acetylation motifs contribute to 
global features of chromatin structure, whereas rare and combinatorial histone acetylation motifs 
constitute marks for bromodomain-mediated signalling.  
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The contributions of all known or suspected KAT and KDAC enzymes to histone acetylation 
motifs 
The inventory of all histone acetylation motifs serves as a point of entry to study the histone acetylome 
as a structural and regulatory system that is installed by KATs and KDACs according to cell-specific 
programmes. The properties of this system depend on the substrate specificity or redundancy of the 
enzymes. Which KATs and KDACs contribute to a specific histone acetylation motif? What are the 
global effects on the histone acetylation landscape if a single enzyme is depleted? Addressing these 
questions we systematically evaluated the contribution of every KAT and KDAC to the inventory.  
Drosophila melanogaster is particularly suited for a single gene perturbation strategy, since most 
KATs, KDACs and KAT/KDAC-associated proteins are well conserved between the fly and human 
cells, yet, the fly genome does not contain extensive KAT and KDAC paralogues, which are common 
for most mammalian genomes.  
We created and curated a list of putative acetyltransferases and deacetylases in D. melanogaster, 
including novel candidate genes coding for proteins with acetyltransferase-related domains, using 
public databases, primary research articles and cross-homology search using BLAST (Table S6). Of 
the at least 44 putative lysine acetyltransferases with recognisable KAT domains, we focused on the 
23 KATs, which are expressed in most cell types and developmental stages and thus are likely to 
constitute the most relevant determinants of Drosophila’s histone acetylation system. This list includes 
(1) the extensively studied ‘model’ KATs (GCN5/PCAF, CBP/P300, MOF, HAT1, TIP60), (2) less 
well characterised KATs (KAT6 [MOZ/MORF], HBO1, ELP3, TAF1, ATAC2), (3) a mostly 
uncharacterised class of GCN5-related KATs (NAT6, NAT9, NAT10), (4) N-terminal 
acetyltransferases suggested to also acetylate internal lysines (NAA10, NAA20, NAA30, NAA40, 
NAA50, NAA60), (5) putative acetyltransferases with no recognizable direct homologue in non-
Drosophilid species (CG5783, CG12560), (6) the acetyltransferase ECO and (7) a bi-functional 
enzyme containing a O-GlcNAcase - activity and potentially a KAT activity (MGEA5, also known as 
NCOAT or OGA).  
The D. melanogaster genome encodes five recognisable zinc-dependent lysine deacetylases of the 
HDAC class (RPD3/HDAC1, HDAC3, HDAC4, HDAC6, HDAC11) und five NAD-dependent 
Sirtuins (SIR2/SIRT1, SIRT4, SIRT6, SIRT7). With the exception of HDAC11 and SIRT7, all 
KDACs are ubiquitously expressed und analysed in our study.  
Because the majority of KATs and KDACs are not or only poorly characterised and consequently 
mutants and antibodies are lacking, we depleted KAT and KDAC proteins by RNA interference 
(RNAi) in the Drosophila model cell line KC. RNAi efficiently depletes proteins in Drosophila cell 
lines within 4 – 7 days (Zhou et al., 2014).  
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As a proof of concept we initially focused on the acetyltransferase MOF, for which well characterised 
mutants and antibodies exist. MOF levels were strongly diminished after incubating cells for 4 days 
with interfering RNAs directed against MOF transcript, and were undetectable after 5.5 days (Figures 
S4A, B). At this time H4.K16ac, the known product of MOF activity, was most strongly reduced 
(Figure S4C). The two different interfering RNAs yielded very similar results (Table S5). Because 
MOF is considered to be responsible for the majority of H4.K16ac in Drosophila and human cells 
(Smith et al., 2005; Conrad et al., 2012), we were surprised to observe that depletion of MOF in the 
female KC cell line reduced the amounts of H4.K16ac by only 40%.  
To compare the acute RNAi depletion strategy with constitutive loss of gene function, we analysed the 
status of H4.K16ac in adult flies mutated for MOF (Gu et al., 1998). Similar to KC cells, mof2 mutant 
females retained over 50% of H4.K16ac (Figure S4D). Apparently, other KATs besides MOF 
contribute to setting the H4.K16ac mark. Therefore, RNAi against MOF led to quantitatively similar 
reduction of H4.K16ac as loss-of-function mutation of the MOF gene. We conclude that RNAi is an 
appropriate method for our survey of KAT and KDAC activities.  
We next ablated each KAT and KDAC in KC cells with two distinct interfering RNAs for 5.5 days 
and measured the abundance of 22 acetylation, 6 mixed acetylation-methylation and 11 methylation 
motifs as well as the 5 unmodified peptide backbones. Using RT-qPCR, we determined a mean 
knockdown efficiency of 80% across the 31 gene knockdowns (Figure S5). Multiple biological 
replicates increased the confidence to measure even subtle differences and demonstrated a high 
reproducibility among the RNAi pairs and across replicates (Table S5, Suppl. Note 3). We observed 
no major growth and cell cycle phenotypes upon depleting individual KATs and KDACs (data not 
shown), in agreement with a previous report (Kondo and Perrimon, 2011). Notable exceptions were 
cells in which CBP, TAF1 and RPD3 were targeted, which slowed their proliferation after four days of 
RNAi (data not shown).    
The heat map in Figure 2A shows the relative changes of 24 histone acetylation motifs upon depletion 
of 23 KATs. Most KATs show a clear specificity for certain acetylation motifs, but CBP and NAA10 
contribute to many motifs. KAT depletion leads to decreased levels of 104 acetylation motifs, with 
interesting specific effects. Many relations between KATs and particular histone motifs would have 
been missed had a conventional instead of a combinatorial analysis been applied (compare Figure 2B 
with 2A). Contrary to expectation, acetylation motifs did not only decline but at the same time the 
abundances of 160 motifs increased. Detailed analysis (see below) reveals that pre-existing acetylation 
and methylation patterns modulate the substrate selectivity for further modification. 
Below, we use this dataset to i) describe the putative direct in vivo targets for KATs, ii) infer common 
properties of KATs as a class (Figure 3) and between the KATs and KDACs (Figure 4) and iii) 
describe the global changes of the histone acetylome as individual enzymes are removed from the 
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system (Figure 5). The analysis reports the response of the system to enzyme depletion, including 
primary effects reflecting direct enzyme-substrate relationship, and secondary effects for example of 
compensatory nature. To our knowledge, these 1364 individual enzyme - histone PTM relationships – 
monitoring the involvement of 23 KATs and 8 KDACs in 39 acetylation and methylation motifs – 
constitute the most comprehensive functional histone PTM dataset reported so far.  
 
Mining the database for testable hypotheses and characteristics of acetyltransferase classes 
An in-depth analysis of the data summarised in Figure 2 allows not only to shed light on controversial 
enzyme-substrate relationships but also to derive testable hypotheses about pathways that generate 
complex acetylation motifs. In Supplementary Note 4, this will be illustrated with two examples, the 
cytoplasmic HAT1 and with HBO1, substrates of which are currently debated (Suppl. Note 4 and 
Figures 3A-D).  
Mining the data underlying Figure 2 demonstrates that many KATs specifically contribute to low 
abundant and combinatorial motifs. Most KATs have a narrow yet not absolute substrate specificity, 
which is modulated by adjacent acetylation (markedly observed for HAT1, HBO1, MOF, ATAC2, 
NAT10 and MGEA5) and methylation (KAT6, HBO1, NAT10 and others). This hitherto 
unappreciated level of crosstalk between neighbouring methylation and acetylation sites (see below) 
suggests that, like bromodomain recognition of histone tails, the interactions of KATs with substrate 
peptides are sensitive to the context of specific combinatorial motifs. 
The realisation that most KATs have restricted substrate selectivity is in stark contrast to the 
widespread notion that most KATs are rather promiscuous enzymes (Sterner and Berger, 2000; 
Kouzarides, 2007; Lee and Workman, 2007). This view may have arisen by studies of the model 
acetyltransferase CBP, which, however, is a clear outlier within the KAT class (Figures 2, 3C, D). 
Loss of CBP leads to a reduction of many acetylation motifs, including acetylation at K5 and K8 of 
H4 and K14, K18, K23 and K27 on H3. Furthermore, whereas most KAT depletions reduce only a 
distinct subset of the motifs containing the putative primary target lysine, CBP RNAi reduces almost 
all H4 combinations containing acetylated K5 and K8 (Figure 3C). Evidently, CBP is a rather 
promiscuous KAT, which may explain its robust acetylation activity of many substrates in vitro 
(Sterner and Berger, 2000). Clearly, the enzymatic properties of CBP do not reflect common 
properties of KATs as a class. 
Commonly, several KATs contribute to setting a histone acetylation motif. This fundamental 
conclusion echoes the combinatorial nature of histone modifications at the level of the enzymes that 
bring it about. While on average three KATs contribute to setting an acetylation motif, one often finds 
a dominant KAT with minor contributions by others. For example, CBP depletion leads to a reduction 
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of H4.K5acK8ac by 61% whereas MGEA5 and NAA10 each contribute only 30% and 23%, 
respectively (Figure 3E). Although HAT1 is the dominant KAT that sets H4.K5acK12ac, NAA10 and 
NAA60 also contribute substantially. Figure 3F plots the cumulative contributions of all KATs, 
calculated from the extent of motif reduction upon KAT depletion to all acetylation motifs. Notably, 
several bars approximate a cumulative depletion of 100% if all KAT RNAi effects are summed up 
(median = 113%, mean = 129%), suggesting that our systematic KAT depletion approach captures the 
majority of the cell’s acetylation events. Cases were the cumulative contributions stay below 100% 
may be explained by functional redundancy between enzymes: the effect of an individual knockdown 
is underestimated because an alternative HAT takes over. For several rare and highly combinatorial 
motifs the cumulative contributions add up to more than 100%, which points to potential contributions 
of KDACs to the steady-state levels of acetylation motifs.  
 
The relaxed specificity of deacetylases restricts the levels of rare, combinatorial motifs  
The immediate reversibility that endows acetylation marks with regulatory potential requires strong 
deacetylase activities. Unlike KATs, KDACs are characterised by relaxed substrate specificity. 
Depletion of any of the eight commonly expressed KDACs increased the levels of many H4 and most 
H3 acetylation motifs in a similar way (Figure 4A). RPD3 is by far the dominant deacetylase in KC 
cells, and its depletion leads to strong gains of those rare, combinatorial motifs on H4 that bear 
regulatory potential.  
Overall, motifs with multiple acetylation sites increase stronger than individually acetylated motifs. 
For example, di-acetylated H3.K9acK14ac increases more than 4 fold after ablation of RPD3. At the 
same time, the levels of the highly abundant H3.K14ac mark were only marginally increased by 20% 
whereas the ubiquitous H3.K23ac mark was not affected at all. We also did not detect any new 
acetylation of the lysines of the H3 and H4 tails that were not acetylated in unperturbed KC cells. In 
no case did the overall acetylation increase upon KDAC depletion lead to saturation and massive 
accumulation of even a simple motif (Figure 4B and Table S5).  
 
The system’s response to KAT deprivation effectively maintains global histone acetylation levels  
Contrary to wide-held expectations we observed that the levels of many histone motifs increased if 
cells are deprived of histone acetyltransferases (Figure 2A). To explore this phenomenon more 
systematically, we summed up all gains and losses of the individual H3 and H4 acetylation motifs. To 
our surprise, we found that cells have balanced or even higher histone acetylation levels when depleted 
for most individual lysine acetyltransferases (Figures 5A and S6B). Ablation of only three KATs 
(KAT6, NAA10 and GCN5) lead to the expected significant reduction of global histone H3 and H4 
acetylation. For a major group of 17 KATs, among them CBP and HBO1, the depletion did not change 
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the cell’s total number of acetylated histone H3 and H4 peptides relative to non-acetylated peptides 
significantly, despite the fact that the abundance of some ‘primary’ acetylation motifs (the presumed 
direct products of KAT activity) were severely reduced. These losses were accompanied by gains in 
other, some times unrelated motifs (Figure 5B). We arrived at a similar conclusion when we counted 
the total number of acetyl groups instead of the number of acetylated peptides (Figure S6B). 
Losses of acetylation are not only accompanied by gains within the same histone tail, as might have 
been expected, but also by gains on the other histone (Figures 2A, 5B). A prominent case is the 
depletion of CBP, where a reduction of the acetylation motifs from H4 (H4.K5ac and H4.K8ac) and 
H3 (H3.K14ac, H3.K18ac and H3.K18acK23ac) go along with an increase in H4.K12ac, 
H3.K9me2K14ac and H3.K23ac. Very often the acetylation gains are close to those sites that loose 
acetylation (Figures 2A, 5B), leading us to speculate that the system strives to compensate local 
charge imbalances upon KAT removal.  
For a number of enzymes (NAT6, GC5783, NAA40 and TAF1) we do not detect any loss of 
acetylation upon depletion, but only gains (Figure 2A). These enzymes may not be KATs after all, or 
may strictly depend on cofactors that are not present in KC cells. Moreover, some KATs may only 
acetylate non-histone proteins (Sterner and Berger, 2000; Choudhary et al., 2009). Conceivably, the 
losses and gains in acetylation motifs upon perturbation of KATs reflect the response of a system that 
strives to compensate structural perturbations. 
 
The methylation response to KAT depletion allows their functional classification 
Depletion of most KATs lead to global changes in histone methylation marks. Hierarchical clustering 
of the methylation responses upon KAT deprivation revealed a clear grouping of KATs (Figure 6A). 
Many KAT depletions led to a substantial reduction of H3.K36me2/3, a mark associated with 
transcribed chromatin, as well as to a massive increase in the repressive H3.K27me3 mark, which 
indicates polycomb repression. This response is well expected for those KATs that are known 
transcription co-activators (GCN5, CBP, TIP60). The similarity of the response scored upon ablation 
of MGEA5 suggests that this poorly characterised KAT also function as a transcription activator. 
Interestingly, the putative acetyltransferases CG5783 and NAT6 are the only enzymes whose absence 
is accompanied by a substantial increase of K36me2. Similar, loss of NAA40 is accompanied with a 
severe reduction of the repressive K9me2 mark. These results suggest that CG5783, NAT6 and 
NAA40 may confer repressive functions.  
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Primary and secondary contributions of KATs to mixed acetylation/methylation motifs 
For PTM motifs involving both, acetylation and methylation, it is difficult to conclude about the 
individual contribution of candidate enzymes. Figures 6B and 6C exemplify this challenge for KAT6 
and HBO1.  
Cells lacking KAT6 have reduced levels of H3.K14ac only in the context of tri-methylated lysine 9. 
Because H3.K9me3 alone is not reduced under these conditions, it is reasonable to assume that KAT6 
directly acetylates K14ac on a tri-methylated K9 substrate. A similar argument can be made to 
conclude that KAT6 does not acetylate K14 if K9 is acetylated or mono-/di-methylated. The 
recognition of K14ac by antibodies may be modulated by adjacent methylation. By contrast, cells 
deprived of HBO1 not only reduce the H3.K9me3K14ac motif, but also the K9me3 mark alone, a 
secondary effect that may confuse the analysis of HBO1 substrates by other means.  
 
Modulation of substrate specificity by molecular context 
Acetyltransferases are commonly found in complexes with associated proteins, which may target the 
enzyme to specific chromosomal loci and fine-tune substrate selectivity. Variation in associated 
complex subunits may harness a KAT activity for cell-specific and developmental functions. This is 
well illustrated using the case of MOF, which is found in two distinct multi-protein complexes. In the 
context of the ubiquitous NSL (MBDR-2) complex MOF regulates housekeeping genes as a classical 
transcription co-activator (Feller et al., 2012; Lam et al., 2012). In male somatic cells, MOF 
additionally associates with the so-called male-specific-lethal (MSL) proteins to form the dosage 
compensation complex (MSL-DCC). The MSL-DCC compensates the X chromosome monosomy by 
an increased transcription output, which involves MOF-dependent H4.K16 acetylation of transcribed 
gene sequences (Prestel et al., 2010a).  
In order to determine whether the protein complex environment modulates MOF’s substrate selectivity 
we monitored changes in histone acetylation motifs after depleting male or female cells of MOF or of 
the diagnostic subunits of the NSL and MSL-DCC complex. RNA interference targeting MOF 
expression led to a reduction of H4.K16ac by about 40% in female cells or 60% in male cells (Figures 
7A, S4D). MOF depletion in KC cells has to be seen against a robust increase of the almost three-fold 
more abundant H4.K12ac and additional gains in H3K9- and K14-containing acetylation motifs, 
leading to overall elevated levels of H3 and H4 acetylation. Likewise, H4.K16 loss in male S2 cells 
was accompanied by a clear increase in H4.K12ac and H4.K5ac. Ablation of the MSL-DCC subunit 
MSL1 in male cells essentially mirrored this effect (with less crosstalk to H4.K5ac), indicating that 
most MOF effects in S2 cells are mediated by the MSL-DCC. By comparison, interference with the 
NSL complex through ablation of its core subunit NSL1 only modestly affected H4.K16ac levels. 
Interestingly, we detected a strong decrease of H3.K27ac in both cell types and of H4.K5ac in female 
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cells lacking NSL1, but not MSL1 (Figure 7A, B). These findings illustrate the male-specific 
acetylation of H4.K16 over and above a lower, more general level. They also suggest that the NSL 
complex affects histone acetylation independent of MOF.  
 
X chromosome dosage compensation is accompanied by global redistribution of acetylation and 
methylation marks 
Due to the specific dosage compensation mechanism, male Drosophila cells contain more H4.K16ac 
than female cells (Figure 7C, D). In light of the observed global balancing of total acetylation levels 
(Figure 5) we wondered whether such chromosome-wide regulation had any consequences for the 
acetylation system as a whole. We, therefore, compared histone acetylation and methylation motifs in 
male and female cells as well as in male cells lacking MOF. Remarkably, male and female cells 
showed similar total histone acetylation levels, if all H3 and H4 acetylation motifs were summed up 
(Figure 7C). However, the distribution of acetyl groups between motifs in male cells differs 
dramatically from that of female cells, and the differences are due to MOF (Figures 7C, D, see also 
Table S4). Male cells displayed twice the amount of H4.K16ac, but reduced levels of several other 
acetylation motifs including H4.K5ac, H4.K12ac and H3.K14ac as compared to female cells. 
Conversely, depletion of MOF in male S2 cells reduced H4.K16ac and increases H4.K5ac, H4.K12ac 
and H3.K14ac to levels found in female cells.  
Comparing methylation signatures between male and female flies indicate that dosage compensation 
correlates with an increased abundance of the repressive K27me3 mark as well as increased 
H3.K36me2/3 (Figure 7E). Abolishing dosage compensation in S2 cells by ablation of MOF converts 
the methylation pattern to a one that resembles females. Together, these results indicate that the 
evolution of dosage compensation not only boosted the levels of H4.K16 acetylation, but also 
triggered a network of secondary effects that may be interpreted as adaptations of the system to a 
global change in acetylation state. 
 
The global response of the histone modification system upon MOF depletion is conserved 
between Drosophila and human cells  
One of the surprise findings of our study is that a reduction of H4.K16 acetylation, which is thought to 
be a histone mark with unique structural implications, led to an inevitable increase of acetylation at the 
neighbouring K12. The robustness of the effect suggests K12ac may structurally compensate for a loss 
of K16ac. Since H4.K16 acetylation is thought to affect the basic properties of the chromatin fibre, 
such an effect should be observable in other species as well. To test this prediction we deprived human 
cells of MOF. In mammalian cells, MOF preferentially associates with subunits of the NSL complex, 
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but its substrate specificity is still under debate (Cai et al., 2010; Chelmicki et al., 2014). The ablation 
of MOF in HeLa cells not only reduced its supposed primary product, H4.K16ac, but also increased 
acetylation of the adjacent lysine 12, in striking resemblance to the effect in Drosophila (Figures 7F, 
S4F). Moreover, similar to female flies, where MOF functions as a global transcriptional co-regulator, 
human cells lacking MOF showed increased levels of H3.K9me2 and K27me3, while K9me3 and 
K36me3 are reduced (Figure 7G). 
These results suggest that the global response of the system of histone modifications that we observed 
through our comprehensive, quantitative study of the acetylation motifs after depletion of critical 
enzymes, is a conserved feature of higher eukaryotic nuclei.  
 
DISCUSSION 
Although lysine acetylation was the first chemical modification described for histones already more 
than 50 years ago, our knowledge of the contributions of acetylation to the complex, combinatorial 
histone modification system is still superficial. Optimising LC-MS workflows and correcting for its 
inherent detection bias we generated a comprehensive inventory of all acetylation sites and many 
combinatorial motifs for histones H3 and H4 in an asynchronous population of Drosophila cells. Some 
highly abundant motifs may contribute to the general structure of chromatin, whereas rare, often 
combinatorial, motifs may transmit regulatory signals via bromodomain adaptor proteins. 
Knowing the abundance of acetylation sites helps designing and interpreting genomic experiments, 
distinguishing rate-limiting from saturating components in a chromatin pathway and assessing the 
dynamic turnover of acetylation motifs (Waterborg, 2002; Zheng et al., 2013).  
Acetyltransferases were the first histone modifying enzymes to be cloned, yet the substrate specificity 
of some KATs has remained controversial or even not known (Lee and Workman, 2007; Yuan and 
Marmorstein, 2013). Traditionally, identifying KAT substrates involved testing the acetylation status 
of selected lysines with antibodies, whose specificities have recently been questioned. Further 
problems arise from relating the apparent KAT substrate specificities determined in vitro to their 
physiological activities, which are commonly modulated by the molecular environment of the multi-
subunit complexes they reside in. Remarkably, we found that most KATs display a narrow, yet not 
absolute, substrate specificity in cells, which is influenced by adjacent modifications. This contrasts 
common perceptions of rather promiscuous KAT activities that originate from the prominent 
characterisation of a few ‘model’ enzymes with relaxed substrate selectivity, such as CBP, which is a 
clear outlier of the class of KATs in this respect.  
Our catalogue of the quantitative changes in histone acetylation and methylation motifs in response to 
ablating all known or suspected acetyltransferases and deacetylases allowed to re-evaluate 
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controversial enzyme-substrate relationships and to discover putative primary targets of 
uncharacterised KATs. This database can be further mined to derive testable hypotheses about the 
functional crosstalk between histone modifying enzymes and the assignment of KATs and KDACs to 
cellular pathways and disease states.  
Surprisingly, we found that ablation of many KATs not only reduced acetylation of its putative 
primary target but also led to acetylation gains at secondary sites, such that the global level of histone 
acetylation in cells were maintained. Our survey of the secondary effects upon KAT depletion serves 
as point of entry to study the intertwined regulatory network of histone modifications as a system. 
Related phenomena that suggest ‘compensation’ of a modification loss by corresponding gains on 
other proteins have occasionally been observed before. Analysing the phospho-proteome of a 
collection of yeast kinase and phosphatase mutants, Aebersold and colleagues reported a similar 
number of gains and losses in phosphorylation sites across all mutants together (Bodenmiller et al., 
2010). Voss and colleagues found that reduced levels of H3.K14ac in hbo1 knockout mice were 
accompanied by increases in H4.K16ac and to a lesser extent in H4.K5ac and H3.K9ac (Kueh et al., 
2011). Ge and co-workers made similar findings for cbp/p300 double deletion lines, which displayed 
increased levels of H3.K23ac and H3.K9me1K14ac (Jin et al., 2011). These related findings in several 
species may point to a fundamental, conserved principle.  
Conceivably, the loss of a particular acetylation motif evokes a compensatory acetylation of a 
different, but functionally redundant motif by another KAT. The reciprocal responses between 
H4.K12ac and H4.K16ac (HBO1, MOF) and involving H4.K5 and H4.K8 (CBP) support such a view. 
However, particularly critical alterations in acetylation, such as losses in highly abundant, structural 
acetylation motifs, or of motifs with very specific functions during organismal development may not 
be compensated for (Voss and Thomas, 2009). 
Considering histone modifying complexes as components of a system that satisfies local functional 
heterogeneity as well as global structural constraints, sudden perturbation may trigger feedback 
regulation to attenuate the impact. In this respect, global charge distribution and neutralisation comes 
to mind. Histone acetylation significantly diminishes the total number of positive charges in 
chromatin. We speculate that ablating KATs triggers a homeostatic re-adjustment of global charge to 
maintain the stability of chromatin according to polyelectrolyte theory (Clark and Kimura, 1990). In 
support of this hypothetical function, Kurdistani and colleagues reported a correlation between the 
global acetylation levels and the intracellular pH levels (McBrian et al., 2013).  
The fact that lysines can be modified with several mutually exclusive chemical groups constitutes a 
basic principle of functional crosstalk between diverse modification-based signalling pathways. 
Further crosstalk is evident at the level of the modification enzymes, which are sensitive to pre-set 
modifications on histone tails. Monitoring lysine methylation and mixed acetylation-methylation 
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motifs enabled us to identify new candidates, where a pre-set methylation mark may promote (KAT6: 
H3.K9me3  K14ac) or inhibit (NAA10: H3.K9me2 --| K14ac) acetylation. Moreover, we observed 
that ablating individual KATs led to dramatic reduction (GCN5: H3.K79me2) or increase (CBP: 
H3.K27me3) in methylation sites. Reciprocal correlations between the loss of histone lysine 
methyltransferases and altered histone acetylation have been documented before (Plazas-Mayorca et 
al., 2010; Sinha et al., 2010). Our study suggests that crosstalk among lysine acetylation and 
methylation is widespread and must be considered within the system of a comprehensive modification 
landscape. 
The targeting and substrate selectivity of a KAT may be tuned by associated cofactors. Using the 
example of MOF, which resides in two distinct complexes with non-overlapping function (the MSL 
dosage compensation complex and the NSL transcription co-activator complex), we show that while 
the primary targets are similar across cell types and species (with notable quantitative differences), 
secondary effects are strongly influenced by the associated co-factors. Depletion of the NSL complex, 
but not the MSL complex, caused a massive reduction of the enhancer mark H3.K27ac, in interesting 
coincidence with the recent mapping of the human NSL complex to enhancers (Chelmicki et al., 
2014). We cannot distinguish whether NSL subunits direct MOF’s enzymatic activity towards K27 or 
whether the NSL complex regulates another KAT that acetylates H3.K27ac. It has also been suggested 
that MOF within the NSL complex acetylates K5 and K8 in addition to K16 (Cai et al., 2010), yet 
although we detect reduced amounts of H4.K5ac in female cells lacking NSL1, this is not observable 
for MOF depletions in S2, KC or HeLa cells.  
Ablation of MOF activity in the context of the dosage compensation complex led to the expected 
reduction of H4.K16ac, but surprisingly, this was associated with a pronounced increase in the 
neighbouring H4.K12ac. Since the only known function of H4.K16 acetylation is to hinder the folding 
of the nucleosome fibre, we conclude that acetylation of lysine 12 can also fulfil this function to some 
extent. Interestingly, the depletion of the dosage compensation system further affected the recovery of 
distinct methylations. H3.K36me3, a mark that is placed co-transcriptionally and thus marks active 
genes was significantly reduced. Considering that the dosage-compensated chromatin amounts to less 
than 2% of the genome, our finding of massively increased, MSL-DCC-dependent bulk H3.K36me2/3 
levels suggests that this mark almost saturates the nucleosomes along X chromosomal, dosage 
compensated genes. The high density may contribute to the observed genomic spreading capability of 
the MSL-DCC, which involves recognition of H3.K36me3 by MSL3 (Larschan et al., 2007). 
Furthermore, depletion of MOF in male cells triggered a co-depletion of the repressive H3.K9me3 and 
H3.K27me3 levels, leading us to speculate that repressive chromatin attenuates the powerful activation 
potential of H4.K16 acetylation to arrive at the balanced levels that characterise dosage compensation 
(Prestel et al., 2010b).  Our results define a point of entry into a quantitative assessment of the 
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epigenetic principles that enable the chromosome-wide transcriptional fine-tuning in vital processes, 
such as dosage compensation. 
KAT and KDAC inhibitors are considered promising therapeutic agents in the combat against 
complex diseases including cancer and neurological disorders. Our work shows that depleting single 
KAT activities leads to complex alterations of the epigenome, of which we monitored the reduction of 
bona fide primary substrates, the global re-distribution of acetyl groups to secondary sites and changes 
to methylation of histones. Increased knowledge of the systemic response of the chromatin 
modification network will be required for a more targeted utilization of drugs in a clinical setting. 
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EXPERIMENTAL PROCEDURES 
Cell Lines and RNAi 
Cultivation of KC and S2 cells and RNAi were carried out essentially as described before (Feller et al., 
2012). For detailed information, see Supplemental Experimental Procedures.  
LC-MS for histone PTM quantification 
Acid extracted, chemically acetylated and trypsinised histone peptides were separated on a HPLC C18 
analytical column and electrosprayed into an LTQ-Orbitrap Classic. MS was operated in a targeted 
mode and data was analysed with Thermo Xcalibur, Excel and R.  
Detailed information can be found in the Supplementary Notes 1 and 2 and in the Supplemental 
Experimental Procedures.  
 
SUPPLEMENTAL INFORMATION 
Supplemental Information includes six figures, five Supplementary Notes, seven tables and 
Supplemental Experimental Procedures. 
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FIGURE LEGENDS 
 
Figure 1. Optimised liquid chromatography mass spectrometry (LC-MS) workflow for precise 
and accurate quantification of PTM motifs 
(A) Overview of the LC-MS workflow. D3AA method exemplified for H3 PTM isoform with four 
highly abundant modifications: H3.K9me3K14acK23acK27me2. (1) Chemical acetylation by d6-
acetic anhydride transfers a deuterated (d3)-acetyl group to free lysines. (2) The subsequent trypsin 
digestion yields peptides of intermediate size. (3) Lysine methylation induces characteristic shifts in 
retention time, which allows quantification only based on MS1 spectra. Shown are ion intensity traces 
of the parent ions from the H3.K9-R17 peptide. To aid visualisation, intensities among retention time 
segments are scaled on the intensity of the third segment: Original intensities of the first and second 
segments are 6.3 and 3.1 fold higher. (4) The positional isomers with permutations of the lysine 
acetylation sites (H3.K9ac and H3.K14ac), require successive quantification using MS1 of double-
charged parent ions (left) and MS2 of single-charged fragment ions (right).  
(B) High precision quantification for 45 histone motifs in technical and biological replicate 
experiments. We determined the median coefficient of variations (CV) of 4.9% for three technical 
whole-workflow replicates using 2 million Drosophila KC cells (left), and CVs of 10.4% and 8.9% 
across five biological replicates for motifs which require successive MS1-MS2 or MS1-MS2-MS3 
(centre, n=20) or MS1-only (right, n=25). The 45 histone motifs are shown in (D) and Table S4. 
(C) LC-MS response correction factor improves accuracy for motifs containing lysine methylation 
sites. Synthetic peptides to acetylation and methylation modifications for H3_K9R17 peptide were 
individually chemically acetylated, trypsinised and measured by LC-MS. To derive the LC-MS 
response correction factor (right), raw values for the proteotypic peptide (left) were divided by raw 
values for the quantification tag (grey hexamer, centre) and   signals for the H3.K9me1 peptide. 
Quantified synthetic peptides were obtained from JPT Peptide Technologies GmbH (Berlin).  
(D) Abundance for histone PTM motifs after applying LC-MS response correction factor. Low 
(yellow), intermediate (orange) and high (red) abundance classes of histone acetylation motifs are 
indicated. Motifs containing no acetyl group are indicated in white. See Tables S4, S5 and Suppl. Note 
1.3 for full dataset and variation estimates. 
(E) Same as (D) for motifs where the LC-MS response correction factor had only intermediate 
confidence.  
See Figures S1-S3. 
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Figure 2. Global and specific response to comprehensive perturbation of acetyltransferases 
(A) Heat map displaying relative changes in abundance of 28 PTMs involving lysine acetylation in 
response to RNAi depletion of 23 KATs in KC cells. The first eight KATs are sorted according to the 
systematic listing by (Allis et al., 2007), the subsequent ones according to their sub-classes, including 
GCN5 related KATs (NATs) and N-terminal acetyltransferases (NAAs). Relative changes are 
normalised on control RNAi and log2 scaled. Only significant changes are shown (p < 0.05, two-sided 
unpaired t test).  
(B) Relative reductions of acetylation at individual lysines upon RNAi as in (A) cumulating all motifs 
containing the corresponding lysine. This illustrates the best-case outcome of a conventional analysis 
with hypothetical antibodies recognizing individual acetylated lysines with high specificity.  
See Figures S5 and S6. 
 
 
Figure 3. Most acetyltransferases have a narrow yet not absolute substrate specificity, which is 
modulated by the context of adjacent modifications  
Statistical significance for all data in (A-F) was assessed with two-sided unpaired t test (p < 0.05) on 
log2 (target RNAi/ctr RNAi).  
(A) Quantification example of the histone H4 acetylation motifs for HBO1 RNAi. Statistically 
significant gains (red) and losses (blue) are indicated. Error bars display SEM (n=8).  
(B) Scheme visualising the interdependence of combinatorial H4 motifs. HBO1-depleted cells display 
a highly selective reduction (blue arrows) of two acetylation motifs. Blue arrows point to significantly 
changed motifs (two-sided unpaired t test, p < 0.05). 
(C,D) Quantification example and scheme as in (A) and (B), showing that CBP depletion reduces most 
H4 motifs containing acetylated lysine 5 or 8 (n=7).  
(E) Cumulative contributions of KATs, which significantly (two-sided unpaired t test, p < 0.05) 
contribute to H4.K5acK8ac and H4.K5acK12ac.  
(F) Cumulative contributions from all KAT depletion experiments reveals functional redundancy and 
points to the contribution of deacetylases. Cumulative KAT contribution was calculated from the 
extent of motif reduction upon KAT depletion filtered for statistically significant decreases (two-sided 
unpaired t test, p < 0.05).  
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Figure 4. KDACs generally show broad substrate specificity, and RPD3 dominates H4 de-
acetylation 
(A) KDACs display broad substrate specificity. Heat map showing relative changes of acetylation 
motif abundance in response to KDAC depletions, normalised to control RNAi and log2 scaled. Only 
significant changes are shown (p < 0.05, two-sided unpaired t test on log2 (KDAC/ctr)).  
(B) Global increase of histone H3 and H4 acetylation upon depletion of any HDAC and Sirtuin. 
Relative changes of total H3, H4 and combined H3 and H4 acetylation levels normalised to control 
RNAi are shown. Significance was assessed on log2 (KDAC/ctr) using two-sided unpaired t test 
(p<0.05). RNAi to RPD3 and HDAC6 cause stronger gains in acetylation on H4 compared to H3. 
Error bars indicate SEM (for n>2) or minimal and maximal value (for n=2). See Table S5 for number 
of replicates (n = 2 - 6). 
 
Figure 5. KAT deprivation induces and redistributes acetylation, which balances global histone 
acetylation levels  
(A) KAT depletion may lead to globally reduced (blue), balanced (grey), or increased (red) acetylation 
levels. Shown is the global histone acetylation score, calculated by summing up all acetylation motifs 
on H3 and H4, and normalised to control RNAi. Statistically significant changes were assessed using a 
two-sided unpaired t test (p<0.05) on log2 (KAT/ctr) Error bars indicate SEM (for n>2) or minimal 
and maximal value (for n=2). See Table S5 for number of replicates (n = 2 - 5). 
(B) Selective re-distribution of acetyl groups to specific secondary sites. Total loss (blue) and gain 
(red) of individual histone acetylation motifs are shown for cells deprived of CBP and HBO1. The 
contributions of the major motif changes of H3 or H4 acetylation are shown (filtered for significant 
changes, p< 0.05, two-sided unpaired t test).  
See Figure S6. 
 
Figure 6. Depletion of KATs and KDACs triggers a systemic alteration of the histone methylome 
(A) Reorganisation of histone methylation sites after KAT deprivation. Heat map displays relative 
changes after KAT RNAi normalised to control RNAi. Only significant changes are shown (p < 0.05, 
two-sided unpaired t test.). Dendrograms were generated by unsupervised hierarchical clustering using 
the ‘ward’ algorithm on a Euclidean distance matrix. The H3.K27me2 and H3.K79me1 motifs did not 
change significantly in any KAT RNAi and therefore were not integrated in the heat map.  
(B-C) Comparative analysis of acetylation-only, methylation-only and mixed acetylation-methylation 
motifs facilitates prioritization of putative KAT targets and identifies acetylation-methylation 
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crosstalk. Significantly reduced (blue) and increased (red) motifs are indicated (two-sided t test, p < 
0.05). Error bars indicate SEM (n=3 for KAT6, n=4 for HBO1). 
 
Figure 7: X-chromosome dosage dosage compensation is accompanied by global redistribution 
of acetylation and methylation marks 
(A) The MOF-containing MSL-DCC complex dominates the NSL complex for acetylation of H4.K16. 
Female KC or male S2 cells were depleted of MOF, MSL1 or NSL1, and the relative abundance of the 
indicated H4 acetylation (red box) was expressed relative to control cells that were treated with 
interfering RNAs directed against GST and GFP.  
(B) Similar type of experiment as in (A), probing the effect of NSL1, MSL1 or MOF depletion on 
H3.K27ac levels.  
(C) Global histone acetylation levels are similar between male S2 and female KC cells, but the 
distribution of individual sites differs. Cumulative bar plots summing up total levels of individual 
histone motifs.  
(D) Similar experiment as in (A), revealing the re-distribution of acetyl groups upon MOF depletion in 
S2 cells  
(E) Similar experiment as in (A), revealing that MOF depletion correlates with increased H3.K9me3, 
H3.K27me3 and H3 K36me2/3. Error bars in A, B, D and E indicate SEM (n=3 for NSL1 in S2 and 
Kc and MOF in S2; n=4 for MOF in Kc (for H3) and n=11 for MOF in Kc (on H4) and 
minimal/maximal values for MSL1 (n=2). 
(F) Similar experiment as in (D), except that MOF was ablated in Hela cells. 
(G) Similar experiment as in (E), except that MOF was ablated in Hela cells. Error bars in F and G 
represent SEM (n=4). 
Statistical significance between control – target RNAi and S2 – KC are indicated by asterisks (two-
sided t test, p < 0.05).  
See Figure S4. 
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Supplementary Figure 1. Chromatographic separation of  histone PTM motifs. (A) Example of  time-scheduled targeted LC-MS experiment.  MS recordings 
were subdivided into four schedules with selected MS1, MS2 and MS3 scan regimes. A selection of MS quantier and the corresponding number of scans and ion traces are 
shown. Parameters for each scan schedule is shown above each panel of ion traces. Order within scan cycle, scan range (m/z) and the targeted mass for MS2 and MS3 are 
indicated. WideBand activation was applied for MS2 of H3.K27R40_1Ac (m/z = 522.97 ± 0.8) and H4.G4R17_3Ac (m/z=721.92 ± 0.7) and MS3 of H4.G4R17_2Ac_y12 (m/z=1215 ± 2).
See Table S1 for all MS identifer. (B) Example of chromatographic separation of positional isomers from H3.K27R40 peptide. Three top panels are signals from endogenous histones
and bottom seven panels are from experiments with synthetic TQL experiments. Masses corresponding to mono-methylation (m/z= 528.323) belongs to H3.K36me1 and 
H3.K27me1. Because mono-methylated lysines are still reactive, the resulting d3-proponyl (from endogenous mono-methyl + chemical d3-acetyl) at the N-terminus (H3.K27me1)
is more hydrophobic and therefore elutes after H3.K36me1. Masses for di-methylation (m/z= 517.983) correspond to H3.K27me2 and H3.K36me2 and masses for 
three-methylation (m/z= 522.655) correspond to H3.K27me3, H3.K27me2K36me1 and H3.K36me3. Di-and tri-methylated lysines are not reactive to d6-acetic anhydride, which 
leaves the methyl-groups. A more N-terminal methyl group (K27) elutes before a more central methyl group (K36). 
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Supplementary Figure 2. MS1-MS2-MS3 analysis for the quantication of isobaric positional isomers to H4.G4-R17.
(A) Spectra for MS1, MS2 and MS3 of the H4.G4-R17 peptide. Note the shift of the MS3 spectrum by -18 caused by the loss of a water molecule. MS3 signals were quantied with
b10 fragment ion pairs. Inserts for selected spectra ranges are shown (right). (B) Successive MS1-MS2-MS3 based quantication recovers accurate ratios in experiments with 
dened concentrations of synthetic peptides. Shown is a representative experiment where ve out of six di-acetylated H4 motifs were mixed in equal ratios, processed and 
quantied via successive MS1-MS2-MS3. Measured ratios (black) are close to expected ratios (grey). (C)  The b10 MS3 fragment ions can be used for quantication. The 
theoretical  masses of the b10 MS3 fragment ions (849.52 if di-acetylated and 852.52 if mono-acetylated) are close to the theoretical masses of the y8 ions (852.56 if 
di-acetylated and 855.56 if mono-acetylated) yet y8 is not observed or only with a minor signals. The MS3 spectrum from an H4.K8acK12ac peptide (gift of D. Schwarzer, 
Tübingen) generates a dominant b10-2Ac ion at 849.44 (Area: 40400) yet only a minor y8-1Ac signal at 852.52 (Area: 1526), demonstrating that any interference from y8 is 
minimal, and the b10 ion pair can be used for quantication.  (D-F) MS1 spectrum for H4.K20_noPTM (D), H4.K20me1 (E) and H4.K20me2 (F).  (G) MS1 spectrum shows 
triple-charged unmodied H4.K79-R92 peptide, yet no signals for acetylated isoform (theoretical mass of H4.K91ac: 561.220). 
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Supplementary Figure 3. MS1 and MS2 spectra for the quantication of H3 motifs.
(A-C) MS1 spectra of H3.T3R-8 peptide, with no modication (A), H3.K4me1 (B) and H3.K4me2 (C). (D, E, G) MS1 spectra of H3.K9-R17 peptide, with H3.K9me2/3 ± K14ac (D),  
unmodied-, mono- and di-acetylated H3.K9-R17 peptides (E) and H3.K9me1 ± K14ac (G). (F) MS2 on mono-acetylated H3.K9-R17 is required to distinguish H3.K9ac and H3.K14ac.
Insert to diagnostic y7 ion pairs is shown in Figure 1A (panel 4).  (H) MS1 spectrum of  H3.K18-R26 peptide. (I) MS2 on mono-acetylated H3.K18-R26 is required to distinguish 
H3.K18ac and H3.K23ac. Insert shows diagnostic b2 ion pair. Note that signals around 299.20 were 10x enhanced. (J-L) Spectra for H3.Y54-R63 peptide. Robust identication of 
unmodied H3.K56 but not acetylated H3.K56ac in histones from KC cells (J), although synthetic TQL peptides to H3.K56ac (K) produce at least similar signals to unmodied 
H3.K56 TQL peptides (L).  (M-Q) MS1 spectra of H3.K27-R40 peptide, with unmodied- and mono-acetylated isoforms of the non-methylated peptide (M), H3.K27me1 (N), 
H3.K27me2 ± K36ac and H3.K27me3 (O) , H3.K36me2/3 ± K27ac (P), H3.K27me2K36me1 (Q). (R-T) MS2 on mono-acetylated H3.K27-R40 is required to distinguish H3.K27ac, 
H3.K36ac and H3.K37ac. Full MS2 spectrum (T) and diagnostic b3 (R) and y11 (S) ion pairs are shown. (U-W) MS1 spectra of H3.E73-R83 peptide, with unmodied (U), 
mono-methylated (V) and di-methylated (W) H3.K79. The insert in W shows minute signals for H3.K79me3 that elutes shortly before H3.K79me2. (Y, X) Robust signals for 
unmodied H3.K64 and H3.K121, but no signal for acetylated isoforms are detected. 
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Supplementary Figure 4: Cells lacking MOF still retain substantial levels of H4.K16ac. 
(A) Representative example of quantitative immuno blot analysis probing for MOF protein levels during a four to seven days time-course RNAi experiment in female Kc cells. 
Lamin protein levels served as a loading control. (B) Quantication of immuno blot signals from (A) using LI-COR (Biosciences). (C) Quantitative LC-MS analysis of mono-acetylated 
H4 motifs during a time-course RNAi experiment using two independent MOF RNAi constructs. Values were normalized to control RNAi. Error bars show maximum and minimum
from two dierent RNAi constructs targeting MOF. (D) Quantitative LC-MS analysis of mono-acetylated H4 motifs in adult female (black) and 3rd instar larvae male (grey) mof2 
mutants. Error bars represent SEM from 8 (female) and 3 (male) independent biological replicates. The increase of H4.K12ac and the decrease of H4.K16ac is statistically signicant
(p < 0.05 using unpaired two-sided t test). (E) Quantication of immuno blot analysis targeting MOF, NSL1 (NSL complex) and MSL1 (MSL-DCC complex) in Kc and S2 cells after 5.5
days of RNAi using LI-COR (Biosciences). Error bars represent SEM of at least three biological replicates. (F) ECL-based immuno blot analysis of RNAi experiment to target hMOF in
HeLa cells for 2.5 days using three dierent siRNA constructs (lanes 2-4), a pool of 3 MOF siRNA constructs (lane 5) and a luciferase sequence as control. 
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Supplementary Figure 5: Quantication of mRNA levels after KAT and KDAC RNAi.
Bar plots show results of RT-qPCR measurements after RNAi of indicated KATs and KDACs, normalised to control RNAi and gapdh. Error bars show minimal/maximal value
from two dierent dsRNA RNAi constructs targeting the same KAT/KDAC gene (see Table S7 for RNAi and RT-PCR primers). In cases where only a single dsRNA RNAi construct
was used, the replicate experiment was performed on another day. 
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for the LC-MS bias
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SUPPLEMENTARY NOTES 
 
Supplementary Note 1: LC-MS workflow 
1.1 Improved sensitivity, precision and accuracy to quantify positional isomers containing 
lysine acetylation  
We streamlined the histone extraction protocol to enable rapid processing of many samples (see 
Supplemental Experimental Procedures). The low requirement of starting material (typically 1 - 5 x 
106 KC cells) allowed a cost-effective RNAi strategy and histone preparation without chromatographic 
enrichment. The direct extraction of histones from cells, rather than from nuclei or chromatin reduced 
preparation time and did not require usage of deacetylase inhibitors. Commonly used deacetylase 
inhibitors such as sodium butyrate alter the native histone acetylation pattern by inhibiting different 
deacetylases of the HDAC class with different efficiencies (Thorne et al., 1990; Fraga et al., 2005; 
Karmodiya et al., 2012). Our procedure aims at minimising the risk of altering the native histone 
acetylation pattern during sample preparation. 
Histones were chemically acetylated using d6-deuterated acetic anhydride rather than propionylated to 
harmonise the physiochemical properties between the endogenously acetylated and non-acetylated 
lysines. This ensures similar properties during the LC-MS workflow, including comparable 
interactions during pre-LC (similar hydrophobicity, tube interactions etc.), LC (positional isomers co-
elute and hence are electrosprayed at the same acetonitrile concentration) and MS (similar ‘matrix 
effects’ during ionization, fragmentation, MS acquisition), which results in improved accuracy among 
positional isomers. For example, using equimolar solutions of positional isomers from di-acetylated 
H4.G4-R17 peptides resulted in very similar ratios (Figure S2B). Furthermore, positional isomers for 
H3 peptides differing only in their site of acetylation display very similar LC-MS response correction 
factors (Table S3).  
We developed a targeted MS protocol on a standard hybrid linear ion trap Orbitrap instrument (LTQ 
Orbitrap Classic) but the MS strategy can be implemented on different mass spectrometers capable of 
MS3 fragmentation. The general rationale is to iteratively acquire full or targeted survey scans (MS1) 
combined with targeted MS2 or MS3 spectra during the entire peptide elution or scheduled for pre-
defined retention time windows (see Figure S1A for an example of scheduled RT windows). The 
scheduled spectra were recorded using a reduced window (e.g. MS1 acquisition window from 270 to 
505 during the first retention time schedule) and less MS2/MS3 were scheduled. This improved the 
quantification of the MS identifier eluting within narrow LC peaks (e.g. H3.K9me2/3) through 
achieving a higher number of scans. We noted, however, that a few MS identifiers showed 
considerable shifts in their retention time within consecutive LC runs (in particular the non-methylated 
H3.K9R17 identifier with more than 5 minutes shift). Note that most of the data presented in the 
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current study was therefore acquired without retention-time scheduling. In contrast to previously 
developed targeted MS strategies (Schmidt et al., 2008; Gallien et al., 2012a; Gallien et al., 2012b; 
Peterson et al., 2012; Jaffe et al., 2013; Tang et al., 2014) our emphasis was on the high-precision 
quantification of combinatorial PTM motifs. To increase the MS duty cycle, MS1 scans were recorded 
within the Orbitrap at low resolution (7500 at 400 m/z) after accumulating 100,000 ions over a 
maximum time of 500 ms. To increase the precision and sensitivity for MS2 and MS3, enhanced zoom 
scans were acquired within the ion trap targeting the first, second and third isotope, setting a target 
value to 50,000 and accumulating for a maximal time of 100 ms. WideBand activation was performed 
to improve fragmentation for MS2 of the H3K27R40_1Ac (m/z = 522.97 ± 0.8) and H4G4R17_3Ac 
(m/z = 721.92 ± 0.7) identifier and for MS3 of the H4G4R17_2Ac_y12 (m/z = 1215 ± 2) identifier. 
The targeted strategy enhanced the precision, reduced the interference and yielded a high density of 
scans.  
To determine how many cells are required for high-precision analysis, we collected three times 1, 2 
and 4 x 106 cells for a LC-MS dose-response experiment. The median coefficient of variation (CV) 
across 45 histone motifs was 9% for the 1 million starting cell sample and around 5% for the 2 and 4 
million cell samples (Table S4 and data not shown). We therefore used 2 to 4 million cells for most 
experiments. Notably, although we obtained sufficient MS signals and reliable motif ratios even with  
2 x 105 KC cell equivalents and 2 x 104 mammalian cell equivalents if diluted down from cell 
suspensions, we did not succeed to robustly start with less than 1 x 106 KC cells due to varying sample 
loss during various centrifugation steps and acid extraction.  
 
1.2 Successive MS1-MS2-MS3 to quantify combinatorial motifs of the di-acetylated histone H4 
positional isomers 
The abundance of peptides with two out of four acetylations cannot be resolved with MS1 and MS2 
analysis alone, because the set of linear equations for these motifs cannot be mathematically solved (as 
noted before by Phanstiel et al. 2008). One possible solution is to separate these positional isomers by 
chromatography (Young et al., 2009; Leroy et al., 2012). Potential drawbacks of this strategy include 
sample-to-sample variation in chromatographic separation of the positional isomers, uneven matrix 
and acetonitrile effects due to different retention times and high operating skills required for 
elaborated chromatography systems.  
We developed an easy to implement strategy involving iterative loops of targeted MS1-MS2-MS3 
scans. To increase the dynamic range of MS3 acquisition, we performed enhanced zoom scans in the 
ion trap, targeting an increased window centred on the second isotope of the di-acetylated MS2 
fragment ions – but excluding the mono-acetylated precursor ions – and applying WideBand 
activation to increase the efficiency of fragmentation. Note that the second isotope of the MS2 y12 ion 
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that is subjected to MS3 (theoretical mass: 1215.7096) is often at least as strong as the first isotope 
(see Figure S1A second panel zoom in). Although a number of MS3 fragment ions could potentially 
be analysed, we focused on the b10 ion pairs because this gave most reproducible results. The b10 
ions with two acetyl groups represent H4.K8acK12ac (theoretical m/z = 867.469) and b10 ions with a 
single acetyl-group represents H4.K8acK16ac and H4.K12acK16ac (theoretical m/z = 870.492). Note 
that fragmentation of the water loss ion through WideBand activation shifted the observed spectra by -
18 Dalton (see Figures S2A, S2C). Supplementary Table S2 details the formulas that are used to 
calculate the motif abundances for the di-acetylated isoforms.  
Theoretically, the b10 MS3 fragment ion with two acetyl groups (theoretical m/z = 870.492) may 
interfere with the y8 MS3 fragment ion harbouring a single acetyl group (theoretical m/z = 870.516). 
To test for this, we recorded MS3 scans for a synthetic peptide (H4.K8acK12ac) for which we only 
expect signals for the b10 MS3 fragment ion with two acetyl groups (expected m/z at 849) and the y8 
MS3 fragment with a single acetyl group (expected m/z at 855). The MS3 signal intensities for the b10 
ion are dominant over the y8 ion (40400 vs 1526, b10/y8 > 0.96), demonstrating the usability of the 
b10 ion for quantification. Alternatively, one may use the b8 MS3 classifier pair (theoretical m/z at 
739.41 and 742.43) yet we observed less accurate results using synthetic peptides and overall less 
signal and more varying results with most biological samples.  
To test for accuracy, we performed sets of experiments where we mixed synthetic peptides containing 
di-acetylated H4 motifs in different ratios and measured their abundances via LC-MS. The 
representative experiment in Figure S3B shows that the measured ratios are close to the expected ones, 
verifying the MS3-based assay and demonstrating high accuracy.  
In summary, we introduce an easy to implement and robust LC-MS workflow which resolves the 
abundance of PTMs within complex positional isomers. The assay is general applicable and might be 
useful to pinpoint acetylation sites within clusters of any protein.  
 
1.3 Detection and quantification of H3 and H4 histone acetylation motifs  
Histones are basic proteins with clusters of lysines close to the N-terminal ‘tail’ domains. The goal of 
this study was to monitor the acetylation status of any lysine on the canonical histones H3 and H4 with 
a particular focus to probe for potential combinatorial motifs. Because we chemically acetylated 
lysines which are not acetylated in the cell, peptides from endogenously acetylated and non-acetylated 
lysines co-elute during chromatography. This procedure not only has the advantage of increasing the 
precision (see above), but also to increase the confidence in the identification of low abundant 
acetylation sites. Although the MS signals of low abundant acetylation sites often display more 
imprecise masses than high-signal MS identifiers, precise co-elution (or slight shift towards later 
retention times) is a good indication for the existence of an acetylation site (see below for examples 
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including H3.K27me2K36ac, H3.K36me2/3K27ac) whereas the absence of co-elution is a strong 
indication for the absence of an acetylation site (see H4.K20ac and H3.K56ac below). A slight shift 
towards later retention times for endogenously acetylated histones compared to chemically d3-
acetylated histones is caused by the slightly decreased interaction of the deuterated (d3) moieties with 
the C18 column (Goodlett et al., 2001).  
We robustly detected MS1 masses corresponding to the mono-, di-, tri- and tetra-acetylated isoforms 
of the H4.G4-R17 peptide from KC cell histone preparations (Figure S2A). MS2 and MS3 peptide 
sequencing of histones from KC cells enabled the identification and quantification of all positional 
isomers on this peptide with one exception (H4.K5acK16ac). Although we detected synthetic peptides 
to H4.K5acK16ac and accurately determined their abundance in mixtures of synthetic di-acetylated 
H4.G4-R17 peptides (Figure S2B), the low abundance of this motif together with the more 
complicated formula to derive this motif (see Table S2) did not allow its reliable quantification in KC 
cell samples. We therefore do not display the abundance values for this motif. Moreover, to keep the 
other di-acetylated H4.G4-R17 motifs independent of H4.K5acK16ac, we did not artificially correct 
for omitting H4.K5acK16ac. Therefore, if we sum up the abundances of all fifteen quantified H4.G4-
R17 motifs, we only approximate but do not exactly arrive at 1.  
Although we detect all histone H4 peptides in their unmodified form, we did not identify any 
acetylation to lysines K31, K44, K59, K77, K79 and K91 (Figure S2). Acetylation at H4.K20ac has 
been detected in plants (Zhang et al., 2007) and recently also in human cancer cells (Zheng et al., 
2013; Tang et al., 2014). In contrast, we fail to detect H4.K20ac in Drosophila cells. Of note, in a few 
histone preparations from adult flies we detected a MS1 mass at m/z = 279.1940 which is very close to 
the theoretical mass of H4.K20ac (m/z = 279.1927). Its very low signal intensity did not allow MS2 
analysis. Importantly, because the peaks that may indicate H4.K20ac did not co-elute with (or elute 
slightly after) the peaks of the unmodified H4.K20-R23 peptide, we conclude that we are currently 
unable to detect H4.K20ac in Drosophila cells.  
Similar to H4.K20ac, we also did not detect acetylated H4.K91. H4.K91ac has been found in yeast and 
mammalian cells and is associated with histone maturation in the cytoplasm (Ye et al., 2005; Yang et 
al., 2011). Figure S2G shows the existence of a high-signal triple charged MS1 spectrum for the 
unmodified H4.K79R92 peptide, yet we do not detect any signal for the acetylated isoform at a similar 
retention time. 
Consecutive MS1-MS2 analysis on histone H3 peptides identified acetylation to lysines 9, 14, 18, 23, 
27, 36 and 37 in the combinations detailed in Table S4. Figure S3 documents the MS1 and MS2 
spectra. Co-elution of H3.K27me2K36ac, H3.K36me2K27ac and H3.K36me3K27ac with the 
unmodified isoforms H3.K27me2, H3.K36me2 and H3.K36me3 provides high confidence in the 
identification of these motifs. The b3 and y11 fragment ion pairs derived from targeting the mono-
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acetylated H3.K27-R40 peptide revealed that while most acetylation is, as expected, on lysine 27 
(0.20% of all H3 motifs corresponding to estimated 12000 molecules/cell), there was also detectable 
acetylation on lysine 36 (0.058% of H3 motifs or estimated 3500 molecules/cell; for calculations see 
below). Moreover, we detected minute amounts of acetylation on lysine 37 (0.003% of H3 motifs or 
estimated 182 molecules/cell, Figure S3R-T). Although the signals of the 
MS2_K27R40_y4_K36ac_579 identifier reporting on H3.K37ac is above background, the current 
number of replicates within the RNAi dataset did not allow its high-confidence quantification. We 
therefore display only 28 out of 29 acetylation motifs for the KAT and KDAC RNAi datasets. Using 
the motif abundance of H3.K37ac, we estimate that our lowest detection limit is at around 0.003% or 
estimated 182 molecules per cell for those motifs that require consecutive MS1 and MS2 analysis. 
Motifs that require solely MS1 analysis likely have lower detection limits (including H4.K20ac, 
H3.K56ac).  
We did not detect the long hydrophobic peptide H3.F84-R116 and thus cannot interrogate acetylation 
to lysine H3.K115. Furthermore, although we robustly detected all other unmodified H3 peptides, we 
did not detect acetylation to lysines K4, K56, K64, K79 and K122 (Figure S3). 
Acetylation of H3.K56 is high in yeast cells and very low in mammalian cells (see (Drogaris et al., 
2012) and references therein). Using antibodies to detect H3.K56ac, Tyler and colleagues reported that 
deprivation of SIR2 in Drosophila S2 cells increased the levels of H3.K56ac (Das et al., 2009). We 
did not detect H3.K56ac in KC cells treated with control RNAi or RNAi targeting SIR2 (Figure S3J). 
We also did not detect this modification in S2 cells. Measuring synthetic peptides of unmodified and 
acetylated K56 yielded strong signals for both isoforms, arguing that our LC-MS approach is capable 
to detect acetylated K56ac if present on synthetic peptides (Figures S3K, L).  
Acetylation of H3.K64 and H3.K122 was recently observed in mammalian cells (Tropberger et al., 
2013; Di Cerbo et al., 2014), but similar to H3.K56ac, we detected the unmodified but not acetylated 
isoforms in histones from KC cells (Figure S3X, Y).  
We detected methylation at lysine 20 of H4 and lysines K4, K9, K27, K36 and K79 of H3 (Table S4 
and Figure S2, S3). Although occasionally we observed a mass corresponding to a mono-methylated 
H3.K9-R17 peptide, which elutes 3 minutes after H3.K9me1 and thus might be H3.K14me1, MS2 
analysis did not confirm the identity of H3.K14me1. The same applies to MS1 masses, which may 
indicate mono-methylation at the H3.K18-R26 peptide. MS2 analysis targeting this parent ion did not 
yield any fragment ion that would indicate the presence of the mono-methylated H3.K18-R26 peptide.  
Apart from the methyllysine-containing motifs detailed in Figure 1D, E and Table S4, we also 
detected low levels of H3.K36me1, H3.K27me1K36me1 and minute amounts of H3.K79me3. Under 
our conditions, H3.K36me1 elutes very close to the positional isomer of the more dominant 
H3.K27me1 (Figure S1B) and in some samples H3.K36me1 (m/z = 528.3226) co-eluted with 
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acetylated K27ac from the histone variant H3.3, which lead to an interference with its second isotope 
at m/z = 528.3157. We therefore currently cannot reliably report H3.K36me1 throughout all KAT and 
KDAC RNAi samples. We also excluded H3.K27me1K36me1 for a high-confidence comparative 
analysis, because its measured abundance varied substantially even throughout control RNAi samples. 
Similar to other di- and tri-methyl pairs, H3.K79me3 elutes shortly before H3.K79me2 (Figure S1A, 
lowest panel in schedule 4). Because of its very low signal intensity and the observed variability 
across control RNAi samples, we excluded H3.K79me3 for a high-confidence quantitative analysis. 
We estimated the abundance of H3.K79me3 in KC cells to be below 0.2% (Figure S3W), supporting 
that, similar to human DOT1L but unlike to yeast Dot1, D. melanogaster DOT1 almost exclusively 
generates H3.K79me1/2.  
In this study, we do not report on the methylation states of H4.K20 and H3.K4. Although we robustly 
identified the more hydrophobic un-methylated und mono-methylated states to each of these peptides 
(Figure S2D-F, S3A,B), H3.K4me2 showed much lower signal intensities and the me3 states of each 
peptide are only occasionally detected. Reliable quantification of these small hydrophilic peptides 
would require additional or alternative peptide purification strategies. To not compromise 
quantification of the other 45 histone PTM motifs, we excluded the analysis of the H3.T3-R8 and 
H4.K20-R23 peptides.  
 
Calculation of motif abundance and estimation of cellular copy number 
To calculate the relative abundance of a histone motif, its specific peak intensity (area under curve of 
each MS chromatogram) was divided by the sum of all peak intensities of motifs that contribute to a 
peptide (See Table S2). For example, the relative abundance of H3.K14ac was calculated by 
multiplying the fraction of MS2 identifiers that distinguish H3.K14ac from H3.K9ac 
(MS2_K9R17_y7_K14ac_728 / (MS2_K9R17_y7_K14ac_728 + MS2_K9R17_y7_K14noAc_731) 
with the fraction of the non-methylated but mono-acetylated MS1 signals relative to all MS1 signals 
for the H3.K9-R17 peptide (H3.K9-R17_1Ac / (H3.K9-R17_noPTM + H3.K9-R17_1Ac + H3.K9-
R17_2Ac + H3.K9-R17_K9me1/2/3 ± K14ac). Of note, any other modification that occurs on this 
motif but was not quantified in this study will cause an underestimation of the abundances for the 
quantified motifs. This includes, for instances, the phosphorylation sites at H3.S10 and H3.T11 – 
which would require alternative purification strategies – as well as PTMs that have not yet been 
identified.  
We attempted to determine the exact cell copy number of all histone molecules and specific histone 
acetylation and methylation motifs by spiking-in highly purified, precisely quantitated synthetic 
peptides (TQL-spiketide, JPT Berlin) into known quantities of KC cells. However, as described below, 
we observed already strong variations in the abundance of the Q tag dissociated by trypsin digestion 
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from different proteotypic peptides, which complicates its faithful accurate quantitative interpretation. 
Moreover, we observed strong variations of the LC-MS response throughout replicate experiments 
with cells and spike-in TQL-peptide mixes. Lastly, we observed ion suppression effects when we 
titrated the number of cells against the concentration of TQL synthetic peptides, or vice versa.  
Because of the technical problems described above, we estimated the number of histone motifs per cell 
assuming i) a D. melanogaster genome size of 196 mega base pairs (Mb) for females and 170 Mb for 
males (http://flybase.org/reports/FBsp00000001.html), ii) an average nucleosome repeat length of 197 
base pairs (Becker and Wu, 1992), iii) a minimal pool of free histones while most histones are 
organised as nucleosomes (Loyola et al., 2006) and iv) equal number of cells in G1 (n=2) and G2 
(n=4) phase. Accordingly, multiplying the relative abundances measured in this study with 5 969 543 
and 5 177 664 million histone molecules of a diploid female or male cell, respectively, the estimated 
abundance for the rare H3.K37ac motif is around 182 molecules per female cell whereas the high 
abundant H3.K23ac motif is present on approximately 2.8 million histone molecules. 
 
Supplementary Note 2: Introducing an LC-MS response factor to increase the accuracy of 
histone PTM quantification 
Post-translational modifications can have a substantial impact on several steps of the LC-MS 
workflow – including column interactions during liquid chromatography and ionization and 
fragmentation within the mass spectrometer – and can therefore severely bias accurate quantitation 
between different PTMs signatures of the same peptide (Schotta et al., 2008; Farley and Link, 2009; 
Marx et al., 2013). For the current study, we needed to know accurate relative abundances to reliable 
interpret the abundance levels in the light of their roles as high abundant structural motifs or rare 
motifs with signalling character.  
As expected, the D3AA method applied in this study reduced the inherent bias in MS signals for 
motifs that contain a single or multiple acetylations as the only PTM. Measuring defined amounts of 
different synthetic di-acetylated H4.G4-R17 peptides recovered the expected ratios (see above and 
Figures S2B, C). Furthermore, we observed very similar LC-MS response factors among positional 
isomers of H3 peptides that contain lysine acetylation as the only PTM (Table S3).  
In contrast, we observed dramatically different MS signals when we measured the same amount of 
peptides that differed in their methylation status. A similar observation has been made before by 
Jenuwein and colleagues who observed up to 5 fold differences when comparing the raw MS signals 
among synthetic peptides to H4.K20me1/2/3 and the unmodified H4.K20-R23 peptide (Schotta et al., 
2008). We measured synthetic peptides to methylation motifs that contain methylated K9, K27, K36 
and K79. The most dramatic effect was measured between the different methylation states of lysine 9, 
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where the raw MS signals of the H3.K9me3 peptide was 50-fold less than the raw MS signals for the 
H3.K9me1 motif (Table S3, column 5).  
Some of the differences might be due to different initial peptide concentrations, which may vary in a 
peptide-specific manner due to peptide processing workflows between the quantitation of peptides (at 
JPT, Berlin) and their digestion with trypsin (in our laboratory). For example, the exact quantitation of 
the TQL-synthetic peptide by fluorescence might be influenced by the physicochemical properties of 
the peptide sequence including their modification pattern. Furthermore, peptides with different 
physicochemical properties, such as the ones with different methylation states, might be differentially 
affected by peptide loss during the early pre-LC workflows, including insufficient resuspension and 
different interactions with the tube walls.  
To test for this ‘pre-LC error’, we measured the MS signals of the Q tag, which is cleaved off the 
proteotypic peptide by trypsin digestion. Indeed, we observed substantial differences in the Q tag 
signals between experiments with different TQL-synthetic peptides (Figure 1C, middle panel). 
Normalising the MS signals of the proteotypic peptides by the MS signals of the Q tag not only 
reduced the variation between replicate measurements by two-fold (compare the SEM between 
columns 4 and 6 in Table S3) but also yielded more similar LC-MS response correction factors among 
motifs that differ only in their site of acetylation. For example, while the LC-MS response correction 
factors without applying the Q tag normalisation differed markedly between H3.K9ac (3.92), 
H3.K14ac (1.62) and H3.K9acK14ac (2.26), applying the normalisation with the Q tag signals 
converged the LC-MS response correction factors (H3.K9ac: 1.46, H3.K14ac: 1.46 and 
H3.K9acK14ac: 1.58). In addition, the Q tag normalisation also reduced the overall differences 
between the highest and lowest LC-MS response correction factor (e.g. H3.K9me3 before Q tag 
normalisation: 50.49, after Q tag normalisation: 34.17).  
Theoretically, the accuracy of the LC-MS response factors for motifs that elute during different 
retention times can be increased by measuring them in the background of the endogenous histone 
sample. However, because we observed a dose-dependent interference between the synthetic spike-in 
peptides with their co-eluting endogenous counterpart, we did not proceed with this strategy, which is 
also the reason why we refrained from using the spike in peptides for absolute quantitation.  
Application of the LC-MS response correction factor had a significant impact on estimating the 
cellular copy number of histone acetylation and methylation motifs (Table S4). For example, without 
applying the LC-MS response correction factor, we estimated that H3.K27ac is found on 0.7% of H3 
molecules (estimated 41,000 molecules/cell). This number is unexpectedly high, considering that this 
dynamic mark is preferentially detected at active enhancers (> 10,000) (Kharchenko et al., 2011; 
Yanez-Cuna et al., 2014). If we correct for the LC-MS bias, we arrive at a 3.5 times lower number for 
H3.K27ac (0.2% or estimated 12,000 molecules/cell). By contrast, we underestimated the abundance 
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of the repressive H3.K9me3 mark by almost ten-fold (4.2% vs. 39%). Combining the numbers for the 
cellular abundance, genome-wide occupancy and half-live allows deriving testable quantitative models 
on genome organisation and function.  
Application of the LC-MS response correction factor did not change the conclusions of most KAT and 
KDAC RNAi experiments, with a few notable exceptions (Figure S6 and Table S5). While H3.K14ac 
appeared to be elevated in many KAT depletion experiments without applying the LC-MS correction 
factor, this trend was weaker when correcting for the LC-MS bias. Another example is the depletion of 
HBO1, that appeared to cause a moderate reduction of H3.K9me2K14ac (85% of control), which was 
not observable anymore after applying the correction factor (98% of control).   
 
Supplementary Note 3: Experimental design and statistical analysis  
During the course of this study, we continuously developed the LC-MS protocol while expanding the 
scope of KAT and KDACs and histone motifs to be analysed. Therefore, the current manuscript 
summarises datasets that were generated using different LC-MS workflows and different KC cell 
batches grown and harvested during different months and years (time span from 2012 to 2014). As a 
consequence, we observed technical and biological variations, which we addressed by normalising 
KAT/KDAC RNAi samples within each ‘batch’ to their corresponding control RNAi samples (Tables 
S4, S5 and see below).  
We aimed to ablate each KAT and KDAC with two distinct non-overlapping RNAi constructs (Table 
S7) in at least two independent biological experiments for each RNAi construct. For most RNAi 
experiments, we used two dsRNA sequences from the Drosophila RNAi Screening Center (DSRC, 
Harvard). Those constructs have an average size of 500 base pairs and are widely used in genome-
wide RNAi screens. For some genes, we designed new RNAi constructs using the NEXT-RNAi 
platform (www.nextrnai.org) because there was only a single RNAi construct at DSRC (e.g. MGEA5) 
or we expected an insufficient knockdown or elevated off-target reactivity when using short DSRC 
constructs (e.g. NAA10 < 250 bp). Because of their short mRNA size or unfavourable sequence 
composition, we could only target NAT9, NAA40, CG12560 and SIRT6 with a single dsRNA 
construct.  
For most RNAi experiments, we observed an overall high similarity of the responses that are caused 
by different dsRNA constructs targeting the same KAT or target gene (Table S5). However, this was 
not the case for each one dsRNA-CBP and dsRNA-TIP60 construct, which were therefore not 
incorporated in the analysis (see note in Table S5).  
While many KAT RNAi samples where acquired during three different ‘replicate batch groups’ (see 
Table S5), some KAT RNAi samples were acquired in fewer batches (e.g. MGEA5: 3 biological 
replicates in the ‘C’ batch; NAT10: 2 biological replicates each in the ‘B’ and ‘C’ batch). In some 
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cases, we conducted several independent RNAi experiments with the same batch of cells yet on 
different days or weeks. For example, we conducted two independent RNAi experiments each with the 
single NAA40_1 RNAi construct during times of the ‘A’ batch (NAA40_1_1_A and NAA40_1_2_A) 
and the ‘B’ batch (NAA40_1_1_B and NAA40_1_2_B).  
Normalisation to control RNAi samples within each batch was necessary because, while most histone 
motifs did not show major differences in their abundance across the different batches, some motifs 
showed considerable variation. For example, while the abundance of H4.K5ac was similar across the 
batches ‘A’ to ‘E’ (3.38%, 3.42%, 3.75%, 3.15% and 3.38%), the abundance values scattered stronger 
for H4.K12ac (6.95%, 8.20%, 7.66%, 5.98% and 8.03%). Because our interest was primarily in the 
relative change of a motif comparing a KAT/KDAC RNAi with its control (GST RNAi, GFP RNAi, 
EGFP RNAi or mock), this normalisation step reduced biological variation across paired groups of 
KAT/KDAC and control RNAi (= samples between ‘batches’) and thereby increased statistical power 
to detect minor differences. Although we note that some motif abundances systematically varied more 
than others, we currently suspect not only technological reasons (such as noise within LC-MS signals 
due to different quantitation requirements, see Table S2) but also biological explanations, such as the 
time we kept cells in culture or environmental conditions. For example, we observed varying levels of 
H4.K12ac and H3.K18acK23ac in cells, which were either kept for very short or extended periods of 
time in culture (preliminary observation, samples not used during this study). Similarly, we suspect 
altered serum conditions to be responsible for some batch-to-batch variations.  
We excluded MS values for histone motifs that we either did not measure in a particular sample or in 
case the MS values were not reliable. For example, we did not measure histone H3 motifs of samples 
within batch ‘A’. Common sources for non-reliable MS values were low MS signals due to technical 
shortcomings at the LC or MS, interference with other ions (sometimes caused by problems with the 
LC gradient) or ion suppression effects. In case we identified a problem with a single MS identifier 
(e.g. the early eluting MS1_K9R17_K9me3 identifier, which reports on the H3.K9me3 motif), we 
excluded all motifs of this peptide (H3.K9-R17), even if individual motifs, which elute at later 
retention times, appeared fine (H3.K9me1 and acetylated K9 and K14). However, in many cases, other 
peptides were not affected (e.g. H3.R18-K26) and thus remained in the analysis. In these special cases 
where we could not reliably identify peptides, we did not calculate summarised values (e.g. global 
acetylation score).  
 
Supplementary Note 4: Mining the database to derive testable hypotheses and shed light into 
controversial enzyme-substrate relationships 
HAT1 is the well-known cytoplasmic HAT that renders histone H4 competent for nucleosome 
assembly by acetylation at lysines 5 and 12. Up to now, current methodology did not allow measuring 
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the di-acetylated motif per se (see Suppl. Note 1.2). Our analysis shows that the main effect of HAT1 
knockdown is a reduction of the H4.K5acK12ac mark (Figure 2A). Interestingly, it also reveals a 
reduction of K5ac, but not of K12ac. Together with in vitro data on recombinant HAT1 that 
demonstrates efficient acetylation of unmodified and pre-acetylated templates on either positions 5 or 
8 yet not on other sites or combinatorial motifs (K12ac, K5acK12ac, K8acK16ac; Makowski et al. 
2001), this leads us to hypothesise that HAT1 first acetylates H4 at K5, releases a fraction of H4.K5ac 
to the cellular histone pool and di-acetylates another fraction to produce H4.K5acK12ac. Notably, we 
detect a minor decrease of the tri-acetylated H4.K5acK8acK12ac upon HAT1 depletion, which 
suggests that HAT1 further acetylates K8 on a small fraction of its di-acetylated product. This is in 
line with previous reports indicating that cytosolic H4 bound to chaperones is not only acetylated at 
lysines 5 and 12, but that a minor acetylation of K8 can be detected as well (Verreault et al., 1996).   
The physiological substrates of HBO1 are controversially discussed. Whereas some groups report 
HBO1 as the major H4 acetyltransferase with specificity for K5, K8 and K12, others found that 
inactivation of the hbo1 gene in mice did not cause a decline of H4 acetylation, yet led to dramatic loss 
of H3.K14ac (Miotto and Struhl, 2010; Kueh et al., 2011; Lalonde et al., 2013). Indeed, HBO1 
ablation in Drosophila affects H4.K12ac levels only very modestly, if the values of all motifs 
including this mark are combined (as if one used an antibody that does not differentiate H4.K12ac-
containing motifs) (Figure 2B). However, monitoring individual motifs reveals that HBO1-lacking 
cells show a moderate reduction of mono-acetylated H4.K12, but a severe loss of the di-acetylated 
H4.K8acK12ac motif (Figures 2A, 3A, 3B). One of the possible scenarios to explain this finding is 
that HBO1 initially acetylates H4.K12 and then further acetylates K8 on a fraction of its first 
acetylation product.  
 
Supplementary Note 5: Homeostatic control of acetylation levels upon deprivation of KATs 
To determine whether deprivation of KATs reduces the global acetylation levels of histones, we 
calculated a ‘global H3 + H4 acetylation score’ and compared it between cells lacking a specific KAT 
and cells treated with control RNAi constructs (Figure 5A and Table S5, column 59). The ‘global H3 
+ H4 acetylation score’ is calculated by summing up all fractional acetylation events observed on the 
four histone peptides that are subject to acetylation (H4.G4-R17, H3.K9-R17, H3.K18-R26 and 
H3.K27-R40). For example, depletion of CBP in the CBP_2_3_C experiment (targeting CBP with the 
CBP_2 RNAi construct, using the third biological replicate experiment in the batch ‘C’) displayed a 
relative ‘global H3 + H4 acetylation score’ of 96% (Table S5, row 74, column 59). In other words, the 
cumulative acetylation on the four acetylated peptides (H4.G4-R17, H3.K9-R17, H3.K18-R26 and 
H3.K27-R40) was reduced by only 4% relative to control RNAi. This value is derived by dividing the 
‘global H3 + H4 acetylation score’ for CBP_2_3_C of 100.57 (see row 74, column 117) by the mean 
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of the ‘global H3 + H4 acetylation score’ for the control RNAi samples from the ‘C’ batch, which has 
a value of 105.02 (Table S5, row 266, column 117). The ‘global H3+H4 acetylation score’ (column 
117) is the sum of the ‘global acetylation score for H4’ (column 115) and the ‘global acetylation score 
for H3’ (column 116). The ‘global acetylation score for H4’ represents the fraction of histone H4 
peptides that is acetylated, which is 27.14% for the CBP_2_3_C sample. The ‘global acetylation score 
for H3’ is the sum of all fractional acetylation events on the three acetylated H3 peptides (19.78% for 
H3.K9-R17, 53.59% for H3.K18-R26, and 0.06% for H3.K27-R40, total of 73.43%).  
To calculate the % total acetylation change that is contributed by individual motifs (Figure 5B), we 
scaled the relative change of each KAT RNAi/ctr RNAi experiment (filtered for significant losses, 
using unpaired two-sided t test on log2 ratios) to the relative abundance of each motif in KC cells. 
This was done to circumvent the batch effects between different ‘replicate batch groups’ (see Suppl. 
Note 3).  
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Inventory for KATs and KDACs in Drosophila  
A list of putative KATs and KDACs was generated using public databases (FlyBase, ENSEMBL, 
HIstome (Histone Info Database – ACTREC), HomoloGene), primary research articles, reviews and 
cross-homology search using BLAST. Gene expression data was obtained from FlyBase (FlyAtlas, 
modENCODE tissue expression data, modENCODE temporal expression data, modENCODE cell line 
expression data).  
 
Fly stocks, crosses and handling 
Flies were raised on standard cornmeal/yeast medium at 18°C - 22°C. OregonR yw flies were used 
and considered wildtype. The mof2 allele is described in (Gu et al., 1998) and the MOF(+) rescue 
transgene is published in (Prestel et al., 2010). Because we did not observe phenotypic effects for 
female mof2/mof2 mutants under our culturing conditions, we maintained them as stable stocks and 
used directly 20 - 50 females either 1 day or 2 - 4 days old for histone PTM analysis. Hemizygous 
male mof2 mutants are lethal at the larval stages, as described earlier (Gu et al., 1998), and therefore 
cannot be analysed at the adult stages of development. MOF(+)/CyO-GFP flies were generated and 
those males were crossed to homozygous female virgins mof2/mof2; +/+ to obtain mof2/y; +/CyO-
GFP hemizygous male mutants. GFP fluorescence was used to sort male third-instar larval mof2 
mutants.  
 
Cell line cultivation and RNA interference (RNAi) 
Cultivation of KC and S2 cells and RNAi were carried out essentially as described before (Feller et al., 
2012). Briefly, cells were grown in T75 or T175 flasks, washed in PBS and 1.5 million cells were 
transferred to each well of a 6-well plate. Cells were treated with 10 µg dsRNA for 60 min in 1 ml 
serum-free medium. After addition of 2 ml serum-containing medium (10% FCS), cells were 
incubated for 5.5 days before harvest. Primer sequences used for RNAi are described in Table S7. We 
used S2 cells of the ‘L2-4’ subtype, which were obtained from Dr. Patrick Heun (MPI Freiburg, 
Germany). 
Human HeLa Kyoto cells were grown in DMEM medium containing 10% FCS and 1% 
penicillin/streptomycin at 37°C and 5% CO2. Cells were transfected with siRNAs using 
oligofectamine (Invitrogen) according to the manufacturer’s instructions. Growth medium was 
exchanged every day and cells were harvested for histone PTM analysis after 2.5 days. Primer 
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sequences used for RNAi are described in Table S7 and have been published in (Taipale et al., 2005) 
and (Smith et al., 2005).  
 
RT-qPCR experiments 
Total RNA was prepared from KC cells using Trizol followed by the RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s protocol. 600 ng of total RNA was reverse transcribed using random 
primers and the SuperScript III kit (Life Technologies). Real-time PCR was performed with a Roche 
480 light cycler using the second derivative method for quantification. Primer sequences are described 
in Supplementary Table S7. 
 
Immuno blotting 
Quantification of immunoblots was performed using the LI-COR system (Biosciences). The lamin 
antibody was obtained from Harald Saumweber (Berlin) and the MOF antibody was described before 
(Prestel et al., 2010) 
 
Extraction of histones from Drosophila tissue and cell lines and peptide processing 
Third-instar male larvae were extensively washed in PBS, collected in microcentrifuge tubes, flash 
frozen in liquid nitrogen and stored at -80°C. Adult female flies were processed in the same manner 
but the washing step was omitted. Frozen tissue was homogenised in A1 buffer (15mM HEPES pH 
7.6, 60 mM KCl, 15 mM NaCl, 4 mM MgCl2, 0.5% Triton, 0.5mM DTT, protease inhibitor (Roche)), 
centrifuged and the pellet was resuspended in 0.2 M sulphuric acid. Acid extraction and all 
downstream steps were essentially done as with tissue culture cells, as follows. 
KC and S2 cells were harvested and collected by centrifugation, washed once with PBS and pellets 
were flash frozen in liquid nitrogen and stored at -80°C. Frozen cell pellets were suspended in 0.2 M 
sulphuric acid and histones and other acid-soluble proteins were extracted overnight and precipitated 
with 26% TCA. After two to five washes with cold acetone, the histone pellet was resuspended in 
SDS-PAGE loading buffer. If necessary, pH was adjusted with 1 µl of 1 M Tris pH 8.0. Histones were 
separated by SDS-PAGE on 15% polyacrylamide gels, stained with Colloidal Blue Staining Kit 
(Invitrogen) and bands corresponding to histones H3 and H4 were excised from the gels.  
Gel pieces containing histones were washed twice with water, twice with 100 mM ammonium 
bicarbonate (ambic) and incubated in 50 mM ambic/50% acetonitrile for 3 times 10 min while shaking 
at 37°C for destaining. Gel pieces were successively dehydrated by incubating once with 100 mM 
ambic, once with 20 mM ambic and 3 times with acetonitrile. Histones were chemically acetylated 
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with d6-deuterated acetic anhydride (99% D, Sigma) for 45 min at 37°C (pH was monitored to be pH 
7-8). After acetylation, histones were washed 4 times with 100 mM ambic and thrice with acetonitrile 
followed by overnight trypsin (Promega) digestion at 37°C. Tryptic peptides were extracted twice with 
70% acetonitrile/0.25% TFA and twice with acetonitrile, vacuum concentrated and resuspended in 
0.1% TFA. Histone peptides were desalted using C18-StageTips (Rappsilber et al., 2003), eluted in 
80% acetonitrile/0.25% TFA, vacuum concentrated, reconstituted in 0.1% TFA and stored at 4°C 
(short) or -20°C (long).  
 
Processing of TQL spiketides and calculation of LC-MS response correction factor (LCF) 
Purified, isotopically labelled and quantified SpikeTides TQL were purchased from JPT Peptide 
Technologies GmbH (Berlin). 1 nmol of peptides was resuspended in 80% 100 mM ambic, 18% 
acetonitrile and 2% DMSO, followed by two rounds of 1 min vortexing, 3 min sonication and 15 min 
shaking at 25°C. Chemical acetylation and trypsinisation was carried out as described above. Each 
TQL proteotypic peptide was measured in replicates in different concentrations (1, 5 and 15 pmol) 
using the same LC parameters but acquiring MS1 scans only.  
The LC-MS response correction factor (LCF) was calculated by dividing the raw MS signals for the 
proteotypic peptide per pmol (column 5) by the raw MS signals for the Q tag which was followed by 
scaling to the motif that has the highest signal among all motifs for a given peptide. We experienced 
technical problems for individual motifs from the H3.K27-R40 and H3.E73-R83 synthetic peptides 
and therefore can only report LCFs with moderate confidence for those motifs. 
 
LC-MS workflow and peak integration 
Tryptic peptides were injected in two different HPLC systems from Dionex depending on the batch: 
Samples from replicate batch ‘A’ were separated on an Ultimate and replicate batches ‘B’ to ‘D’ were 
separated on an Ultimate 3000 RSLCnano. Peptides were separated with a gradient from 5-60% 
acetonitrile in 0.1% formic acid over 40 min at 300 nl/min on a C18 analytical column (75 µm i.d. ×15 
cm, packed in-house with Reprosil Pur C18 AQ 2.4 µm; Doctor Maisch). The effluent from the HPLC 
was directly electrosprayed into an LTQ-Orbitrap Classic mass spectrometer (Thermo Fisher 
Scientific). MS was operated in a targeted setup (see Suppl. Note 1). Typical MS conditions were 
spray voltage, 1.5 kV; no sheath and auxiliary gas flow; heated capillary temperature, 200°C; MS1 
resolution of 7500 (at 400 m/z); normalised collision-induced dissociation energy 35% (MS2) and 
45% (MS3); activation q = 0.25; and activation time = 30 ms. 
LC-MS data was quantified using the Xcalibur software package (Thermo Fisher Scientific, version 
2.2) based on the area of the peak from the extracted ion chromatogram. A processing method was 
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built using the Xcalibur Processing Setup including the mass-to-charge range and the expected 
retention time (see Table S1). Further parameters were: Peak detection: Genesis; trace: mass range; 
smoothing points: 3, S/N threshold: 0.5. The identities of the MS quantifiers were verified by MS2 
spectra of the natural occurring forms and their corresponding synthetic peptides (JPT Berlin). All 
chromatograms were manually verified in Quan Browser and re-integrated where necessary. 
Typically, this involves baseline adjustment and adjustments to integrate the identical retention time 
across the d0/d3 pair (i. e. endogenous vs. chemical acetylation). Peak integration was optimised to 
yield the maximal co-eluting chromatogram of the d3/d0 pair. The spectra from suspicious 
chromatograms (e.g. if peaks with similar m/z were eluting close-by) were manually inspected, and, if 
necessary, m/z integration range was adjusted (if possible) or MS quantifier were excluded (see Suppl. 
Note 3).  
 
Data analysis and statistical analysis 
After peak integration, the data was exported into an Excel spread sheet and data summarisation and 
statistical analysis was performed in Excel and R. The relative abundance was calculated according to 
the formulas provided in Table S2. Each sample was normalised to control RNAi samples within the 
same biological replicate batch (for details and justification: see Suppl. Note 3) and ratios were log2 
scaled. We applied a two-sided unpaired t test over the log2 ratios of relative changes from all target 
RNAi samples (e.g. HAT1) for a specific motif (e.g. H4.K5acK12ac) relative to all control RNAi 
samples within the same replicate batch. Because we considered the purpose of this study in the 
discovery of changed histone motif abundances upon KAT and KDAC RNAi and we expected only 
moderate differences, we did not apply a conservative filter by adjusting the p--values by their FDRs. 
Nevertheless, for convenience of the individual reader, Table S5 provides all MS raw signals, relative 
and total abundance values to all RNAi samples as well as summarised tables, which report on the 
mean changes of every KAT/KDAC RNAi (unfiltered) and raw and adjusted p values (two-sided 
unpaired t test, p values were adjusted per KAT/KDAC RNAi across all motifs according to 
Benjamini and Hochberg; p-value adjustment was performed in R). This table might be used to 
discover a potential change of a histone motif upon an individual KAT knockdown and to evaluate its 
significance considering the number of replicates and technical and biological variation. 
  
Table S1: List MS quantifier 
MS identifier theoretical m/z
charge 
state sequence 
typical 
retention 
time [min] 
XIC 
range 
(min) 
XIC 
range 
(max) 
MS1_T3R8_NoPTM 375.224 2 TKQTAR 17 375.07 375.37
MS1_T3R8_K4me1 382.233 2 TKme1QTAR 18.2 382.08 382.38
MS1_T3R8_K4me2 366.722 2 TKme2QTAR 16.8 366.57 366.87
MS1_T3R8_K4me3 373.730 2 TKme3QTAR 16.4 373.58 373.88
              
MS1_K9R17_noPTM 496.292 2 KSTGGKAPR 20.7 496.14 496.44
MS1_K9R17_1Ac 494.783 2 K(ac?)STGGK(ac?)APR 20.7 494.63 494.93
MS1_K9R17_2Ac 493.274 2 KacSTGGKacAPR 20.7 493.12 493.42
MS1_K9R17_K9me1 503.301 2 Kme1STGGKAPR 25.8 503.15 503.45
MS1_K9R17_K9me1_K14ac 501.792 2 Kme1STGGKacAPR 25.8 501.64 501.94
MS1_K9R17_K9me2 487.793 2 Kme2STGGKAPR 17.65 487.64 487.94
MS1_K9R17_K9me2_K14ac 486.284 2 Kme2STGGKacAPR 17.65 486.13 486.43
MS1_K9R17_K9me3 494.801 2 Kme3STGGKAPR 17.55 494.65 494.95
MS1_K9R17_K9me3_K14ac 493.291 2 Kme3STGGKacAPR 17.55 493.14 493.44
MS2_K9R17_y7_K14ac_728 728.41 2 TGGK14acAPR 20.7 727.91 728.91
MS2_K9R17_y7_K14noAc_731 731.43 2 TGGK14APR 20.7 730.93 731.93
              
MS1_K18R26_noPTM 538.837 2 KQLATKAAR 38 538.69 538.99
MS1_K18R26_1Ac 537.328 2 K(ac?)QLATK(ac?)AAR 38 537.18 537.48
MS1_K18R26_2Ac 535.819 2 KacQLATKacAAR 38 535.67 535.97
MS2_K18R26_b2_K18ac_299 299.17 2 K18acQ 38 298.67 299.67
MS2_K18R26_b2_K18noAc_302 302.19 2 K18Q 38 301.69 302.69
              
MS1_K27R40_noPTM 523.651 2 KSAPSTGGVKKPHR 40 523.55 523.75
MS1_K27R40_1Ac 522.643 2 KSAPSTGGVKKPHR_1Ac 40 522.54 522.74
MS1_K27R40_K27me1 528.323 2 Kme1SAPSTGGVKKPHR 41.6 528.17 528.47
MS1_K27R40_K27me2 517.983 2 Kme2SAPSTGGVKKPHR 35.1 517.83 518.13
MS1_K27R40_K27me2_K36ac 516.975 2 Kme2SAPSTGGVKacKPHR 35.1 516.83 517.13
MS1_K27R40_K27me3 522.655 2 Kme3SAPSTGGVKKPHR 34.8 522.51 522.81
MS1_K27R40_K36me2 517.983 2 KSAPSTGGVKme2KPHR 37.4 517.83 518.13
MS1_K27R40_K36me2_K27ac 516.975 2 KacSAPSTGGVKme2KPHR 37.4 516.83 517.13
MS1_K27R40_K36me3 522.655 2 KSAPSTGGVKme3KPHR 37.4 522.51 522.81
MS1_K27R40_K36me3_K27ac 521.647 2 KacSAPSTGGVKme3KPHR 37.4 521.50 521.80
MS1_K27R40_K27me2K36me1 522.655 2 Kme2SAPSTGGVKme1KPHR 36.9 522.51 522.81
MS2_K27R40_b3_K27ac_329 329.18 2 K27acSA 40 328.68 329.68
MS2_K27R40_b3_K27NoAc_332 332.21 2 K27SA 40 331.71 332.71
MS2_K27R40_y4_K37NoAc_582 582.36 2 K37PHR 40 578.83 579.83
MS2_K27R40_y4_K37ac_579 579.33 2 K37acPHR 40 581.86 582.86
MS2_K27R40_y5_K27NoAc_752 752.47 2 K36(ac?)K37(ac?)PHR 40 751.97 752.97
MS2_K27R40_y5_K27ac_755 755.49 2 K36K37PHR 40 754.99 755.99
              
MS1_E73R83_noPTM 690.866 2 EIAQDFKTDLR 53.2 690.72 691.02
MS1_E73R83_K79me1 697.874 2 EIAQDFKme1TDLR 55.4 697.72 698.02
MS1_E73R83_K79me2 682.365 2 EIAQDFKme2TDLR 47.5 682.22 682.52
MS1_E73R83_K79me3 689.373 2 EIAQDFKme3TDLR 47.3 689.22 689.52
              
              
MS1_K20R23_noPTM 280.705 2 KVLR 23.2 280.56 280.86
MS1_K20R23_K20me1 287.712 2 Kme1VLR 31.50 287.56 287.86
MS1_K20R23_K20me2 272.203 2 Kme2VLR 18 272.05 272.35
              
MS1_G4R17_noPTM 725.957 2 GKGGKGLGKGGAKR 41 725.81 726.11
MS1_G4R17_1Ac 724.446 2 GKGGKGLGKGGAKR_1Ac 41 724.30 724.60
MS1_G4R17_2Ac 722.934 2 GKGGKGLGKGGAKR_2Ac 41 722.78 723.08
MS1_G4R17_3Ac 721.422 2 GKGGKGLGKGGAKR_3Ac 41 721.27 721.57
MS1_G4R17_4Ac 719.911 2 GKacGGKacGLGKacGGAKacR 41 719.76 720.06
MS2_G4R17_1Ac_y5_K16ac_530 530.31 2 GGAK16acR 41 529.81 530.81
MS2_G4R17_1Ac_y5_K16NoAc_533 533.33 2 GGAK16R 41 532.83 533.83
MS2_G4R17_1Ac_y7_K16K12.1Ac_760 760.46 2 GK12(ac?)GGAK16(ac?)R 41 759.96 760.96
MS2_G4R17_1Ac_y7_K16K12.0Ac_763 763.48 2 GK12GGAK16R 41 762.98 763.98
MS2_G4R17_1Ac_y12_K16K12K8.1Ac_1217 1217.73 2 GGK8GLGK12GGAK16R_1Ac 41 1217.23 1219.23
MS2_G4R17_1Ac_y12_K16K12K8.0Ac_1220 1220.76 2 GGK8GLGK12GGAK16R 41 1220.26 1222.26
MS2_G4R17_2Ac_y5_K16.1Ac_530 530.31 2 GGAK16acR 41 529.81 530.81
MS2_G4R17_2Ac_y5_K16.0Ac_533 533.33 2 GGAK16R 41 532.83 533.83
MS2_G4R17_2Ac_y7_K16K12.2Ac_757 757.43 2 GK12acGGAK16acR 41 756.93 757.93
MS2_G4R17_2Ac_y7_K16K12.1Ac_760 760.46 2 GK12(ac?)GGAK16(ac?)R 41 759.96 760.96
MS2_G4R17_2Ac_y7_K16K12.0Ac_763 763.48 2 GK12GGAK16R 41 762.98 763.98
MS2_G4R17_2Ac_y12_K16K12K8.2Ac_1214 1214.71 2 GGK8GLGK12GGAK16R_2Ac 41 1214.21 1216.21
MS2_G4R17_2Ac_y12_K16K12K8.1Ac_1217 1217.73 2 GGK8GLGK12GGAK16R_1Ac 41 1217.23 1219.23
MS2_G4R17_3Ac_y5_K16ac_530 530.31 2 GGAK16acR 41 529.81 530.81
MS2_G4R17_3Ac_y5_K16NoAc_533 533.33 2 GGAK16R 41 532.83 533.83
MS2_G4R17_3Ac_y7_K16K12.2Ac_757 757.43 2 GK12acGGAK16acR 41 756.93 757.93
MS2_G4R17_3Ac_y7_K16K12.1Ac_760 760.46 2 GK12(ac?)GGAK16(ac?)R 41 759.96 760.96
MS2_G4R17_3Ac_y12_K16K12K8.3Ac_1211 1211.69 2 GGK8acGLGK12acGGAK16acR 41 1211.19 1213.19
MS2_G4R17_3Ac_y12_K16K12K8.2Ac_1214 1214.71 2 GGK8GLGK12GGAK16R_2Ac 41 1214.21 1216.21
MS3_G6R17_2Ac_b10_2Ac_867 867.47 2 GGK8acGLGK12acGGA 41 848.47 849.97
MS3_G6R17_2Ac_b10_1Ac_870 870.49 2 GGK8(ac?)GLGK12(ac?)GGA 41 851.99 852.99
 
 
 
 
 
Column Headers 
MS identifier: name of the MS identifier, containing MS scan type (MS1, MS2 or MS3); target peptide (first and last amino acid); PTM type and 
position (e.g. MS1_K9R17_K9me1: MS1 is sufficient to determine mono-methylation on lysine 9) and for MS2/MS3: y/b fragment ion assignment 
and m/z (e.g. MS2_K9R17_y7_K14ac_728: MS2 on K9R17 peptide that reports on y7 fragment ion (which has m/z of 728) is necessary to 
determine acetylation on lysine 14) 
theoretical m/z: theoretical mono-isotopic mass /charge 
charge state: charge state of MS identifier 
sequence: target peptide sequence 
retention time [min]: typical retention time in minutes 
XIC range [min/max]: mass/charge range used for chromatographic peak integration (minimal and maximal value). Note that for individual MS 
quantifier, the XIC range was adjusted to avoid integration of interfering peaks (e.g. MS1_K27R40_noPTM/1Ac: interfering peak at m/z = 523.79 at 
similar retention time) 
Abbreviations 
Kac  - lysine acetylation 
Kme1  - lysine mono-methylation 
Kme2  - lysine di-methylation 
Kme3  - lysine tri-methylation 
noPTM - peptide without PTM, hence all lysines are chemically (d3)-acetylated 
 
Table S2: Calculations to derive motif abundance from MS quantifier  
 
 
Motifs at histone H4  
 
H4.G4R17_noPTM = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 
 
 
H4.K5ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 * (1 -  
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
 ) 
 
 
 
H4.K8ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 *  
 
 
( 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
  - 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
  ) 
 
 
H4.K12ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 *  
 
( 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
  - 
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
   ) 
 
 
H4.K16ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 *   
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
   
 
 
 
H4.K5acK8ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 * 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _ , _ _ _ _ . _
  
 
 
H4.K5acK12ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 * 
 
 ((1 - 
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
 * 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
) –  
 
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
  - 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _ , _ _ _ _ . _
  ) 
 
 
H4.K5acK16ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 *(( 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
 * 
(
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
 -1 ) + 
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
  )) 
 
 
 
H4.K8acK12ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 * 
 
 
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
 * 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
) 
 
 
H4.K8acK16ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 * ((
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
 * 
 
(1 - -
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
) - 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _ , _ _ _ _ . _
  )) 
 
 
H4.K12acK16ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 *  
 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _ , _ _ _ _ . _
   
 
H4.K5acK8acK12ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 * (1 - 
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
  ) 
 
H4.K5acK8acK16ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 * 
 
 (
_ _ _ _ _
_ _ _ _ _ , _ _ _ _ _
  - 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
  ) 
 
 
H4.K5acK12acK16ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 *  
 
(
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
  - 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
 ) 
 
 
H4.K8acK12acK16ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
 * 
_ _ _ _ . _
_ _ _ _ . _ , _ _ _ _ . _
  
 
H4.K5acK8acK12acK16ac = 
_ _
_ _ , _ _ , _ _ _ _ _ _
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Motifs at histone H3 
 
H3.K9R19_noPTM  =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
	
	 _ _ , _ _ 	
      
 
 
H3.K9ac =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
	
	 _ _ , _ _ 	
      
 
*     _ _
	
_ _ , _ _
 
 
 
H3.K14ac =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
	
	 _ _ , _ _ 	
      
 
*     _ _
	
_ _ , _ _
 
 
 
 
H3.K9me1K14ac  =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
	
	 _ _ , _ _ 	
      
 
 
H3.K9me2K14ac  =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
 
	
	 _ _ , _ _ 	
      
 
 
 
H3.K9me3K14ac  =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
 
	
	 _ _ , _ _ 	
      
 
 
 
H3.K9me1  =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
	
	 _ _ , _ _ 	
      
 
 
H3.K9me2  =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
	
	 _ _ , _ _ 	
      
 
H3.K9me3  =   
_ _ 	
_ _ , _ _ , _ _ 	, _ _ , _ _ , _ _ , _ _ ,			
	
	 _ _ , _ _ 	
      
 
 
H3.K18R26_noPTM  =  
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.K18ac =  
_ _ 	
_ _ , _ _ , _ _ 			
     *     
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
      
 
 
H3.K23ac =  
_ _ 	
_ _ , _ _ , _ _ 			
     *     
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
      
 
 
H3.K18acK23ac =  
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.K27R40_noPTM =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.K27ac =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
     * 
 
 (1 – average ((
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
),( 
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
)) 
 
 
H3.K36ac =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
     * 
 
average ((
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
),( 
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
))   
 
* ( 
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
) 
 
 
 
H3.K37ac =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
     * 
 
average ((
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
),( 
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
))   
 
* (1 -  
_ _ _ _ 	
_ _ _ _ , _ _ _ _ 			
) 
 
 
 
H3.K27R40_K27me1 =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.K27R40_K27me2 =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
H3.K27R40_K27me3 =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.K27R40_K36me2 =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.K27R40_K36me3 =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.K27R40_K27me2K36me1 =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.K27R40_K27me2K36ac =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
 
H3.K27R40_K36me2K27ac =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
 
H3.K27R40_K36me3K27ac =  
_ _ 	
_ _ , _ _ , _ _ , _ _ , _ _ , _ _ , _ _ _ _ 			
      
 
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.E73R83_noPTM  =  
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
H3.E73R83.K79me1  =  
_ _ 	
_ _ , _ _ , _ _ 			
      
 
H3.E73R83.K79me2  =  
_ _ 	
_ _ , _ _ , _ _ 			
      
 
 
Supplementary Table 3:  LC‐MS response correction factor (LCF) 
 
H3 motif 
LCF 
(applied) 
LCF 
(measured) 
LCF (prior to 
Q tag 
normali-
sation) comment 
    
H3.K9K14_noPTM 1.5 ND ND 
estimation of applied 
LCF based on 
averaged K9ac/K14ac 
H3.K9me1 1.0  1.00  ±  0.12   1.00 ± 0.27   
H3.K9me2 7.0  6.84  ± 0.76 11.44 ± 4.00   
H3.K9me3 34.0 34.17 ± 4.28 50.49 ± 5.82   
H3.K9ac 1.5   1.46 ± 0.48   3.92 ± 0.71   
H3.K14ac 1.5   1.46 ± 0.17   1.62 ± 0.35   
H3.K9acK14ac 1.5   1.58 ± 0.17   2.26 ± 0.31   
    
H3.K18K23d3_noPTM 1.0 ND ND 
estimation of applied 
LCF based on 
averaged 
K18ac/K23ac 
H3.K18ac 1.0 1.23 ± 0.22 0.54 ± 0.05   
H3.K23ac 1.0 1.00 ± 0.09 1.00 ± 0.48   
H3.K18acK23ac 1.5 1.43 ± 0.24 0.51 ± 0.01   
    
H3.K27d3_noPTM 1 ND ND   
H3.K27me1 11 11.13 ± 2.49 15.84 ± 20.615 low quality Q tag signal
H3.K27me2 3  3.33 ± 0.61 1.79 ± 1.65   
H3.K27me3 4  4.18 ± 0.12 2.64 ± 2.36   
H3.K27ac 1 ND ND   
H3.K36me1 1      1 ± 0.25 1.00 ± 0.20   
H3.K36me2 1 1.06 ± 0.73 5.91 ± 0.69   
H3.K36me3 1 0.89 ± 0.02 1.51 ± 0.37 low quality Q tag signal
H3.K27me2K36me1 2 2.34 ± 1.03 7.82 ± 1.68   
    
H3.K79d3_noPTM 1 ND ND   
H3.K79me1 2 2.01 ± 0.03 1.49 ± 0.12   
H3.K79me2 1 1.00 ± 0.03 1.00 ± 0.09   
H3.K79me3 2 2.02 ± 0.00 1.67 ± 0.10   
 
Note: Shown are mean values from replicate experiments. Where applicable, SEM is shown. 
Table S4: Histone PTM inventory for KC and S2 cells 
motif 
%  
abun-
dance 
KC prior 
to LCF 
%  
abun-
dance 
KC 
Estimated 
molecules 
/ diploid 
female cell
%  
abun-
dance 
S2 
Estimated 
molecules 
/ diploid 
male cell 
% CV 
(tech.) 
% CV 
(bio.) 
H4.K5ac 3.44 
3.44 ± 
0.08 2.1E+05 
2.45 ± 
0.13 1.3E+05 1.92 6.66 
H4.K8ac 3.09 
3.09 ± 
0.20 1.8E+05 
3.15 ± 
0.37 1.6E+05 5.50 8.59 
H4.K12ac 7.27 
7.27 ± 
0.35 4.3E+05 
6.24 ± 
0.04 3.2E+05 2.23 6.70 
H4.K16ac 3.29 
3.29 ± 
0.12 2.0E+05 
8.44 ± 
0.06 4.4E+05 0.70 4.52 
H4.K5acK8ac 0.59 
0.59 ± 
0.05 3.5E+04 
0.58 ± 
0.05 3.0E+04 3.41 3.41 
H4.K5acK12ac 4.50 
4.50 ± 
0.30 2.7E+05 
2.89 ± 
0.23 1.5E+05 3.51 10.88 
H4.K8acK12ac 0.80 
0.80 ± 
0.09 4.8E+04 
1.14 ± 
0.45 5.9E+04 22.23 35.73 
H4.K8acK16ac 0.41 
0.41 ± 
0.07 2.5E+04 
0.58 ± 
0.35 3.0E+04 25.09 24.66 
H4.K12acK16ac 0.79 
0.79 ± 
0.04 4.7E+04 
1.48 ± 
0.12 7.7E+04 5.16 5.66 
H4.K5acK8ac 
K12ac 0.62 
0.62 ± 
0.06 3.7E+04 
0.55 ± 
0.04 2.8E+04 6.71 9.90 
H4.K5acK8ac 
K16ac 0.13 
0.13 ± 
0.01 7.6E+03 
0.19 ± 
0.01 9.6E+03 19.24 17.15 
H4.K5acK12ac 
K16ac 0.25 
0.25 ± 
0.03 1.5E+03 
0.45 ± 
0.04 2.3E+04 10.40 30.02 
H4.K8acK12ac 
K16ac 0.32 
0.32 ± 
0.04 1.9E+04 
0.49 ± 
0.04 2.5E+04 1.72 15.78 
H4.K5acK8ac 
K12acK16ac 0.30 
0.30 ± 
0.06 1.8E+04 
0.57 ± 
0.09 2.9E+04 21.58 9.66 
H3.K9ac 0.96 
0.41 ± 
0.04 2.5E+04 
0.21 ± 
0.01 1.1E+04 11.43 11.23 
H3.K14ac 25.63 
10.98 ± 
0.98 6.6E+05 
6.55 ± 
0.24 3.4E+05 14.30 1.79 
H3.K9acK14ac 1.10 
0.47 ± 
0.06 2.8E+04 
0.27 ± 
0.01 1.4E+04 16.86 12.94 
H3.K9me1K14ac 5.52 
1.60 ± 
0.21 9.5E+04 
1.49 ± 
0.08 7.7E+04 12.98 7.99 
H3.K9me2K14ac 1.93 
3.72 ± 
0.33 2.2E+05 
5.02 ± 
0.14 2.6E+05 19.82 7.69 
H3.K9me3K14ac 0.48 
4.44 ± 
0.31 2.6E+05 
5.48 ± 
0.84 2.8E+05 25.98 12.15 
H3.K18ac 2.41 
2.34 ± 
0.09 1.4E+05 
2.71 ± 
0.24 1.4E+05 2.18 4.00 
H3.K23ac 48.56 
47.19 ± 
0.83 2.8E+06 
44.99 
± 0.74 2.3E+06 1.25 3.48 
H3.K18acK23ac 5.76 
8.40 ± 
0.28 5.0E+05 
8.62 ± 
0.41 4.5E+05 3.96 4.42 
H3.K27ac 0.69 
0.20 ± 
0.03 1.2E+04 
0.25 ± 
0.04 1.3E+04 3.02 13.12 
H3.K36ac 0.20 
0.058 ± 
0.01 3.5E+03 
0.09 ± 
0.002 4.8E+03 7.42 10.98 
H3.K37ac 0.011 
0.003 ± 
0.0004 1.82E+02 
0.005 
± 
0.001 2.5E+02 17.53 18.80 
H3.K27ac 
K36me2 0.09 
0.026 ± 
0.004 1.5E+03 
0.03 ± 
0.01 1.4E+03 21.97 13.99 
H3.K27ac 
K36me3 0.26 
0.075 ± 
0.003 4.5E+03 
0.06 ± 
0.001 3.1E+03 2.44 26.60 
H3.K27me2 
K36ac 0.79 
0.22 ± 
0.05 1.3E+04 
0.55 ± 
0.04 2.8E+04 11.61 16.46 
H3.K9me1 10.42 
3.00 ± 
0.35 1.8E+05 
3.56 ± 
0.27 1.8E+05 10.85 10.22 
H3.K9me2 10.31 
19.98 ± 
1.63 1.2E+06 
20.01 
± 0.31 1.0E+06 33.79 8.06 
H3.K9me3 4.18 
38.60 ± 
2.16 2.3E+06 
44.9 ± 
1.75 2.3E+06 35.81 8.81 
H3.K27me1 7.14 
22.53 ± 
1.82 1.3E+06 
21.97 
± 0.67 1.1E+06 2.89 8.69 
H3.K27me2 41.69 
36.25 ± 
1.63 2.2E+06 
32.47 
± 0.17 1.7E+06 0.88 5.32 
H3.K27me3 29.29 
33.88 ± 
0.93 2.0E+06 
36.88 
± 0.71 1.9E+06 0.34 6.16 
H3.K36me2 1.18 
0.34 ± 
0.03 2.0E+04 
0.61 ± 
0.01 3.2E+04 4.85 11.68 
H3.K36me3 3.81 
1.10 ± 
0.08 6.6E+04 
1.55 ± 
0.01 8.0E+04 4.67 9.66 
H3.K27me2 
K36me1 3.59 
2.05 ± 
0.33 1.2E+05 
2.65 ± 
0.12 1.4E+04 20.54 11.76 
H3.K79me1 20.12 
33.46 ± 
0.86 2.0E+06 
35.67 
± 1.29 1.8E+06 3.92 7.50 
H3.K79me2 8.73 
7.26 ± 
0.49 4.3E+05 
6.66 ± 
0.06 3.4E+05 2.62 14.55 
H4.G4R17 
noPTM 74.04 
74.04 ± 
1.20 4.4E+06 
70.17 
± 0.95 3.6E+06 0.29 0.80 
H3.K9R17 
noPTM 39.48 
16.80 ± 
1.19 1.0E+06 
12.51 
± 0.71 6.5E+05 12.24 8.86 
H3.K14R26 
noPTM 43.27 
42.06 ± 
1.10 2.5E+06 
43.68 
± 0.84 2.3E+06 0.66 3.99 
H3.K27R40 
noPTM 11.20 
3.25 ± 
0.34 1.9E+05 
2.89 ± 
0.09 1.5E+05 0.99 11.33 
H3.E73R83 
noPTM 71.15 
59.28 ± 
1.14 3.5E+06 
57.66 
± 1.23 3.0E+06 3.71 4.81 
 
Notes 
- % CV for technical replicates (column 6) was derived from 3 whole-workflow 
replicates using 2 million KC cells 
- % CV for biological replicates (column 7) was derived from 5 biological replicates 
(using ‘C’ batch control RNAi dataset) 
- KC dataset: average of 6 biological ‘replicate batches’ (batch A-E and technical 
whole-workflow replicate); S2 dataset: average of 3 biological replicates. ‘±’ indicates 
SEM. For estimation of cellular copy number: see Suppl. Note 1.3. 
Supplementary Table 6: List of Drosophila melanogaster KATs and KDACs  
 
Putative KATs analysed in this study 
Name used 
in this 
study 
Nomenclature 
by Allis et al. Synonyms (D. mel, human) 
HAT1 KAT1   
GCN5 KAT2 hPCAF (KAT2A), hGCN5 (KAT2B) 
CBP KAT3 dNEJIRE (CG15319), hCBP (KAT3A), hP300 (KAT3B) 
TAF1 KAT4 TAF250 
TIP60 KAT5 PLIP (splice variant) 
KAT6 KAT6 dENOK, KAT6A (MYST3/MOZ), KAT6B (MYST4/MORF) 
HBO1 KAT7 dCHAMEAU, MYST2 
MOF KAT8 MYST1 
ELP3 KAT9   
ATAC2 KAT14* hCSRP2BP 
NAT6   CG8481, hFUS2 
NAT9   CG11539 
NAT10   CG1994, hALP, hKRE33 
NAA10   CG11989 (ARD1, VNC) 
NAA20   CG14222 
NAA30   CG11412 
NAA40   CG7593 
NAA50   SAN (CG12352), NAT5, MAK3 
NAA60   HAT4 
CG5783    
CG12560   
ECO   ESCO1/2 
MGEA5   OGA (CG5871), MEA5, NCOAT 
 
Putative KDACs analysed in this study 
Name used 
in this 
study 
Nomenclature 
by Allis et al Synonyms (D. mel, human) 
RPD3   CG7471, hHDAC1/2 
HDAC3   CG2128 
HDAC4   CG1770, hHDAC4/5/7/9 
HDAC6   dHDAC2 (CG6170), hHDAC10 
SIR2   CG5216, hSIRT1 
SIRT2   CG5085 
SIRT4   CG3187  
SIRT6   CG6284  
 
 
Putative KATs not analysed in this study 
Name  Comments 
CLOCK (CG7391) 
restricted expression pattern (preferentially late developmental stages), 
not expressed in KC cells 
CG31493 
restricted expression pattern (male accessory gland), not expressed in 
KC 
CG31730  restricted expression pattern (testis‐specific), not expressed in KC 
CG31851  restricted expression pattern (testis‐specific), not expressed in KC 
CG32319  restricted expression pattern (testis‐specific), not expressed in KC 
CG1894  restricted expression pattern, not expressed in KC cells 
CG17681  restricted expression pattern, not expressed in KC cells 
CG9486  restricted expression pattern, not expressed in KC cells 
CG15766  restricted expression pattern, not expressed in KC cells 
CG18607  restricted expression pattern, not expressed in KC cells 
CG34010  restricted expression pattern, not expressed in KC cells 
CG15628  restricted expression pattern, not expressed in KC cells 
CG14615  restricted expression pattern, not expressed in KC cells 
CG31248  restricted expression pattern, not expressed in KC cells 
CG10659  restricted expression pattern, not expressed in KC cells 
CG10476  restricted expression pattern, not expressed in KC cells 
CG18606  restricted expression pattern, not expressed in KC cells 
CG13759  restricted expression pattern, not expressed in KC cells 
DAT1 (CG3318)  Dopamine N acetyltransferase 
SAT1 (CG4210)  spermidine/spermine N1‐acetyltransferase 1 
GNPNAT1 (CG1969)  glucosamine‐phosphate N‐acetyltransferase 1 
 
Putative KDACs not analysed in this study 
Name  Comments 
HDAC11 (dHDAC‐X, 
CG31119)  restricted expression pattern, not expressed in KC cells 
SIRT7 (CG11305)  restricted expression pattern, not expressed in KC cells 
 
 
Notes 
- Column 2 indicates new nomenclature to histone lysine acetyltransferases according 
to: Allis, C.D., Berger, S.L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., 
Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007). New nomenclature for chromatin-
modifying enzymes. Cell 131, 633-636. 
- The name KAT14 was introduced after the initial publication by Allis et al. 2008 
(Suganuma, T., Gutierrez, J.L., Li, B., Florens, L., Swanson, S.K., Washburn, M.P., 
Abmayr, S.M., and Workman, J.L. (2008). ATAC is a double histone acetyltransferase 
complex that stimulates nucleosome sliding. Nature structural & molecular biology 15, 
364-372.) 
 
Supplementary Table 7: List of primers used in this study 
 
Primer used for RNAi 
primer name primer sequence comment 
GST_for 
TTAATACGACTCACTATAGGGAGAATGTCCCC
TATACTAG GTTA Feller et al. 2012 
GST_rev 
TTAATACGACTCACTATAGGGAGAACGCAT 
CCAGGCACATTG   
GFP_for 
TTAATACGACTCACTATAGGGTGCTCAGGTA
GTGGTTGTCG Regnard et al. 2011 
GFP_rev 
TTAATACGACTCACTATAGGGCCTGAAGTTCA
TCTGCACCA   
EGFP_for 
TTAATACGACTCACTATAGGGAGAACGTAAACGGC
CACAAGTTCAGC  
EGFP_rev 
TTAATACGACTCACTATAGGGAGATGCTGGTAGTG
GTCGGCGAG  
HAT1_1_for 
TAATACGACTCACTATAGGGACGAAAAGTACA
AGAACAACGA DRSC12298 
HAT1_1_rev 
TAATACGACTCACTATAGGGATCCATTTTCTT
CAAATCCTTTAAC   
HAT1_2_for 
TAATACGACTCACTATAGGGACATCTACTTGG
GCGTCGATT DRSC29235 
HAT1_2_rev 
TAATACGACTCACTATAGGGATCCACGAACC
ACAAGATGAA   
HAT1_3_for 
TAATACGACTCACTATAGGGGTATTCACCGTC
TTGCGTTG Next-RNAi 
HAT1_3_rev 
TAATACGACTCACTATAGGGATGAAAGGTCA
GGGCATCAT   
GCN5_1_for 
TAATACGACTCACTATAGGGAGCGAGATTCT
GAAGGAGCTG DRSC26932 
GCN5_1_rev 
TAATACGACTCACTATAGGGACACTGCATCAT
TTGTCCCAC   
GCN5_2_for 
TAATACGACTCACTATAGGGAATGAAATCGGT
GTCCGAGTC DRSC35936 
GCN5_2_rev 
TAATACGACTCACTATAGGGAATGTAGCCCG
CATAAACTGG   
CBP_1_for 
TAATACGACTCACTATAGGGACGGTGGAAAA
GTTGTCTGCT DRSC25087 
CBP_1_rev 
TAATACGACTCACTATAGGGAAATTCCTTTGC
TAATTGCCG   
CBP_2_for 
TAATACGACTCACTATAGGGAGTGGCAGTTA
GCCAACAGGT DRSC26774 
CBP_2_rev 
TAATACGACTCACTATAGGGAATTGGTCGATT
CATTACGGG   
TAF1_1_for 
TAATACGACTCACTATAGGGAGAACCAGAAG
CTTCAGCCAG DRSC36664 
TAF1_1_rev 
TAATACGACTCACTATAGGGATGCTGAGCGT
TACTTTGGTG   
TAF1_2_for 
TAATACGACTCACTATAGGGAGTCTGGGACG
GTAACGACAT DRSC36665 
TAF1_2_rev 
TAATACGACTCACTATAGGGACGTTGGGATC
CAAAGTGAGT   
TIP60_1_for 
TTAATACGACTCACTATAGGGACCTACAACTC
CGCAGACA DRSC18661 
TIP60_1_rev 
TTAATACGACTCACTATAGGGAGAACTCTGTC
ATTACGTAGAAG   
TIP60_2_for 
TTAATACGACTCACTATAGGGATTGGCAACTG
AAAAGAAGGG DRSC31332 
TIP60_2_rev 
TTAATACGACTCACTATAGGGAAAATGTTGAT
GACATGGGCA   
TIP60_3_for 
TAATACGACTCACTATAGGGCTTTATCAGCCA
AAACCCGA DRSC37670 
TIP60_3_rev 
TAATACGACTCACTATAGGGAAGCTACAACG
AAGCCAGGA   
KAT6_1_for 
TTTAATACGACTCACTATAGGGACGTCTAATG
AGGCAAAGAAAC DRSC04096 
KAT6_1_rev 
TTTAATACGACTCACTATAGGGACCGTTTTTG
CCACTTTAACC   
KAT6_2_for 
TTAATACGACTCACTATAGGGAGTATCGACTT
GTCGCCCAAT DRSC32736 
KAT6_1_rev 
TTAATACGACTCACTATAGGGAGGTGACGAG
CATGTAGAGCA   
HBO1_1_for 
TAATACGACTCACTATAGGGACATGCGAAGG
ACAAAACAG DRSC03341 
HBO1_1_rev 
TAATACGACTCACTATAGGGATTGTTATTCGC
CGGCTTAA   
HBO1_2_for 
TAATACGACTCACTATAGGGAGCTACAAAAAT
GGCCTTGGA DRSC24941 
HBO1_2_rev 
TAATACGACTCACTATAGGGAGTTTTCTCCTG
GCTGCTGAG   
MOF_1_for 
TTAATACGACTCACTATAGGGAGAATGTCTGA
AGCGGAGCTGGAAC Straub et al. 2005 
MOF_1_rev 
TTAATACGACTCACTATAGGGAGATTTCTGCT
TCTGCGGCTGC   
MOF_2_for 
TAATACGACTCACTATAGGGCTATGACTACAG
CGACCGCA  
MOF_2_rev 
TAATACGACTCACTATAGGGCAGCGACTTCTT
TTCCTTGG  
ELP3_1_for 
TAATACGACTCACTATAGGGAACAGCAGCGC
CAATGTG DRSC00448 
ELP3_1_rev 
TAATACGACTCACTATAGGGATGGTACAAGG
GCCAAAATCT   
ELP3_2_for 
TAATACGACTCACTATAGGGACGGCCTAAAG
ATCTATCCCA Next-RNAi 
ELP3_2_rev 
TAATACGACTCACTATAGGGCGCACCTTGTT
GTGGATTT   
ATAC_1_for 
TTAATACGACTCACTATAGGGAGTTTGGAAAG
CGATGATTTTAC DRSC02053 
ATAC_1_rev 
TTAATACGACTCACTATAGGGACTAGGAATG
GCCATGTCATC   
ATAC_2_for 
TTAATACGACTCACTATAGGGACGCAAGAGG
CAAACGAAAGCA Next-RNAi 
ATAC_2_rev 
TTAATACGACTCACTATAGGGAGCCGCACAT
AGGCAGGTATGGA   
NAT6_1_for 
TAATACGACTCACTATAGGGACCTAATCAACG
CAGAGTGG DRSC16429 
NAT6_1_rev 
TAATACGACTCACTATAGGGAGCGTTCGTAG
AATCCATCC   
NAT6_2_for 
TAATACGACTCACTATAGGGATATCTGTCCAC
CATCGACCA DRSC28038 
NAT6_2_rev 
TAATACGACTCACTATAGGGAGAGGCAATCA
CACATGCACT   
NAT9_1_for 
TAATACGACTCACTATAGGGAGCCCAAGTAC
CACGAGTG DRSC14325 
NAT9_1_rev 
TAATACGACTCACTATAGGGACAGCCAGTTG
ATCCAATCTG   
NAT10_1_for 
TAATACGACTCACTATAGGGGTATTTGGTATT
CATGGCCAGT DRSC18198 
NAT10_1_rev 
TAATACGACTCACTATAGGGCCTTCTTGCCCC
TGCCC   
NAT10_2_for 
TAATACGACTCACTATAGGGTGCTGAAGAAC
AAGTCCGTG DRSC35809 
NAT10_2_rev 
TAATACGACTCACTATAGGGAAAATTTCGCCA
ACAACTGG   
NAA10_1_for 
TAATACGACTCACTATAGGGACCATGCAGCA
CTGCAATC DRSC09867 
NAA10_1_rev 
TAATACGACTCACTATAGGGACCATGTCCGC
CGGATCT   
NAA10_2_for 
TAATACGACTCACTATAGGGGCTGCCCTGAA
CCTCTACAC Next-RNAi 
NAA10_2_rev 
TAATACGACTCACTATAGGGAATGGCCTTCAA
ACCCTTTA   
NAA20_1_for 
TAATACGACTCACTATAGGGAACCACGTTGC
GACCCTT DRSC19579 
NAA20_1_rev 
TAATACGACTCACTATAGGGAGAAATGTCCTC
CAGGAAACTC   
NAA20_2_for 
TAATACGACTCACTATAGGGGAGAAAGGCCT
TATCCAGGG DRSC38508 
NAA20_2_rev 
TAATACGACTCACTATAGGGGTGGTTATTTAC
GCATCGGC   
NAA30_1_for 
TAATACGACTCACTATAGGGACCAAAAGTGTC
GGAGGATGT DRSC23214 
NAA30_1_rev 
TAATACGACTCACTATAGGGACCACGTACTG
ATTGTCGTGC   
NAA30_2_for 
TAATACGACTCACTATAGGGAAATCGAGATC
GGATTGATCG DRSC30080 
NAA30_2_rev 
TAATACGACTCACTATAGGGATTTGGATTGTG
ATTGGGGTT   
NAA40_1_for 
TAATACGACTCACTATAGGGAAAGAATCCCCT
CGAATCTCT DRSC16265 
NAA40_1_rev 
TAATACGACTCACTATAGGGAGATCTCGTCCT
TGACGTAG   
NAA50_1_for 
TAATACGACTCACTATAGGGAAGCAGCATCG
AACTGGG DRSC07695 
NAA50_1_rev 
TAATACGACTCACTATAGGGATGTCGAAGTTT
CCGTCCTT   
NAA50_2_for 
TAATACGACTCACTATAGGGAAACGATAACTT
GCGACCTGC DRSC31317 
NAA50_2_rev 
TAATACGACTCACTATAGGGACTGCAGTCAC
AATCCTCCAA   
NAA60_1_for 
TAATACGACTCACTATAGGGAAGCTGTGCCA
AGAATGGTT DRSC10301 
NAA60_1_rev 
TAATACGACTCACTATAGGGACTCTTCTCGTA
GAAAAATATGG   
NAA60_2_for 
TAATACGACTCACTATAGGGAATTCCACCACC
TCTGTCGTC DRSC26416 
NAA60_2_rev 
TAATACGACTCACTATAGGGAAGCTTGTGGTA
GAACCACCG   
NAA60_3_for 
TAATACGACTCACTATAGGGGCAAAGAACAA
CATCAAAGGC Next-RNAi 
NAA60_3_rev 
TAATACGACTCACTATAGGGTAGAAACAGCG
AACGGGATT   
CG5783_1_for 
TAATACGACTCACTATAGGGAACAAGGCGGC
TACTTGG DRSC02894 
CG5783_1_rev 
TAATACGACTCACTATAGGGACTCGGGCCAT
GTGAACTG   
CG5783_2_for 
TAATACGACTCACTATAGGGAGCCTTGTTGG
AAAAGCTCTG DRSC35394 
CG5783_2_rev 
TAATACGACTCACTATAGGGAAATCCAACACT
GACGCACAG   
CG12560_1_for 
TAATACGACTCACTATAGGGAGATTGGATCC
CTGGGTCTG DRSC02174 
CG12560_1_rev 
TAATACGACTCACTATAGGGAGCAGCCCAGT
ATGTATTGTC   
ECO_1_for 
TAATACGACTCACTATAGGGACAACCTCCCG
TCCACTATT DRSC11006 
ECO_1_rev 
TAATACGACTCACTATAGGGACGCTGGCCCG
GATGTT   
ECO_2_for 
TAATACGACTCACTATAGGGACGGTCCAGAA
ATCCCCAAC VDRC13980 
ECO_2_rev 
TAATACGACTCACTATAGGGAGGTCGTCTCC
TCCGCATCAA   
MGEA5_1_for 
TAATACGACTCACTATAGGGACAGCCCCAGG
TTTCTCTTC DRSC15901 
MGEA5_1_rev 
TAATACGACTCACTATAGGGAGAGAGCCAAG
CGTGGGT   
MGEA5_2_for 
TAATACGACTCACTATAGGGAGGACGAACAG
CAAGTCAAC derivative of VDRC10644 
MGEA5_2_rev 
TAATACGACTCACTATAGGGATGGAGGGTGG
CGAGGAGGT   
RPD3_1_for 
TTAATACGACTCACTATAGGGAGGAGGAGGC
GTTCTATACC DRSC08696 
RPD3_1_rev 
TTAATACGACTCACTATAGGGAGACTAATGTG
CAGCTTAAAATC   
RPD3_2_for 
TTAATACGACTCACTATAGGGATCCTCTTCGC
GAATTTGTCT DRSC32186 
RPD3_2_rev 
TTAATACGACTCACTATAGGGACGCTTTTTGC
TGTGAGACTG   
RPD3_3_for 
TAATACGACTCACTATAGGGCGCCAAGGAGA
ACAACATTT DRSC37634 
RPD3_3_rev 
TAATACGACTCACTATAGGGCCACATTGGATC
GCTTGTAA   
HDAC3_1_for 
TTAATACGACTCACTATAGGGACGGGCGGAC
TGCATCA DRSC12352 
HDAC3_1_rev 
TTAATACGACTCACTATAGGGAACCGCCTCC
GACCACC   
HDAC3_2_for 
TTAATACGACTCACTATAGGGACGAGGATTTG
GTCCACAACT DRSC32474 
HDAC3_2_rev 
TTAATACGACTCACTATAGGGATCATTTTCTT
GTGCAGTCCG   
HDAC3_3_for 
TAATACGACTCACTATAGGGCTTCCACAGCG
ACGAGTACA DRSC32475 
HDAC3_3_rev 
TAATACGACTCACTATAGGGTGGTTGTGGTTC
AGCTTCTG   
HDAC4_1_for 
TAATACGACTCACTATAGGGATGAGCACACTA
TACGCCAGC DRSC25237 
HDAC4_1_rev 
TAATACGACTCACTATAGGGAAAATCGATAAC
ACAACCGGC   
HDAC4_2_for 
TAATACGACTCACTATAGGGAATATCGCTGCA
TTCCGTACC DRSC37980 
HDAC4_2_rev 
TAATACGACTCACTATAGGGAGTTGATCGTCT
CGGACTCGT   
HDAC6_1_for 
TAATACGACTCACTATAGGGAGGATAATCGTT
TGCCTGGAA DRSC29348 
HDAC6_1_rev 
TAATACGACTCACTATAGGGATCGCTGAGCG
TTTTTACCTT   
HDAC6_2_for 
TAATACGACTCACTATAGGGAATGACGCTGC
TGGGATCTAC DRSC38396 
HDAC6_2_rev 
TAATACGACTCACTATAGGGAATGTTCACATT
GAAGCCCCT   
SIR2_1_for 
TAATACGACTCACTATAGGGAGGATGAGTAC
CACACGGTC DRSC03435 
SIR2_1_rev 
TAATACGACTCACTATAGGGAAACGCTTTCCA
CAGCTAAAA   
SIR2_2_for 
TAATACGACTCACTATAGGGAAGGATGAGGA
CTCCAGCTCA DRSC36016 
SIR2_2_rev 
TAATACGACTCACTATAGGGAGCTCCCGTTA
GCACAATGAT   
SIRT2_1_for 
TAATACGACTCACTATAGGGATCTGGACTACT
TCGAAAAGAA DRSC15714 
SIRT2_1_rev 
TAATACGACTCACTATAGGGACCACTGCATC
GCGATTG   
SIRT2_2_for 
TAATACGACTCACTATAGGGAAGTACGAGCT
GCCACATCCT DRSC26964 
SIRT2_2_rev 
TAATACGACTCACTATAGGGACAGATCGCAAT
CCTGGAAAT   
SIRT4_1_for 
TAATACGACTCACTATAGGGAAAGGCGTGGG
CCTCTAC DRSC18290 
SIRT4_1_rev 
TAATACGACTCACTATAGGGATCCAGCGGTA
TCTCTACATC   
SIRT4_2_for 
TAATACGACTCACTATAGGGAGGCTATGTGG
TCAAGTGCCT DRSC27472 
SIRT4_2_rev 
TAATACGACTCACTATAGGGACGGAGAAGAC
CAGGAGACTG   
SIRT6_1_for 
TAATACGACTCACTATAGGGAATTGCACGGC
AACATTTACA DRSC29965 
SIRT6_1_rev 
TAATACGACTCACTATAGGGATTGCTTGTGG
GTATTGTCCA   
NSL1_1_for 
TTAATACGACTCACTATAGGGAGCGTCCGAG
CTCAACCTTC Feller et al. 2012 
NSL1_1_rev 
TTAATACGACTCACTATAGGGACACATGGGT
GTGTTCATTAGTC Feller et al. 2012 
NSL1_2_for 
TTAATACGACTCACTATAGGGAGATGTCGCAT
CAAAGTCAGAGG Feller et al. 2012 
NSL1_2_rev 
TTAATACGACTCACTATAGGGAGACTCGAGA
AGAGCTCGCTGAT Feller et al. 2012 
NSL1_3 for 
TTAATACGACTCACTATAGGG 
AGATGGCCCCAGCGCTCACA Raja et al. 2010 
NSL1_3 rev 
TTAATACGACTCACTATAGGGAGATGAACTTG
TGGCCACTGCC Raja et al. 2010 
MSL1_for 
TTAATACGACTCACTATAGGGAGAATGGAC 
AAGCGATTCAAG     
MSL1_rev 
TTAATACGACTCACTATAGGGAGACTTCGC 
TGGTTCTTTCG   
HeLa_luciferase CUUACGCUGAGUACUUCGA 
gift from Sandra Hake, LMU 
Munich 
HeLa_control1 AAUUCUCCGAACGUGUCAC 
gift from Sandra Hake, LMU 
Munich 
hMOF1 GUGAUCCAGUCUCGAGUGA Taipale et al. 2005 
hMOF2 UGCUGUACAGAAGAACUC Smith et al. 2005 
hMOF3 GGAAAGAGAUCUACCGCAA 
designed using Dharmagon 
siDesignCenter 
 
 
Primer used for RT-qPCR 
primer name primer sequence 
gapdh_cDNA_for GTGACCTACGCAGAAAGCTAG 
gapdh_cDNA_rev GCTATTACGACTGCCGCTTTTTC
HAT1_1_cDNA_for CTTTCCAGAAACTCGGCTTG 
HAT1_1_cDNA_rev TCCTCAGATGGATCCTCCAC 
HAT1_2_cDNA_for TATTCACCGTCTTGCGTTGT 
HAT1_2_cDNA_rev CTTTTTGCAGGCGTTCTAGC 
GCN5_cDNA_for GCCTGCGGATGTAGTAATGC 
GCN5_cDNA_rev CGCGACACATTAACCGGAAA 
CBP_1_cDNA_for GCGGCGGTAAGGATAACATA 
CBP_1_cDNA_rev TGGGTTTTATGTCCACAGCA 
TAF1_1_cDNA_for GAGGTAACGATGGCAAGGAA 
TAF1_1_cDNA_rev TTGCGAACTGCTTGATGAAC 
TAF1_2_cDNA_for GGGCGTTAAAAGGGAGGAT 
TAF1_2_cDNA_rev GTCCTCGGATAACTCGGTGA 
TIP60_1_cDNA_for TGTCTGATCTGGGTTTGCTG 
TIP60_1_cDNA_rev CGGGTTTTGGCTGATAAAGA 
TIP60_2_cDNA_for TTTCTCACCCTATCCGCAAG 
TIP60_2_cDNA_rev GCACTTCCTGCTCTTCCTGT 
KAT6_cDNA_for TTGCGGAGACAGTATTGCAG 
KAT6_cDNA_rev TCCGGCGAAAGCTTTAAGTA 
HBO1_1_cDNA_for AGATATACCGCAAGGGCAAA 
HBO1_1_cDNA_rev CAGGCACAGATGCTGACAGT 
HBO1_2_cDNA_for AGCCGAGCTCATCTCCATAA 
HBO1_2_cDNA_rev AGCCAAGAATTCGTCATCGT 
MOF_1_cDNA_for AGAAGGAGGACGGTCAGGAT 
MOF_1_cDNA_rev TCCACCACCTCTTTCTGCTT 
MOF_2_cDNA_for CTGGGTAGGCTGAGCTATCG 
MOF_2_cDNA_rev TTTCGCTCAGCTCCTTGATT 
ELP3_1_cDNA_for AGTGCATTGGCATCACCATA 
ELP3_1_cDNA_rev CTTCGTAAACCGATTGCACA 
ELP3_2_cDNA_for TTCGGTATGTTGCTGATGGA 
ELP3_2_cDNA_rev TAGTTTCTGGTGCCCACTCC 
ATAC2_1_cDNA_for ATGACATGGCCATTCCTAGC 
ATAC2_1_cDNA_rev CTGATGCTCCAGTGCGAATA 
ATAC2_2_cDNA_for AAAGGATACCTTGGCTGCTG 
ATAC2_2_cDNA_rev AGAATCCATGGTGTCCCAAG 
NAT6_cDNA_for TTTGTGCTCTCACACGGAAC 
NAT6_cDNA_rev CGACGAAGTGAACAGAACGA 
NAT9_cDNA_for GGAGATCTTCCACGAGGTCA 
NAT9_cDNA_rev CACTGCATACGCAGATCCAC 
NAT10_1_cDNA_for ACGCCCTGTTTTCGTATCAC 
NAT10_1_cDNA_rev TGCAAATCGTTTGGTGTGTT 
NAT10_2_cDNA_for CAGTCCTCGGACGAACCTAC 
NAT10_2_cDNA_rev AACCGTTTCCACAGTTCGAG 
NAA10_1_cDNA_for TCTGGAAGGCGTTTCTATCG 
NAA10_1_cDNA_rev GATGATCCCAAGCAAGTGGT 
NAA10_2_cDNA_for TTAGAATGTCCCTGCAAACG 
NAA10_2_cDNA_rev CAAAATAATTGCTGCGACGA 
NAA20_1_cDNA_for GATCTGCCCGGTGATAACAT 
NAA20_1_cDNA_rev GGGAAATAATGCACGCAAAT 
NAA20_2_cDNA_for CTATTGCCGGCGAGTATAGC 
NAA20_2_cDNA_rev GTCGCAACGTGGTCATCTTA 
NAA30_cDNA_for AAGCCCATAACAGCCACAAG 
NAA30_cDNA_rev CACAGCTACATCCTCCGACA 
NAA40_1_cDNA_for AAGAACTGGGCTCGCTACTT 
NAA40_1_cDNA_rev GATCCATGTCGAAGCGGAAC 
NAA40_2_cDNA_for GGCTACGTCAAGGACGAGAT 
NAA40_2_cDNA_rev TCAGCTTAGCATCGATTTGC 
NAA50_1_cDNA_for CGGCGCCTGTATATCATGAC 
NAA50_1_cDNA_rev CGGCGAAGTTCATAATGTGC 
NAA50_2_cDNA_for CGCGAACTCAAATTCACGTA 
NAA50_2_cDNA_rev GCCGCCTCTACATGTCTGTT 
NAA60_1_cDNA_for AATCGTTGCCGAAATCAAAC 
NAA60_1_cDNA_rev CTTGTCCTGCATGGGAAAAC 
NAA60_2_cDNA_for CAAAAACACGCACCAAACTG 
NAA60_2_cDNA_rev TTAAGCGCGAAATCTTGTCC 
CG5783_1_cDNA_for TTGGCAGTGTGGTGACTAGG 
CG5783_1_cDNA_rev CATCTCCGATGACGGCTTAT 
CG5783_2_cDNA_for TACAAGCAAAACTGGCCAAA 
CG5783_2_cDNA_rev ATTCCTCATATGGGGCTGTT 
CG12560_1_cDNA_for GAGCGAAAATTTGGATCGAG 
CG12560_1_cDNA_rev CGCGTAGAAAACCCAAAGAA 
CG12560_2_cDNA_for ATACGGATCCCCAAGGCTAT 
CG12560_2_cDNA_rev AGTCGCCATTCAACGATAGG 
ECO_1_cDNA_for GTGGAGAAGCGGTCACAAAG 
ECO_1_cDNA_rev AATAGTGGACGGGAGGTTGG 
ECO_2_cDNA_for GAGATCGCTAGGGAGTGCAT 
ECO_2_cDNA_rev GAAGTTATCCAACCCGGTGA 
MGEA5_1_cDNA_for GTACACGGAACTGCGTGAGA 
MGEA5_1_cDNA_rev AAGGGAGGTGACGAGCTGTA 
MGEA5_2_cDNA_for CCTGTTCTATCTGCCCTTCG 
MGEA5_2_cDNA_rev ACATTAGCGTTGCCCTTCAG 
RPD3_1_cDNA_for GTGCCCATTATCAGCAAGGT 
RPD3_1_cDNA_rev TGACGGTGAGATTGAAGCAG 
RPD3_2_cDNA_for GCGAAGATTGTCCCGTCTTC 
RPD3_2_cDNA_rev ATTCAGTTTTACGGCCGCAG 
HDAC3_1_cDNA_for CACGGGAGACATGTACGAGA 
HDAC3_1_cDNA_rev TGGTCATCAATGCCCTCCTT 
HDAC3_2_cDNA_for GATGGCCTCTTCGACTTCTG 
HDAC3_2_cDNA_rev TATGTCGCTGTGGTTGTGGT 
HDAC4_1_cDNA_for CGGACATTGTGCTGGTATCC 
HDAC4_1_cDNA_rev GTCATGAACCCAAAGCAGGC 
HDAC4_2_cDNA_for AATAGAAGGCGATGCAGACG 
HDAC4_2_cDNA_rev TCCCACTCTACCAGGTCCAC 
HDAC6_1_cDNA_for ATTCGGGATTTCGGTCTGGA 
HDAC6_1_cDNA_rev TGGACTCGAAAATGTGCTGC 
HDAC6_2_cDNA_for CGCCACTAAGGCACCTAATC 
HDAC6_2_cDNA_rev CTCAGTGGGCCAGGAAGTAG 
SIR2_1_cDNA_for CTGTGCTGCGATGAGTCAGT 
SIR2_1_cDNA_rev GTGGCGGTGGTGAAGTAGAT 
SIR2_2_cDNA_for ATACACTCGCACCCACATCA 
SIR2_2_cDNA_rev ATTTCAAACACGCACACCAA 
SIRT2_1_cDNA_for GGATTTCAGATCCCCAGGTT 
SIRT2_1_cDNA_rev GATCGAATATGGCCGTAGGA 
SIRT2_2_cDNA_for TGTCAACTTCGGGACATGAA 
SIRT2_2_cDNA_rev GCAGCTGAAACTGCAACAAA 
SIRT4_1_cDNA_for TGAAGCCGGAAATTGTCTTC 
SIRT4_1_cDNA_rev GGCCATCGCTATTGTACACC 
SIRT4_2_cDNA_for CGTGCGCTCACCTCTAGTAA 
SIRT4_2_cDNA_rev CCCACACGCATTGTTTTGT 
SIRT6_1_cDNA_for ATTGCACGGCAACATTTACA 
SIRT6_1_cDNA_rev ACGTTGCAGGGATTTTTGAC 
SIRT6_2_cDNA_for TGTGGATGTGGTTTTGTCCA 
SIRT6_2_cDNA_rev GGCTTGGACTGCTTTGTAGG 
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3.4.4 Discussion on substrate specificity of lysine acetyltransferases using the examples 
of HAT1 and HBO1 
For many lysine acetyltransferases, there is no consensus with regard to their histone target sites. As 
described before (section 2.3.1), most KATs function in the context of multi-subunit protein 
complexes, where accessory subunits are often required for a robust KAT activity and specificity 
towards distinct sites. This strong dependency on co-factors complicates the ability to measure the 
substrate specificity in vitro, which necessitates well-defined reconstituted systems matching closely 
the in vivo observed stoichiometries and protein modifications. The observed specificities vary 
strongly when using different substrates, such as histones, octamers or nucleosomes and when 
performing the reactions with different KAT sub-complexes (Grant et al., 1999; Morales et al., 2004; 
Lee and Workman, 2007).   
Previous studies characterizing the in vivo specificity to a given KAT often appear controversial. This 
may be attributed to different cellular contexts or technical limitations. Most of our current knowledge 
of KAT – substrate relationships is based on characterizations using antibodies. Antibodies raised 
against specific histone acetylation sites may show substantial lot-to-lot variations and have often been 
associated with substantial cross-reactivity (Egelhofer et al., 2011; Fuchs et al., 2011; Nishikori et al., 
2012; Rothbart et al., 2012). Moreover, in the most cases, only a few putative histone target sites were 
tested. This hampers the overall comparability between individual studies and makes it difficult to 
arrive at a comprehensive conclusion. Using the examples of HAT1 and HBO1, I discuss below the 
reported substrate specificities for these enzymes and how this relates to the data presented in section 
3.4.2. 
 
HAT1 not only di-acetylates lysines 5 and 12 on H4 to promote nuclear import of histones but it also 
contributes to H3 lysine 27 acetylation, which may provide links to its nuclear function on DNA 
repair, histone turnover and transcription. 
Histone acetyltransferase 1 (HAT1) is considered to be the main cytosolic histone lysine 
acetyltransferase (Verreault et al., 1996) and the only known KAT that generates a combinatorial 
histone PTM. Di-acetylation on lysines 5 and 12 on the newly synthesised histone H4 molecules by 
HAT1 promotes their association as H3/H4 dimers with chaperones and their subsequent nuclear 
import and chromatin assembly (Parthun, 2012). Although newly synthesised histones are marked by 
H4.K5acK12ac in most species (Ruiz-Carrillo et al., 1975; Chicoine et al., 1986; Sobel et al., 1995), it 
is less well understood how HAT1 produces this combinatorial mark and whether there are additional 
HAT1 target sites on histones. Moreover, recent studies link HAT1 to nuclear functions including 
DNA repair (Parthun, 2012) yet whether this involves different histone targets remains elusive. 
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In this study, we confirm that HAT1 is the major KAT responsible for H4.K5acK12ac. Moreover, we 
identify putative novel targets on H4 (K5ac, K5acK8acK12ac) and H3 (K27ac, K27acK36me2). 
Reduction of mono-acetylated K5 on histone H4 (H4.K5ac) is unexpected, because the majority of in 
vitro studies using recombinant HAT1 identified its main activity towards H4.K12 (Kleff et al., 1995; 
Parthun et al., 1996; Verreault et al., 1996; Dose et al., 2011). Interestingly, our observation on the 
reduction of H4.K5ac is well in line with early studies, which showed that the cytoplasmic HAT-B 
activity purified from the cytoplasm or micronuclei of Tetrahymena produces di-acetylated H4 by first 
acetylating K5 and subsequently K12 (Richman et al., 1988). In addition, our observation of reduced 
tri-acetylated H4.K5acK8acK12ac is consistent with the finding that the HAT-B activity from pie 
converts non-modified H4 into mono-acetylated, di-acetylated and tri-acetylated H4 isoforms 
(Mingarro et al., 1993). Moreover, newly synthesised histones complexed within chaperones or 
immunoprecipitated with HAT1 contain acetylated K8 but not K16 in addition to acetylated K5 and 12 
(Verreault et al., 1996; Yang et al., 2013).  
Mechanistic insights into the specificity towards the di-acetylation H4.K5acK12ac by HAT1 came 
from a series of structural and biochemical studies. Modeling the histone peptides into the crystal 
structure of HAT1 suggested that lysines 8 and 16 must remain unmodified and positively charged to 
electrostatically stabilise the acidic patch within the active site of the enzyme (Dutnall et al., 1998). 
This prediction was verified by a series of in vitro acetyltransferase assays comparing a set of pre-
acetylated histone peptides as substrates: H4 peptides di-acetylated at lysines 8 and 16 abrogated the 
KAT activity almost as efficient as di-acetylated peptides at lysines K5 and 12. In contrast, peptides 
mono-acetylated at K5 or K8 but not K12 qualified as substrates almost as efficient as the unmodified 
peptide (Makowski et al., 2001; Benson et al., 2007). These mechanistical experiments together with 
the in vivo results presented before (Yang et al., 2013) and our data suggest that after the initial 
acetylation of H4.K5, HAT1 either releases its substrate (unprocessive mode) or further modifies it to 
its major product, the di-acetylated H4.K5acK12ac. However, a minor fraction of H4.K5acK12ac is 
likely not relased until it is further processed to tri-acetylated H4.K5acK8acK12ac. 
Grunstein and colleagues challenged the paradigm that di-acetylated H4.K5acK12ac is required for 
nuclear import and proper chromatin assembly. Analysing sets of yeast histone mutants, they 
concluded that only mutants with lysine to glycine substitutions at three (K5, K8, K12) or four (K5, 
K8, K12, K16) H4 lysine positions impaired yeast viablility and chromatin maturation (Ma et al., 
1998). These findings indicate that other histone marks may contribute to the initial setup of chromatin 
– particular if the default system via H4.K5acK12ac is disturbed. In line, we observe that HAT1 RNAi 
provokes an increase of the H4 di-acetylation motif H4.K8acK16ac and several H3 acetylation motifs 
(most of them are not statistically significant, including H3.K9ac, H3.K9me2K14ac and 
K27acK36me3).  It is interesting to note that the H4.K8acK16ac peptide, which efficiently inhibited 
HAT1 activity in vitro (Makowski et al., 2001), is upregulated after HAT1 deprivation. Similarly, 
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yeast genetic experiments with histone mutants suggested that some phenotypes with H4 tail deletion 
or lysine point mutations can be rescued by manipulating the charge distribution on histone H3 
(Shahbazian and Grunstein, 2007). Moreover, acetylated H3.K14ac and H3.K23ac have been observed 
at cytoplasmic histones and as part of chaperone complexes (Jackson et al., 1976; Sobel et al., 1995; 
Tyler et al., 1999). It is tempting to speculate that in the absence of the default H4.K5acK12ac nuclear 
import signal, a compensatory system uses other H4 di-acetylation motifs or H3 acetylation motifs to 
serve as a backup strategy. 
While the cytoplasmic function of HAT1 is well described, recent attention has been devoted to its 
nuclear function. HAT1 is pre-dominantly found in the nucleus (Verreault et al., 1998; Poveda et al., 
2004; Yang et al., 2013), where it may contribute to ensure proper chromatin assembly by regulating 
the histone turnover in the wake of the DNA repair machinery (Qin and Parthun, 2002; Verzijlbergen 
et al., 2011; Yang et al., 2013). Our observation of reduced H3.K27ac, which is considered to be a 
hallmark of active enhancers, may point to a novel function of HAT1 in transcriptional regulation. 
This is further supported by the observation that cells depleted for HAT1 show reduced levels of 
histone methyl marks associated with active transcription (H3.K36me2/3) and an increase of the 
repressive mark H3.K27me3.  
 
dHBO1/Chameau: The finding that dHBO1 is responsible for most mono-acetylated H4.K12ac and 
the combinatorial motifs H4.K8acK12ac and H3.K9me3K14ac may contribute to resolve the long-
standing controversy whether HBO1 acetylates H3 or H4.  
Published reports on HBO1 are controversial with respect to its histone acetylation targets, its role on 
DNA replication and cell growth and its capacity to promote or repress transcription. Our finding that 
dHBO1 is responsible for most mono-acetylated H4.K12ac and the combinatorial marks 
H4.K8acK12ac and H3.K9me3K14ac may contribute to resolve some of the long-standing 
controversies for HBO1’s histone targets. In addition, we did not observe a significant change in the 
cell cycle or cell number, suggesting that dHBO1 is not required for proper maintenance of the cell 
cycle, DNA replication and cell growth in Drosophila KC cells.  
HBO1 was initially described as Histone acetyltransferase Binding to ORC with acetyltransferase 
activity to histones H3 and H4 (Iizuka and Stillman, 1999). However, most reports following its 
original description characterised HBO1 as either i) the major acetyltransferase responsible for histone 
H4 acetylation, ii) the major acetyltransferase for lysine 5, 8 and 12 yet not 16 on histone H4, iii) the 
major histone H3 acetyltransferase or iv) the major KAT for H3.K14ac (Doyon et al., 2006; Foy et al., 
2008; Wu and Liu, 2008; Miotto and Struhl, 2010; Kueh et al., 2011; Mishima et al., 2011; Havasi et 
al., 2013). Moreover, individual studies reported significant reduction of H3.K9ac or H3.K23ac while 
the beforehand mentioned sites remain largely unaffected (Hung et al., 2009; Saksouk et al., 2009; 
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Lalonde et al., 2013). In particular the immuno blot experiments that showed a global loss of histone 
H4 acetylation using pan-acetyl H4 antibodies are somewhat surprising taking into account that more 
than 70% of histone H4 acetylation in most human and murine cells is on position lysine 16. Notably, 
most of the mentioned reports stressed that ablation of HBO1 reduces acetylation on either H3 or H4. 
For example, Kueh et al used immuno blotting to demonstrate that hbo1 knockout mouse primary 
fibroblasts have greatly diminished H3.K14ac levels, which are accompanied by a strong increase in 
H4.K16ac and a moderate increase in H4.K5ac and H3.K9ac (Kueh et al., 2011). In contrast, Miotto 
and Struhl also used immuno blotting yet they reported that HeLa cells depleted for HBO1 show 
massively decreased acetylation on lysines 5,8 and 12 on H4, while acetylation at H4K16 and H3 stay 
almost constant (Miotto and Struhl, 2010). Although recently Cote and colleagues suggested that 
HBO1 co-exists in two different complexes in HeLa cells – where the HBO1-JADE complex 
acetylates H4 while the HBO1-BRPF1 complex acetylates H3.K23ac (and to a lesser extent 
H3.K14ac, (Lalonde et al., 2013) – others observed different putative target sites and no concomitant 
reduction of H3 and H4 acetylation in HeLa cells depleted for HBO1 (Iizuka et al., 2009; Miotto and 
Struhl, 2010).  
To my knowledge, there are only two studies which directly addressed the acetylation target sites of 
the Drosophila homologue to HBO1, Chameau: McConnell and colleagues reported that Chameau and 
CBP are required together to reduce H4.K12ac in Drosophila ovaries, whereas the individual KAT 
mutants did not affect histone acetylation levels (McConnell et al., 2012). In contrast, Miotto et al. 
reported an increase of H4K16ac on a reporter gene in HEK293 cells when Drosophila Chameau is 
targeted to it (Miotto et al., 2006).   
We found that depleting dHBO1 (Chameau) in female KC cells or mutating dHBO1 in male flies 
(unpublished preliminary results) reduced acetylation of lysine 14 on histone H3 only in the context of 
adjacently tri-methylated lysine 9 (H3.K9me3K14ac). Notably, while H3.K9me3K14ac contributes to 
only a minority of all combinations containing acetylated lysine 14 (~ 4%), the major acetylation 
isoform H3.K14ac (~ 11%) is not reduced but even increased in HBO1 depleted cells. Because, to our 
knowledge, all reports addressing HBO1 histone targets used anti-acetylation antibodies, modulation 
of complex epitopes such as the mixed acetylation-methylation motif H3.K9me3K14ac may have 
skipped previous attention. Importantly, we also observed that dHBO1 depleted cells show a reduction 
of tri-methylated K9 in the context of unmodified K14 (-17% of H3.K9me3K14). These levels are 
comparable to the reduction of H3.K9me3K14ac by 31%. These results may indicate that the observed 
reduction of acetylated K14 could be a secondary effect due to the strong global decrease of K9 tri-
methylation. This finding highlights the necessity to also examine non-target modifications at adjacent 
residues to distinguish putative primary from secondary effects.  
Our finding that dHBO1 depleted cells show reduced levels of H4.K12ac and H4.K8acK12ac are in 
agreement with previous studies which reported that HBO1 preferentially acetylates histone H4 over 
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H3. However, considering that some antibodies raised against histone H4 acetylation sites recognise 
multi-acetylated peptides more than an order of magnitude better than mono-acetylated peptides 
(Rothbart et al., 2012), our finding of reduced H4.K8acK12ac levels may indicate that the previously 
reported strong reduction of acetylated lysines 5 and 8 upon HBO1 RNAi might be interpreted with 
caution. This holds in particular true because, at least in Drosophila KC cells as well as S2 cells 
(unpublished results), dCBP is responsible for the majority of mono-acetylated K5 and K8. Finally, 
our observation that dHBO1 provokes an increase of H4.K16ac and H3.K9ac-containing motifs is in 
agreement with a previous report (Kueh et al., 2011).  
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4 GENERAL CONCLUSIONS AND OUTLOOK 
Post-translational histone modifications serve as a model to study how chemical modifications 
diversify protein functions. Because histones and their PTM-derived isoforms are abundant cellular 
biomolecules they are more easily accessible to experimentation then PTMs at most other proteins. 
Moreover, because histones are intimately engaged in organizing DNA, individual nucleosomal 
histone PTMs can be tracked spatiotemporally by determining with which region of DNA they 
associate. This often allows correlating a specific modification to a biological process. For example, 
through functional genomic approaches we know of specific individual histone modifications 
associated with DNA elements such as transcriptional enhancers and promoters.  
A further layer of complexity is introduced by the combinatorial potential of co-occurring 
modifications along the same histone molecule, the partner histones within the same nucleosomes or 
adjacent nucleosomes. There is accumulating biochemical evidence that pre-set modifications 
influence the binding and activity of chromatin-modifying activities (Fischle, 2008; Suganuma and 
Workman, 2011). In some cases, a combinatorial histone PTM motif rather than the individual marks 
may serve as the biological signal. An illustrative example is the di-acetyl motif H4.K5acK12ac, 
which is associated with nascent cytosolic histones (Sobel et al., 1995). Moreover, dedicated effector 
proteins may preferentially recognise combinatorial motifs. Examples include certain bromodomains 
that show increased affinity towards complex peptide motifs harbouring distinct acetylation patterns 
(Moriniere et al., 2009; Filippakopoulos et al., 2012) and effector proteins that contain multiple linked 
histone PTM recognizing domains (Ruthenburg et al., 2007; Patel and Wang, 2013; Rothbart et al., 
2013). However, because traditional genomic approaches depend on highly specific antibodies, which 
are, in most cases, unable to assess complex PTM motifs, new strategies are required to locate 
combinatorial motifs to functional DNA elements and biological processes. Recent advances in native 
proximity ligation assays (Koos et al., 2014), multivalent, recombinant and intracellular binder 
reagents (Haque et al., 2011; Hayashi-Takanaka et al., 2011; Hattori et al., 2013), super-resolution 
microscopy (Schermelleh et al., 2010; Sauer, 2013), and the mass spectrometry-based analysis of 
selected genomic regions (Wang et al., 2013a; Pourfarzad et al. 2013; Waldrip et al., 2014) promise 
attractive experimental strategies to fill some of the current technological gaps. Concepts and 
technologies developed to analyse combinatorial PTMs at histones are likely to also spur the progress 
towards understanding complex PTM motifs at other proteins.  
One of the next challenges is to study how different types of PTMs cross-talk on a systems level and 
under varying internal and external conditions, including perturbation scenarios. To what extent does a 
modification depend on a pre-existing mark? What are the compensatory strategies to circumvent 
compromising effects if individual PTM-modifying pathways are blocked? 
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The study presented in section 3.4 provides a first insight in the changes of histone acetylation and 
methylation patterns in response to systematically depleting every known or suspected KAT and 
KDAC. However, by analysing the changes after 5.5 days of RNAi mediated protein depletion, we 
only present a static snapshot of these events. The recent developments of specific inhibitors to KATs 
and KDACs, acute and reversible protein depletion strategies and the increasing availability of well-
characterised constitutive and conditional mutants will enable monitoring the choreography of cellular 
responses to perturbations at different time scales with potentially fascinating insights between 
different temporal stages. This will not only allow us to better discriminate primary from secondary 
effects but will also improve our understanding of how chromatin pathways are interconnected. 
Previous literature already provided a glimpse in the cross-regulation of individual chromatin-
modifying enzymes, as exemplified by their mutual protein-protein interactions (see section 2.3). 
Monitoring protein and activity levels of a panel of histone PTM modifiers when an individual 
enzyme is ablated will likely uncover more cross-regulatory potential.  
Moreover, we mainly catalogued KATs and KDACs in a single cell line, yet the substrate specificities, 
functions and cellular responses may vary across cell types, developmental stages and species and may 
dependent on induced or transient signals or specific environmental conditions. Likewise, we only 
analysed histone substrates but acetyltransferases also target non-histone proteins. Is there cross-talk 
between histone and non-histone acetylation in cells deprived of acetyltransferases? Finally, we 
restricted this study to the analysis of single gene perturbations. It will be of interest how the system of 
acetylation motifs (and other PTM systems) responds to ablating two or a set of KATs. Will we still 
detect balanced global histone acetylation levels? What will we learn about redundancy among the 
enzymes or across histone sites/motifs? Will we uncover local and global epistatic interactions?  
 
Knowledge of the abundance of histone PTMs can facilitate the design and interpretation of genomic 
and biochemical studies 
Quantitative mass spectrometry (MS) studies indicated that the default states of histones in the cell are 
highly chemically decorated rather than unmodified isoforms. Our study refines this view by using a 
panel of synthetic peptides to correct for differential MS detection bias and thereby improves the 
accurateness to quantify histone PTMs. For example, this correction procedure allowed is to describe 
that a substantial fraction of histone H3 molecules is modified by tri-methylation on lysine 9 (39% 
instead of 4% without correction), which is in line with the high occurrence of repetitive DNA 
elements within the Drosophila genome that are covered by this histone mark.  
Other marks such as the polycomb signatures (H3.K27me2/3) have traditionally been associated with 
a few developmentally regulated genes yet recent ChIP-chip/Seq studies uncovered in addition 
domains of substantial sizes (Hawkins et al., 2010). Previous mass spectrometry studies already 
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demonstrated the high abundance of this mark in mouse cells (40% and 10% of H3.K27me2/3, (Peters 
et al., 2003)), and we confirmed this finding for Drosophila cells (36% and 34% in KC cells).  
This concordance between genomic and proteomic studies is not observed for H4.K16ac in 
mammalian cells. Despite its high abundance, as judged by mass spectrometry (>30%), ChIP-chip/Seq 
studies describe very limited binding patterns for this mark, preferentially localizing to promoter and 
some putative enhancer regions (Wang et al., 2008b; Sridharan et al., 2013; Taylor et al., 2013). Thus, 
the low number of ChIP peaks may be interpreted as high local accumulation of this mark at these loci 
relative to regions in the direct vicinity. Alternatively, because histone acetylation antibodies have 
been shown to display a greatly enhanced affinity towards poly-acetylated H4 (Rothbart et al., 2012), 
the H4.K16ac-ChIP signals may preferentially report on these multi-acetylated H4 isoforms.  
In contrast to mammalian cells, H4.K16ac is of lower abundance in Drosophila male (8%) and female 
(3%) cells. Here, ChIP-chip/Seq experiments in female cells identified distinct peaks at promoters of 
active genes and at intergenic regions associated with replication regions (Kind et al., 2008; Schwaiger 
et al., 2009). Male cells showed in addition to the female H4.K16ac pattern extensive signals along 
gene bodies, which is the defining histone signature for fly dosage compensation (Gelbart et al., 2009). 
Comparing the cellular abundances of this mark between female and male cells as well as male cells 
with perturbations to the MSL-DCC allows to estimate the density of this modification along the 
dosage compensated gene bodies. Moreover, employing quantitative ChIP-MS strategies further 
refines this estimation and likely will uncover new chromatin marks associated with dosage 
compensation (unpublished results). In summary, knowing the accurate cellular abundances is helpful 
to design and interpret genomic experiments. 
Likewise, information on the cellular abundance of histone PTMs may also guide biochemical studies 
that are aimed to decipher the effect of selected modifications to the structure of chromatin. Here, 
knowing the most prevalent patterns of co-occurrence may help to select appropriate chromatin 
templates to study a selected modification in the context of its naturally co-occurring ‘partner’ 
modification(s). For example, studying the effect of H4.K16ac in the context of the highly abundant 
H4.K20me2 mark (Pesavento et al., 2008) may facilitate to resolve some of the current controversies 
on how ISWI-containing nucleosome remodelers are regulated by this acetylation mark (see 2.3.1). 
Similar, the rather moderate effects of H3.K56ac and H3.K79me on the nucleosome structure may be 
modulated in the context of the very prevalent H3.K23ac, H3.K9me3 and H3.K27me2 marks. Recent 
advances in generating nucleosomal arrays in a fast and streamlined manner, simultaneously 
characterizing many different templates in quantitative biochemical assays and monitoring the effect 
of PTM motifs on enzyme kinetics in real-time foreshadow exciting future directions to understand 
mechanistically how histone modifications modulate chromatin enzymes and structures (Dose et al., 
2011; Nguyen et al., 2014).  
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Feed-forward and feedback as compensatory responses to evolutionary-manifested and spontaneous 
perturbation 
Dosage compensation can be conceptualised as a feed-forward principle, where the system anticipates 
the genetic perturbation – that is the reduced gene dose caused by the ‘missing’ X chromosome – and 
hence had evolved a compensatory mechanism to deal with this evolutionary-manifested gene dosage 
deficiency (for a thorough discussion see section 3.2.2 and (Zhang et al., 2010)). One prediction for 
such mechanism would be to implement a single activating principle that achieves directly two-fold 
stimulation on top of the basal gene activity. Indeed, a previous study has shown that tethering MSL2 
to a reporter gene brings the expected two-fold activation characteristic for dosage compensation 
(Straub et al., 2005). In this experiment, MSL2 likely recruits the missing members of the MSL-DCC 
to reconstitute a full and functionally intact dosage compensation complex. 
In our study discussed in section 3.1 we further dissected the ‘activating principle’ by tethering MOF 
instead of MSL2. Comparing the MOF-driven reporter gene in male and female flies allowed us to 
recognise that the strong transcriptional activation potential of MOF, which is observable in female 
flies, is constrained in male flies to the two-fold range. The key experiment was depleting MSL2 in 
these cells. Under this conditions, transcription from the MOF-driven reporter gene was enhanced 
rather than reduced, arguing that MSL2 itself or an MSL2-associated factor limits the transcription 
stimulation brought by MOF. More generally, this result suggests that dosage compensation does not 
use a single principle to directly achieve ‘two-fold up’, but rather constrains a strong general activator 
(MOF/H4.K16ac) to arrive at the finely-tuned set point of two-fold activation.  
Two recent screens discovered a novel factor that may provide a candidate that constrains the activity 
of the MSL complex (Larschan et al., 2012; Lim and Kelley, 2013). Employing a genome-wide RNAi 
screen, Kuroda and colleagues identified CG3363 as the strongest repressor of the MSL-DCC activity 
on a roX2 reporter gene (Larschan et al., 2012). In a genetic screen for novel regulators of dosage 
compensation, Kelley and colleague identified the same gene, which they termed over compensating 
males (ocm), that, when mutated, caused elevated dosage compensation (Lim and Kelley, 2013). This 
feature is strikingly similar to our observation of increased transcription from the MOF-driven reporter 
gene after ablating MSL2. Not much is known about the ocm gene, which encodes a large, 250 kDa 
protein without any recognizable functional domain except for a short cysteine rich motif. Future 
studies addressing the functions of ocm are likely to also advance our understanding of balancing 
activating and repressive principles during fly dosage compensation.  
A potentially more indirect way to constrain the strong activation brought about by MOF-mediated 
hyper-acetylation of H4.K16ac is by modulating heterochromatin components. It has long been known 
that the male X chromosome is in particular sensitive to the levels of certain heterochromatin proteins. 
Reducing the dose of NURF, HP1 or the HP1-interactor Su(var)3-7 results in a strong decondensation 
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phenotype specifically at the male X chromosome (‘X bloating’) (Spierer et al., 2005; Corona et al., 
2007; Spierer et al., 2008). HP1 may directly form more repressive chromatin structures and NURF 
may promote compaction by incorporation of the linker histone H1 (Corona et al., 2007).  
The data presented in section 3.4 provides further support towards an involvement of heterochromatin 
factors for the process of dosage compensation. Comparing histone modifications between male and 
female wildtype and MOF-deprived cells allowed us to recognise that male cells contain elevated 
levels of the heterochromatin marks H3.K9me3 and H3.K27me3. Importantly, ablating MOF (and 
hence dosage compensation) in male cells re-adjusted these marks towards the levels found in female 
cells. Extending the current study from analysing bulk histones towards comparing these 
modifications in cells either containing or lacking MOF using ChIP-Seq will allow determining 
whether these heterochromatin marks are directly enriched at target genes of the MSL-DCC. In 
addition, these experiments will allow testing whether the re-distribution of heterochromatin 
components is an integral part of the feed-forward principle of dosage compensation or whether it is 
the result of a feedback mechanism.  
Many biological systems function as highly connected and responsive networks, where spontaneous 
perturbation to a single component elicits a feedback mechanism to compensate for the loss of a single 
member. The most surprising finding of the third study was the observation that depletion of almost 
every acetyltransferase resulted in a gain of acetylation at secondary sites that balanced the loss of 
acetylation at primary sites. I speculate that this phenomenon functions as a feedback mechanism to 
keep the global acetylation levels constant. Testing this hypothesis requires to identify suitable 
‘compensatory pairs’ that allow to quantify the functional consequences after depleting a single or 
both components of this pair. The system of dosage compensation may provide a suitable model to 
study this potentially ‘compensatory’ phenomenon, because of the experimental power to monitor 
quantitative changes in transcription over thousand active genes, which are all under the regime of the 
same regulatory system. We observed similar global histone acetylation levels between male and 
female cells. The strongly increased levels of H4.K16ac in male cells are ‘balanced’ by reduced levels 
of H4.K5ac, H4.K12ac and H3.K14ac, and conversely, depleting MOF restores the levels to the ones 
found in female cells. Comparative ChIP-Seq analysis for these modifications should reveal whether 
these marks are specifically depleted at dosage compensated genes. Further, manipulating the enzymes 
that modulate these modifications followed by quantifying the consequence on X-chromosomal gene 
expression should not only allow testing whether they have a role during dosage compensation but 
also provide insights into the functional significance of induced acetylation at secondary sites.  
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7 LIST OF ABBREVIATIONS 
 
ACF  ATP-utilizing chromatin assembly and remodelling factor 
ATAC  Ada Two A containing (complex) 
BPTF  bromodomain PHD finger transcription factor 
CAF-1   chromatin assembly factor 1 
CBP   CREB-binding protein 
CHD  chromodomain-helicase-DNA-binding 
ChIP  chromatin immunoprecipitation 
CHRAC chromatin accessibility complex 
DCC   dosage compensation complex 
DREF  DNA replication element factor 
ELP3  elongation protein 3 
Esa1  essential Sas2-related acetyltransferase 1 
FISH   fluorescence in situ hybridization 
FRAP  fluorescence recovery after photobleaching 
GCN5   general control non-derepressible 5 
GNAT  GCN5-related N-acetyltransferases 
HAS  high affinity site 
HAT   histone acetyltransferase 
HBO1   histone acetyltransferase binding to ORC 
HDAC  histone lysine deacetylase 
HP1   heterochromatin protein 1 
ISWI   imitation switch 
KAT  lysine acetyltransferase 
kDa   kilodalton 
KDAC  lysine deacetylase 
KDM  lysine demethylases 
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KMT  lysine methyltransferase 
LC-MS  liquid chromatography mass spectrometry 
MBD-R2  methyl-CpG-binding domain protein 2 
MCRS2  microspherule protein 2 
MLE   maleless 
MLL  mixed lineage leukemia (protein) 
MOF   males absent on the first 
MORF   MRG-related factor 
MOZ   monocytic leukemia zinc finger protein 
MSL   male-specific lethal  
MYST  MOZ, Ybf2/Sas3, Sas2, and TIP60 
NSL   non-specific lethal 
NURD   nucleosome remodelling and deacetylation 
NURF  nucleosomal remodelling factor 
OCM  over compensating males 
OGT   O-linked ß-N-acetylglucosaminetransferase 
PCAF   p300/CBP associated factor 
PHD   plant homeo domain 
PHF20   PhD finger protein 20 
PRC      polycomb repressive complex 
PRMT     protein arginine methyltransferase 
PTM  post-translational modification 
RPD3   reduced potassium dependency 3 
RNAi   RNA interference 
roX  RNA on the X 
RSC   remodels the structure of chromatin 
SAGA   Spt–Ada–Gcn5–acetyltransferase 
SAS2   something about silencing gene 2 
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SIR2   silent information regulator-2 
SUMO  small ubiquitin-related modifier 
Su(var)3-9  suppressor of variegation 3-9 
SXL  sex lethal 
TIP60   Tat-interacting protein 60 
UAS  upstream  activating sequence 
WDR5  WD40 repeat protein 5 
WDS  will die slowly 
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